07.05.2012 Views

Rexam PLC Annual Report 2011

Rexam PLC Annual Report 2011

Rexam PLC Annual Report 2011

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

annual report <strong>2011</strong>


Consumer packaging is an integral part of modern day living.<br />

It protects, preserves and enables efficient distribution.<br />

It also helps brand owners to inform end users and to<br />

promote their goods.<br />

And, it makes an essential contribution to a sustainable<br />

society as it helps reduce waste from spoilage.<br />

The lifestyle many of us take for granted is predicated, in part,<br />

on the availability of a sustainable packaging supply chain.<br />

find out more online<br />

Our website www.rexam.com contains a full<br />

interactive version of the <strong>2011</strong> annual report.<br />

It also contains annual reports from previous<br />

years (back to 1999) as well as investor<br />

presentations, publications and other material<br />

on <strong>Rexam</strong>, its markets and business.<br />

The annual report <strong>2011</strong> contains statements which are not based on current or historical fact and which are forward looking in nature. These forward looking statements<br />

reflect knowledge and information available at the date of preparation of this annual report <strong>2011</strong> and the Company undertakes no obligation to update these forward<br />

looking statements. Such forward looking statements are subject to known and unknown risks and uncertainties facing the Group including, without limitation, those risks<br />

described in this annual report <strong>2011</strong>, and other unknown future events and circumstances which can cause results and developments to differ materially from those<br />

anticipated. Nothing in this annual report <strong>2011</strong> should be construed as a profit forecast.<br />

<strong>Rexam</strong> <strong>PLC</strong> is registered and domiciled in England and Wales: company number 191285.


directors’ report<br />

overview<br />

Our chairman introduces the <strong>2011</strong> annual report and we<br />

explain who we are, what we make and where we operate.<br />

You will also find a table of the headline figures for <strong>2011</strong> that<br />

summarises our performance during the year.<br />

business review<br />

Our chief executive outlines how we performed against<br />

our strategy to deliver value. The operating and financial<br />

reviews outline our performance in <strong>2011</strong>. We also give<br />

an overview of the markets in which we operate and of<br />

the risks facing the business and what we are doing to<br />

mitigate them.<br />

sustainability<br />

This section provides a review of our sustainability performance in<br />

<strong>2011</strong>. It explains our approach to and progress in this area, and<br />

details our commitments, measures and targets going forward.<br />

governance<br />

We introduce our board and explain why a strong sense of<br />

governance and compliance is imperative in every area of our<br />

operations. We give details of the Company’s remuneration<br />

principles and policy which complement the Group’s<br />

strategic vision.<br />

financial statements<br />

4 chairman’s statement<br />

6 who we are<br />

7 what we make<br />

8 where we operate<br />

9 how we performed in <strong>2011</strong><br />

12 chief executive’s review (including KPIs)<br />

16 market review<br />

20 operating review<br />

26 financial review<br />

34 key risks<br />

44 products<br />

47 operations<br />

49 people<br />

54 directors and officers<br />

56 corporate governance<br />

69 remuneration report<br />

81 other disclosures<br />

86 <strong>Rexam</strong> <strong>PLC</strong> consolidated financial statements <strong>2011</strong><br />

134 five year financial summary<br />

136 <strong>Rexam</strong> <strong>PLC</strong> Company financial statements <strong>2011</strong><br />

144 shareholder information<br />

145 addresses<br />

1<br />

overview<br />

business review<br />

sustainability<br />

governance<br />

financial statements


2<br />

overview<br />

Beverage cans are used for a wide range of products<br />

including beer, carbonated soft drinks, sports, energy<br />

and functional drinks, as well as iced tea and wine.


Our chairman introduces the <strong>2011</strong> annual<br />

report and we explain who we are, what<br />

we make and where we operate. You will<br />

also find a table of the headline figures for<br />

<strong>2011</strong> that summarises our performance<br />

during the year.<br />

4 chairman’s statement<br />

6 who we are<br />

7 what we make<br />

8 where we operate<br />

9 how we performed in <strong>2011</strong><br />

3<br />

overview<br />

financial statements governance<br />

sustainability<br />

business review


4 <strong>Rexam</strong> annual report <strong>2011</strong> overview<br />

chairman’s statement<br />

<strong>Rexam</strong>’s record results for <strong>2011</strong> extended the strong progress we<br />

made in 2010. We continued to focus on our strategic priorities –<br />

controlling costs, optimising cash and improving our return on<br />

capital employed – to deliver another set of excellent results and<br />

further strengthen our balance sheet. The board is proposing an<br />

increased final dividend of 9.7p per share, making a total dividend<br />

of 14.4p for the year. Against a background of increasingly tough<br />

economic conditions, this performance bears witness to the<br />

underlying strength of the business.<br />

Under Graham’s leadership, the executive team and all our people<br />

have continued to manage those levers over which we have<br />

control. We are driving operational excellence, through relentless<br />

cost control and improved asset utilisation. We are strengthening<br />

our customer and supplier relationships, with our focus on quality,<br />

service, value and innovation. We are building a winning<br />

organisation, fostering a culture which enables our people to<br />

achieve great results. We are expanding in emerging markets, with<br />

disciplined investment plans announced in Brazil and India, which<br />

will develop and extend our existing geographic footprint. And we<br />

are managing our portfolio of businesses, ensuring all the<br />

constituent parts add value to the whole. As part of our focus on<br />

improving our returns across the Group, we sold our beverage and<br />

specialty Closures businesses in <strong>2011</strong> and have recently started the<br />

process to market the Personal Care business for divestment.<br />

dividend<br />

In 2009, the board agreed a policy to establish dividend cover in the<br />

2–2.5 times underlying earnings range in the medium term, and we are<br />

delivering on that policy for <strong>2011</strong>. The board recommends a <strong>2011</strong> final<br />

dividend of 9.7p per share (2010: 8p), amounting to a total dividend<br />

for the year of 14.4p per share (2010: 12p). Subject to shareholder<br />

approval at <strong>Rexam</strong>’s AGM on 3 May 2012, the final dividend will be<br />

paid on 7 June 2012 to shareholders on the register at close of business<br />

on 11 May 2012.<br />

A major challenge as we move forward is the fragile global<br />

economy in which we have to operate. That said, <strong>Rexam</strong> is well<br />

positioned to anticipate and react swiftly to changing circumstances<br />

and adverse conditions.<br />

It is important that as a board we are fully cognisant of our<br />

responsibilities to all our stakeholders: to our shareholders, who<br />

have experienced good returns in <strong>2011</strong>; to our customers and<br />

suppliers with whom we have continued to build mutually beneficial<br />

relationships; to our people, in whom we continue to invest; and to<br />

the environment, where we have again reduced our carbon<br />

footprint.<br />

The way the Group manages risk is also vital for our future<br />

prosperity. It was therefore encouraging that, in our review of board<br />

effectiveness, the management of risk was acknowledged as an<br />

area where we perform particularly effectively. Also coming out<br />

of this review were indications that even more needs to be done<br />

in the areas of strategy, people development and succession.<br />

While more time is spent on these areas than ever before, we<br />

rightly concluded that in such a turbulent and competitive world<br />

these issues will continue to be given a strong focus.<br />

We have seen a number of board changes.<br />

Leo Oosterveer joined the board as a non executive director in<br />

September. He leads the global food service division of Unilever<br />

and has a proven track record in marketing, sales and strategy<br />

development gained both in Europe and Asia. His global<br />

management experience will be a great asset to the board<br />

and to <strong>Rexam</strong>.<br />

Carl Symon retired from the board in November, having played<br />

an important part in <strong>Rexam</strong>’s success as senior independent director<br />

and chairman of the remuneration committee. I thank him for his<br />

hard work over the past eight years.<br />

4.7p + 9.7p =<br />

14.4p


During <strong>2011</strong>, I announced my retirement and so this is my last<br />

statement as chairman of <strong>Rexam</strong>. I am delighted that Stuart<br />

Chambers is taking over from me as chairman. His extensive<br />

business experience, including his senior executive business to<br />

business experience and his broad global expertise, will be of<br />

tremendous benefit to the board’s future deliberations and to the<br />

success of the Company.<br />

I am proud of what, together, we have achieved since I joined the<br />

board. <strong>Rexam</strong> is in a strong position and well prepared to tackle the<br />

challenges ahead. We have clear objectives, strong management<br />

and talented people.<br />

It just remains for me to express my appreciation to my fellow<br />

board members for their contribution and support, not just during<br />

this year but since I have been chairman, and to say how grateful<br />

I am for the confidence of our shareholders, customers and<br />

suppliers. But I should like to save my final words for our people.<br />

In the challenging global economic climate of recent years<br />

everyone within <strong>Rexam</strong> has shown resilience and dedication,<br />

and there is so much enthusiasm and commitment for what we do<br />

that it is impossible not to be inspired. I have enjoyed greatly my<br />

time at <strong>Rexam</strong>, and wish the Company and all its people every<br />

success in the future.<br />

Sir Peter Ellwood<br />

chairman<br />

22 February 2012<br />

Stuart Chambers<br />

I am really pleased to be taking over from Sir Peter.<br />

He leaves the Company in a strong position which is<br />

a testament to his significant achievements. <strong>Rexam</strong> is<br />

confident of its direction and is well placed to develop<br />

further. I look forward very much to working with<br />

Graham and his team to achieve our ambitions for<br />

the Company.<br />

Stuart Chambers<br />

chairman designate<br />

22 February 2012<br />

5<br />

overview<br />

financial statements governance<br />

sustainability<br />

business review


6 <strong>Rexam</strong> annual report <strong>2011</strong> overview<br />

who we are<br />

<strong>Rexam</strong> is a leading global consumer packaging company<br />

We make the packaging for many of the world’s favourite brands. We help to shape the experience<br />

for all kinds of products that consumers choose, use and depend on every day. We make drinks cans<br />

for some of the most famous names in the world. We also manufacture precision medical devices,<br />

from bronchial inhalers to transdermal drug delivery systems, as well as products for personal<br />

care applications.<br />

Our job is to make high quality packaging as efficiently, profitably and sustainably as possible. This is<br />

why, wherever you go in <strong>Rexam</strong>, you will see a common focus on operational excellence through lean<br />

enterprise, innovation and safety to meet our customers’ expectations.<br />

our vision<br />

Our vision is to be the best global consumer packaging<br />

company. This means balancing profitable revenue<br />

growth, cash generation and the appropriate risk<br />

profile for the Group to deliver a strong return on<br />

capital employed and a steady increase in profits year<br />

on year.<br />

We use the framework below to focus on what is<br />

important to drive our strategy, to align and mobilise<br />

our organisation and to accelerate time to execution.<br />

With a winning organisation, we will generate the<br />

operational excellence in all our processes to deliver<br />

on customer expectations which is vital to achieving<br />

best performance.<br />

Invest for value<br />

Best performance<br />

Customer expectations<br />

Drive operational<br />

excellence<br />

Build a winning organisation<br />

case studies: icons aligned to vision<br />

Ensure our future<br />

our values<br />

Our values underpin everything we do. They reflect<br />

who we are and how we want to act and interact with<br />

each other and everyone we deal with.<br />

continuous improvement<br />

recognition<br />

teamwork<br />

trust<br />

blue chip<br />

In <strong>2011</strong>, we launched a Group<br />

wide recognition scheme known<br />

as the ‘Blue Chip’.<br />

This on the spot scheme, which has<br />

a cash value equivalent to 50 <strong>Rexam</strong><br />

ordinary shares, recognises individuals<br />

who visibly demonstrate our values<br />

and/or leadership practices.<br />

To date we have awarded Blue Chips<br />

to more than 220 employees.


what we make<br />

beverage cans<br />

<strong>Rexam</strong> Beverage Cans is a leading global beverage can<br />

maker comprising three regional businesses. We make around<br />

57bn beverage cans each year mainly in aluminium, but also<br />

in steel, in more than 20 countries around the world. Can size<br />

is an important element of customer marketing efforts and we<br />

offer the broadest range and a wide choice of innovative inks<br />

and coatings to add further value. We also make the ends to<br />

seal the cans and have a range of printed and coloured ends<br />

as well as distinctive features such as cut out or laser coded tabs.<br />

plastic packaging<br />

<strong>Rexam</strong> Plastic Packaging is a major global player in rigid plastic<br />

packaging. It has two divisions, Healthcare and Personal Care, that<br />

make a wide range of products. These include dry powder inhalers,<br />

pharmaceutical pumps and valves, eye droppers, nasal sprays,<br />

medical devices, pill jars and closures for healthcare customers,<br />

as well as a range of products for the toiletries, cosmetics, personal<br />

care and food markets. We have recently started the process to<br />

market Personal Care for sale.<br />

customers<br />

We make products for a wide selection of customers<br />

across the globe, but our top 10 account for 60%<br />

of sales.<br />

AB InBev Carlsberg<br />

Coca-Cola Hansen Beverages<br />

Heineken Hornell<br />

L’Oréal PepsiCo<br />

Red Bull Schincariol<br />

60%<br />

Europe & Asia<br />

We are the largest beverage can and can end maker in Europe.<br />

We also have beverage can plants in Egypt, China and India,<br />

as well as an associate in South Korea.<br />

North America<br />

We are the second largest beverage can and can end maker<br />

in the US. We also have a plant in Mexico and a joint venture<br />

in Guatemala.<br />

South America<br />

We are the largest beverage can and can end maker in<br />

South America with operations in Argentina, Brazil and Chile.<br />

more information in the operating review<br />

healthcare<br />

We produce standard and custom packaging solutions for<br />

pharmaceutical customers worldwide, as well as complete custom<br />

packaging systems for healthcare and prescription packaging.<br />

personal care<br />

We are a leading supplier of advanced packaging solutions<br />

for beauty, personal care and home product customers.<br />

We also make high barrier containers for food.<br />

more information in the operating review<br />

carbon intensity<br />

We are well on our way to achieving our target<br />

of reducing our carbon intensity by 10% in 2013<br />

vs 2010.<br />

In <strong>2011</strong>, we reduced our carbon intensity by<br />

3.5% to 0.83kg carbon/kg of raw material<br />

converted (2010: 0.86kg).<br />

3.5%<br />

more information in the sustainability section<br />

7<br />

financial statements governance<br />

sustainability<br />

business review<br />

overview


8 <strong>Rexam</strong> annual report <strong>2011</strong> overview<br />

where we operate<br />

we have 83 manufacturing sites in 25 countries across the globe<br />

<strong>Rexam</strong>’s operations are located in Europe, North, South and Central America,<br />

North Africa and Asia.<br />

In <strong>2011</strong>, we employed on average 19,000 people in our continuing operations.<br />

further details of our employees can be found in the sustainability section as well as note 4 to the consolidated financial statements<br />

our locations<br />

US<br />

The US is our largest<br />

market in terms of sales.<br />

We have 14 beverage<br />

can and end making<br />

plants and 15 plastic<br />

packaging operations.<br />

The can plants are located<br />

close to major customers<br />

and large metropolitan<br />

centres which positions<br />

us well in terms of logistics<br />

and freight.<br />

South America<br />

We are the number one<br />

beverage can maker<br />

in South America and<br />

specifically Brazil, the<br />

largest market in the region.<br />

Our plants are strategically<br />

located to capture growth<br />

and optimise asset<br />

utilisation.<br />

1 Continuing operations.<br />

Beverage Cans<br />

Plastic Packaging<br />

head office<br />

regional offices<br />

sales1 by customer location (£m)<br />

<strong>2011</strong> 2010 <strong>2011</strong> 2010<br />

● US 1,576 1,586 ● UK 203 200<br />

● Brazil 747 700 ● France 188 178<br />

● Austria 327 288 ● Germany 136 131<br />

● Russia 281 267 ● Other countries 1,050 1,051<br />

● Spain 226 218<br />

83<br />

Europe<br />

Europe is our second<br />

largest market in terms<br />

of sales. Our corporate<br />

head office is in London<br />

while the headquarters<br />

for our European<br />

Beverage Can and<br />

Healthcare and Personal<br />

Care businesses are in<br />

Luton, UK, and Paris,<br />

France, respectively.<br />

China<br />

We have had<br />

operations in China<br />

since 1998 where our<br />

focus is on plastic<br />

packaging. The business<br />

was originally set up for<br />

export, but is now<br />

mainly focused on<br />

local markets.<br />

+8%<br />

In <strong>2011</strong>, <strong>Rexam</strong>’s emerging markets<br />

sales grew by 8%. Over 30% of<br />

<strong>Rexam</strong>’s sales come from these fast<br />

growing markets, driven largely by<br />

our Beverage Cans businesses in<br />

Brazil and Russia.


how we performed in <strong>2011</strong><br />

<strong>2011</strong> results summary<br />

1 Underlying business performance from continuing operations before exceptional items, the amortisation of certain acquired intangible assets and fair value changes on<br />

financing derivatives.<br />

2 Continuing operations.<br />

3 Includes exceptional items, the amortisation of certain acquired intangible assets and fair value changes on financing derivatives.<br />

4 Includes discontinued operations.<br />

more information in the operating and financial reviews<br />

<strong>2011</strong> 2010 change<br />

Underlying business performance 1<br />

Sales £m 4,734 4,619 2%<br />

Underlying operating profit £m 549 513 7%<br />

Underlying profit before tax £m 450 390 15%<br />

Underlying earnings per share p 36.1 31.4 15%<br />

Total dividend per share p 14.4 12.0 20%<br />

Statutory results<br />

Sales2 £m 4,734 4,619<br />

Operating profit2,3 £m 507 473<br />

Profit before tax3 £m 431 338<br />

Total profit for the financial year3,4 £m 376 124<br />

Total basic earnings per share3,4 p 43.1 14.2<br />

sales (£m) <strong>2011</strong> 2010<br />

● Beverage Cans 3,786 3,677<br />

● Plastic Packaging 948 942<br />

Continuing operations 4,734 4,619<br />

underlying operating prot 1 (£m) <strong>2011</strong> 2010<br />

● Beverage Cans 447 394<br />

● Plastic Packaging 102 119<br />

Continuing operations 549 513<br />

sales2 (£m)<br />

<strong>2011</strong> 4,734<br />

2010 4,619<br />

2009 4,533<br />

2008 4,254<br />

2007 3,423<br />

underlying operating prot1 (£m)<br />

<strong>2011</strong> 549<br />

2010 513<br />

2009 418<br />

2008 423<br />

2007 326<br />

9<br />

financial statements governance<br />

sustainability<br />

business review<br />

overview


10<br />

directors’ report<br />

business review<br />

Can making is a high speed, high precision manufacturing<br />

process with line speeds of up to 2,200 cans per minute.


Our chief executive outlines how we<br />

performed against our strategy to deliver<br />

value. The operating and financial reviews<br />

outline our performance in <strong>2011</strong>. We also<br />

give an overview of the markets in which we<br />

operate and of the risks facing the business<br />

and what we are doing to mitigate them.<br />

12 chief executive’s review (including KPIs)<br />

16 market review<br />

20 operating review<br />

26 financial review<br />

34 key risks<br />

11<br />

overview<br />

financial statements governance<br />

sustainability<br />

business review


12 <strong>Rexam</strong> annual report <strong>2011</strong> directors’ report<br />

chief executive’s review<br />

progress on all fronts<br />

In 2010, we set out our plans for creating<br />

value and improving returns going forward.<br />

At the same time, we established the metrics<br />

we would use to measure our progress.<br />

In short, we said that while laying the<br />

foundations for the future, we would<br />

continue to focus on the management of<br />

three main areas of our business – cash, cost<br />

and return on capital. We also said that we<br />

would continue to focus on reducing debt.<br />

During <strong>2011</strong>, we made considerable<br />

progress on all of these fronts.<br />

Graham Chipchase<br />

chief executive<br />

In <strong>2011</strong>, against a tough economic backdrop, I am proud to report<br />

that we have delivered on our commitments for the year. As you will<br />

see from the detail in the operating and financial results on pages<br />

20 to 33, we delivered strong profit growth. It was particularly<br />

pleasing to see that, despite a deteriorating economic climate and<br />

a disappointing performance from a number of businesses within<br />

Plastic Packaging, the Group managed to maintain its momentum<br />

throughout the year.<br />

In terms of cash, we continued to focus on tight management of<br />

working capital and a disciplined approach to investing capital.<br />

We increased capital expenditure in continuing operations to<br />

£227m (2010: £189m), 1.2 times depreciation. Projects included<br />

the reopening of the plant in Pouso Alegre, Brazil, a new specialty<br />

can line in Mexico, the investment to lightweight can ends in North<br />

America and the conversion from steel to aluminium of can making<br />

lines in Egypt and Spain. While we have seen no signs of weakness<br />

in can volumes, we are monitoring the situation closely to allow<br />

us to defer spend should market conditions deteriorate. Free cash<br />

flow from continuing operations was £277m before dividends<br />

(2010: £298m).<br />

Our relentless focus on operational excellence helped to achieve<br />

good cost savings, improve returns and offset input cost inflation.<br />

Three main areas have generated the £35m of savings and<br />

efficiencies delivered this year: reduction in material usage,<br />

especially downgauging and lightweighting of our aluminium cans<br />

and can ends; lean manufacturing, which includes investing in new<br />

equipment and optimising processes to improve productivity and<br />

reduce scrap; and strengthening the organisation and practices of<br />

our Group supply chain which has enabled us to capitalise better<br />

on our global footprint and manage our metal, resin and other<br />

direct material costs more efficiently. Early in 2012, we were<br />

delighted when our Águas Claras beverage can plant in Brazil was<br />

awarded The Shingo Prize, generally considered the pinnacle of<br />

achievement in operational excellence (see case study on page 23).<br />

Return on capital employed (ROCE) improved to 13.7%<br />

(2010: 12.3%) thanks to good profit growth and disciplined<br />

capital management. We are on track to reach the top end of the<br />

12% to 15% ROCE target range by the end of 2013. We expect<br />

the most significant uplift towards that target to occur in 2013 as<br />

the contracts signed in North America to recover the beverage<br />

can volume lost in <strong>2011</strong> come into force. In addition, we continue<br />

to manage actively the portfolio to improve returns.<br />

Our net debt reduced to £1.3bn and our balance sheet is stronger.<br />

<strong>Report</strong>ed net debt/EBITDA was 1.8 times compared with 2.4 times<br />

at the end of 2010. Our credit rating is investment grade with<br />

stable outlook with both Moody’s and Standard & Poor’s.<br />

We have no significant debt maturities until 2013.<br />

In the annual report 2010 we highlighted a number of priorities,<br />

in addition to efficiencies, to improve our returns going forward.<br />

These were maximising asset utilisation, focusing on product<br />

innovation, managing our business portfolio and capitalising on<br />

organic growth opportunities in emerging markets, all the while<br />

maintaining strict capital discipline.


good progress on asset utilisation<br />

For the year, the Group’s overall growth was in line with<br />

our expectations, and asset utilisation plans remain on track.<br />

In Beverage Cans in Europe, capacity utilisation was good as<br />

a result of strong market growth. In Western Europe, capacity<br />

utilisation was around 95%.<br />

In North America, the wider market slowdown meant that demand<br />

for standard can volumes was lower than expected but we saw<br />

stronger growth in specialty cans. Capacity utilisation was around<br />

80% but we expect to see an improvement going forward as most<br />

of the volume loss in <strong>2011</strong> will have been recovered by 2013<br />

through signed contracts.<br />

In South America, our specialty can capacity was fully utilised<br />

as volumes continued to grow. The newly installed lines in South<br />

America have come on stream and are making cans that last year<br />

were imported. Our overall capacity utilisation rate in the region<br />

was about 90%.<br />

innovation strengthens customer ties<br />

Innovation helps to strengthen ties with our customers and stimulate<br />

demand. During the year we saw the successful launch of a<br />

number of new products in both Beverage Cans and Plastic<br />

Packaging. Our award winning Fusion™ bottle is starting to gain<br />

commercial traction and in Russia we introduced Europe’s first<br />

75cl beverage can to fill a gap in that market. In Brazil, our use of<br />

innovative technologies such as high definition printing, UV and<br />

fluorescent inks has helped customers strengthen their brands,<br />

increase their sales and win awards.<br />

In Beverage Cans, we established a Global Innovation Council<br />

during the year to support further our customers’ brand objectives<br />

as well as to help us align and refine cross regional opportunities,<br />

processes and product development.<br />

In Plastic Packaging, we launched new pumps and airless<br />

dispensing tubes to protect fragile formulations as well as a new<br />

spray technology, Panache™, designed to deliver an improved<br />

consumer experience through the improved spray pattern and thus<br />

help our customers build their business. In Healthcare,<br />

Advancia™, a new generation of nasal spray pumps specially<br />

designed to enhance protection of preservative free drugs, is<br />

expected to help consolidate our position as a leader in this field.<br />

In <strong>2011</strong>, we piloted in our European beverage can operations<br />

a new process for measuring customer satisfaction with scores<br />

encompassing all areas of interaction from key account<br />

management through to fulfilment and including our performance<br />

on innovation and, where applicable, sustainability. This process<br />

will be rolled out across the Group in 2012.<br />

‘In <strong>2011</strong>, against a tough economic backdrop, I am proud<br />

to report that we have delivered strong profit growth<br />

...improved our return on capital employed ...reduced<br />

net debt ...and strengthened our balance sheet.’<br />

Graham Chipchase chief executive<br />

total efciency gains 2007–<strong>2011</strong><br />

<strong>2011</strong><br />

2010<br />

2009<br />

2008<br />

2007<br />

£35m<br />

£39m<br />

£42m<br />

£35m<br />

£32m<br />

Beverage Cans<br />

Plastic Packaging<br />

£22m<br />

£20m<br />

£19m<br />

£14m<br />

£17m<br />

£13m<br />

£19m<br />

£23m<br />

£21m<br />

£15m<br />

balancing the portfolio for growth and returns<br />

On 1 September, we completed successfully the sale of the<br />

beverage and specialty Closures businesses to Berry Inc.<br />

The underlying fundamentals of the business had changed<br />

and it was clear that the return profile going forward was not<br />

adequate for the goals we have set ourselves. The sale helped<br />

focus our operations and was fully in line with our strategy to<br />

deliver profitable growth and to improve returns.<br />

Following a strategic review of our Personal Care business, which<br />

includes the High Barrier food container operation, the board<br />

recently decided that, given our focus on returns, it should be<br />

marketed actively for divestment in its entirety. We also believe<br />

that this will improve the range of projects in which we can invest<br />

in both Beverage Cans and Healthcare. So, while Personal Care<br />

is an attractive, well run business and given that we can generate<br />

better returns elsewhere in the Group, it is likely to be of greater<br />

value to another owner.<br />

Healthcare will remain a key component of the Group. It is a<br />

business with good growth prospects, well established customer<br />

relationships and long term contracts, as well as high barriers to<br />

entry and a strong return profile.<br />

13<br />

overview<br />

financial statements governance<br />

sustainability<br />

business review


14 <strong>Rexam</strong> annual report <strong>2011</strong> directors’ report<br />

chief executive’s review<br />

growth in emerging markets<br />

In <strong>2011</strong>, our sales in emerging markets grew 8% as we continued<br />

to support our customers, and we see further potential for both our<br />

Beverage Cans and Healthcare businesses.<br />

In Beverage Cans, we are seeking further opportunities for<br />

investment as well as bolt on acquisitions or joint venture<br />

partnerships. We announced in August that we were expanding<br />

our existing plant outside Mumbai to increase our manufacturing<br />

capacity in India. We were the first to manufacture two piece<br />

beverage cans in India and this latest investment will help secure<br />

our foothold and develop the market further. India offers significant<br />

growth potential as a result of increasing GDP per capita as well<br />

as the presence of major global and regional customers, especially<br />

from the brewing industry.<br />

There are a number of regions where we see good opportunities<br />

to develop new positions or expand the operations that<br />

we currently have. In the Middle East and Africa, for example,<br />

strong GDP growth and the relatively low penetration of beverage<br />

cans make these attractive growth markets. There is also a<br />

favourable movement in the pack mix towards cans supported by<br />

a youthful population more disposed towards this type of beverage<br />

container. In addition, the resilience of the can is well suited to the<br />

often tough conditions that exist in the supply chain. The Middle<br />

East market is fragmented with a high degree of vertical integration<br />

and we are confident that opportunities for consolidation will<br />

emerge as markets mature and customers seek credible<br />

independent supply sources.<br />

Asia also has attractive beverage can growth rates. Beverage<br />

can suppliers are already investing to meet that increased demand.<br />

We do not directly own any can making facilities in South East Asia<br />

but we are exploring opportunities in the region continually. The<br />

increased internationalisation of our global customers is an<br />

advantage and we are pursuing opportunities arising from existing<br />

relationships and are in regular talks about their expansion plans<br />

into these regions. We have decided that China, which is currently<br />

a highly fragmented market, is not a priority at this time. Having<br />

said that, we shall monitor the market to ensure that we are in a<br />

position to act on any favourable opportunities should they arise.<br />

We continue to invest in South and Central American markets<br />

but, as demonstrated by the deferral of the opening of our Belém<br />

beverage can plant in Brazil until the second half of 2012, we will<br />

ensure we match capacity with market demand. We have one<br />

plant in Mexico where we make both standard and specialty cans<br />

and where the demand for specialty cans is growing strongly.<br />

Mexico has a high per capita consumption of drinks sold in cans.<br />

Around half of the can making market is vertically integrated with<br />

the beverage producers and we believe that there is potential for<br />

consolidation over time. In Guatemala we have a successful 50/50<br />

joint venture with a well established and respected regional<br />

packaging company in this high growth region. We have<br />

increased production in recent years and we see further potential<br />

for consolidation in the market and for bolt on acquisitions.<br />

In Healthcare, we are in the process of doubling the capacity of our<br />

plant in Bangalore to meet continued growth in the region. At the<br />

same time we are finalising a contract to manufacture generic drug<br />

delivery devices for a customer in India which will, in time, require<br />

us to build a plant in Western India.<br />

sustainable thinking<br />

Last year we highlighted the importance of securing <strong>Rexam</strong>’s long<br />

term future around a sustainability framework based on the three<br />

main areas of products, operations and people. We have made<br />

good progress in developing this model during the year, further<br />

refining and adding specific measures and targets to the<br />

commitments we set out last year. You can read more about<br />

this on pages 44 to 51.<br />

Building a winning organisation is critical to our success.<br />

Making sure that our people work in a safe, fair and enjoyable<br />

environment is core to our values. Our safety statistics remain<br />

strong, as you will see below, but, although there were a number<br />

of outstanding performances by some of our businesses and<br />

individual plants, I am concerned that, as a Group, we did not hit<br />

our 10% year on year improvement goal. We are determined to<br />

deliver a better performance. We will be learning from the<br />

experiences of our best performing plants and redoubling our<br />

efforts to ensure that in 2012 we make further progress towards<br />

our ‘zero accidents’ target.<br />

During the year, we also implemented a number of action plans<br />

to address the feedback of our 2010 employee survey. Areas<br />

such as training and development, as well as communication and<br />

recognition, were recurrent themes across the Group in the focus<br />

groups that we held and many of the plans have been targeted<br />

at these areas. In response, we have made a concerted and<br />

successful effort to prioritise the visibility of our leadership teams.<br />

On training and development, one of our objectives is to enable<br />

performance that will differentiate our business. We saw the<br />

successful deployment of the <strong>Rexam</strong> Business School and a good<br />

uptake of the courses and training on offer, which range from half<br />

hour online courses delivered via the company intranet in a range<br />

of languages, to comprehensive, residential courses focusing on<br />

specific skills and areas of leadership. On recognition, we<br />

introduced the ‘Blue Chip’ programme, a cash award equivalent<br />

to the value of 50 <strong>Rexam</strong> ordinary shares, which helps deliver<br />

immediate recognition and reward to people who show<br />

outstanding performance and excellence. To date, more than<br />

220 Blue Chips have been awarded and the programme has<br />

proved to be a great success.


key performance indicators<br />

These key performance indicators (KPIs) are used by management to measure and track performance. Each KPI relates directly to our long<br />

term strategy and additional information on each of them is contained in the various sections of this annual report.<br />

As discussed last year, <strong>2011</strong> was a year for collecting base data for a number of the KPIs. There are therefore some KPIs where there is no<br />

comparable data.<br />

targets <strong>2011</strong> 2010 2009 2008 2007<br />

best performance<br />

Organic sales growth1 % GDP+ 4 3 (7) 7 11<br />

Underlying operating profit growth1 % GDP++ 8 22 (17) 3 (7)<br />

Free cash flow £m Note 2 245 316 290 (128) 24<br />

Return on capital employed 3 % 15% by 2013 13.7 12.3 9.5 11.0 11.9<br />

customer expectations<br />

Customer satisfaction score 4 1–10 To be set 7.8 n/a n/a n/a n/a<br />

Emerging market sales as percentage of sales % Continuous improvement 32 31 27 27 23<br />

Research and new product development 5 £m Note 2 17 19 20 19 14<br />

operational excellence<br />

<strong>Annual</strong> cost savings and efficiencies 6 £m c £30m 35 34 42 35 32<br />

Lost time accident rate 7 LTAR Zero accidents pa 0.28 0.30 0.63 0.76 1.13<br />

Carbon intensity 8 ratio –10% by 2013 vs 2010 0.83 0.86 0.91 n/a n/a<br />

winning organisation<br />

Employee engagement index favourable score 9 % Continuous improvement n/a 62 n/a n/a n/a<br />

Values and leadership practices favourable score 9 % Continuous improvement n/a 53 n/a n/a n/a<br />

1 Underlying business performance is continuing and discontinued operations (excluding Glass which was sold in 2007 and Closures in 2010 and <strong>2011</strong>) before exceptional items,<br />

the amortisation of certain acquired intangibles and fair value changes in financing derivations. Organic sales growth and underlying operating profit growth are as reported in<br />

the financial review for the relevant years and represent the organic change after adjusting for acquisitions, disposals and currency fluctuations.<br />

2 Will depend on investment plans (including capital) going forward.<br />

3 Underlying operating profit plus share of associates profit after tax from total operations divided by the average of opening and closing shareholders’ equity after adding back<br />

retirement benefit obligations (net of tax) and net borrowings.<br />

4 Customer referral score out of 10 from externally conducted survey. This survey was piloted in Europe in <strong>2011</strong> and, from 2012, will be rolled out across the Group’s operations.<br />

The Group target will be set once we have the Group wide data.<br />

5 R&D spend on a statutory accounting basis, which includes design, construction and testing of preproduction prototypes, models and processes. Our operations also invest in new<br />

product and process initiatives which are not captured in the statutory figure. Includes spend by discontinued operations prior to <strong>2011</strong>.<br />

6 Assuming current Group structure.<br />

7 LTAR is the number of lost time accidents times 200,000/total hours worked. Our long term target is zero accidents pa with a near term target of 10% reduction pa.<br />

8 Kilogram of carbon per kilogram of raw materials converted (continuing operations).<br />

9 Scores from the Group global employee engagement survey conducted around every 18 months (first one conducted in 2010). The next survey is scheduled for the first quarter of 2012.<br />

15<br />

overview<br />

financial statements governance<br />

sustainability<br />

business review


16<br />

<strong>Rexam</strong> annual report <strong>2011</strong> directors’ report<br />

market review<br />

This summary review is based on a number<br />

of external packaging industry sources<br />

such as PIRA International, Canadean<br />

and The Freedonia Group, as well as our<br />

own in-house market intelligence team.<br />

It highlights the state of the global consumer<br />

packaging market with a brief summary<br />

of trends for the two packaging types that<br />

<strong>Rexam</strong> manufactures, beverage cans and<br />

rigid plastic packaging. For the first time,<br />

we also include a summary of statistics for<br />

some of our key markets which provides<br />

a comprehensive overview of their main<br />

characteristics and drivers.<br />

consumer packaging market value<br />

by pack material <strong>2011</strong> 1<br />

● Paper and board 35%<br />

● Rigid plastics 27%<br />

● Glass 12%<br />

● Flexible plastics 10%<br />

● Other metal 9%<br />

● Beverage cans 5%<br />

● Others 2%<br />

1 Excludes secondary/bulk and industrial packaging.<br />

source: PIRA International <strong>2011</strong><br />

<strong>2011</strong><br />

In <strong>2011</strong> the packaging industry faced rising input costs, inflation and<br />

softer trading conditions in many of the larger developed markets.<br />

According to the latest economic data, the global economy grew by<br />

3.8% in <strong>2011</strong> (2010: 5.2%). The global consumer packaging industry<br />

grew 4.2% and was valued at US$409bn. This compares with a 9%<br />

increase in 2009/10, when the market played catch up following the<br />

global economic downturn.<br />

The outlook for 2012 is cautious and there is still uncertainty as to how<br />

markets will evolve over the next few years. Emerging economies are<br />

expected to represent the driving force of global growth with strong<br />

domestic demand (see table on pages 18 and 19 for individual<br />

country real GDP growth). In <strong>2011</strong>, for example, the Asia and Rest of<br />

World (ROW) region increased its value share of the total packaging<br />

market to 35%, overtaking Europe. PIRA forecasts that the value of<br />

consumer packaging industry global sales will continue to grow in the<br />

next five years at an average annual rate of 3.1% to reach US$477bn<br />

by 2016.<br />

Packaging for food was the largest end use market in <strong>2011</strong> accounting<br />

for just over half the market. Packaging for beverages accounted for<br />

18% and packaging for healthcare and personal care for 11% of<br />

sales. The industry saw increased demand for packaging in all end<br />

use markets, led by healthcare.<br />

Over the period <strong>2011</strong> to 2016, healthcare packaging is forecast<br />

to register the highest value growth (4.5% pa). Food and beverage<br />

packaging is expected to grow by around 3% pa to 2016 in line<br />

with overall packaging.<br />

materials<br />

beverage cans<br />

On a global basis, beverage cans accounted for 5% of the<br />

consumer packaging market value in <strong>2011</strong> with North America<br />

being the largest regional market. Overall, the value of global<br />

beverage can packaging sales showed positive growth of just<br />

over 2% driven largely by emerging markets.<br />

Beverage can consumption remained healthy in Europe in <strong>2011</strong><br />

growing 3% while fillings grew 5%. Consumption of carbonated soft<br />

drinks (CSDs) and energy drinks in cans in Europe increased by 3%.<br />

The table on pages 18 and 19 shows the beverage can share for beer<br />

and soft drinks and where there are opportunities for beverage cans<br />

to grow share.<br />

In the US, beer and energy drinks performed better than CSDs in cans.<br />

Beer in cans was helped by some brewers of craft beers switching to<br />

cans from the traditional glass bottle.<br />

The emerging economies offer the greatest potential for beverage<br />

can growth. The strongest growth in value terms is expected in<br />

South America at 3.5%, followed closely by Asia and ROW at 3.1%.<br />

Overall global beverage can sales are expected to grow by around<br />

3% pa until 2016 driven by general GDP growth, gains in market<br />

share over other container types (mainly refillable glass) and, in<br />

the more mature markets, the increase in innovative applications.


Cans are expanding into new segments like wine, creating new<br />

occasions for drinking from cans. The environmental credentials of<br />

the can are now better understood (see pages 44 and 45) and the<br />

fact that cans are infinitely recyclable should support an increase<br />

in demand.<br />

plastic packaging<br />

Plastic accounted for 37% of all global packaging sales on<br />

a material basis in <strong>2011</strong>. Within this category, rigid plastic<br />

packaging accounted for 27% of the consumer packaging market<br />

value and dominated healthcare and cosmetics packaging.<br />

The total healthcare packaging market grew 6.6% in value in <strong>2011</strong><br />

(2010: 10.6%). Rigid plastics accounted for 52% of the total value<br />

and is expected to grow annually by 4.4%. The healthcare industry<br />

has been impacted by a combination of external factors such as<br />

products coming off patent and tighter healthcare cost control.<br />

Although drug consumption is increasing globally due to greater<br />

prevalence of chronic diseases, an ageing population and higher<br />

incomes in emerging countries, there is pricing pressure on the<br />

industry, and regulatory standards are also becoming stricter.<br />

A new era is opening up for the pharmaceutical industry, however,<br />

with a new mix of growth drivers, such as the rise of generics and<br />

biotech medicines, the over the counter (OTC) segment and growth<br />

in emerging markets. Expenditure per capita on OTC medicine<br />

varies widely with Ireland topping the list in Europe at US$116 per<br />

capita vs US$21 in Brazil and US$8 in China.<br />

Growth in the healthcare packaging market will be supported<br />

by continued improvements in packaging materials leading<br />

to pharmaceutical containers with better aesthetics, barrier<br />

protection, security, ease of use and compliance features. Trends<br />

in the level and mix of worldwide drug consumption will also<br />

create favourable growth opportunities. The introduction of new,<br />

advanced biotechnology and nanotechnology based medicines<br />

will boost demand for high value added packaging systems.<br />

High value added healthcare packaging will also be employed<br />

increasingly to differentiate brand products from generic drugs.<br />

The cosmetics packaging market grew by 4.5% in value in <strong>2011</strong><br />

compared with 11% in 2010. Difficult trading conditions continue in<br />

many of the more developed markets. Growth is being driven by<br />

emerging markets and the need for basic/medium range products,<br />

particularly in skin and hair care. The overall cosmetics packaging<br />

market is forecast to grow in value by 4.2% a year.<br />

Given global recessionary pressures, mass and so called<br />

‘masstige’ cosmetics are growing faster than premium cosmetics.<br />

Premium make up brands are now competing in an ‘era of<br />

consequences,’ characterised by more careful consideration<br />

of the risks associated with consumption. However, it seems<br />

that consumers are still willing to pay a premium for cosmetic<br />

packaging that provides practical and functional benefits. In the<br />

developing markets, where the premium share for personal care<br />

and cosmetics products is very low, creating packaging that can<br />

give mass/masstige a more premium look and feel can be used<br />

to differentiate a product and create growth opportunities.<br />

consumer packaging market value<br />

by geographical region <strong>2011</strong> 1<br />

● Asia and Rest of World 35%<br />

● Europe 33%<br />

● North America 28%<br />

● South America 4%<br />

1 Excludes secondary/bulk and industrial packaging.<br />

source: PIRA International <strong>2011</strong> <strong>2011</strong><br />

consumer packaging market value<br />

by end use <strong>2011</strong> 1<br />

● Food 51%<br />

● Beverages 18%<br />

● Healthcare 6%<br />

● Cosmetics 5%<br />

● Other 20%<br />

1 Excludes secondary/bulk and industrial packaging.<br />

source:<br />

source:<br />

PIRA<br />

PIRA<br />

International<br />

International<br />

<strong>2011</strong><br />

<strong>2011</strong><br />

beverage cans only market value<br />

by geographic region <strong>2011</strong><br />

● North America 43%<br />

● Europe 26%<br />

● Asia and Rest of World 25%<br />

● South America 6%<br />

source: PIRA International <strong>2011</strong><br />

17<br />

overview<br />

financial statements governance<br />

sustainability<br />

business review


18 <strong>Rexam</strong> annual report <strong>2011</strong> directors’ report<br />

market review<br />

market characteristics by numbers<br />

This section looks at some of the important market characteristics<br />

and factors that are acknowledged growth drivers for the<br />

consumer packaging market across a number of our end markets.<br />

These drivers include GDP per capita and age demographics,<br />

as well as specific ones such as off trade or at home consumption,<br />

which is pertinent to our beverage cans business, and average<br />

life expectancy which has an impact on the healthcare product<br />

market. A fuller description of global market trends and influences<br />

can be found in ‘packaging unwrapped’, a detailed report<br />

on global trends in consumer packaging which we published<br />

in mid <strong>2011</strong>.<br />

Europe<br />

<strong>Rexam</strong> on the map Austria Czech R Denmark France Germany Ireland Italy Netherlands Poland Russia<br />

Our plants – beverage cans 2 1 1 1 3 1 2 – – 3<br />

Our plants – plastic packaging – – – 6 1 – – 1 1 –<br />

macro facts in our markets<br />

Population (millions) 8.4 10.5 5.5 63.2 81.4 4.6 60.6 16.7 38.1 142.4<br />

Population over the age of 65 (%) 18 16 17 17 21 12 20 16 14 13<br />

GDP per capita (US$’000) 41.8 25.9 37.7 35.0 37.9 39.5 30.2 42.3 20.1 16.7<br />

Real GDP growth <strong>2011</strong>/12E (%) 0.9 0.7 1.4 0.2 0.3 1.1 -2.2 0.5 2.5 3.3<br />

beverages<br />

Can consumption per capita (cans) 97 19 221** 62 13 91 39 104 102 32<br />

Can share (unit volume) – soft drinks (%) 16 4 25 18 2 19 9 22 8 6<br />

Can share (unit volume) – beer (%) 26 7 61 22 2 49 22 25 48 25<br />

Off trade beer consumption 2010 (%) 63 52 78 78 78 34 61 71 72 91<br />

Beverage can recycling share 2009 (%) 50 47 87 40 91 50 53 85 67 75<br />

healthcare<br />

Average life expectancy (years) 80 77 79 81 80 80 82 81 76 66<br />

Total exp. on health per capita 2008/9 (US$’000) 4.3 2.1 4.3 4.0 4.2 3.8 3.1 4.9 1.4 1.0<br />

OTC medicine expenditure per capita (US$) 106 98 63 81 110 116 71 67 80 n/a<br />

personal care and household care<br />

Total exp. on colour cosmetics per capita (US$) 36.9 17.7 34.1 30.1 23.7 28.2 24.2 28.0 10.6 11.3<br />

Beauty and personal care – premium share (%) 14 6 35 41 22 25 33 29 10 14<br />

Rigid plastic share – PC/HC packaging (%) 63 52 63 63 63 64 72 66 59 50<br />

All figures based on <strong>2011</strong>, except where indicated.<br />

Financial data uses average currency exchange rates, except for GDP per capita which uses purchasing power parities sourced from the IMF Economic Indicators in September <strong>2011</strong>.<br />

* Associate or joint venture. ** Includes cross border trade.


packaging unwrapped<br />

Under the title ‘packaging unwrapped’, this <strong>Rexam</strong> report<br />

published in <strong>2011</strong> looks at the global trends in consumer<br />

packaging and the key growth drivers in mature and<br />

developing markets around the world. The report can be<br />

viewed and downloaded on www.rexam.com or ordered<br />

from our corporate affairs department.<br />

Americas Asia/Middle East &Africa<br />

Spain Sweden Turkey UK Argentina Brazil Chile Guatemala Mexico US China India Indonesia S. Korea Egypt<br />

2 1 1 2 1 9 1 1* 1 15 1 1 – 1* 1<br />

– – – – – 1 – – 2 13 4 1 1 – –<br />

46.1 9.4 72.2 62.6 40.9 194.9 17.4 14.7 109.7 312.9 1,348.1 1,206.9 240.5 49.0 79.4<br />

17 20 6 17 11 7 10 4 7 13 9 6 6 11 5<br />

30.6 40.6 14.6 36.0 17.4 11.8 16.2 5.0 15.1 48.1 8.4 3.7 4.7 31.8 6.5<br />

-1.7 1.4 3.0 0.6 4.6 3.0 4.7 3.0 3.5 1.8 8.2 7.0 6.3 4.4 1.8<br />

153 119 23 124 13 109 55 40 86 337 19 1 4 119 10<br />

26 23 11 25 1 20 5 20 9 43 18 1 2 44 7<br />

40 80 31 53 20 52 58 15 38 57 8 17 25 43 50<br />

52 81 71 48 85 47 74 n/a 79 79 79 69 44 53 40<br />

57 91 75 52 91 97 65 n/a 50 54 99 n/a n/a n/a n/a<br />

81 81 73 80 77 73 78 71 77 78 75 67 72 79 73<br />

3.1 3.7 0.9 3.5 1.1 0.9 1.2 0.3 0.9 8.0 0.3 0.1 0.1 1.9 0.3<br />

53 53 22 78 9 21 14 n/a 18 94 8 2 7 56 9<br />

18.8 49.8 4.4 31.9 4.0 10.9 8.1 n/a 7.4 20.1 1.0 0.2 0.4 16.5 1.3<br />

30 25 7 31 10 2 9 7 8 33 18 5 n/a n/a n/a<br />

72 70 63 59 40 46 51 n/a 45 67 40 16 n/a n/a n/a<br />

19<br />

overview<br />

financial statements governance<br />

sustainability<br />

business review


20<br />

<strong>Rexam</strong> annual report <strong>2011</strong> directors’ report<br />

operating review<br />

group results<br />

In <strong>2011</strong>, <strong>Rexam</strong> as a Group delivered a<br />

strong performance. Sales overall increased<br />

2% to £4,734m in line with our GDP+ goal<br />

as volume growth in Beverage Cans offset<br />

a mixed performance in Plastic Packaging.<br />

Group underlying operating profit rose 7%<br />

to £549m mainly due to improved volumes<br />

in standard cans in Europe and in specialty<br />

cans in all our regions, supported by our<br />

continued focus on cost reduction and<br />

efficiencies. Underlying profit before tax<br />

increased 15% to £450m chiefly due to<br />

the improvement in operating profit and<br />

also to a lower total underlying net finance<br />

cost. Underlying earnings per share rose<br />

15% to 36.1p.<br />

André Balbi Cerviño group director,<br />

beverage can Americas<br />

Tomas Sjölin group director,<br />

beverage can Europe & Asia<br />

Malcolm Harrison group director,<br />

plastic packaging<br />

On an organic basis, which excludes the impact of disposals and<br />

currency translation, sales grew 4%, mainly due to the strong<br />

performance in Beverage Cans. Organic underlying operating<br />

profit increased 8%.<br />

statutory results<br />

On a statutory basis, which includes the effect of currency<br />

translation and exceptional and other items, profit before tax from<br />

continuing operations was £431m (2010: £338m). Exceptional<br />

and other items totalled £19m before tax comprising restructuring,<br />

amortisation of certain acquired intangible assets and fair value<br />

changes on financing derivatives. Total profit for the financial<br />

period, which includes discontinued operations, was £376m<br />

(2010: £124m) and total basic earnings per share was 43.1p<br />

(2010: 14.2p). The financial review on pages 26 and 27 contains<br />

a reconciliation between statutory and underlying results.<br />

beverage cans<br />

<strong>2011</strong> 2010<br />

Sales £3,786m £3,677m<br />

Underlying operating profit £447m £394m<br />

Return on sales 11.8% 10.7%<br />

Return on net assets 31.6% 27.6%<br />

Beverage Cans is a high speed, high precision manufacturing<br />

business. Excellence in manufacturing and engineering,<br />

along with innovation, quality and customer service, are key<br />

to delivering value to our customers. <strong>Rexam</strong> Beverage Cans is<br />

a global business centred on three main regions: Europe, North<br />

America and South America. It also has operations in Russia,<br />

the Middle East, India, China and Central America. This mix gives<br />

us a healthy exposure to both developed and emerging markets.<br />

Our businesses collaborate on a global basis in areas such as<br />

supply chain, innovation, engineering, research and development<br />

and marketing intelligence. In all, Beverage Cans accounted for<br />

81% of <strong>Rexam</strong>’s underlying operating profit from continuing<br />

operations (2010: 77%).<br />

In <strong>2011</strong>, Beverage Cans outperformed our expectations. Organic<br />

sales, which adjusts for the impact of currency translation, were up 4%<br />

including the expected market share loss in North America. Excluding<br />

standard cans in North America, our beverage cans volumes grew<br />

close to 5% bolstered by good volume growth in Europe and in<br />

specialty cans across all regions. Excluding the cost of aluminium<br />

passed through to customers, organic sales growth was 1%. Organic<br />

underlying operating profit was better than expected, improving by<br />

15% to £447m driven predominantly by volume growth but also good<br />

pricing and an excellent performance on cost savings and efficiencies<br />

mainly related to downgauging and lightweighting. Our underlying<br />

operating profit margin improved to 11.8% (2010: 10.7%).<br />

In 2012, our cost saving efforts will be very much in focus as we<br />

face the specific challenge of absorbing an additional £20m of<br />

metal conversion costs in our European beverage can business,<br />

increases in energy and freight charges as well as start up costs.


everage can Europe & Asia<br />

The European can market currently comprises some 57bn cans.<br />

It is our largest beverage can market and we are the leading can<br />

maker with a more than 40% share. In <strong>2011</strong>, the market grew 5%<br />

as cans continued to gain share of the beverage packaging mix<br />

supported by a continued shift towards home consumption where<br />

beverage cans are the single serve package of choice. Our own<br />

volumes increased 6% following good growth in standard and<br />

specialty cans and growth in Russia. Specialty cans continued<br />

to grow across Europe in general and now represent almost 30%<br />

of all cans sold. Our own specialty volumes increased 10% driven<br />

by the continued success of energy drinks in Europe and those filled<br />

in Europe for export.<br />

A strong first half in Russia was followed, as expected, by a slower<br />

second half but, for the year as a whole, our volumes were up<br />

6% in line with our expectations. Returns on our Russian business<br />

(including the acquisition of Rostar in 2008) remain consistently<br />

well above our regional weighted average cost of capital.<br />

The introduction of Europe’s first 75cl can was another milestone<br />

for <strong>Rexam</strong> in the Russian market. Can size is often a key element<br />

in our customers’ marketing strategies and they now have an even<br />

broader range from which to select. Whilst we will be disciplined<br />

in terms of capital expenditure given the focus on returns, we<br />

are currently evaluating options to invest in Eastern Russia to meet<br />

growing demand and the need to reduce the cost of shipping<br />

products such as SLEEK™ cans which are growing in popularity.<br />

Our can plant network across Western Europe ran at 95%<br />

utilisation during the year and given that we expect the market to<br />

continue to grow, we announced the construction of a new two line<br />

can making plant in Finland for £68m to open at the start of 2013.<br />

We are making further investments in India, installing a high speed<br />

aluminium beverage can manufacturing line at the current site in<br />

Taloja close to Mumbai. The new line will represent a capital<br />

investment of c £30m over two years. It will initially produce 33cl,<br />

50cl and SLEEKTM cans and increase capacity from under 400m<br />

cans to c 950m per year. Production start up is planned for the<br />

fourth quarter of 2012.<br />

At the start of 2012, a decision was taken to invest in a fourth<br />

production line at our can making plant in Ludesch, Austria to<br />

support the growth of the energy drinks market. The investment<br />

of some £20m will increase our specialty can capacity by around<br />

0.7bn cans per year. Start up is planned for the third quarter<br />

of 2013.<br />

investing in growth<br />

Finland has enjoyed a steady transition from refillable<br />

glass bottles to cans in recent years, as has the<br />

Scandinavian and Baltic region in general. The cans<br />

share of the beer pack mix in Finland has risen to more<br />

than 60%, assisted by favourable legislation, but still<br />

lags behind Sweden at 82%. We currently serve this<br />

1.2bn can market from our plants in Sweden<br />

and Denmark.<br />

With our can making network close to full utilisation,<br />

additional capacity is required in order to manage<br />

plant efficiency across Europe so that we can capture<br />

future growth in the market. Long distance imports are<br />

not viable in the long run.<br />

During <strong>2011</strong> we announced that we would be investing<br />

in a new two line can making plant in Finland for £68m.<br />

It is planned to open at the start of 2013. The majority<br />

of our customers in Finland and the Baltic countries<br />

are contracted to 2015.<br />

21<br />

overview<br />

financial statements governance<br />

sustainability<br />

business review


22 <strong>Rexam</strong> annual report <strong>2011</strong> directors’ report<br />

operating review<br />

metal efficiency matters<br />

Improving resource efficiency in our operations is at the core<br />

of our manufacturing processes, not least because of the<br />

cost benefit it brings to us and the packaging supply chain.<br />

In beverage can production, approximately 90% of our raw<br />

material cost is metal. Metal efficiency is therefore a key area<br />

of priority throughout our can business and we are focused on<br />

the twin processes of lightweighting and downgauging.<br />

The gauge of the metal determines the thickness of the dome at<br />

the base of the can. Downgauging – reducing the thickness of<br />

the metal used – means that more cans can be produced from<br />

the same amount of metal, whether it is aluminium or steel.<br />

Reducing the thickness of the can wall is called lightweighting.<br />

Using finite element analysis we can evaluate any proposed<br />

refinements to can design before we set up a line. This has<br />

reduced the risk and the associated cost of tooling development.<br />

Another significant advance resulting from the metal efficiency<br />

programme in Europe is the adoption of the 'non round cut<br />

edge'. A complex modification to the shape of the blanks<br />

pressed from the coil means less metal is wasted and less<br />

excess is trimmed from the top of the can body.<br />

beverage can North America<br />

North America remains the largest single can market in the world<br />

at around 95bn cans and we are the second largest can maker<br />

with a c 20% share. In <strong>2011</strong>, our overall volumes declined 14%<br />

impacted by the contract losses announced last year. As previously<br />

stated, we have signed contracts to recover most of the volume<br />

loss by 2013, which will help improve asset utilisation.<br />

Encouragingly, specialty cans, which now account for some 23%<br />

of our overall volume, grew 16% driven mainly by increased<br />

consumption of energy drinks, beer and iced teas as well as new<br />

innovative beverage categories. Standard cans were down 20% of<br />

which 15% related to the loss of contracts and the remaining 5% to<br />

weakness in the US soft drinks market.<br />

Overall profit in the business, which at the start of the year we<br />

expected to be comparable to that in 2010, was significantly<br />

higher. The faster than expected growth in specialty cans and the<br />

relentless pursuit of efficiencies and cost reduction across our<br />

entire product and manufacturing platform, combined with the<br />

improvement in margins on retained as well as newly secured<br />

volumes, helped drive this strong performance.<br />

Our good cash conversion continued and we maintained the strong<br />

return on net assets that characterises this part of the business.<br />

beverage can South America<br />

South America is a c 25bn beverage can market dominated by<br />

Brazil. <strong>Rexam</strong> is the leading can maker in the region. Following a<br />

very strong performance in 2010 when the main market, Brazil,<br />

grew 18%, our volumes in <strong>2011</strong> were flat as the beverage can<br />

market in Brazil faced a number of challenges. These included a<br />

slowdown in Brazilian GDP growth (from 7% to 3% pa), price<br />

increases by our customers and particularly unfavourable winter<br />

weather conditions. Volumes were also affected by the direct<br />

import of cans by our customers. In addition, we lost some volume<br />

share as customers reallocated their volume requirements closer to<br />

their filling locations to optimise freight costs as new capacity came<br />

on line.<br />

Growth in <strong>Rexam</strong>’s specialty cans remained strong at 16%<br />

driven primarily by beer producers seeking new formats for their<br />

products. Specialty cans now account for 21% of our sales.


<strong>Rexam</strong> has around 60% of the Brazilian beverage can market and<br />

we are conscious that growth will not always be linear in emerging<br />

markets. Consistent with our disciplined approach to capital<br />

expenditure, our planned investment in the new can making plant<br />

in Belém (initially announced in April <strong>2011</strong>) will be timed to match<br />

customer volume expectations, and is now planned to open in the<br />

second half of 2012. As stated last year, we have a long term<br />

contract with our largest customer in Brazil which underpins the<br />

returns on existing and future investments in the region.<br />

We remain confident of the medium and long term prospects for<br />

the Brazilian market. In the short term, disposable incomes are set<br />

to rise in 2012 following legislation on increasing minimum wage<br />

levels and, with customers already preparing for events such<br />

as the FIFA Confederations Cup in 2013, the FIFA World Cup in<br />

2014 and the Olympic Games in 2016, we expect to see further<br />

economic growth.<br />

global recognition of excellence<br />

At the start of 2012, our beverage can plant in Águas Claras,<br />

Brazil, was awarded The Shingo Prize – acknowledged as the<br />

highest global recognition for operational excellence. Two other<br />

<strong>Rexam</strong> plants in Brazil, Recife (beverage can ends) and Jundiaí<br />

(personal care products) were awarded the Shingo Silver medal<br />

and Bronze medal respectively.<br />

Improving operational efficiency is at the core of<br />

our manufacturing processes. Plants are regularly assessed<br />

under <strong>Rexam</strong>’s own audit programme but, in the quest for<br />

continuous improvement, <strong>Rexam</strong> wanted to benchmark its<br />

performance against the best in the world.<br />

Águas Claras was recognised as outstanding in all areas<br />

of operation, demonstrating a culture where principles of<br />

operational excellence are deeply embedded into the thinking<br />

and behaviour of all leaders, managers and employees.<br />

With only a small number of organisations awarded<br />

The Shingo Prize each year, <strong>Rexam</strong> now joins an elite group.<br />

plastic packaging<br />

<strong>2011</strong> 2010<br />

Sales £948m £942m<br />

Underlying operating profit £102m £119m<br />

Return on sales 10.8% 12.6%<br />

Return on net assets 23.3% 29.1%<br />

Our Plastic Packaging business consists of Healthcare and Personal<br />

Care (which includes High Barrier food containers). It produces<br />

standard and customised rigid plastic packaging solutions for<br />

a variety of end markets including pharmaceutical and healthcare<br />

applications, cosmetics, toiletries, household care and food.<br />

Many of our products are the leading choice in their markets for<br />

customers worldwide. In <strong>2011</strong>, Plastic Packaging accounted for<br />

19% of <strong>Rexam</strong>’s underlying operating profit from continuing<br />

operations (2010: 23%).<br />

Plastic Packaging has a wide variety of products at varying stages<br />

of maturity. Our priority is to improve consistently the returns from<br />

this portfolio of businesses. The keys to success are innovation in<br />

markets where there are relatively short life cycles, for example,<br />

cosmetics, and the ability to remain entrepreneurial while<br />

leveraging a global network of production and technical<br />

capabilities. Operational excellence, including the use of leading<br />

edge technology, and the understanding of end market trends<br />

are also essential to maintain stature in these markets.<br />

In <strong>2011</strong>, trading in Plastic Packaging was mixed. Organic sales<br />

grew 2% but, excluding resin pass through, sales were flat.<br />

Underlying operating profit was 13% down on an organic basis.<br />

There were good efficiencies from increased process automation<br />

and lower resin usage from lightweighting and savings from<br />

reduced working hours and the elimination of shared costs<br />

following the sale of Closures. These were, however, not sufficient<br />

to offset the effects of reduced pricing and increased costs and<br />

the impact of lower volumes in Personal Care in North America,<br />

particularly in Home and Personal Care, and overall weaker sales<br />

in the Healthcare business.<br />

23<br />

overview<br />

financial statements governance<br />

sustainability<br />

business review


24 <strong>Rexam</strong> annual report <strong>2011</strong> directors’ report<br />

operating review<br />

healthcare<br />

With over 3,000 employees and 14 factories across three continents,<br />

<strong>Rexam</strong> Healthcare is the global leader in rigid plastic packaging<br />

and devices for healthcare applications. It is a well invested<br />

business with an experienced management team. It designs,<br />

develops and manufactures innovative packaging, including<br />

containers and healthcare closures, drug delivery devices,<br />

metering pumps and valves and medical components. Its core<br />

expertise lies in injection moulding and blow moulding<br />

technologies and high speed automated assembly in compliance<br />

with Good Manufacturing Practice to meet the quality, safety and<br />

consistency demanded by customers. It also has broad regulatory<br />

knowledge to provide value added support to customers.<br />

In <strong>2011</strong>, Healthcare volumes (sales excluding pass through of resin<br />

cost) were flat. There was weak demand in North America and our<br />

overall performance reflects our strategy to focus on price and<br />

increase returns.<br />

In Pharmaceutical Packaging, strong growth in insulin pens<br />

was offset by weakness in inhalers following a quiet flu season.<br />

In Prescription, there were some pricing benefits, despite increased<br />

competitiveness, but these were offset by lower volumes, again<br />

due to the absence of major flu outbreaks. Primary Packaging<br />

had lower volumes due to pricing pressures.<br />

One of the main devices we manufacture for drug delivery is in<br />

the process of coming off patent and this will impact the results of<br />

the Healthcare business in 2012. This is part of the normal cycle<br />

within the pharmaceutical industry which is why we continue to<br />

develop a strong product pipeline to fuel future growth.<br />

Looking ahead, we expect that there will be more opportunities to<br />

develop or codevelop solutions with pharmaceutical companies as<br />

they focus increasingly on their core business. We have a range of<br />

new products including insulin pens and the next generation<br />

of sophisticated drug delivery devices to replace those coming<br />

off patent.<br />

safe’n’sound ®<br />

personal care<br />

In Personal Care, overall trading was disappointing despite<br />

pockets of good performance. High Barrier Food volumes were<br />

up strongly due to share gains but results in the rest of Personal<br />

Care varied significantly by region. In Europe volumes were flat.<br />

We saw some growth in dispensing systems for fragrances and<br />

make up and some weakness in foam pumps. In North America,<br />

the consumer remained cautious which led to lower volumes,<br />

particularly in Home and Personal Care. In emerging markets,<br />

good growth in Brazil was more than offset by weakness of make<br />

up in Asia due to high input costs and competitive pricing.<br />

As stated on page 13 we have started the process to actively<br />

market the Personal Care business for divestment.<br />

going forward<br />

We are targeting revenue growth slightly above GDP, by which<br />

we mean the aggregate GDP of the major markets in which we<br />

operate, primarily in North and South America and Europe. In<br />

Europe, pack mix changes and increased at home consumption<br />

are driving faster than GDP growth. In North America, standard<br />

cans are flat to marginally declining but specialty cans continue<br />

to grow; overall, however, the US is a gently declining market<br />

regardless of GDP. Finally in South America and other emerging<br />

markets, we consistently see faster than GDP growth in beverage<br />

cans due to increased can penetration as the pack mix changes<br />

away from returnable glass.<br />

We expect operating profit to grow faster than sales as increased<br />

volumes and better utilisation provide good drop through and,<br />

over time, efficiencies and pricing offset cost inflation.<br />

<strong>Rexam</strong> is a highly cash generative company. Over the last two<br />

years, we have succeeded in strengthening the balance sheet<br />

and protecting our credit rating. We will maintain an appropriate<br />

financial position but will shift our focus to a combination of<br />

reinvestment in the business and cash returns to shareholders.<br />

In <strong>2011</strong>, <strong>Rexam</strong> Healthcare received 510(k) approval from the Food and Drug Administration (FDA) for Safe’n’Sound ® , a passive safety device for<br />

prefilled syringes.<br />

The approval is the crowning achievement of significant investment and efforts in terms of design by the <strong>Rexam</strong> teams. The aim of the project was to<br />

design a safety device that meets the current regulations in North America and in Europe. These regulations are aimed at protecting workers in the<br />

health sector from needle injuries and contamination from blood borne pathogens.<br />

The fully passive Safe’n’Sound ® device provides effective protection against the risks of being pricked by a soiled needle, thanks to the protective<br />

sheath which activates automatically once the medicine has been administered.<br />

This FDA approval shows <strong>Rexam</strong>’s commitment to innovation, safety and quality.


alancing returns and growth<br />

Surplus cash<br />

Returned to shareholders<br />

Investment<br />

Organic investment<br />

c 1.0–1.5 times<br />

depreciation<br />

underpins<br />

GDP + growth<br />

Bolt on acquisitions<br />

It is important to reinvest in the business so as to deliver our growth<br />

target on a sustainable basis. We recognise the need for discipline<br />

and will invest only in projects with good growth and return<br />

profiles. We aim to keep investment in the range of 1.0–1.5 times<br />

depreciation. In 2012 there are several large projects happening<br />

at the same time and we will be at the high end of the range this<br />

year. We will be similarly disciplined with regard to any bolt<br />

on acquisitions to strengthen our market positions or increase<br />

our capabilities.<br />

In terms of cash returns to shareholders, our dividend policy is to<br />

have a dividend cover in the range of 2.0–2.5 times underlying<br />

earnings. With a strengthened balance sheet and the good <strong>2011</strong><br />

trading performance, we are now in the range. Surplus cash<br />

which is not reinvested in the business over time will be returned<br />

to shareholders.<br />

Since 2009 we have generated close to £550m of free cash<br />

flow, reduced costs by more than £120m and improved return<br />

on capital employed from 9.5% to 13.7%.<br />

Sales growth GDP +<br />

Pack mix changes in Europe<br />

Growth in specialty cans in<br />

North America<br />

Growth in emerging markets<br />

Maximise long<br />

term shareholder<br />

value aiming to<br />

reach 15% ROCE<br />

by 2013<br />

Cash generation<br />

Strong balance sheet<br />

Investment grade<br />

credit rating<br />

Dividend<br />

Dividend cover 2.0–2.5 times<br />

Operating prot<br />

growth GDP ++<br />

Efciencies and<br />

pricing offset cost<br />

ination over time<br />

Good drop through<br />

from increased<br />

volume and<br />

utilisation<br />

Net debt has reduced from £1.8bn at the end of 2009 to £1.3bn<br />

at the end of <strong>2011</strong> aided by good profits and the proceeds from<br />

Closures, but also largely through our own management<br />

of working capital and capital discipline.<br />

2012 outlook<br />

In closing, we are delighted with the continued progress of the<br />

business in <strong>2011</strong>. Our strong profit growth was achieved by a<br />

better than expected performance in our Beverage Cans business,<br />

primarily in Europe, and continued focus on cost management.<br />

Looking ahead, we remain cautious about the global economy<br />

and, as indicated, we face certain cost challenges in 2012 together<br />

with the impact of a key Healthcare product coming off patent. The<br />

volume environment for Beverage Cans remains robust, although<br />

we do not anticipate any turnaround in the performance of Plastic<br />

Packaging in the near term. Overall, we expect 2012 to be another<br />

year of progress as we continue to focus on cash, costs and return<br />

on capital employed.<br />

25<br />

overview<br />

financial statements governance<br />

sustainability<br />

business review


26 <strong>Rexam</strong> annual report <strong>2011</strong> directors’ report<br />

financial review<br />

group overview<br />

In <strong>2011</strong> we delivered record profits,<br />

reported a robust cash flow and further<br />

strengthened our balance sheet. With good<br />

profit growth and our continued discipline<br />

regarding investment and use of capital,<br />

we have made significant progress towards<br />

our ROCE target for 2013.<br />

David Robbie<br />

finance director<br />

This financial review of our results is principally based on what we<br />

term the underlying business performance, as shown in the tables<br />

below. This excludes exceptional items, the amortisation of certain<br />

acquired intangible assets and fair value changes on financing<br />

derivatives (together ‘exceptional and other items’). We feel that<br />

the underlying figures aid comparison and understanding of the<br />

Group’s financial performance.<br />

Discontinued operations comprise the Closures business which<br />

manufactured beverage and specialty closures. Further details<br />

of the trading results of Closures and the accounting impact of<br />

its disposal are set out on page 30.<br />

<strong>2011</strong><br />

Underlying<br />

business<br />

performance¹<br />

£m<br />

Exceptional<br />

and other<br />

items<br />

£m<br />

Total<br />

£m<br />

Continuing operations:<br />

Sales 4,734 – 4,734<br />

Operating profit/(loss)<br />

Share of associates and joint<br />

549 (42) 507<br />

ventures profit after tax 9 – 9<br />

Total net finance cost2 (108) 23 (85)<br />

Profit/(loss) before tax 450 (19) 431<br />

Profit/(loss) after tax<br />

Discontinued operations:<br />

315 (12) 303<br />

Profit for the year 73<br />

Total profit for the year 376<br />

Total basic earnings per share (p) 43.1<br />

Underlying earnings per share (p) 36.1<br />

Interim dividend per share<br />

Proposed<br />

(p) 4.7<br />

3 final dividend<br />

per share<br />

(p) 9.7


2010<br />

Underlying<br />

business<br />

performance¹<br />

£m<br />

Exceptional<br />

and other<br />

items<br />

£m<br />

Total<br />

£m<br />

Continuing operations:<br />

Sales 4,619 – 4,619<br />

Operating profit/(loss) 513 (40) 473<br />

Share of associates and joint<br />

ventures profit after tax 5 – 5<br />

Total net finance cost 2 (128) (12) (140)<br />

Profit/(loss) before tax 390 (52) 338<br />

Profit/(loss) after tax 274 (38) 236<br />

Discontinued operations:<br />

Loss for the year (112)<br />

Total profit for the year 124<br />

Total basic earnings per share (p) 14.2<br />

Underlying earnings per share (p) 31.4<br />

Interim dividend per share (p) 4.0<br />

Final dividend per share (p) 8.0<br />

1 Underlying business performance is the primary performance measure used<br />

by management, who believe that the exclusion of exceptional and other items aid<br />

comparison of underlying performance of continuing operations. Exceptional items include<br />

the gains and losses on disposal of businesses, the restructuring and integration of<br />

businesses, major asset impairments and disposals, significant litigation and tax related<br />

claims and significant gains arising on reduction of retiree medical and pension liabilities.<br />

Other items include the amortisation of certain acquired intangible assets (customer<br />

contracts and relationships and technology and patents) and fair value changes on<br />

financing derivative financial instruments.<br />

2 Total underlying net finance cost comprises net interest of £92m (2010: £113m) and<br />

retirement benefit obligations net finance cost of £16m (2010: £15m).<br />

3 Subject to approval at the AGM 2012 and payable on 7 June 2012.<br />

Results on a statutory basis include disposed businesses, currency<br />

translation and exceptional and other items and discontinued<br />

operations. The exceptional and other items and the results of<br />

discontinued operations are described in more detail on pages<br />

102 and 106. Sales for continuing operations were £4,734m<br />

(2010: £4,619m) and profit before tax including exceptional and<br />

other items was £431m (2010: £338m). Total profit after tax for the<br />

year, including the results of discontinued operations, was £376m<br />

(2010: £124m) and total basic earnings per share was 43.1p<br />

(2010: 14.2p).<br />

The following tables, showing sales and underlying operating<br />

profit, compare the continuing operations on a consistent basis<br />

to demonstrate ‘like for like’ trading performance. This basis<br />

excludes discontinued operations. Organic change is the year<br />

on year change arising on continuing operations at constant<br />

exchange rates.<br />

analysis of sales movement<br />

Total<br />

£m<br />

Beverage<br />

Cans<br />

£m<br />

Plastic<br />

Packaging<br />

£m<br />

Sales reported 2010 4,619 3,677 942<br />

Currency fluctuations (53) (43) (10)<br />

Sales 2010 pro forma basis 4,566 3,634 932<br />

Organic change in sales 168 152 16<br />

Sales reported <strong>2011</strong> 4,734 3,786 948<br />

Organic sales, which exclude the impact of discontinued<br />

operations, disposals and currency, increased by £168m<br />

or 4%. The increase in Beverage Cans includes £113m relating to<br />

the increase in aluminium cost pass through together with volume<br />

gains in Europe and in specialty cans globally and good pricing in<br />

Europe and South America partly offset by previously announced<br />

reductions in standard can volume in North America. For Plastic<br />

Packaging, the growth was attributable to the pass through of<br />

higher resin costs and some volume recovery in High Barrier<br />

Food containers offset by volume reductions in Personal Care<br />

and Healthcare.<br />

analysis of underlying operating profit movement<br />

Total<br />

£m<br />

Beverage<br />

Cans<br />

£m<br />

Plastic<br />

Packaging<br />

£m<br />

Underlying operating profit<br />

reported 2010 513 394 119<br />

Currency fluctuations (6) (4) (2)<br />

Underlying operating profit 2010<br />

pro forma basis 507 390 117<br />

Organic change in underlying<br />

operating profit 42 57 (15)<br />

Underlying operating profit<br />

reported <strong>2011</strong> 549 447 102<br />

27<br />

overview<br />

financial statements governance<br />

sustainability<br />

business review


28 <strong>Rexam</strong> annual report <strong>2011</strong> directors’ report<br />

financial review<br />

A further analysis of the organic change in underlying operating<br />

profit from continuing operations is set out below.<br />

Total<br />

£m<br />

Beverage<br />

Cans<br />

£m<br />

Plastic<br />

Packaging<br />

£m<br />

Sales price and cost changes 7 18 (11)<br />

Volume and mix changes – 17 (17)<br />

Efficiency and other savings 35 22 13<br />

Organic change in underlying<br />

operating profit 42 57 (15)<br />

Underlying operating profit, after adjusting for the impact<br />

of discontinued operations, disposals and currency, rose by<br />

£42m or 8% reflecting an improvement in pricing and efficiency<br />

savings across the Group partly offset by lower volumes and<br />

less favourable mix in Plastic Packaging. Efficiency savings of<br />

£35m came from the application of six sigma and lean enterprise<br />

methodologies across the Group. In Beverage Cans, major savings<br />

arose from lightweighting, spoilage reduction, downgauging and<br />

reduced utility usage. In Plastic Packaging, the major contributors<br />

were lower material usage and improved operating efficiency.<br />

exchange rates<br />

The main exchange rates used to translate the consolidated income<br />

statement and balance sheet are set out below:<br />

<strong>2011</strong> 2010<br />

Average:<br />

Euro 1.15 1.17<br />

US dollar 1.60 1.55<br />

Russian rouble<br />

Closing:<br />

47.12 46.96<br />

Euro 1.19 1.17<br />

US dollar 1.54 1.54<br />

Russian rouble 49.59 46.77<br />

consolidated income statement<br />

The principal currencies that impact our results are the US dollar,<br />

the euro and the Russian rouble. The US dollar and the Russian<br />

rouble weakened against sterling in the year while the euro<br />

strengthened. The net effect of currency translation caused sales<br />

and underlying operating profit from ongoing operations to<br />

reduce by £53m and £6m respectively compared with 2010<br />

as shown below.<br />

Sales<br />

£m<br />

Underlying<br />

operating<br />

profit<br />

£m<br />

US dollar (81) (9)<br />

Russian rouble (1) –<br />

Euro 20 3<br />

Other currencies 9 –<br />

(53) (6)<br />

In addition to the translation exposure, the Group is also exposed<br />

to movements in exchange rates on certain of its transactions.<br />

These exposures are largely hedged and principally include the<br />

US dollar/euro/Russian rouble and the US dollar/Brazilian real<br />

movement for the European and South American beverage can<br />

operations respectively.<br />

consolidated balance sheet<br />

Most of the Group’s borrowings and net assets are denominated<br />

in US dollars and euros. Currency movements reduced net<br />

borrowings by £29m and net equity by £16m.<br />

total underlying net finance cost<br />

<strong>2011</strong><br />

£m<br />

2010<br />

£m<br />

Net interest (92) (113)<br />

Retirement benefit obligations net finance cost (16) (15)<br />

Total underlying net finance cost (108) (128)<br />

The total underlying net finance cost fell by £20m compared with<br />

the prior year. The reduction in total net interest is primarily due<br />

to lower average net borrowings following strong cash inflows<br />

together with lower bank facility fees offset by foreign exchange<br />

transaction losses on financing items. The overall average interest<br />

rate for the year was around 5.8% compared with 5.7% in 2010.<br />

Based on underlying operating profit, interest cover was 6.0 times<br />

(2010: 4.5 times). Interest cover is based on underlying operating<br />

profit from continuing operations and underlying net interest expense<br />

excluding charges in respect of retirement benefit obligations.


tax<br />

The tax charge for the year on continuing operations was<br />

£135m (30%) on profit before exceptional and other items<br />

(2010: £116m (30%)). The rate reflects the mix of territories<br />

in which we operate offset in part by the availability of tax<br />

incentives in certain jurisdictions and the management of tax<br />

risks. We anticipate the rate to remain around the same level<br />

in 2012.<br />

Cash tax payments by continuing operations in the year were<br />

£81m (2010: £67m) with an additional £5m (2010: £8m) being<br />

borne by discontinued operations. Cash tax is lower than the<br />

charge to the income statement due to the utilisation of deferred<br />

tax assets and the timing of tax payments. It is expected that the<br />

cash tax paid in future years will remain below the underlying tax<br />

charge in the consolidated income statement, in the range of 65%<br />

to 75% of that charge.<br />

exceptional and other items<br />

The exceptional and other items arising in <strong>2011</strong> in respect of<br />

continuing operations were as follows:<br />

£m<br />

Restructuring of businesses, including impairments (16)<br />

Amortisation of certain acquired intangible assets (26)<br />

Total exceptional and other items included<br />

in operating profit (42)<br />

Financing derivative market value changes 23<br />

Total exceptional and other items before tax (19)<br />

Tax on:<br />

Restructuring of businesses, including impairments 4<br />

Amortisation of certain acquired intangible assets 9<br />

Financing derivative market value changes (6)<br />

Total tax on exceptional and other items 7<br />

Total exceptional and other items after tax (12)<br />

exceptional items<br />

restructuring of businesses<br />

The restructuring charge of £16m on continuing operations<br />

comprises £11m in Plastic Packaging (including £2m related<br />

to asset impairments) and £5m in Beverage Cans. We have<br />

previously stated that following the disposal of Closures it would be<br />

necessary to reorganise the remaining Plastic Packaging business<br />

to address the level of shared service administration support and<br />

to rationalise those retained plants which were co production sites<br />

with the Closures businesses. Overall, this restructuring is expected<br />

to cost £24m: in <strong>2011</strong>, £11m was charged in respect of continuing<br />

operations and a further £11m reported under discontinued<br />

operations. The remainder will be charged in future periods.<br />

The Beverage Cans cost was in respect of the previously<br />

announced plant closures. The total cash cost of restructuring<br />

in continuing operations in the year was £19m.<br />

other items<br />

amortisation of certain acquired intangible assets<br />

Intangible assets, such as technology patents and customer<br />

contracts, are required to be recognised on the acquisition of<br />

businesses and amortised over their useful life. The directors<br />

consider that separate disclosure, within exceptional and other<br />

items, of the amortisation of such acquired intangibles relating<br />

to total operations amounting to £26m (2010: £32m) aids<br />

comparison of organic change in underlying profit.<br />

fair value changes on financing derivatives<br />

The fair value of the derivatives arising on financing activities<br />

directly relates to changes in interest rates and foreign exchange<br />

rates. The fair value will change as the transactions to which they<br />

relate mature, as new derivatives are transacted and due to the<br />

passage of time. The fair value change on financing derivatives<br />

for the year was a net gain of £23m (2010: net loss £12m). The<br />

impact of derivatives arising on trading items such as commodities<br />

and forward foreign exchange contracts is included within<br />

underlying operating profit.<br />

29<br />

overview<br />

financial statements governance<br />

sustainability<br />

business review


30 <strong>Rexam</strong> annual report <strong>2011</strong> directors’ report<br />

financial review<br />

discontinued operations – closures<br />

A summary of the performance of discontinued operations is set<br />

out below.<br />

<strong>2011</strong><br />

£m<br />

2010<br />

£m<br />

Sales 205 343<br />

Underlying operating profit 13 22<br />

Underlying profit before tax 13 22<br />

Underlying profit after tax before exceptional<br />

and other items 8 13<br />

Exceptional and other items included<br />

in operating profit:<br />

Profit on disposal 91 –<br />

Impairment of goodwill and other assets (34) (179)<br />

Restructuring (5) (6)<br />

Amortisation of certain acquired<br />

intangible assets – (14)<br />

Tax on exceptional and other items 13 74<br />

Exceptional and other items after tax 65 (125)<br />

Profit/(loss) for financial year after tax 73 (112)<br />

The underlying performance reflected the decline in beverage<br />

closures, with sales down by some 10% for the period to disposal,<br />

offset partly by efficiency and other savings.<br />

The disposal of the Closures business was completed on<br />

1 September <strong>2011</strong> giving rise to an overall profit in <strong>2011</strong> of £91m.<br />

This profit included foreign exchange translation differences<br />

arising on Closures net assets since the date of their acquisition,<br />

some £89m, which have been recognised in the income statement.<br />

In <strong>2011</strong>, the assets of Closures were impaired by £28m and further<br />

impairments of £6m, together with £5m of related costs, were<br />

incurred under the restructuring programme initiated following<br />

its disposal as described under ‘exceptional items’ above.<br />

earnings per share<br />

<strong>2011</strong> 2010<br />

Underlying earnings per share – continuing<br />

operations (p) 36.1 31.4<br />

Basic earnings per share – total operations (p) 43.1 14.2<br />

Average number of shares in issue (millions) 872.6 875.6<br />

Year end number of shares in issue (millions) 877.0 876.9<br />

Underlying earnings per share from continuing operations<br />

increased by 15% to 36.1p (2010: 31.4p). This is due to the<br />

improvement in underlying operating profit together with the<br />

reduction in total underlying net finance cost.<br />

The basic earnings per share, which includes exceptional and<br />

other items and discontinued operations, was 43.1p per share<br />

(2010: 14.2p). The increase reflects the improvement in underlying<br />

profit, the reduced impact of exceptional items and the gain<br />

realised on completion of the disposal of Closures.<br />

retirement benefits<br />

Retirement benefit obligations (net of tax) as at 31 December <strong>2011</strong><br />

were £371m, an increase of £54m compared with £317m reported<br />

at 31 December 2010. This was principally due to changes in<br />

actuarial values amounting to £76m (after tax) as set out below.<br />

£m<br />

Defined benefit pension plans:<br />

Plan liabilities – lower discount rates<br />

Plan assets – higher than expected returns,<br />

(280)<br />

principally on bonds 139<br />

Demographic changes 35<br />

Actuarial losses before tax (106)<br />

Tax 30<br />

Actuarial losses after tax (76)<br />

Changes to the actuarial value of retirement benefits at the<br />

balance sheet date are reported in the consolidated statement<br />

of comprehensive income.<br />

A detailed analysis of retirement benefits is set out in note 27 to the<br />

consolidated financial statements.


The retirement benefit obligations net finance cost is analysed<br />

as follows:<br />

<strong>2011</strong><br />

£m<br />

2010<br />

£m<br />

Defined benefit pension plans:<br />

Expected return on plan assets 142 144<br />

Interest on plan liabilities (148) (152)<br />

(6) (8)<br />

Retiree medical – interest on liabilities (6) (7)<br />

Cost recognised in the income statement on<br />

(12) (15)<br />

annuitisation of certain US retirement obligations (4) –<br />

Retirement benefit obligations net finance cost (16) (15)<br />

The retirement benefit obligations net finance cost, which is a<br />

non cash accounting charge, increased marginally to £16m from<br />

£15m in the prior year. A charge in respect of historic fair value<br />

movements recognised in the income statement following the<br />

annuitisation of certain US pension obligations was offset by a<br />

lower net finance cost. It is estimated that the overall net finance<br />

cost in 2012 will remain at a similar level.<br />

The total cash payments in respect of retirement benefits are<br />

as follows:<br />

<strong>2011</strong><br />

£m<br />

2010<br />

£m<br />

Defined benefit pension plans 46 27<br />

Other pension plans 10 12<br />

Retiree medical 9 12<br />

Total cash payments 65 51<br />

Cash payments to defined benefit pension plans were higher than<br />

in 2010 mainly as a result of increases in the deficit funding to the<br />

UK and US plans. Based on current actuarial projections, it is<br />

expected that cash contributions to defined benefit pension plans<br />

in 2012 will be at a similar level to <strong>2011</strong>. A triennial valuation<br />

of the UK defined benefit plan was undertaken as at 31 March<br />

<strong>2011</strong>. It is expected, when the valuation is complete, that the plan<br />

will be fully funded at that date. Future funding arrangements are<br />

currently being discussed with the plan trustees.<br />

cash flow<br />

Total free cash flow for the year from continuing operations resulted<br />

in an inflow of £277m compared with £298m for 2010. This lower<br />

inflow primarily reflects an increase in capital expenditure, higher<br />

retirement benefit cash contributions offset by a significant<br />

improvement in underlying operating profit and lower restructuring<br />

charges. Net cash flow was £337m (2010: £212m), including free<br />

cash flow from discontinued businesses, net proceeds from the<br />

disposal of Closures and after paying dividends.<br />

<strong>2011</strong><br />

£m<br />

2010<br />

£m<br />

Continuing operations:<br />

Underlying operating profit 549 513<br />

Depreciation and amortisation 1 191 197<br />

Retirement benefit obligations (41) (27)<br />

Change in working capital (19) (20)<br />

Restructuring costs (19) (41)<br />

Other movements 3 25<br />

Cash generated 664 647<br />

Capital expenditure (net) (226) (181)<br />

Net interest and tax paid (165) (173)<br />

Loan from joint venture 4 5<br />

Free cash flow from continuing operations 277 298<br />

Free cash flow from discontinued operations (32) 18<br />

Free cash flow 245 316<br />

Dividends paid to non controlling interests (1) –<br />

Equity dividends (111) (105)<br />

Business cash flow 133 211<br />

Disposals 2 204 1<br />

Cash flow including borrowings acquired<br />

and disposed 337 212<br />

Share capital changes (18) (6)<br />

Exchange differences 29 (38)<br />

Other non cash movements 24 (24)<br />

Net borrowings at the beginning of the year (1,684) (1,828)<br />

Net borrowings at the end of the year 3 (1,312) (1,684)<br />

1 Excludes amortisation of certain acquired intangibles amounting to £26m (2010: £32m).<br />

2 Disposal proceeds offset by £1m (2010: £nil) in respect of a capital injection in a<br />

joint venture.<br />

3 Net borrowings comprises borrowings £1,838m (2010: £1,881m) less cash and cash<br />

equivalents £412m (2010: £114m) and financing derivatives £114m (2010: £83m).<br />

31<br />

overview<br />

financial statements governance<br />

sustainability<br />

business review


32 <strong>Rexam</strong> annual report <strong>2011</strong> directors’ report<br />

financial review<br />

capital expenditure – continuing operations<br />

<strong>2011</strong> 2010<br />

Capital expenditure (gross) 1 (£m) 227 189<br />

Depreciation and amortisation 2 (£m) 191 197<br />

Ratio (times) 1.19 0.96<br />

1 Capital expenditure is on a cash basis and includes computer software that has been<br />

capitalised.<br />

2 Amortisation excludes £26m (2010: £32m) amortised on patents, customer contracts and<br />

intangibles other than computer software.<br />

Gross capital expenditure by continuing operations was £227m,<br />

c 1.2 times depreciation and amortisation, of which approximately<br />

70% was attributable to strategic and growth projects. The<br />

principal projects in Beverage Cans were to support growth<br />

in South America, the development of specialty can products,<br />

a new plant in Finland, the conversion of three lines from steel<br />

to aluminium in Spain, Egypt and India and the introduction of<br />

a lightweight end in response to market developments and<br />

customer requirements. Plastic Packaging investment continued<br />

to be focused on new product development.<br />

It is expected that capital expenditure from continuing operations<br />

in 2012 will be around £300m, 1.5 times depreciation and<br />

amortisation.<br />

balance sheet and borrowings<br />

As at<br />

31.12.11<br />

£m<br />

As at<br />

31.12.10<br />

£m<br />

Goodwill and other intangible assets 2,177 2,231<br />

Property, plant and equipment 1,590 1,571<br />

Retirement benefits (net of tax) (371) (317)<br />

Net assets classified as held for sale 2 232<br />

Other net assets 233 292<br />

3,631 4,009<br />

Total equity, including non controlling interests 2,319 2,325<br />

Net borrowings1 1,312 1,684<br />

3,631 4,009<br />

Return on capital employed2 (%) 13.7 12.3<br />

Net borrowings/EBITDA 3 (times) 1.8 2.4<br />

Interest cover4 (times) 6.0 4.5<br />

Gearing5 (%) 57 72<br />

1 Net borrowings comprise borrowings, cash and cash equivalents and certain derivative<br />

financial instruments.<br />

2 Underlying operating profit plus share of associates and joint ventures profit after tax of<br />

continuing and discontinued operations divided by the average of opening and closing<br />

of shareholders’ equity after adding back retirement benefit obligations (net of tax) and<br />

net borrowings.<br />

3 Based on net borrowings divided by underlying operating profit plus depreciation and<br />

amortisation from continuing operations, excluding amortisation of certain acquired<br />

intangible assets.<br />

4 Based on underlying operating profit of continuing operations divided by underlying net<br />

interest expense.<br />

5 Based on net borrowings divided by total equity including non controlling interests.<br />

The level of net borrowings at 31 December <strong>2011</strong>, down by £372m<br />

compared with the previous year, primarily reflects strong cash<br />

flow and favourable impact of currency translation and other<br />

non cash movements. The currency denomination of our net<br />

borrowings, including financing derivatives, is as follows:<br />

As at<br />

31.12.11<br />

£m<br />

As at<br />

31.12.10<br />

£m<br />

US dollar 1,051 1,424<br />

Euro 439 299<br />

Sterling and other (178) (39)<br />

Net borrowings 1,312 1,684<br />

For the management of foreign currency asset matching and<br />

interest rate risk, the profile of gross borrowings is 68%<br />

(2010: 75%) in US dollars, 32% (2010: 22%) in euros and nil%<br />

(2010: 3%) in other currencies.<br />

Our net borrowings/EBITDA based on continuing operations<br />

has strengthened from 2.4 times in 2010 to 1.8 times following<br />

the reduction in net borrowings and improvement in underlying<br />

operating profit. Interest cover is at 6 times and we remain<br />

comfortably within our debt covenants. Our liquidity is strong<br />

with committed debt headroom of over £1.2bn at the year end.<br />

At 31 December <strong>2011</strong>, the Group’s principal committed loan and<br />

bank facilities totalled some £2.6bn in varying currencies and<br />

maturities, as detailed below:<br />

Currency Maturity<br />

Facility<br />

£m<br />

Subordinated bond Euro swapped to US$ 2067 654<br />

Revolving credit facility Multi currency 2016 602<br />

Bilateral credit facilities<br />

US private placement<br />

Multi currency 2016 207<br />

and bond US$ 2013 503<br />

Medium term note Euro 2013 536<br />

Bilateral credit facilities<br />

Total committed loan<br />

Multi currency 2012 50<br />

and bank facilities 2,552<br />

Following the disposal of Closures, and to take advantage of<br />

prevailing market conditions, the revolving credit facility and<br />

certain bilateral credit facilities were amended during the year.<br />

Their maturity was extended to November 2016 with options to<br />

extend by a further two years, the level of facilities was reduced<br />

by £219m and ongoing commitment fees were lowered.


Net borrowings include interest accruals and certain financial<br />

derivatives as set out below:<br />

As at<br />

31.12.11<br />

£m<br />

As at<br />

31.12.10<br />

£m<br />

Net borrowings excluding derivative<br />

financial instruments 1,426 1,767<br />

Derivative financial instruments (114) (83)<br />

Net borrowings 1,312 1,684<br />

Derivative financial instruments comprise instruments relating to<br />

net borrowings (cross currency and interest rate swaps) and those<br />

related to other business transactions (forward commodity and<br />

forward foreign exchange deals). Total derivative financial<br />

instruments are set out below:<br />

As at<br />

31.12.11<br />

£m<br />

As at<br />

31.12.10<br />

£m<br />

Cross currency swaps 110 82<br />

Interest rate swaps 4 3<br />

Foreign exchange forward contracts – (2)<br />

Derivative financial instruments included<br />

in net borrowings 114 83<br />

Other derivative financial instruments (55) 47<br />

Total derivative financial instruments 59 130<br />

The increase in the value of cross currency swaps can be mainly<br />

attributed to a decrease in the longer term forward interest rates<br />

and to a decline in the liquidity of the euro. The reduction in value<br />

of other derivatives was due mainly to the fall in aluminium prices.<br />

33<br />

overview<br />

financial statements governance<br />

sustainability<br />

business review


34 <strong>Rexam</strong> annual report <strong>2011</strong> directors’ report<br />

key risks<br />

enterprise risk management<br />

Effective management of risk is essential to<br />

the achievement of our business objectives<br />

and to the protection of our people, assets<br />

and reputation. Identifying, assessing<br />

and managing risks is integral to the way<br />

we run our business. It is part of our focus<br />

on operational excellence and best<br />

performance which are key priorities for<br />

the Group. The various risks attached to our<br />

activities are consistently assessed, recorded<br />

and reported in a visible, structured and<br />

continuous manner to ensure necessary<br />

controls are in place.<br />

<strong>Rexam</strong> risk management process<br />

<strong>Rexam</strong> objectives<br />

risk identication<br />

risk assessment<br />

risk mitigation<br />

risk reporting<br />

risk monitoring<br />

development<br />

<strong>Rexam</strong> risk management process<br />

The enterprise risk management function reports directly to<br />

the chief executive. The function serves to further improve the<br />

integration and efficiency of our risk management framework and,<br />

in doing so, to address the increased demands and requirements<br />

from external and internal stakeholders. It draws together our risk<br />

based responsibilities and enhances the good risk management<br />

process and practices already in place across the Group.<br />

This section describes our well established risk management<br />

process including the enhancements made during <strong>2011</strong>,<br />

and outlines the main factors that may affect the implementation<br />

and execution of our strategy.<br />

<strong>Rexam</strong> objectives<br />

The purpose of the <strong>Rexam</strong> risk management process (known<br />

internally as the ARC process) is to support achievement of <strong>Rexam</strong>’s<br />

overall objective to deliver shareholder value. Although risk can<br />

never be eliminated, the process aims to identify and set<br />

appropriate mitigation responses for the key risks faced by <strong>Rexam</strong>.<br />

The approach is based around the ISO 31000 risk management<br />

process and on both the bottom up and top down assessments<br />

of strategic, financial and operational risks.<br />

risk identification<br />

The first stage of our risk management process is to identify the<br />

risks faced by <strong>Rexam</strong>. This is initially a bottom up process with<br />

business units and functions undertaking a biannual process of<br />

risk identification. Risk workshop sessions, current risk registers,<br />

intelligence on risks identified by other companies and a risk<br />

categorisation check list are used to structure and support the<br />

process. The enterprise risk management function leads and<br />

supports the process but is also there to challenge the findings.<br />

Executive directors and other senior leaders are closely involved<br />

at critical stages in the process. They review, challenge and debate<br />

the risks identified from a top down perspective. The resultant<br />

output is a list of risks faced by <strong>Rexam</strong> for each business unit and<br />

function – the risk register.


isk assessment<br />

The next stage involves the assessment of each identified risk on<br />

the register in terms of its likelihood of occurring, and the impact<br />

on <strong>Rexam</strong> if the risk does occur. Performing an assessment of<br />

likelihood and impact at both a gross and net level (before and<br />

after the effect of mitigation) enables us to identify the key material<br />

risks for each business and function and consider the effect of current<br />

mitigations on reducing risk. To aid assessment we use specific tools,<br />

such as the Heat Map Matrix and Radar, to illustrate the impact<br />

and likelihood of different risks, and to show their trend over time.<br />

Images of these tools are shown below for illustrative purposes<br />

<strong>Rexam</strong> risk management tool – radar<br />

Risk 9<br />

Risk 8<br />

Risk 10<br />

Risk 7<br />

Risk 1<br />

Risk 6<br />

■ Year 1 ■ Year 0<br />

Risk 2<br />

Risk 5<br />

Risk 3<br />

Risk 4<br />

<strong>Rexam</strong> risk management tool – heat map matrix<br />

impact<br />

of risk<br />

Major<br />

Signicant<br />

Moderate<br />

Minor<br />

Insignicant<br />

Rare Unlikely Moderate Likely Almost<br />

certain<br />

likelihood of risk occurring<br />

■ Very high ■ High ■ Medium ■ Low<br />

risk mitigation response<br />

Once risks have been assessed an appropriate mitigation response<br />

is determined for each risk identified. The mitigation response will<br />

depend upon the impact and likelihood assessment and, for<br />

example, may consist of a control action or insurance. The risk<br />

mitigation response reduces either the likelihood of the risk<br />

occurring or the impact on <strong>Rexam</strong> if the risk does occur or both.<br />

risk reporting<br />

When we have assessed the risks and the responses have been<br />

determined, each business unit and function provides a risk report<br />

to the enterprise risk management function. These reports are<br />

considered together and a Group level risk register is produced<br />

showing the key risks to <strong>Rexam</strong> and key mitigation responses.<br />

Ownership of each key Group risk is allocated to a member of<br />

the executive leadership team.<br />

35<br />

overview<br />

financial statements governance<br />

sustainability<br />

business review


36 <strong>Rexam</strong> annual report <strong>2011</strong> directors’ report<br />

key risks<br />

risk monitoring<br />

The Group level risk register is monitored by the board through<br />

a monthly report which updates on the trend of the key risk and<br />

mitigations. During <strong>2011</strong> this monthly report was enhanced by<br />

the addition of ‘key risk indicators’ to support the monitoring of risk<br />

trends. The executive leadership team, the audit and risk committee<br />

and the board all review the output from the risk management<br />

process on a periodic basis. The audit and risk committee also<br />

reviews the overall risk management process itself. The main<br />

mitigation activities for key identified risks are used as an input<br />

to determine coverage under the annual internal audit plan.<br />

development<br />

We are looking continually to improve our risk management<br />

process. During <strong>2011</strong>, a project to determine future development<br />

opportunities considered external best practices and the following<br />

were implemented:<br />

heat map matrix<br />

This tool was developed along best practice lines into a 5 by 5<br />

impact and likelihood matrix. The risk assessment process groups<br />

risks into four areas of ‘very high’, ‘high’, ‘medium’ and ‘low’ and<br />

the matrix uses a colour coding to illustrate this at both a gross and<br />

net assessment level. The new matrix also considers risks with non<br />

financial impact, such as reputational and health and safety,<br />

to avoid solely focusing on the financial impact of risks.<br />

risk descriptions<br />

The way risks are described within the process was made<br />

consistent and a requirement to describe risk drivers and<br />

consequences was added. This aids analysis and also the creation<br />

of mitigation plans by considering the factors driving risks.<br />

risk mitigations actions form<br />

The risk mitigation section of the process was developed to<br />

support improved tracking and follow up of mitigations by<br />

business units and functions to ensure they are in place and<br />

having the required effect.<br />

behaviour based safety programme<br />

The behaviour based safety programme (BBS) was devised to<br />

encourage <strong>Rexam</strong>’s plant employees to focus on safety during<br />

their daily activities. During <strong>2011</strong> we enhanced the ‘safety<br />

bingo’ initiative which was designed to recognise employees<br />

and plants that were actively participating in the ‘good<br />

behaviour’ programme. Its main objective was to reinforce<br />

<strong>Rexam</strong>’s commitment to its employees’ safety, and highlight<br />

how important each person’s behaviour is in preventing<br />

accidents. <strong>2011</strong> was the year when the plants that use it really<br />

got to see the results of a well implemented BBS programme.<br />

The employees’ level of engagement and safety awareness<br />

was higher than ever, which enabled some plants to achieve<br />

outstanding performance. In total more than 70% of our sites<br />

did not have a lost time accident in <strong>2011</strong>.<br />

“In the Jacareí beverage can plant in South America, BBS is a<br />

tool that promotes a change in culture and motivates employees<br />

to protect themselves and their peers. Pointing out unsafe<br />

behaviour is important, but recognising safe behaviour<br />

strengthens our vision of safety,” said Rui Cesar Silva,<br />

Production Manager, Jacareí.<br />

The overall BBS programme has ambitious targets and<br />

innovations for 2012 and will be strengthened across <strong>Rexam</strong>.<br />

legislative risk monitoring tool<br />

The legislative framework of the countries in which we operate<br />

and sell products is evolving constantly as new governments<br />

are elected and the profiles of different issues are raised.<br />

From experience, we know that a small percentage of any<br />

new legislation could have an impact on our business, through<br />

increased costs or changes to markets. The main risk to the<br />

business is legislation that is primarily focused on our products<br />

(ie packaging), but legislation that is designed to address other<br />

issues can have an indirect effect on our markets (eg taxes on<br />

certain food and drink products).<br />

In <strong>2011</strong> our Beverage Can Europe & Asia sector established<br />

a team from across our European operations which monitors<br />

proposed changes to existing legislation and proposed new<br />

legislation to assess its impact on our business. This enables<br />

us to understand and reduce the risks associated with any<br />

proposed changes to legislation and focus resources to mitigate<br />

these potential risks where appropriate. In 2012 this approach<br />

will be rolled out across <strong>Rexam</strong>.


summary of key Group risks<br />

Set out in the tables below (in no particular order) is a summary<br />

of the key risks for the Group as a whole. Although the global<br />

financial and economic situation has heightened many risks and<br />

exposed new ones, the challenge remains the same in terms of<br />

identifying the most relevant risks, assessing their impact and<br />

importance and developing appropriate methods to eliminate<br />

or mitigate them.<br />

The tables provide brief descriptions of the key types of risk to<br />

which the Group is exposed and identifies, in each case, their<br />

potential impact on the Group and the principal processes in place<br />

risk description key mitigation<br />

Economic downturn The risk of economic downturn in <strong>Rexam</strong>’s<br />

key markets and its impact upon demand<br />

for consumer packaging. This risk has<br />

trended higher through <strong>2011</strong> following<br />

concerns over growth and debt levels in<br />

Western economies leading to reduced<br />

GDP growth forecasts.<br />

Aluminium and other<br />

input cost increases<br />

Aluminium is our most significant raw material<br />

cost. Resin is also important to us and we<br />

purchase steel for our European beverage<br />

can operation. High volatility in input prices<br />

may have a material impact on our results.<br />

One consequence of a substantial rise could<br />

be a change in demand for our products as<br />

customers adjust their packaging mix and the<br />

materials they use. This risk has trended higher<br />

through <strong>2011</strong> as, despite easing somewhat in<br />

the final quarter, commodity prices have been<br />

higher overall in <strong>2011</strong>, thus flowing through<br />

into inflationary pressure.<br />

to manage and mitigate the risk. Each risk is specifically owned<br />

by a member of the executive leadership team. The tables do not<br />

provide an exhaustive analysis of all risks affecting the Group.<br />

Not all of the factors listed are within the control of the Group and<br />

other factors besides those listed may affect the performance of<br />

its businesses. Some risks may be unknown at present and other<br />

risks, currently regarded as immaterial, could turn out to be<br />

material in the future. Further information on the process by which<br />

risk is managed and reported is covered in the risk management<br />

and internal control section in the corporate governance report<br />

(pages 64 and 65).<br />

In line with the strategic priority of best performance,<br />

<strong>Rexam</strong> closely manages capital investment and<br />

is focused on maximising utilisation of its assets.<br />

Furthermore, in response to the increasing trend<br />

of this risk, we use scenario planning within our<br />

budgeting and planning processes to help identify<br />

mitigation actions which would be implemented should<br />

this risk increase further.<br />

In beverage cans, almost all of our aluminium ingot<br />

needs are on a pass through basis or hedged. In the<br />

Americas businesses, we charge the majority of our<br />

customers on a pass through basis while in Europe 75%<br />

of our supply costs are on this basis. To mitigate the risk<br />

on the remaining aluminium ingot exposure, we hedge<br />

the aluminium cost and associated currency<br />

requirements. The pass through and hedge risk<br />

management applies to metal ingot but not the can sheet<br />

which is covered by long term supply contracts.<br />

We purchase aluminium and steel from a small number<br />

of regional and global suppliers with whom we have<br />

long term relationships and contracts.<br />

In plastic packaging, over 80% of the resin costs are<br />

on a pass through basis which includes resin escalator/<br />

de‑escalator provisions that allow change in our selling<br />

price as resin prices change. Where possible, we also<br />

hedge some of our resin exposure.<br />

37<br />

overview<br />

financial statements governance<br />

sustainability<br />

business review


38 <strong>Rexam</strong> annual report <strong>2011</strong> directors’ report<br />

key risks<br />

risk description key mitigation<br />

National political and<br />

economic stability<br />

Competitive<br />

environment trends<br />

Changes in packaging<br />

legislation and regulatory<br />

environment<br />

the risk council<br />

The risk of political or economic instability<br />

within a region that <strong>Rexam</strong> operates in and<br />

its impact on performance. <strong>Rexam</strong> operates<br />

in countries and regions with diverse<br />

economic and political conditions and<br />

sensitivities. Our expansion in emerging<br />

markets, as well as the regional political<br />

instability and civil unrest seen through<br />

<strong>2011</strong>, means that the trend of this risk<br />

is increasing.<br />

The risk of adverse commercial impact upon<br />

<strong>Rexam</strong> from customer and competitor activities.<br />

This risk can be driven by dependency on key<br />

customers, competitor activity, price pressure<br />

or contract negotiations.<br />

The risk of changing legislation impacting<br />

the markets in which <strong>Rexam</strong> operates.<br />

Packaging will continue to be a focus for<br />

government legislators working within<br />

the sustainability agenda. Changes in<br />

packaging legislation and regulation<br />

affecting producer responsibility for<br />

recycling, recycled content, carbon<br />

footprint and landfill taxation represent<br />

an increasing trend risk.<br />

Emerging market risks are assessed in detail<br />

by management when considering investment<br />

opportunities and setting financial policies and<br />

procedures. These risks are then regularly reviewed<br />

as part of the ongoing management of our business.<br />

We also take external advice on specific matters and<br />

use local external advisors. We will continue to carry<br />

out reviews of key risk areas both internally and with<br />

external expert support.<br />

Many of our largest customers have traded with us for<br />

many years, during which time we have built up a strong<br />

interdependency and sense of partnership and added<br />

production capacity to strengthen our footprint. These<br />

relationships and investments increase the likelihood of<br />

retaining customers. We continue to focus on providing<br />

value adding service and innovation as well as competitive<br />

performance which are key parts of our strategic focus<br />

of strengthening our customer relationships.<br />

<strong>Rexam</strong> continually monitors changes or proposed<br />

changes in laws or regulations that may adversely<br />

affect our business if implemented arbitrarily. This is<br />

done through established and effective membership of<br />

relevant trade associations, by direct collaboration with<br />

governmental and non governmental organisations and<br />

through our own efforts which include a new legislative<br />

risk monitoring tool that was introduced in <strong>2011</strong> as<br />

described on page 36. This ensures the best possible<br />

chance of shaping a constructive outcome which<br />

is not detrimental to <strong>Rexam</strong> or our stakeholders.<br />

A key development action in <strong>2011</strong> was the creation of the Risk Council. The team meets quarterly and consists of a senior management<br />

representative from each of <strong>Rexam</strong>’s business units along with key people from the enterprise risk management and internal audit functions.<br />

The team is responsible for supporting the development and implementation across the Group of agreed enhancements in enterprise risk<br />

management and to facilitate best practice sharing and implementation of processes, tools, mitigation plans and controls. The team also oversees<br />

and supports the <strong>Rexam</strong> risk management process with the representative from each of the business units leading the risk management work in their<br />

respective area. This enhanced governance structure has helped us to integrate and develop risk management across the business, for example<br />

by supporting and implementing the developments in the risk management process and sharing best practice mitigations such as the legislative risk<br />

monitoring tool (see page 36).


isk description key mitigation<br />

Counterparty failure Risk of counterparty failure (for example<br />

bank, insurer, customer or supplier) resulting<br />

in financial exposure for <strong>Rexam</strong>. The current<br />

more challenging macroeconomic<br />

environment increases the risk of<br />

counterparty failure.<br />

Changes in consumer<br />

tastes, nutritional<br />

preferences, health<br />

related concerns and<br />

environment related<br />

concerns<br />

The risk of changing consumer trends resulting<br />

in a shift in demand away from products<br />

for which <strong>Rexam</strong> manufactures packaging.<br />

Drivers of this risk can include lifestyle<br />

and taste change, nutrition and health<br />

considerations or environmental concerns.<br />

Pension deficit Risks relate to cash contributions, charges<br />

to the income statement and balance<br />

sheet volatility.<br />

A range of financial counterparties are used and<br />

we have strict limits on our exposure to each of them.<br />

These limits are determined by a range of qualitative<br />

and quantitative measures that are embedded into our<br />

treasury system such that any breaches are automatically<br />

reported. The limits are automatically updated by factors<br />

such as credit rating change and also reviewed regularly<br />

for any qualitative changes. The risk of insurer failure<br />

is monitored by our insurance broker and reported<br />

regularly. Customer credit limits are imposed and<br />

their credit risk, as well as that of suppliers, is reviewed<br />

and monitored. In addition, we have procedures across<br />

the business to manage working capital tightly.<br />

We continue to monitor market and consumer trends<br />

as well as political developments through our own and<br />

external business intelligence services and through our<br />

involvement in national and international packaging<br />

associations in the countries and regions where<br />

we operate.<br />

<strong>Rexam</strong>’s retirement benefit risk management is overseen<br />

by the retirement benefits committee (RBC) which<br />

is chaired by the finance director. The RBC reviews<br />

all proposed new promises for and improvements to<br />

retirement benefits. Managing pension deficit volatility<br />

on the balance sheet and general de‑risking of funded<br />

plans, which includes equity, interest rate and inflation<br />

risk are undertaken by pension plan fiduciaries in<br />

consultation with the RBC. Cash contributions are paid<br />

having regard for regulatory requirements in the<br />

countries in which the respective plans operate.<br />

39<br />

overview<br />

financial statements governance<br />

sustainability<br />

business review


40 <strong>Rexam</strong> annual report <strong>2011</strong> directors’ report<br />

key risks<br />

risk description key mitigation<br />

Business interruption Every business faces the potential risk of<br />

its operations being impacted by disruption<br />

due to loss of supply, industrial disputes,<br />

failures with technology, physical damage<br />

as a result of fire, flood or other such event.<br />

Environmental, fire,<br />

health and safety<br />

The risk of a significant environmental<br />

contamination, fire or health and safety<br />

issue at one of our locations which can<br />

have an impact on the safety of our<br />

employees, or on our financial situation or<br />

our reputation.<br />

As part of our strategic focus on operational excellence,<br />

<strong>Rexam</strong> has established protocols and procedures across<br />

the Group as a whole such that plans are in place to<br />

ensure business continuity in our operations. Strong<br />

relationships with customers and suppliers mean that,<br />

where possible, there are arrangements in place to<br />

ensure alternative sources of supply or production for<br />

critical product lines. <strong>Rexam</strong> also has insurance in place<br />

to cover losses associated with interruption to business<br />

for a limited period as a result of property damage<br />

or supply failure.<br />

We carry out regular environment, health and safety<br />

(EHS) audits in cooperation with internal and external<br />

specialists to drive the plants to best practice. The audit<br />

approach was developed through <strong>2011</strong> to provide the<br />

basis for delivering a more sustainable and robust<br />

improvement of EHS management systems and<br />

performance at all sites.<br />

In addition we introduced a high standard fire safety<br />

and property protection audit supported and performed<br />

by AXA Matrix, an independent provider of such<br />

services.


isk description key mitigation<br />

Supply of faulty or<br />

contaminated products<br />

<strong>Rexam</strong>’s reputation as a business partner relies<br />

heavily on its ability to supply quality products<br />

on time and in full. The consequences of not<br />

being able to do so could be severe. Such<br />

consequences might include adverse effects<br />

on consumer health, loss of market share,<br />

financial costs and loss of turnover.<br />

Tax risks In an increasingly complex international tax<br />

environment, some uncertainty is inevitable<br />

in estimating our tax liabilities.<br />

Fraud, bribery, internal<br />

control failure<br />

The risk of an internal control failure such<br />

as a <strong>Rexam</strong> employee committing fraud<br />

or bribery.<br />

Funding Risks related to the cost and availability of funds<br />

to meet our business needs, movements in<br />

interest rates, foreign currency exchange rates<br />

as well as commodity prices. Improvement in<br />

balance sheet metrics through <strong>2011</strong> means this<br />

risk has a reducing trend, but it remains a key<br />

risk for <strong>Rexam</strong>.<br />

Within our strategic focus on operational excellence we<br />

have strict control measures and externally accredited<br />

systems in place to ensure that the safety and quality of<br />

our products are maintained. <strong>Rexam</strong> also has insurance<br />

in place to cover legal liabilities to third parties<br />

associated with product liability.<br />

We seek to plan and manage our tax affairs efficiently<br />

in the jurisdictions in which we operate. Tax planning<br />

will complement and be based around the needs of our<br />

operating businesses. We exercise our judgement in<br />

assessing the required level of provision for tax risk and<br />

allocate resources appropriately to protect our position.<br />

The <strong>Rexam</strong> Code of Conduct provides a framework<br />

for all of our policies at Group, sector and individual<br />

business level. Training is also carried out in key areas<br />

such as the antibribery policy, to ensure that employees<br />

are aware of their responsibilities. A Group control<br />

framework, setting out key financial controls to be<br />

applied across the Group, is being developed for<br />

implementation in 2012 in order to ensure consistency<br />

and further enhance the control environment.<br />

<strong>Rexam</strong>’s Raise Your Concern helpline also allows<br />

employees to raise anonymously any concerns<br />

regarding behaviour that does not conform with<br />

<strong>Rexam</strong> policies.<br />

<strong>Rexam</strong>’s financial risk management is based upon sound<br />

economic objectives and good corporate practice. <strong>Rexam</strong><br />

negotiates funding requirements in a timely manner ensuring<br />

appropriate headroom is secured to mitigate availability risk.<br />

Derivative and other financial instruments are used to<br />

manage exposures under conditions identified by the board<br />

and monitored by its finance committee. In response to the<br />

current instability in Europe a ‘euro crisis committee’ has been<br />

established to monitor risks, create contingency plans and<br />

take actions as appropriate. Further details of our financial<br />

risks and the way in which we mitigate them are set out in<br />

note 26 to the consolidated financial statements.<br />

41<br />

overview<br />

financial statements governance<br />

sustainability<br />

business review


42 <strong>Rexam</strong> annual report 2010<br />

directors’ report<br />

sustainability<br />

<strong>Rexam</strong> Healthcare’s core expertise lies in injection<br />

moulding and high speed automated assembly<br />

in compliance with Good Manufacturing Practice.


This section provides a review of our<br />

sustainability performance in <strong>2011</strong>.<br />

It explains our approach to and progress<br />

in this area, and details our commitments,<br />

measures and targets going forward.<br />

44 products<br />

47 operations<br />

49 people<br />

43<br />

overview<br />

financial statements governance<br />

sustainability<br />

business review


44 <strong>Rexam</strong> annual report <strong>2011</strong> directors’ report<br />

sustainability<br />

We believe that running our business<br />

sustainably is essential to near term success<br />

and long term prosperity. Our Group vision<br />

is to be the best global consumer packaging<br />

company and this includes our actions in<br />

and around sustainability, encompassing<br />

products, operations and people.<br />

Our customers look for partners who take<br />

their corporate responsibilities seriously.<br />

Our approach has been to identify realistic<br />

goals that our customers can depend upon<br />

as they seek to reduce the environmental<br />

impacts of the products they commercialise<br />

and to assure an ethical supply chain.<br />

products: enhanced value<br />

operations: efficient use of resources<br />

people: engaged employees<br />

<strong>Rexam</strong> remains an established member of the London Stock Exchange<br />

FTSE4Good index, an international responsibility performance<br />

benchmark. The index’s expectations mirror the way we believe<br />

business should be conducted to deliver sustainable success<br />

through environmental management, upholding human and labour<br />

rights, ethical business practices and supply chain labour standards.<br />

Line management responsibility for sustainability sits in the<br />

Group’s executive leadership team, and at the start of 2012 we<br />

appointed a director of group sustainability within the corporate<br />

affairs function.<br />

Following earlier work to determine the main issues relevant to us<br />

and our stakeholders, in <strong>2011</strong> we further developed our<br />

sustainability framework, built around our 12 specific commitments<br />

on products, operations and people, identifying the most<br />

appropriate quantifiable measures and objectives for these<br />

commitments and agreeing stretching targets for each measure.<br />

products: enhanced value<br />

Primary packaging is designed to prevent waste and to get<br />

customers’ products efficiently and safely into consumers’ hands.<br />

It is an essential component of a modern and sustainable society,<br />

where consumers place a high priority on convenience.<br />

By its very nature, however, packaging is highly visible and in a<br />

world of scarce resources it is something that can attract negative<br />

attention from some consumers, media and environmentalists.<br />

<strong>Rexam</strong> is aware of the need to review and optimise the<br />

environmental performance of its packaging with respect to all<br />

relevant life cycle stages. But this analysis of environmental impacts<br />

must include the effects of product losses that might result from the<br />

use of too little packaging as well as that of using too much.<br />

Working across the complete supply chain, finding the balance<br />

between under‑packaging and over‑packaging, is at the heart of<br />

our approach and is the key to ensuring packaging continues to<br />

make a positive contribution to a sustainable society.<br />

The availability of raw materials is vital to <strong>Rexam</strong>’s future and we<br />

are taking more ownership for their sustainability. The strategy for<br />

our different raw materials is similar in terms of conservation and<br />

efficiency but is different in terms of end of life recycling/recovery<br />

or substitution.<br />

Beverage cans are made entirely from metal, principally aluminium<br />

and some steel. Both materials are permanent, ie the metal is both<br />

fully recoverable and recyclable as an infinitely reusable material.<br />

Independent life cycle studies confirm that promoting and supporting<br />

an increase in recycling rates is the most valuable contribution to<br />

sustainability that beverage can manufacturers can make.


For plastics, we recognise that fossil fuels are a finite resource and<br />

we design for recycling and use recycled products as raw materials<br />

wherever feasible. As plastic has a high energy content, and its<br />

CO2 emissions are some 25% less than coal, we also support<br />

the use of energy recovery from waste as a means to providing<br />

an environmentally beneficial solution to managing plastic<br />

packaging waste.<br />

we will promote and support the most relevant recycling<br />

and value recovery system for our products<br />

Across our beverage can sectors our vision is to keep the metal<br />

in a closed material loop: our aim is for zero cans ending up in<br />

landfill following consumers’ use of the product. This makes good<br />

economic sense due to the high value of the materials, more than<br />

covering the cost of their collection, as well as environmental sense<br />

with up to 95% of the energy needed for primary production<br />

saved. As metal can be continually reused, every tonne of recycled<br />

material offsets the need to use a tonne of virgin raw material.<br />

Many countries in which we operate have well established<br />

recycling infrastructures that function efficiently. In those markets<br />

that require long term support to establish and enhance collection<br />

mechanisms and build a recycling culture with consumers we are<br />

committed to providing this support.<br />

the consumer goods forum<br />

In <strong>2011</strong> the Consumer Goods Forum released the Global<br />

Protocol on Packaging Sustainability to enable the consumer<br />

goods industry to better assess the relative sustainability of<br />

packaging. This endorsed the Innventia AB model which shows<br />

that the environmental consequences of product losses caused<br />

by excessive packaging reduction are far greater than<br />

guaranteeing adequate protection through an incremental<br />

excess of packaging.<br />

Negative<br />

environmental<br />

impact<br />

Under-packaging<br />

Over-packaging<br />

Minimum<br />

material<br />

Optimum pack design<br />

Minimum<br />

environmental<br />

impact<br />

Increasing packaging<br />

material weight or volume<br />

1 Derived from ‘Environmental Impact of Packaging: Performance in the<br />

Household’ report by Dr Jan Kooijman, Food Technology Consulting.<br />

source: source: The The Consumer Consumer Goods Goods Forum<br />

Forum<br />

‘In <strong>2011</strong>, we reduced our total carbon intensity per<br />

kilogramme of raw material converted by 3.5% to<br />

0.83 CO2 equivalent (2010: 0.86 CO2 equivalent)<br />

underpinned by further reductions in our electricity<br />

and gas consumption.’<br />

Graham Chipchase chief executive<br />

The Every Can Counts (ECC) programme, which <strong>Rexam</strong> funds and<br />

helps manage, has continued to expand in Europe. Its goal is to<br />

encourage the recycling of beverage cans used outside the home,<br />

in the workplace and on the go. For example, in <strong>2011</strong>, 10 UK music<br />

festivals actively supported ECC with over 1,000,000 cans<br />

recycled after c 500,000 young people participated. ECC now<br />

operates in four countries with low recycling rates and further<br />

expansion is planned for 2012.<br />

As detailed on page 51, our businesses in Europe, North and<br />

South America cooperated with local organisations and charities<br />

to promote recycling within their sites’ local communities.<br />

In Plastic Packaging we have initiated a taskforce to create<br />

an eco design scorecard that recognises the importance of<br />

recyclability and the use of recycled materials. Any new product<br />

that we introduce in the future will be measured against this<br />

scorecard in order to determine its sustainability credentials.<br />

key measures and targets<br />

The key measures for this commitment are the average can<br />

recycling rates in our major markets and, going forward, how<br />

our new plastic packaging products measure up against our<br />

eco design scorecard.<br />

Recycling rates for beverage cans vary across countries, due to<br />

different operating environments, culture and lifestyles. We report<br />

these together with the targets set by industry associations of which<br />

we are a member.<br />

Beverage<br />

can average<br />

recycling<br />

rates (%)<br />

2015 targets 2010 2009 2008 2007<br />

Europe 75 n/a1 68 68 66<br />

USA 63 58 57 54 54<br />

Brazil 98 98 98 91 96<br />

1 European 2010 recycling rates will be published mid 2012.<br />

We intend to incorporate the eco design scorecard into the<br />

new product development process within Healthcare and to<br />

have 100% of potential new products being evaluated by the<br />

end of 2012.<br />

45<br />

overview<br />

financial statements governance<br />

sustainability<br />

business review


46 <strong>Rexam</strong> annual report <strong>2011</strong> directors’ report<br />

sustainability<br />

we will work with policymakers to ensure packaging<br />

makes a positive contribution to sustainability<br />

<strong>Rexam</strong> is an active member of various national and international<br />

industry and research associations as well as trade bodies,<br />

encompassing our beverage cans and plastic packaging<br />

operations, who engage with policymakers on our behalf.<br />

These often draw their membership from the whole supply<br />

chain so that they have a cohesive constructive approach<br />

to policy issues at national, regional and local levels.<br />

<strong>2011</strong> saw the launch of Metal Packaging Europe (MPE),<br />

established by senior executives from the major aluminium, steel<br />

and packaging converter companies. MPE brings together metal<br />

packaging manufacturers, metal producers and their existing trade<br />

associations to promote the unique strengths of metal packaging<br />

to help address the social, environmental and policy challenges<br />

faced by the industry.<br />

In our beverage can business in Europe, we piloted a legislative<br />

and environmental risk assessment and mitigation management<br />

system. This ensures that policy issues impacting our business are<br />

identified, their potential impact assessed and appropriate risk<br />

mitigation strategies put into place. This highlighted a number of<br />

policy risks which together with mitigation strategies were shared<br />

with senior executives in the business as part of the overall risk<br />

management process. We aim to expand this system across the<br />

whole Group in 2012.<br />

key measure and target<br />

Our key measure is the percentage of mitigation plans in place<br />

against identified risks with regard to legislative, regulatory and<br />

environmental issues across all of our regions. Our target is 100%.<br />

metal is forever<br />

Metal offers infinite recycling<br />

possibilities while preserving<br />

virgin metal qualities and<br />

providing unlimited availability<br />

for future generations.<br />

source: Metal Packaging Europe<br />

we will engage with our customers and the supply chain<br />

to minimise the environmental impact of packaging and<br />

packaged goods<br />

Packaging cannot be taken in isolation. The best way to achieve<br />

lasting improvements in environmental performance is to engage<br />

constructively with our customers and suppliers, seeking solutions<br />

in a partnership approach although priorities may differ. This<br />

provides opportunities for <strong>Rexam</strong> to take a leadership position<br />

through the promotion and application of best practice across the<br />

Group, whether in employee health and safety, lightweighting,<br />

logistics efficiency or packaging optimisation.<br />

Priorities for customers vary from how we treat our employees to<br />

the delivery of lower carbon products where step changes in<br />

materials and closed loop material cycles are sought. Many of our<br />

customers work in partnership with us to progress their corporate<br />

responsibility and sustainability objectives.<br />

Part of our commitment to being a responsible and sustainable<br />

organisation is our membership of the Carbon Disclosure Project<br />

(CDP) as detailed on page 48. A large proportion of the<br />

greenhouse gas emissions related to our packaging comes from<br />

the raw materials we convert. In <strong>2011</strong>, we asked our key suppliers<br />

to participate in the CDP to give us an understanding of our<br />

combined carbon footprint and also to understand where,<br />

together, we can make improvements and drive out cost.<br />

During the second half of <strong>2011</strong> <strong>Rexam</strong> engaged with a third party<br />

to audit our European businesses required to comply with REACH.<br />

A subsequent best practice road map was developed for review<br />

and implementation through 2012.<br />

key measures and targets<br />

From 2012, we will report the customer feedback survey results<br />

from sustainability professionals within our client base. We aim<br />

to achieve a consistently ‘good’ score (ie above 7/10).<br />

In <strong>2011</strong>, 50% of our major suppliers signed up to the CDP, and our<br />

target is to increase our supplier response rate to 80% by 2015.


we will meet long term environmental and regulatory<br />

trends with innovative new products<br />

Innovation is critical to our success both commercially and in<br />

terms of underpinning our long term prosperity.<br />

In <strong>2011</strong> we introduced a Global Innovation Council to promote<br />

innovation ideas relating to our products and processes across the<br />

Group’s beverage cans operations. This increased focus and firm<br />

process for sharing ideas will drive future product and process<br />

development. In Plastic Packaging, we launched various new<br />

products, including the PanacheTM spray mechanism, the R shaped<br />

lipstick case and the AdvanciaTM nasal spray.<br />

We continue to research and evaluate the viability of non fossil resins.<br />

key measure<br />

During <strong>2011</strong>, on a statutory accounting basis, we invested £17m in<br />

R&D in continuing operations. This includes design, construction<br />

and testing of preproduction protoypes, models and processes.<br />

Our operations also invested in related new product and process<br />

initiatives which are not reported in this statutory figure. In 2010 we<br />

invested £19m (including £3m in discontinued operations). Going<br />

forward, we shall continue to ensure that our total investment in<br />

R&D remains appropriate to ensure our long term future.<br />

operations: efficient use of resources<br />

<strong>Rexam</strong> has a good record of increasing material efficiency and<br />

reducing energy consumption. In <strong>2011</strong>, we demonstrated our high<br />

standards of operational excellence by nominating several<br />

exemplar plants to be externally verified against the Shingo<br />

assessment, an internationally recognised evaluation of world<br />

class operational excellence. One plant was awarded the<br />

renowned Shingo Prize (see page 23). Underpinning this external<br />

verification, we have an established internal process measuring<br />

lean enterprise progress, with an internal award system of Bronze,<br />

Silver, Gold and Beyond Gold. Ongoing training in lean tools is<br />

well established and integrated into all levels of our plant operating<br />

structure. In <strong>2011</strong>, 70% of our plants (2010: 50%) achieved Gold<br />

or Beyond Gold.<br />

we will improve our material efficiency<br />

We believe that by continuing to share operational best practice,<br />

and applying six sigma and other continuous improvement<br />

methods across the Group, we will be able to achieve <strong>Rexam</strong>’s<br />

vision of best performance both in terms of our financial results<br />

and our environmental record.<br />

This year we have continued to improve on our raw material<br />

efficiency by cutting the tonnes of raw material per tonne of<br />

production to 1.14 (2010: 1.15).<br />

The beverage can is infinitely recyclable and our raw material<br />

includes metal that has been reprocessed many times over.<br />

We have been committed to driving further reductions in terms<br />

of the amount of metal used per can this year, and our persistence<br />

has paid off. We pride ourselves on bringing innovative products<br />

to market, and this year we began to adopt a new lightweight<br />

innovation in Healthcare<br />

Novelia TM is the unique preservative free multidose eye drop<br />

system designed by <strong>Rexam</strong>. Compared with traditional unit<br />

dose solutions, it also significantly reduces the amount of plastic<br />

required, reduces drug wastage by over 90% and also reduces<br />

volume by nearly 90% due to its space efficient design.<br />

90%<br />

supporting beverage customers<br />

in Brazil<br />

We enhanced a customer’s range of 11 juice drinks by printing<br />

fruit images with high quality definition inks which dramatically<br />

increase consumer attractiveness of the brand.<br />

We used tactile inks to help relaunch a major beer brand with<br />

a unique touch effect. This can was recently highlighted in<br />

a case study by a packaging magazine in Brazil.<br />

can end technology which uses 10% less metal compared with<br />

the standard beverage can ends. Across our can making business<br />

our global lightweighting programmes in <strong>2011</strong> resulted in a metal<br />

saving of 10,000 tonnes vs 2010.<br />

Our plastic packaging operations maintained their strong<br />

performance on material efficiency. We also promote actively<br />

the recycling of plastic waste.<br />

key measures<br />

The key measures to monitor our improved material efficiency<br />

are the conversion efficiencies across the Group and the total<br />

annual lightweighting savings for beverage cans. In line with<br />

one of our four core values, we target continuous improvement<br />

in material efficiency.<br />

<strong>2011</strong> 2010 2009<br />

Tonnes of raw Group 1.14 1.15 1.24<br />

material per<br />

tonne of<br />

Beverage Cans 1.16 1.17 1.30<br />

production<br />

Lightweighting<br />

Plastic Packaging 1.07 1.07 1.08<br />

savings (‘000 tonnes) Beverage Cans 10.0 11.7 12.0<br />

47<br />

overview<br />

financial statements governance<br />

sustainability<br />

business review


48 <strong>Rexam</strong> annual report <strong>2011</strong> directors’ report<br />

sustainability<br />

road to rail<br />

Our North American beverage can business is spearheading<br />

a new intermodal freight system that prioritises trains over trucks.<br />

In <strong>2011</strong>, nearly 1,500 truck loads were moved to rail, representing<br />

a 1,700 tonnes saving of CO2.<br />

1,700 tonnes<br />

we will improve our carbon efficiency and reduce the<br />

energy and water we use<br />

We use resources every day, whether it is electricity, natural gas<br />

or water to make our products or fuel to transport them to customers<br />

(sea, road, rail). With this frequent consumption <strong>Rexam</strong> is extremely<br />

conscious of, and committed to, reducing usage.<br />

By focusing on energy consumption reduction and more efficient<br />

supply chain management, we reduced our total CO2 footprint<br />

to 1.00m equivalent tonnes (2010: 1.06m equivalent tonnes).<br />

We are members of the CDP, an international reference<br />

organisation dedicated to reducing industry’s carbon impact<br />

on the environment, and we provided energy consumption and<br />

management data for the <strong>2011</strong> survey (which is the full year<br />

information for 2010).<br />

In <strong>2011</strong>, we set up a project to establish a comprehensive carbon<br />

management system, including emissions which cover indirect<br />

emissions from sources not directly controlled by the organisation.<br />

In the UK, we are registered with two energy/CO2 schemes: the<br />

Climate Change Agreement (CCA) to ensure our compliance with<br />

the Climate Change Levy; and the CRC Energy Efficiency Scheme<br />

which will seek to capture energy usage from non CCA sites. The<br />

majority of our energy usage in the UK is covered by the<br />

longstanding CCA at our UK manufacturing sites and we continue<br />

to comply with the requirements of this scheme.<br />

Although we do not use a large amount of water in our operations,<br />

we recognise the value of this increasingly scarce resource which is<br />

becoming more central to the sustainability strategies of many of<br />

our beverage customers. In our beverage can plants, we reuse the<br />

water needed for washing the cans during the manufacturing<br />

process via closed loop recovery systems. In our plastic packaging<br />

businesses, the water needed for the manufacturing process is<br />

almost negligible.<br />

In <strong>2011</strong> we provided water consumption and management data for<br />

the CDP (Water) survey.<br />

key measures and targets<br />

The key measures we use to monitor our performance in reducing<br />

our use of energy and water, and in improving our carbon<br />

efficiency, are our consumption of resources and carbon intensity<br />

normalised against production.<br />

For Beverage Cans, we measure the reduction in energy used per<br />

tonne of production. In <strong>2011</strong>, we achieved a 3% reduction versus<br />

2010. Our target is to achieve a total reduction of 10% in the<br />

period between 2010 and 2013.<br />

In Plastic Packaging, the amount of energy used per tonne of<br />

production increased by 2% in <strong>2011</strong> driven by lower overall<br />

production volumes. Our target is to achieve a total reduction of<br />

8% in the period between 2010 and 2013.<br />

With regard to our carbon efficiency, we are targeting a reduction<br />

in carbon intensity per kilogramme of raw material converted of<br />

10% between 2010 and 2013.<br />

MWh of gas/electricity<br />

used per tonne of can<br />

production<br />

MWh of gas/electricity<br />

used per tonne of plastic<br />

production1 Total Group carbon<br />

intensity (kg carbon per<br />

kg of raw material<br />

converted) 1<br />

1 Excludes discontinued operations<br />

2013 targets <strong>2011</strong> 2010 2009<br />

–10%<br />

(vs 2010) 2.72 2.80 3.30<br />

–8%<br />

(vs 2010) 2.92 2.85 3.12<br />

–10%<br />

(vs 2010) 0.83 0.86 0.91<br />

In 2012, we will establish the baseline for our water consumption<br />

and then develop targets going forward.<br />

reducing waste in Austria<br />

Our two beverage can plants in Austria have installed a new<br />

filtration system that avoids the creation of filter cake, our<br />

largest waste stream by weight, and which normally goes to<br />

landfill. In <strong>2011</strong> this innovative process avoided approximately<br />

500 tonnes of filter cake waste and prevented the use of<br />

48 tonnes of waste water chemicals.<br />

500 tonnes


we will reduce our waste to landfill<br />

We use lean six sigma tools to drive out waste from our<br />

manufacturing processes. A specific KPI based on the reduction<br />

of waste to landfill is being implemented across the Group to<br />

ensure we are sharing strategies to reduce this towards zero.<br />

In Beverage Cans, the single largest component of our waste to<br />

landfill is a side product from the manufacturing process called<br />

filter cake. There are a number of different approaches depending<br />

on local conditions. In some locations we are able to eliminate filter<br />

cake (see page 48) whereas in others we are diverting this waste<br />

from landfill to an alternative use. An internal project team is<br />

working to roll out the appropriate solutions across the business.<br />

key measure and target<br />

In the short term, we aim to establish a consistent measure of waste<br />

to landfill at all our sites with the immediate objective of reducing<br />

further waste to landfill. Our long term objective is to achieve zero<br />

waste to landfill.<br />

we will improve the environmental performance<br />

of our sites<br />

All our sites have robust Environmental Management Systems (EMS)<br />

in place, and we encourage external verification where appropriate.<br />

Even when external verification is not sought, we adopt EMS, which<br />

are internally verified, that include key elements of ISO 14001.<br />

In <strong>2011</strong>, 100% of our 83 plants were verified against ISO 14001<br />

or equivalent standard (2010: 58%/48 plants).<br />

We target zero significant uncontrolled or abnormal releases,<br />

and delivered this again in <strong>2011</strong>.<br />

In addition to our focus on improving the environmental<br />

performance of our manufacturing plants, we are also acting<br />

to reduce the environmental impact of our office sites. In <strong>2011</strong>,<br />

our North American beverage can headquarters moved into<br />

new offices which we designed and refurbished to exacting<br />

environmental standards. This office has received Leadership in<br />

Energy and Environmental Design (LEED) status, which certifies<br />

that the construction of the new space was completed within<br />

a recommended framework of leading environmental‑friendly<br />

design, construction, operations and maintenance solutions.<br />

key measures and targets<br />

Our measures for <strong>Rexam</strong> sites’ environmental performance are<br />

the amount of uncontrolled or abnormal releases we have, what<br />

percentage of our plants are ISO 14001 certified (or equivalent),<br />

as well how many of our regional/Group offices are<br />

environmentally accredited.<br />

Our long term targets are to continue having zero uncontrolled or<br />

abnormal releases, to continue to have 100% of our plants ISO<br />

14001 certified (or equivalent) and for 100% of our regional/Group<br />

offices to be environmentally accredited.<br />

people: engaged employees<br />

We realise that we can only achieve our vision to be the best global<br />

consumer packaging company with committed, engaged and well<br />

supported employees. We base our approach to, and expectation<br />

of, our employees around our four <strong>Rexam</strong> values of continuous<br />

improvement, recognition, teamwork and trust.<br />

We are committed to ensuring our employees work in a safe, fair<br />

and enjoyable environment. We also encourage our people to be<br />

active members of their local communities. Furthermore, we believe<br />

investing in our people: providing the resources, environment and<br />

opportunity for them to develop their skills and capabilities is<br />

integral to our vision.<br />

we will make sure our people work in a safe and<br />

healthy environment<br />

<strong>Rexam</strong> is dedicated to implementing world‑class environmental,<br />

health and safety processes and culture across the Company.<br />

In <strong>2011</strong>, our health and safety performance showed continued<br />

improvement with a 7% reduction in Lost Time Accident Rates<br />

(LTAR) 1 compared with 2010. In excess of 70% of our sites did not<br />

have a lost time accident in <strong>2011</strong>. We believe in the importance of<br />

continually engaging with our employees and for this reason our<br />

Behaviour Based Safety (BBS) initiative continued into <strong>2011</strong>.<br />

We record all incidents relating to health and safety. Metrics such<br />

as LTAR and Days Away Restricted Time allow us to investigate and<br />

share best practice across the Group. We use the number of work<br />

days and/or restricted time incidents to track the severity of injuries.<br />

In <strong>2011</strong>, we had 14 significant injuries (which exceed 30 lost or<br />

restricted days), consisting of fractures, strains and cut injuries. We<br />

also introduced a new environmental health and safety audit,<br />

which over 40% of our sites have completed to date.<br />

During the year, we established a central operational technical<br />

standard to ensure a consistent approach to safe working<br />

practices. We also created a global operational risk management<br />

policy which will be launched in 2012. The policy covers fire safety<br />

and property protection, site and travel security, business continuity<br />

management and environmental health and safety. Each of these<br />

is measured through proactive input and KPIs. We believe these<br />

approaches to health and safety will drive benchmarking and best<br />

practice sharing across the Group to achieve world class<br />

operational risk status.<br />

In <strong>2011</strong> we had no significant property loss incidents (2010: nil).<br />

We support employees’ wellbeing by offering employee wellness<br />

programmes (eg subsidised gym memberships, health checks or<br />

exercise regimes).<br />

1 LTAR is the number of lost time accidents times 200,000/total hours worked.<br />

49<br />

overview<br />

financial statements governance<br />

sustainability<br />

business review


50 <strong>Rexam</strong> annual report <strong>2011</strong> directors’ report<br />

sustainability<br />

key measures and targets<br />

The key quantitative measures for this commitment are LTAR<br />

and the percentage of sites offering some form of employee<br />

wellness programme.<br />

We target a 10% reduction per annum in LTAR with an ultimate<br />

LTAR of zero and we aim to have 100% of our sites offering<br />

employee wellness programmes by the end of 2012.<br />

long term<br />

targets<br />

2012<br />

targets <strong>2011</strong> 2010 2009<br />

LTAR<br />

Sites offering an<br />

employee wellness<br />

Zero 0.25 0.28 0.30 0.63<br />

programme (%) 100 85 75 n/a n/a<br />

we will continue to build a winning organisation<br />

Our employees are crucial to the delivery of <strong>Rexam</strong>’s goals. During<br />

the year, we used the feedback from 2010’s global employee<br />

engagement survey to implement a range of improvement actions.<br />

With an 87% response rate and in depth focus groups conducted<br />

subsequently, we were able to identify key areas of opportunity at<br />

local, sector and global levels. Both our executive leadership team<br />

and all sector leadership teams are committed to improving their<br />

visibility, fostering trust in leadership, through personally visiting as<br />

many plants as possible, and holding face to face meetings to build<br />

on the dialogue with our employees.<br />

Training and development was another key theme. The <strong>Rexam</strong><br />

Business School was launched globally in <strong>2011</strong>, offering a range<br />

of learning opportunities for our employees. Our course offering<br />

is diverse, from half hour online courses (in a range of languages)<br />

through to comprehensive residential courses which focus on<br />

leadership and specific skill building. In <strong>2011</strong>, we had around<br />

620 employees participate in classroom courses and 592 learners<br />

logged into CrossKnowledge, our online option. We also had over<br />

110 registrations to our ‘Improve your English’ online programme.<br />

<strong>Rexam</strong> recognises that communication is key to employee<br />

understanding and engagement and we use a variety of tools and<br />

channels. From newsletters and team briefings to intranet updates<br />

and news bulletins, communication is thought of as a two way<br />

process between management and employees.<br />

12 months without a lost time accident<br />

After a huge amount of commitment to engage and shape safe<br />

behaviour, our entire South American beverage can operation<br />

reached an unprecedented milestone during <strong>2011</strong>– one year<br />

without a lost time accident. This exceptional accomplishment<br />

in safety was achieved through the introduction of various<br />

innovative safety programmes and embedment of them with<br />

the aid of various communication channels.<br />

Our South American beverage can business explored new methods<br />

of communication and invited employees to share comments,<br />

praise or suggestions through an online ‘Open Channel’.<br />

To strengthen everybody’s understanding of our leadership<br />

practices and core values we have introduced a 360 degree<br />

feedback tool for leaders across <strong>Rexam</strong>. The tool helps provide<br />

a detailed overview of leaders’ strengths and areas of opportunity,<br />

as well as self assessment and reflection. The 360 degree<br />

feedback is now available in a range of different languages and<br />

has been well received by the nearly 900 leaders who have<br />

participated to date.<br />

In 2010, with the implementation of a global SAP HR platform,<br />

<strong>Rexam</strong> started a worldwide programme aimed at achieving<br />

excellence in HR service delivery, based on improved people<br />

processes and on an integrated HR information system platform.<br />

The expected business benefits are providing consistent and timely<br />

HR transactional services and generating greater employee<br />

satisfaction with basic HR processes.<br />

During <strong>2011</strong>, a new global Manager Self Service Portal (MSSP) was<br />

rolled out across the North America and Europe regions. This tool<br />

provides line managers with direct access to information about his/<br />

her team and enables them to carry out basic people management<br />

activities directly via the web based portal.<br />

The first activity facilitated through the MSSP was the <strong>2011</strong> salary/<br />

merit review process, and <strong>Rexam</strong> line managers now receive<br />

real‑time access to online organisation charts and employee<br />

directory listings.<br />

The <strong>Rexam</strong> European Forum is a joint employee representative and<br />

management body created for the exchange of information and<br />

dialogue concerning issues which may impact <strong>Rexam</strong>’s employees<br />

within the European Economic Area.<br />

Communication with employees is considered a key responsibility<br />

for all managers, and employees are encouraged to participate<br />

and give their views on any aspect of the Group’s business<br />

including the annual and half year financial results and the<br />

economic factors affecting the Group’s performance.<br />

<strong>Rexam</strong> also has a well established employee share scheme to<br />

promote share ownership.<br />

key measures<br />

The key measures for this commitment are sourced from the Group<br />

employee engagement survey, which will be conducted around<br />

every 18 months. The next survey is scheduled for early 2012.<br />

We aim to continually improve these scores over time.<br />

<strong>2011</strong> 2010<br />

Employee engagement index favourable<br />

score (%)<br />

Values and leadership practices<br />

n/a 62<br />

favourable score (%) n/a 53


we will ensure our actions/interactions are guided<br />

by fairness, respect, integrity and honesty<br />

To achieve our vision it is critical that our employees behave with<br />

integrity, fairness and honesty at all times.<br />

We are committed to providing a work environment which is free<br />

of discrimination and/or harassment on any level, whether based<br />

on race, sex, disability or any other basis.<br />

<strong>Rexam</strong> has equal opportunity policies ranging from selection and<br />

recruitment to training and development to meet the needs of its<br />

operations around the world. Disabled people are given full<br />

consideration for employment and subsequent training (including,<br />

if needed, retraining for alternative work where employees have<br />

become disabled), career development and promotion on the basis<br />

of their aptitudes and abilities.<br />

Our Raise Your Concern (RYC) programme offers the opportunity<br />

for employees to report anonymously any behaviour or activity<br />

they believe is in contravention of the Code of Conduct (CoC)<br />

and/or of any of our policies (see pages 66 and 67 for more<br />

information on CoC and RYC).<br />

key measures and targets<br />

The key measures for this commitment are the percentage<br />

of successfully completed CoC training modules and the<br />

response rate to allegations made via RYC.<br />

For CoC training, we target achievement of 100% completion<br />

of training modules.<br />

Regarding RYC response rates, historically we have consistently<br />

achieved an initial response to the concern raised within five days,<br />

however, going forward we are targeting an initial response within<br />

four days.<br />

we will encourage all teams to be constructive members<br />

of our local communities<br />

<strong>Rexam</strong> is a committed partner in the communities in which we<br />

operate, and as part of this commitment many of our plants<br />

and sites work closely with local charities and groups to make<br />

a positive impact.<br />

In January <strong>2011</strong>, Rio de Janeiro suffered from a series of destructive<br />

floods and mudslides. Our employees raised almost US$60,000<br />

within 15 days, and we provided a lorry to help clear up and<br />

reconstruct the area.<br />

We also pride ourselves on being an ambassador for recycling,<br />

dedicating a large amount of effort in promoting and encouraging<br />

it. Our North American beverage can operations’ involvement in<br />

the annual ‘America Recycles Day’ included a six week recycling<br />

contest. They collected a total of 1,836 metric tonnes of aluminium<br />

cans; this great result saw <strong>Rexam</strong> win first place for the fifth year in<br />

a row. Our ‘Community Can Challenge’ was launched in <strong>2011</strong> and<br />

involved 12 plants across nine European countries. It raised over<br />

£15,000 for the plants’ chosen charities and helped promote<br />

recycling and can collection. Over the 10 weeks, employees<br />

collected nearly 400,000 cans (over 6.5 tonnes of metal), equating<br />

to 58 tonnes of CO2. In Brazil, through Abralatas, we sponsored<br />

and supported can collection activities during the Carnival season.<br />

sources: Associação Brasileira dos Fabricantes de Latas de Alta<br />

Reciclabilidade, Association of European Producers of Steel for Packaging,<br />

Beverage Can Makers Europe, Can Manufacturers Institute, Consumer Goods<br />

Forum, European Aluminium Association and Metal Packaging Europe.<br />

The <strong>Rexam</strong> Academy is a leadership training programme that is<br />

run by the <strong>Rexam</strong> Business School. Each year around 25 of our<br />

employees are selected from across our global operations to<br />

participate in this investment in our people. As part of the<br />

programme, participants are involved in a leadership challenge,<br />

and this year the group hosted a charity dinner for UNICEF’s East<br />

Africa Children’s Crisis Appeal. Our employees also donated<br />

money to the fund and our South American beverage can<br />

operations carried out local fundraising. In total, the event raised<br />

over £41,000 for UNICEF.<br />

<strong>Rexam</strong>’s total charitable cash donations and community activities<br />

(including in kind community and charitable support in the form<br />

of time, facilities and products but excluding employees’ dedicated<br />

fundraising such as the Academy dinner) during <strong>2011</strong> amounted to<br />

some £497,000 (2010: £480,000).<br />

cash donations<br />

We increased charitable cash donations by the Group in <strong>2011</strong><br />

to £458,000 as shown in the table (2010: £442,000):<br />

<strong>2011</strong> 2010<br />

UK £55,000 £52,000<br />

Rest of World (excluding UK) £403,000 £390,000<br />

The Group has not made any EU political donations during the<br />

year and does not intend to do so in the future in respect of which<br />

shareholder authority is required, or for which disclosure is<br />

required under the Companies Act 2006.<br />

key measure and target<br />

We monitor how many of our sites are involved in some form of<br />

community programme, and in the long term we are targeting that<br />

100% of our sites will be involved in at least one local community<br />

programme (<strong>2011</strong>: 59%).<br />

community investment in<br />

North America<br />

Since 2010 our plastic packaging facility in Perrysburg,<br />

Ohio has raised and donated more than US$5,000 and<br />

volunteered over 150 hours in area classrooms for Junior<br />

Achievement (JA). JA is an organisation that teaches the<br />

economics of life through entrepreneurship, financial<br />

literacy and work readiness education programmes to<br />

more than 24,000 students annually.<br />

150 hours<br />

51<br />

overview<br />

financial statements governance<br />

sustainability<br />

business review


52<br />

directors’ report<br />

governance<br />

Cans are made from coils of aluminium or steel.<br />

Over the past three years <strong>Rexam</strong> has saved<br />

34,000 tonnes of metal through lightweighting.


We introduce our board and explain why a<br />

strong sense of governance and compliance<br />

is imperative in every area of our operations.<br />

We give details of the Company’s<br />

remuneration principles and policy which<br />

complement the Group’s strategic vision.<br />

54 directors and officers<br />

56 corporate governance<br />

69 remuneration report<br />

81 other disclosures<br />

53<br />

overview<br />

financial statements governance<br />

sustainability<br />

business review


54 <strong>Rexam</strong> annual report <strong>2011</strong> directors’ report<br />

directors and officers<br />

chairman chairman designate<br />

Sir Peter Ellwood (68)<br />

appointed Chairman on 1 May 2008<br />

(non executive director on 1 February<br />

2008) and retiring on 22 February 2012.<br />

committees Nomination (chairman).<br />

strengths An experienced chairman<br />

with an international business and<br />

leadership focus.<br />

previous business experience Chairman<br />

of ICI <strong>PLC</strong> until its acquisition by Akzo<br />

Nobel NV in 2008. Group chief<br />

executive of Lloyds TSB Group plc.<br />

other directorships Member of the<br />

supervisory board of Akzo Nobel NV.<br />

executive directors<br />

Graham Chipchase (49)<br />

chief executive<br />

appointed 1 January 2010 as chief<br />

executive. Joined the board as finance<br />

director on 10 February 2003 and<br />

was group director plastic packaging<br />

from 2005.<br />

committees Finance.<br />

strengths Extensive financial and<br />

operational knowledge, proven leadership<br />

skills and a comprehensive understanding<br />

of <strong>Rexam</strong>’s businesses and markets.<br />

previous business experience Finance<br />

director of GKN plc’s aerospace services<br />

business and held various positions within<br />

the European and US subsidiaries of<br />

BOC Group plc. Operational experience<br />

as group director of <strong>Rexam</strong>’s plastic<br />

packaging business.<br />

Stuart Chambers (55)<br />

appointed 1 February 2012 as a<br />

non executive director and chairman<br />

designate to succeed Sir Peter Ellwood<br />

on 23 February 2012.<br />

committees Nomination.<br />

strengths Extensive breadth of business<br />

experience, including experience of<br />

global business to business markets.<br />

previous business experience Group<br />

chief executive of NSG Group, the Tokyo<br />

based global glass company, until 2009.<br />

Chief executive of Pilkington <strong>PLC</strong> until its<br />

acquisition by NSG Group in 2006.<br />

Senior positions at Mars Inc. and a variety<br />

of European roles at Royal Dutch Shell plc.<br />

other directorships Non executive<br />

director of Smiths Group plc, Tesco <strong>PLC</strong><br />

and The Manchester Airport Group <strong>PLC</strong>.<br />

David Robbie (48)<br />

finance director<br />

appointed 3 October 2005.<br />

committees Finance.<br />

strengths Strong financial, accounting,<br />

strategic and corporate finance<br />

experience and skills.<br />

previous business experience Chief<br />

financial officer of Royal P&O Nedlloyd<br />

NV and finance director of CMG plc.<br />

other directorships Trustee of Aldeburgh<br />

Music.<br />

executive leadership team<br />

Jon Atchue<br />

human resources<br />

André Balbi Cerviño<br />

beverage can Americas<br />

Graham Chipchase<br />

chief executive<br />

David Gibson<br />

legal<br />

Malcolm Harrison<br />

plastic packaging<br />

Claire Jenkins<br />

corporate affairs<br />

Iain Percival<br />

enterprise risk<br />

David Robbie<br />

finance director<br />

Tomas Sjölin<br />

beverage can Europe & Asia


non executive directors<br />

Noreen Doyle (62)<br />

appointed 22 March 2006.<br />

committees Finance (chairman), audit<br />

and risk, nomination.<br />

strengths A diverse business background<br />

with experience and knowledge of<br />

financial markets.<br />

previous business experience Senior<br />

operational positions at Bankers Trust<br />

Company and at the European Bank for<br />

Reconstruction & Development.<br />

other directorships Non executive<br />

director of Credit Suisse, Newmont<br />

Mining Corporation and QinetiQ Group<br />

<strong>PLC</strong>, and a member of the advisory<br />

panels for the Macquarie European<br />

Infrastructure Fund and the Macquarie<br />

Renaissance Infrastructure Fund.<br />

Leo Oosterveer (52)<br />

appointed 1 September <strong>2011</strong>.<br />

committees Nomination.<br />

strengths Strong operational leader with<br />

global management experience and a<br />

track record in marketing, sales and<br />

strategy development gained both<br />

in Europe and Asia.<br />

business experience Leads the global<br />

food service division of Unilever. From<br />

2002 to 2006 chairman/CEO of<br />

Unilever in Thailand and Indochina whose<br />

operations are mainly focused on home<br />

and personal care products.<br />

John Langston (62)<br />

appointed 30 October 2008. Became<br />

the acting senior independent director on<br />

24 November <strong>2011</strong>.<br />

committees Audit and risk (chairman),<br />

finance, nomination, remuneration.<br />

strengths A chartered accountant with<br />

international, commercial and corporate<br />

finance experience.<br />

previous business experience Joined the<br />

board of Smiths Group plc in 2000<br />

holding operational roles until<br />

appointment as finance director from<br />

2006 to his retirement in May 2010.<br />

A director of TI Group plc prior to<br />

its acquisition by Smiths Group.<br />

other directorships Non executive<br />

director of Cross Match Technologies Inc.<br />

Jean‑Pierre Rodier (64)<br />

appointed 7 June 2006.<br />

committees Remuneration (chairman),<br />

audit and risk, nomination.<br />

strengths Significant international<br />

business experience and an extensive<br />

knowledge of the packaging and<br />

aluminium industries.<br />

previous business experience Chairman<br />

and chief executive of Pechiney until<br />

Pechiney merged with Alcan in 2003.<br />

Chief executive of Union Minière and<br />

chairman and chief executive of<br />

MetalEurop France.<br />

other directorships Advisor to Corporate<br />

Value Associates and an associate with<br />

Mediobanca Banca di Credito Finanziario<br />

until his resignation on 1 January <strong>2011</strong>.<br />

Wolfgang Meusburger (58)<br />

appointed 1 December 2006.<br />

committees Nomination, remuneration.<br />

strengths Experience in the fast moving<br />

consumer goods (FMCG) industry and an<br />

in depth understanding of business<br />

development.<br />

previous business experience Held senior<br />

international positions in the FMCG industry<br />

and was chief executive of Tchibo until 2001.<br />

other directorships Sits on the board of<br />

several international FMCG companies<br />

in Europe and an educational facility in<br />

Switzerland. Chairman of Kägi Söhne AG<br />

and Kaffee Partner GmbH, and of the non<br />

executive board of Schoellershammer. Non<br />

executive directorships include BS Group,<br />

CCT Reig Group and Chiquita Fruit Bar.<br />

company secretary<br />

David Gibson (49)<br />

changes to the board<br />

Carl Symon, the non executive senior<br />

independent director, retired from the<br />

board on 23 November <strong>2011</strong>.<br />

Apart from the appointments of<br />

Stuart Chambers and Leo Oosterveer<br />

disclosed in this section, there were no<br />

other changes to the board during <strong>2011</strong><br />

and up until the date of this annual report.<br />

55<br />

overview<br />

financial statements governance<br />

sustainability<br />

business review


56 <strong>Rexam</strong> annual report <strong>2011</strong> directors’ report<br />

corporate governance<br />

good governance<br />

During <strong>2011</strong> we focused on executing our<br />

strategy to deliver value to our shareholders and<br />

stakeholders. In doing so, we realise that it is<br />

imperative that the Company promotes a strong<br />

sense of meaningful and relevant governance in<br />

each area of our operations. Our policies and<br />

procedures ensure that the Company is directed<br />

and guided to follow good governance practices.<br />

We have an experienced board of directors<br />

who are responsible to all our stakeholders for the<br />

long term strategy and sustainable success of the<br />

Company. During the year there were changes<br />

to the board that were carefully considered to<br />

ensure that the Company and its shareholders<br />

benefit from a board with a depth of experience,<br />

a diversity of influences, an independent<br />

viewpoint and a varied skill set.<br />

I am retiring as chairman of the board and this<br />

will be my last report as chairman. With clear<br />

objectives, strong management and talented<br />

people, together with a board committed to<br />

good governance practices, <strong>Rexam</strong> is in a<br />

strong position for the future.<br />

Sir Peter Ellwood<br />

chairman<br />

compliance<br />

This corporate governance report has been prepared in<br />

accordance with the UK Corporate Governance Code of June<br />

2010 (the Code). The Code is published by the Financial <strong>Report</strong>ing<br />

Council (FRC) and can be viewed on the www.frc.org.uk website.<br />

This report, being part of the directors’ report which includes the<br />

business review and the remuneration report, provides a summary<br />

of the Group’s procedures for applying the principles of the Code<br />

and the extent to which such principles have been applied. It is the<br />

board’s view that throughout the period 1 January to 31 December<br />

<strong>2011</strong> the Company has complied with the Code.<br />

leadership<br />

the role of the board<br />

The board’s primary role is to ensure the sustainable long term<br />

success of the Group. This it does through the development, review<br />

and implementation of the Group’s strategy and the leadership<br />

of the executive directors to whom the board delegates the day to<br />

day management of the business.<br />

The role of the board is to:<br />

• ensure the sustained long term success of the Group;<br />

• ensure that the board’s obligations to its shareholders<br />

are understood and met;<br />

• ensure that the strategy takes into account the interests<br />

of the Group’s customers, suppliers, employees and the<br />

local communities in which <strong>Rexam</strong> operates;<br />

• maintain control over the Group’s assets;<br />

• monitor changes to the Group’s management and<br />

control structures;<br />

• develop robust corporate governance and risk<br />

management practices and procedures; and<br />

• establish high ethical standards of behaviour.<br />

The Company operates through the board and its main board<br />

committees, namely the audit and risk, the nomination and the<br />

remuneration committees. The board also has a finance committee<br />

which oversees the financial risk management strategy, policy and<br />

treasury transactional matters delegated to it, and reviews and<br />

approves major financial transactions on behalf of the board.<br />

The board evaluates the membership of its individual board<br />

committees on an annual basis and aims to ensure that its<br />

principal committees have different non executive directors as<br />

their chairman. The board committees are governed by terms<br />

of reference which detail the matters delegated to the committee<br />

and for which they have authority to make decisions. The terms<br />

of reference for the main committees can be found on the<br />

<strong>Rexam</strong> website.


schedule of matters reserved for the board<br />

Board appointments and removals<br />

The Group’s strategy, including the acquisition and disposal of businesses<br />

Material financial decisions relating to equity, marketable securities, borrowing<br />

facilities, guarantees or indemnities and changes in accounting policies<br />

or practice<br />

All capital expenditure projects over £10m or any capital expenditure project<br />

which, regardless of the amount, does not meet the Group’s financial criteria<br />

Changes to the Group’s management and control structures<br />

Matters relating to the Company’s share listing<br />

The appointment and removal of principal advisors and external auditors<br />

The board does not routinely involve itself in day to day business<br />

matters but there is a formal schedule of matters that require the<br />

board’s specific approval, as well as those which can be delegated<br />

to committees of the board or senior management. Matters referred<br />

to the board are considered by the board as a whole and no one<br />

individual has unrestricted powers of decision.<br />

the main areas dealt with by the board during <strong>2011</strong><br />

best<br />

performance<br />

customer<br />

expectations<br />

operational<br />

excellence<br />

winning<br />

organisation<br />

Strategy planning, implementation and monitoring<br />

Strategy for each business sector and focus on emerging markets<br />

<strong>Report</strong>s on the key issues affecting the business<br />

Sale of the Closures business<br />

Financial position of the Group and its performance against budget and forecast<br />

Bank facility refinancing proposals<br />

The Group’s budget for 2012 and long range plan to 2014<br />

<strong>Report</strong>s on matters discussed at audit and risk committee meetings<br />

Review of the effectiveness of the system of internal control<br />

The Group’s full year and half year results<br />

2010 final dividend and <strong>2011</strong> interim dividend<br />

<strong>Annual</strong> general meeting<br />

<strong>Report</strong>s on meetings with customers and suppliers<br />

Major customer and supplier contracts<br />

Research, development and innovation in relation to the strategic agenda<br />

Board visit to a supplier operation in South America<br />

board membership <strong>2011</strong> meetings <strong>2011</strong> 1<br />

Sir Peter Ellwood (chairman of the board) 9/9<br />

Graham Chipchase 9/9<br />

Noreen Doyle 9/9<br />

John Langston 9/9<br />

Wolfgang Meusburger 9/9<br />

Leo Oosterveer (appointed 1 September <strong>2011</strong>) 3/3<br />

David Robbie 9/9<br />

Jean‑Pierre Rodier 9/9<br />

Carl Symon (retired 23 November <strong>2011</strong>) 2 7/8<br />

1 Number of scheduled meetings attended/maximum number of meetings that the<br />

director could have attended.<br />

2 Carl Symon was unable to attend one meeting of the board. He received the agenda<br />

and the papers for that meeting and commented in advance of it.<br />

Capital expenditure requests including new manufacturing start ups, additional lines and line conversions in Brazil,<br />

Egypt, Finland, France and India<br />

<strong>Rexam</strong>’s sustainability programmes (incorporating all aspects of corporate social responsibility)<br />

The Group and business procedures and controls<br />

The Group risk management process, risk tracking and mitigation<br />

Presentations from business sectors<br />

Legal compliance, code of conduct and anti bribery and corruption policies<br />

Information management strategy<br />

Health and safety matters<br />

<strong>Report</strong>s on matters discussed at nomination committee and remuneration committee meetings<br />

Appointment of a chairman designate and a non executive director<br />

Board composition, diversity, development and succession planning<br />

Effectiveness of the board following the board evaluation<br />

Organisation and talent review<br />

Employee engagement survey<br />

Investor audit and feedback<br />

Board meeting and plant visits with the South American beverage can and plastic packaging management teams<br />

57<br />

overview<br />

financial statements governance<br />

sustainability<br />

business review


58 <strong>Rexam</strong> annual report <strong>2011</strong> directors’ report<br />

corporate governance<br />

chairman and chief executive<br />

The roles of the chairman and chief executive are separate with<br />

each having clearly defined responsibilities. Nonetheless, they<br />

retain a close working relationship to ensure the integrity of the<br />

board’s decision making process and the successful delivery of<br />

the Group’s strategy.<br />

Sir Peter Ellwood was chairman of the Company throughout the<br />

period 1 January to 31 December <strong>2011</strong>. The chairman creates and<br />

manages a constructive dialogue between the executive and non<br />

executive directors. He works with the company secretary to ensure<br />

that appropriate matters are discussed during board meetings.<br />

The main duties of the chairman are to:<br />

• lead the board;<br />

• promote a culture of openness, challenge and debate;<br />

• review the effectiveness of the board;<br />

• ensure that the board has the appropriate balance of<br />

skills and experience and to give consideration to<br />

succession planning;<br />

• ensure compliance with Group policies concerning the<br />

conduct of the business;<br />

• provide guidance to the executive directors and senior<br />

management; and<br />

• safeguard the interests of shareholders.<br />

Sir Peter advised the board that he wished to retire from office<br />

with effect from close of business on 22 February 2012. Stuart<br />

Chambers was appointed as non executive director and chairman<br />

designate on 1 February 2012, and will succeed Sir Peter as<br />

chairman. The board considers that Stuart Chambers was<br />

independent on his appointment as non executive director and<br />

will be independent on his appointment as chairman.<br />

Graham Chipchase’s primary objective as chief executive is<br />

to enhance long term shareholder value.<br />

The main duties of the chief executive are to:<br />

• develop and manage the Group and its trading<br />

performance within the authorities delegated by<br />

the board;<br />

• deliver the Group’s strategic plan;<br />

• lead the executive management and ensure that<br />

management has the appropriate balance of skills<br />

and experience;<br />

• oversee the Group’s performance in safety, health<br />

and environmental matters;<br />

• be the primary interface with shareholders; and<br />

• promote high standards of ethical business conduct.<br />

The written job specifications for the roles of chairman and chief<br />

executive are reviewed annually by the nomination committee.<br />

non executive directors<br />

At the date of this report, <strong>Rexam</strong> has seven non executive directors,<br />

including the chairman, whose role is to understand the business<br />

and its markets, consider proposals on strategy and constructively<br />

challenge the management. Collectively they hold or have held<br />

senior positions in industry and contribute a wide range of<br />

international experience and objective perspective to the board.<br />

Through the board committees, the non executive directors bring<br />

focus on governance and succession planning, internal controls,<br />

risk management and remuneration policies.<br />

Non executive directors serve the Company under letters of<br />

appointment which are generally for an initial three year term.<br />

On appointment, an undertaking is requested confirming that<br />

the non executive director has sufficient time to fulfil his or her<br />

role on the board.<br />

Carl Symon, <strong>Rexam</strong>’s senior independent director, retired from<br />

the board on 23 November <strong>2011</strong>. Carl Symon had served on the<br />

board since 2003 and, having successfully led and completed the<br />

search for the new chairman, felt that this was an appropriate time<br />

to step down from the board. The board approved the appointment<br />

of John Langston as acting senior independent director with effect<br />

from 24 November <strong>2011</strong> and until such time as the nomination<br />

committee can consult with the new chairman of the board and<br />

make a recommendation for a permanent appointment.<br />

The senior independent director, when necessary, supports the<br />

chairman and the other non executive directors on Company<br />

related matters. He is available to talk to shareholders if they have<br />

any issues or concerns or if there are any unresolved matters that<br />

shareholders believe should be brought to his attention. There is a<br />

written job specification for this role and it is reviewed annually by<br />

the nomination committee.<br />

The non executive directors met several times during the year<br />

with the chairman to discuss, on a less formal basis, the Group’s<br />

performance, governance, strategy and succession planning.<br />

The executive directors were not in attendance at these meetings.<br />

directors’ indemnities and insurance cover<br />

The Company granted indemnities to Leo Oosterveer and Stuart<br />

Chambers on their appointments to the board in <strong>2011</strong> and 2012<br />

respectively. The indemnities relate to certain losses and liabilities<br />

which they may incur in the course of their duties and are in force<br />

as at the date of this report. Insurance cover also remains in place<br />

to protect all directors and senior management in the event of<br />

a claim being brought against them in their capacity as directors<br />

or officers of the Company and its subsidiaries. Similar indemnities<br />

will be offered to other directors.


length of service of non executive directors as at<br />

22 February 2012<br />

effectiveness<br />

● 0–2 years 2<br />

● 3–4 years 2<br />

● 5–6 years 3<br />

composition of the board<br />

<strong>Rexam</strong> has a board of directors with international business<br />

backgrounds and a range of diverse skills, experience and<br />

nationalities. This diversity is invaluable in challenging and<br />

developing the Group’s strategy and enables the board to govern<br />

effectively a global business. The board works as a team but<br />

independence of thought and approach as well as constructive<br />

debate is encouraged.<br />

Throughout <strong>2011</strong> and up to the date of this annual report the<br />

Company had a majority of independent non executive directors<br />

on the board.<br />

The board is aware of the other commitments of the directors and<br />

considers that these commitments do not conflict with their non<br />

executive duties as directors of the Company. A biography of each<br />

member of the board, including details of their business experience<br />

and other directorships, is given on pages 54 and 55.<br />

appointments to the board<br />

The appointment and replacement of directors is governed<br />

by the Company’s articles of association, which may only<br />

be amended with shareholders’ approval in accordance with<br />

relevant legislation. Recommendations for appointments to the<br />

board are the responsibility of the nomination committee which<br />

acts in accordance with its terms of reference and the articles<br />

of association.<br />

board balance as at 22 February 2012<br />

● 7 non executive directors<br />

including the chairman<br />

● 2 executive directors<br />

the nomination committee<br />

All of the members of this committee are independent<br />

non executive directors.<br />

committee membership <strong>2011</strong> meetings <strong>2011</strong> 1<br />

Sir Peter Ellwood (committee chairman) 2 6/6<br />

Noreen Doyle 3 5/6<br />

John Langston 6/6<br />

Wolfgang Meusburger 6/6<br />

Leo Oosterveer (appointed 6 December <strong>2011</strong>) 4 –<br />

Jean‑Pierre Rodier 6/6<br />

Carl Symon (retired 23 November <strong>2011</strong>) 5/5<br />

1 Number of scheduled meetings attended/maximum number of meetings that the<br />

director could have attended.<br />

2 Sir Peter Ellwood will retire as committee chairman on 22 February 2012.<br />

Stuart Chambers was appointed as a member of the committee on 20 February 2012<br />

and will succeed Sir Peter as committee chairman with effect from 23 February 2012.<br />

3 Noreen Doyle was unable to attend one meeting of the committee. She received the<br />

agenda and the papers for that meeting and was able to comment in advance of it.<br />

4 No meetings were held in <strong>2011</strong> after Leo Oosterveer’s appointment date.<br />

59<br />

overview<br />

financial statements governance<br />

sustainability<br />

business review


60 <strong>Rexam</strong> annual report <strong>2011</strong> directors’ report<br />

corporate governance<br />

The main responsibilities of the committee are to:<br />

• review the structure, size and composition of the board<br />

(including the skills, knowledge, experience and diversity,<br />

including gender diversity);<br />

• give full consideration to succession planning and ensure<br />

that processes and planning are in place with regard<br />

to both the board and senior executive appointments;<br />

• identify and consider candidates on merit against<br />

objective criteria and to make recommendations to<br />

the board on appointments to the board and board<br />

committees, and on the appointment of the company<br />

secretary;<br />

• assess the time needed to fulfil the roles of chairman,<br />

senior independent director and non executive directors;<br />

• keep up to date about strategic issues and commercial<br />

changes affecting the Company and its markets; and<br />

• assist the chairman with the annual board performance<br />

evaluation process to assess the overall performance<br />

and effectiveness of the board and each board<br />

committee, and the individual performance<br />

of directors.<br />

The performance and effectiveness of the committee are reviewed<br />

as part of the main performance evaluation of the board and all<br />

its committees.<br />

All board appointments are conducted through a formal, rigorous<br />

and transparent procedure between the nomination committee<br />

and the board. The committee identifies through the management<br />

review process any internal people whose skills, experience and<br />

contribution to the Group would add value to the board. The<br />

committee also works alongside executive recruitment consultants<br />

to evaluate and consider prospective external candidates and<br />

review internal candidates. Following an evaluation of candidates,<br />

the committee meets with prospective candidates who are then<br />

considered and, if appropriate, recommendations are made to the<br />

board for approval.<br />

During <strong>2011</strong> the committee identified the requirement to appoint<br />

a new non executive director and, on Sir Peter Ellwood’s intended<br />

retirement, a new chairman. The processes leading to the<br />

appointments of Leo Oosterveer and Stuart Chambers were<br />

conducted through external recruitment consultants who adhere<br />

to a voluntary code of conduct to ensure that at least 30% of<br />

the candidates on their initial list of candidates are women<br />

(the Voluntary Code of Conduct). The committee considered the<br />

candidates against the board’s requirements and recommendations<br />

for the appointment of Leo Oosterveer and Stuart Chambers were<br />

made to the board for approval.<br />

Lord Davies’ February <strong>2011</strong> report into ‘Women on Boards’ and<br />

the amendments to the Code subsequently proposed by the FRC<br />

have highlighted the importance of effective diversity policies in<br />

companies. The <strong>Rexam</strong> board is aware of the benefits of all forms<br />

of diversity, including gender diversity, when seeking new<br />

candidates for the board. It is the board’s aspiration that by 2015<br />

at least 25% of the board will be women. Diversity is one of the<br />

important factors in the specification given by the committee to<br />

recruitment consultants when appointing new directors and the<br />

committee ensures that, with the assistance of executive recruitment<br />

consultants who adhere to the Voluntary Code of Conduct, it has<br />

visibility of a range of suitable candidates, including women.<br />

The Group’s gender balance in senior management roles is<br />

currently 86% male and 14% female and, throughout the Group,<br />

76% male and 24% female. The board reviews how diversity, in all<br />

forms, can be enhanced through the senior management team and<br />

across the Group with the overriding objective that the most<br />

appropriate candidates are employed and the most effective<br />

employees are retained and promoted.<br />

succession planning<br />

The board’s responsibility for succession planning means that it is<br />

actively involved in the Group’s talent processes to identify internal<br />

candidates for promotion and develop senior managers to give<br />

them every opportunity to progress their careers. During <strong>2011</strong>, the<br />

board discussed the current senior management positions within<br />

the organisational structure and, led by the chief executive,<br />

considered potential successors to meet the Group’s leadership<br />

needs over time.<br />

development, information and support<br />

Formal board meetings are held during the year and the chairman<br />

and the company secretary ensure that, prior to each meeting,<br />

the directors receive accurate, clear and timely information<br />

which helps them to discharge their duties. In the months with no<br />

scheduled board meeting, the directors receive the prior month<br />

and cumulative financial and operating information relating to<br />

the Group and its businesses.<br />

All newly appointed directors participate in an internal induction<br />

programme that introduces the director to the Group and includes<br />

visiting Group businesses. This programme is tailored to each<br />

director’s needs, taking into account individual qualifications and<br />

experience. If required, an overview of the role and responsibilities<br />

of a director can be facilitated by an external consultant.<br />

The company secretary gives guidance on board procedures<br />

and corporate governance.


Leo Oosterveer joined the board as a non executive<br />

director on 1 September <strong>2011</strong> and is participating in an<br />

induction programme. Leo has met with functional heads<br />

for an overview of the Group. He has participated in a<br />

one to one external course on the role and responsibilities<br />

of a director, and has discussed areas of governance<br />

relevant to board membership with the company<br />

secretary. Leo is scheduled to visit some of <strong>Rexam</strong>’s<br />

manufacturing plants and meet with operational<br />

management. Stuart Chambers, who joined the board as<br />

chairman designate on 1 February 2012, has started an<br />

induction programme and is meeting with functional<br />

heads and representatives from the Group’s advisors prior<br />

to commencing a tour of the Group’s businesses.<br />

The chairman is responsible for and regularly reviews and agrees<br />

with each director their training and development needs and<br />

members of the committees receive specific updates on matters<br />

that are relevant to their role. The chairman arranges for the board<br />

to visit at least one of the Group’s business locations each year to<br />

ensure that the directors’ knowledge and familiarity with the<br />

Group’s businesses are updated and maintained.<br />

During <strong>2011</strong>, the board held a meeting at the South<br />

American beverage can headquarters in Brazil and<br />

visited the beverage can plant in Jacareí and the plastic<br />

packaging plant in Jundiaí. The board also visited the<br />

main aluminium supplier to the South American<br />

beverage can business.<br />

Members of the senior management team with responsibility for<br />

the Group’s businesses and those with corporate and service centre<br />

functional responsibilities make periodic presentations at board<br />

meetings about their businesses, functions, performance, suppliers,<br />

customers, markets and strategy.<br />

The company secretary, who is appointed by the board, is<br />

responsible for ensuring compliance with board procedures.<br />

This includes taking minutes of the board meetings and the<br />

recording of any concerns relating to the running of the Company<br />

or proposed actions arising therefrom that are expressed by a<br />

director in a board meeting. The company secretary is also<br />

secretary to the audit and risk, nomination and remuneration<br />

committees. Under the direction of the chairman, he is responsible<br />

for the communication of relevant information between the board,<br />

its committees and the senior management team. He also advises<br />

the board, through the chairman, on all governance and regulatory<br />

compliance matters.<br />

Should a director reasonably request independent professional<br />

advice to carry out their duties, such advice is made available at<br />

the Company’s expense.<br />

board performance evaluation<br />

All directors, including the chairman, receive a formal performance<br />

evaluation to which all other members of the board have the<br />

opportunity to contribute. The board’s 2010 performance evaluation<br />

was led by an external independent consultant. In <strong>2011</strong> the annual<br />

evaluations of the non executive directors, senior independent<br />

director and chief executive were led by the chairman and<br />

supported by the company secretary. In view of the announced<br />

change in the chairmanship of the Company, a formal evaluation<br />

of the chairman’s performance was not undertaken. The chief<br />

executive led the evaluation of the finance director. The chairmen<br />

of the respective committees reviewed the performance of their<br />

own committees.<br />

The chairman met with the non executive directors during <strong>2011</strong><br />

to discuss the evaluation of the board and succession plans.<br />

Achievement in <strong>2011</strong> of actions identified through the board performance<br />

evaluation in 2010<br />

strategic planning Focus on regular reporting to the<br />

board on the progress of strategic<br />

issues and actions<br />

risk management Enterprise risk management function<br />

provided regular updates to the board;<br />

Finance director provided regular<br />

updates to the board on key risks and<br />

mitigation measures<br />

financial and non<br />

financial monitoring<br />

talent management and<br />

succession planning<br />

New format of financial report;<br />

Development and understanding<br />

of the Group’s balanced scorecard<br />

Chairman designate and non executive<br />

director appointed in accordance with<br />

succession plans;<br />

Review of executive leadership team<br />

board development Participation in board updates focusing<br />

on gender diversity in the boardroom,<br />

the UK Bribery Act and changes to the<br />

Takeover Code<br />

61<br />

overview<br />

financial statements governance<br />

sustainability<br />

business review


62 <strong>Rexam</strong> annual report <strong>2011</strong> directors’ report<br />

corporate governance<br />

In <strong>2011</strong> each director completed a questionnaire scoring his or her<br />

response to statements focusing on the areas identified below and<br />

commenting more specifically as appropriate.<br />

board performance evaluation <strong>2011</strong><br />

Board structure Strategy<br />

Board meetings and administration Customers and suppliers<br />

Talent management and succession Financial and non financial<br />

planning<br />

Risk management<br />

monitoring<br />

The results of the <strong>2011</strong> board performance evaluation were<br />

presented to the board. The evaluation focused on the effectiveness<br />

of the board and its main committees.<br />

The directors shared the view that, following this comprehensive<br />

review, the board and its committees continue to operate<br />

effectively. However, the board has agreed that during 2012<br />

the following processes will be further developed and improved:<br />

process 2012 actions following <strong>2011</strong> evaluation<br />

strategic planning To further refine the strategic review<br />

process<br />

risk management To maintain a clear focus on risk<br />

anticipation, risk management and crisis<br />

management aligned to the challenges<br />

of the global economic climate<br />

non financial monitoring To progress non financial monitoring<br />

and reporting through the Group’s<br />

balanced scorecard<br />

talent management and<br />

succession planning<br />

To continue to review and contribute<br />

towards succession planning,<br />

consideration of the talent pool and<br />

people development<br />

board development To further develop the way in which the<br />

board works together as a unit<br />

customers and suppliers To continue to develop knowledge<br />

of and focus on the Group’s customers<br />

and suppliers<br />

A full performance evaluation of the board and its committees<br />

will continue to be conducted annually and an independent<br />

external assessment will take place at least every three years<br />

as recommended by the Code.<br />

election and re‑election of directors<br />

The Company’s articles of association require that any director<br />

appointed to the board since the date of the last annual general<br />

meeting (AGM) should be proposed for election at the first AGM<br />

after such appointment. Thereafter a director must be proposed<br />

for re‑election at the third AGM following the AGM at which the<br />

director was last elected or re‑elected. However, to promote<br />

good governance and in accordance with the Code, the board<br />

has recommended that all directors should submit themselves<br />

for election or re‑election on an annual basis.<br />

directors in office as at the date of this report to be proposed for election<br />

or re‑election at the AGM 2012<br />

Stuart Chambers non executive director and<br />

chairman designate<br />

Graham Chipchase chief executive<br />

David Robbie finance director<br />

Noreen Doyle non executive director<br />

John Langston non executive director<br />

Wolfgang Meusburger non executive director<br />

Leo Oosterveer non executive director<br />

Jean‑Pierre Rodier non executive director<br />

Following a rigorous evaluation of the performance of each<br />

director and on the recommendation of the nomination committee<br />

the board is proposing that Stuart Chambers and Leo Oosterveer,<br />

who were appointed non executive directors since the date of the<br />

last AGM, stand for election and that the other directors named<br />

above stand for re‑election at the AGM 2012.<br />

The board considers that Stuart Chambers was independent on<br />

appointment as a non executive director and chairman designate.<br />

Stuart Chambers is being recommended for election as the board<br />

believes that he has an extensive breadth of business experience,<br />

especially within the business to business markets, and his global<br />

expertise will be of benefit to the board’s deliberations.<br />

Leo Oosterveer is considered by the board to be independent.<br />

He is being recommended for election as the board believes that<br />

his global management experience and skills in marketing, sales<br />

and strategy development will be an asset to the Company.<br />

Graham Chipchase is being recommended for re‑election as the<br />

board believes his leadership and insight into the Group and its<br />

markets will help to develop <strong>Rexam</strong> and create shareholder value.<br />

David Robbie is being recommended for re‑election as the board<br />

believes his strong financial and corporate finance experience and<br />

his financial and strategic skills are important to the board and to<br />

the maintenance of tight financial controls.<br />

Noreen Doyle, John Langston, Wolfgang Meusburger and<br />

Jean‑Pierre Rodier are being recommended for re‑election as,<br />

in the board’s view, they remain independent and, following<br />

their formal performance evaluation, the chairman of the board<br />

has confirmed that they continue to be effective and demonstrate<br />

their commitment to the board. A biography of each member of<br />

the board can be found on pages 54 and 55.


accountability<br />

During <strong>2011</strong> the audit and risk committee focused<br />

on a number of activities associated with and<br />

complementary to its core internal financial<br />

control responsibilities.<br />

As well as reviewing the half year and full year<br />

results, the committee carried out a detailed<br />

assessment of the Group’s risk profile along with<br />

the process and management of the Group’s<br />

enterprise risk management function. It reviewed<br />

the effectiveness of the external auditors and the<br />

actions taken by internal audit following the<br />

independent review of its effectiveness in 2010.<br />

John Langston<br />

audit and risk committee chairman<br />

The board recognises its responsibility for ensuring the<br />

implementation and maintenance of effective systems of risk<br />

management and internal control, and presenting a balanced<br />

and understandable assessment of the Group’s position and<br />

prospects. The systems and controls in place include policies<br />

and procedures which provide reasonable assurance that<br />

transactions are recorded as necessary to facilitate the financial<br />

reporting process and the preparation of consolidated financial<br />

statements in accordance with International Financial <strong>Report</strong>ing<br />

Standards (IFRS). Representatives of the businesses are required<br />

to certify that their reported information gives a true and fair view<br />

of the state of affairs of the business and its results for the year.<br />

To discharge these duties and responsibilities the board works<br />

closely with the audit and risk committee.<br />

After taking account of the detailed work of the audit and risk<br />

committee, the board confirms that it carried out a review of the<br />

effectiveness of the system of internal control which operated<br />

within the Group during <strong>2011</strong> and up to the date of this annual<br />

report in accordance with the requirements of the revised Turnbull<br />

Guidance on Internal Control published by the FRC. This review<br />

covered the effectiveness of all internal controls, namely financial,<br />

operational, compliance and risk management.<br />

No significant failings or weaknesses were identified in the review<br />

for <strong>2011</strong>. The board is satisfied that, where areas for improvement<br />

were identified, processes are in place to ensure that the necessary<br />

action is taken and that progress is monitored. The board will<br />

continue to carry out such reviews on an annual basis. Details<br />

of the specific actions taken during <strong>2011</strong> to review the control<br />

environment and continue to improve controls are set out in the<br />

table under risk management and internal control in this section.<br />

the audit and risk committee<br />

The committee members comprise independent non executive<br />

directors. John Langston is the chairman of the committee. As a<br />

qualified chartered accountant and former finance director he is<br />

well placed to provide the committee with the relevant financial<br />

experience to enable it to carry out its responsibilities.<br />

committee membership <strong>2011</strong> meetings <strong>2011</strong> 1<br />

John Langston (committee chairman) 4/4<br />

Jean‑Pierre Rodier (appointed 6 December <strong>2011</strong>) 2 –<br />

Noreen Doyle 4/4<br />

Carl Symon (retired 23 November <strong>2011</strong>) 2 4/4<br />

1 Number of scheduled meetings attended/maximum number of meetings that<br />

the director could have attended.<br />

2 No meetings were held in <strong>2011</strong> after Jean‑Pierre Rodier’s appointment date.<br />

The committee membership comprised three independent non executive directors<br />

at the date of each meeting.<br />

The main responsibilities of the committee are to:<br />

• oversee and review the financial and operational risks,<br />

policies and management;<br />

• assist the board in meeting its responsibilities by<br />

ensuring an effective system of internal control and<br />

compliance and accurate external financial reporting;<br />

• assist the board in managing the relationship with the<br />

Company’s external auditors, to review and monitor<br />

their independence, and in particular the provision of<br />

non audit services provided by them to the Group;<br />

• keep under review the effectiveness of the process<br />

for the identification, assessment, mitigation, reporting<br />

and monitoring of risks facing the business; and<br />

• approve the appointment of the director internal audit<br />

and review and approve the annual programme of<br />

internal audit assignments.<br />

The committee meets at least four times a year. At the request of<br />

the committee chairman, the chairman of the board, the chief<br />

executive, the finance director, the group director enterprise<br />

risk, the director group finance, the director internal audit and<br />

the external auditors are invited to attend each meeting.<br />

63<br />

overview<br />

financial statements governance<br />

sustainability<br />

business review


64 <strong>Rexam</strong> annual report <strong>2011</strong> directors’ report<br />

corporate governance<br />

Should it be requested, the committee has access to independent<br />

expert advice at the Company’s expense. The performance and<br />

effectiveness of the committee are reviewed as part of the main<br />

performance evaluation of the board and all its committees.<br />

financial and business reporting<br />

The audit and risk committee shares responsibility with the<br />

board for reviewing in detail the annual report and half year<br />

results announcement, which provide a clear assessment of the<br />

performance and prospects of the Group through the business<br />

model, strategy and a review of strategic risks and financial and<br />

non financial performance. Also included in the annual report<br />

is the external auditors’ report to the members providing an<br />

independent view of the state of the Group’s affairs. The half<br />

year results announcement includes the external auditors’ review<br />

report to the Company.<br />

Other published financial information is reviewed by the committee<br />

for statutory and regulatory compliance and is submitted to the<br />

board with a recommendation for approval.<br />

risk management and internal control<br />

The Group has well established risk management and internal control<br />

systems. While all elements of risk cannot be eliminated, the<br />

processes and systems aim to identify, assess, prioritise and, where<br />

possible, mitigate the Group’s risks. Although no system can provide<br />

absolute assurance against material misstatement or loss, the Group’s<br />

systems are designed to provide the board with reasonable<br />

assurance that assets are safeguarded, transactions are properly<br />

authorised and recorded and that material errors and irregularities<br />

are either prevented or detected within a timely period.<br />

A separate enterprise risk function was established in 2010 led by<br />

a senior executive who is a member of the executive leadership<br />

team. The enterprise risk management function has brought an<br />

increased focus and emphasis on global risk management,<br />

providing leadership and co‑ordination across the Group’s business<br />

and operational risk activities. Other responsibilities include health<br />

and safety, environment, fire and property protection, security,<br />

insurance, business continuity and crisis management.<br />

key areas of the internal control framework activity in <strong>2011</strong><br />

financial reporting The Group has a comprehensive system for reporting<br />

financial results to the board. An annual budget and<br />

strategic review are prepared for each business and<br />

are consolidated for review by the board before being<br />

formally adopted. During the year, monthly management<br />

accounts, including cash flow and capital expenditure<br />

reporting, are prepared with a comparison against<br />

budget and prior year. Forecasts are revised in light of<br />

this comparison and are also reviewed by the board.<br />

delegated authority There are clearly defined lines of responsibility and<br />

levels of authority in operation throughout the Group,<br />

with specific matters reserved to the board. Businesses<br />

are decentralised with operating autonomy and<br />

financial responsibility delegated to corporate and<br />

local management to the extent that they have approval<br />

to operate within defined levels of authority and risk.<br />

There is an ongoing process for identifying, assessing, mitigating,<br />

reporting and monitoring the risks faced by the Group with a<br />

formal audit and risk process (known as the ARC process) led by<br />

the group director enterprise risk together with the finance director,<br />

the director internal audit and other senior management<br />

representatives. Meetings are held with businesses and functional<br />

managers who present their risk registers, enabling discussion<br />

of the risks identified, the management of those risks and the<br />

mitigation measures as well as the effectiveness of the systems<br />

of internal control. The process ensures that risks are not just the<br />

product of a bottom up approach but are also examined from a top<br />

down perspective and closely aligned with the Group’s strategy.<br />

Through the risk council, chaired by the group director<br />

enterprise risk, and comprising representatives from<br />

each of the sectors and the director internal audit,<br />

improvements to the ARC process were made during<br />

<strong>2011</strong> with an increased focus on risk mitigation actions.<br />

The results of the ARC process are reported to the audit and risk<br />

committee and provide an opportunity for the committee to discuss<br />

and analyse the risks reported. In addition to reviewing the risks,<br />

as presented by management, the committee also receives<br />

presentations from the Group’s businesses or functional managers<br />

to assess first hand the effectiveness of the process, and whether<br />

the risks identified are being managed successfully, and to<br />

challenge management on the mitigation measures in place.<br />

The committee then reports its conclusions to the board for review.<br />

Details of the key risks to which the Group is exposed and additional<br />

information on risk processes and management are included in the<br />

business review and can be found on pages 34 to 41.<br />

The framework which the board has established to provide effective<br />

internal control for both the Group and its associates and joint<br />

ventures is supported by the key areas set out in the table below.<br />

Regular reviews took place to ensure businesses<br />

were performing in line with budget and strategy.<br />

The chief executive and the finance director met<br />

regularly with operational management to ensure<br />

businesses were performing as expected and<br />

reporting in accordance with the Group’s standards.<br />

Following those meetings the chief executive and the<br />

finance director reported back to the board. A new<br />

financial report format was introduced for the board.<br />

The Group authority levels and related financial limits,<br />

which include information on those matters that are<br />

specifically reserved for the board’s consideration,<br />

were reviewed and updated.


procedures and controls There are formal written Group financial procedures<br />

and controls in operation, including specific<br />

procedures for treasury matters, capital investment<br />

and the approval of significant contracts. Corporate<br />

and local management are required to complete<br />

bi‑annual representation letters formally confirming<br />

that their businesses comply with the Group’s financial<br />

reporting policies and other Group policies<br />

and procedures.<br />

internal audit The internal audit function monitors financial and<br />

other risks faced throughout the Group and the<br />

control systems in operation to manage those risks.<br />

All significant internal audit findings are reported<br />

to the audit and risk committee.<br />

operational risk<br />

management<br />

Operational risk management, part of the enterprise<br />

risk function, provides the leadership to develop and<br />

monitor processes which identify, assess and manage<br />

risks associated with health and safety, environment,<br />

business continuity and crisis management, fire and<br />

loss prevention, security and asset protection. Purpose<br />

built audit programmes allow for businesses to be<br />

evaluated against <strong>Rexam</strong>’s and external best practice<br />

standards in these areas, and provide the basis for<br />

continuous improvement action plans. In addition,<br />

many <strong>Rexam</strong> businesses are accredited to external<br />

internationally recognised standards. The function<br />

also manages <strong>Rexam</strong>’s global insurance programme.<br />

Periodic updates including any significant findings and<br />

issues are reported to the audit and risk committee.<br />

Group authority levels were updated.<br />

Improvements were made to access and security<br />

controls along with a detailed review of the<br />

consistency of the Group’s computerised management<br />

systems and controls operating around the Group.<br />

A Group control framework is being developed which<br />

will be rolled out across the Group in 2012 to ensure<br />

that controls are operated consistently and in line with<br />

best practice.<br />

The online legal compliance training developed to<br />

ensure employees’ familiarity and compliance with<br />

the Code of Conduct was further extended to include<br />

specific training on Financial Integrity, Combating<br />

Bribery in Business and Competition and Anti Trust<br />

Law, and was completed by all levels of senior<br />

management.<br />

The annual internal audit plan was produced from<br />

an assessment of the risks following the ARC process<br />

reviews and was presented to the audit and risk<br />

committee for approval.<br />

Meetings were held regularly between internal audit<br />

management and the finance director, together<br />

with business management, to review progress on<br />

implementing audit recommendations and to ensure<br />

any significant issues identified were addressed.<br />

Updates on performance were provided to the audit<br />

and risk committee by the director internal audit.<br />

In <strong>2011</strong>, following the independent effectiveness<br />

review of internal audit, the director internal audit<br />

presented to the audit and risk committee a road map<br />

for the internal audit function. This addressed the<br />

structure and the remit of internal audit to ensure it was<br />

focused and delivering the necessary assurance to the<br />

committee and management, and was operating in<br />

line with best practice.<br />

In line with the <strong>Rexam</strong> values a system of awards was<br />

introduced to recognise businesses receiving high<br />

scores based on the audits.<br />

An enhanced global Environment, Health and Safety<br />

(EHS) audit approach was developed to provide the<br />

basis of challenge for a more sustainable and robust<br />

improvement of EHS management systems and<br />

performance at all sites. In addition we introduced a<br />

high standard fire safety and property protection audit<br />

supported and performed by AXA Matrix. Further<br />

details can be found in the key risks section of this<br />

annual report on page 40.<br />

65<br />

overview<br />

financial statements governance<br />

sustainability<br />

business review


66 <strong>Rexam</strong> annual report <strong>2011</strong> directors’ report<br />

corporate governance<br />

internal audit<br />

The internal audit function plans and undertakes audits of the<br />

businesses to ensure that the controls operating in the businesses<br />

conform with Group controls and procedures, and reviews the<br />

effectiveness of the risk management process.<br />

The director internal audit provides regular updates to the audit<br />

and risk committee and reports on all significant audit findings.<br />

He also has separate meetings with the chairman of the audit<br />

and risk committee without any other member of management<br />

being present.<br />

In <strong>2011</strong> the committee reviewed and approved the annual internal<br />

audit plan including the proposed audit approach, coverage and<br />

allocation of resources. It also reviewed the results of the audits<br />

undertaken, with particular emphasis on the recommendations<br />

made and management’s response to the matters raised. A change<br />

in the audit ratings used by internal audit in its reports to better<br />

evaluate the control environment was also approved.<br />

external auditors<br />

The committee has primary responsibility for and advises the board<br />

on the appointment, reappointment and the remuneration of the<br />

Company’s external auditors. PricewaterhouseCoopers LLP (PwC)<br />

have been the Company’s external auditors since 2003 with the<br />

lead audit partner changing by rotation in 2008. During <strong>2011</strong>, the<br />

committee reviewed the effectiveness of the external auditors and<br />

recommended to the board that a resolution to reappoint PwC be<br />

proposed at the AGM 2012. A further review of PwC’s<br />

effectiveness will be undertaken in 2012 following completion of<br />

the <strong>2011</strong> year end audit. The committee will continue to keep under<br />

review the independence and objectivity of the external auditors.<br />

The external auditors attend all audit and risk committee meetings.<br />

The committee chairman also has separate meetings with the<br />

external auditors to discuss relevant matters.<br />

The first meeting within the Group’s annual audit cycle is to<br />

consider the nature and scope of the audit and to consider any<br />

additional special reviews that may be necessary. Further meetings<br />

are held prior to the approval of the half year and full year results<br />

to consider, as relevant, the audit conclusions, the results of any<br />

special reviews undertaken, the business risks facing the Group<br />

and the reports from the ARC process meetings. The committee<br />

reports its findings on the audit process and on the wider aspects<br />

of internal control to the board.<br />

Non audit services are provided by PwC to the Group only in<br />

accordance with <strong>Rexam</strong>’s policy on the provision of non audit<br />

services, which assesses the type of service to be provided and the<br />

associated fees. Any request for non audit services above a fee<br />

threshold of £25,000 is presented to the finance director for<br />

approval prior to commencement of the work. The finance director<br />

will, depending on the nature of and fee for the service, obtain the<br />

prior authorisation of the chairman of the audit and risk committee.<br />

This committee reviews the level of non audit fees to ensure that the<br />

provision of non audit services does not impair PwC’s<br />

independence or objectivity. Non audit fees in <strong>2011</strong> relate mainly<br />

to assurance reporting on historic financial information required for<br />

business disposals, assurance in relation to IT projects, including a<br />

new treasury system, and global tax advisory services. The fees for<br />

non audit services are disclosed in note 5 to the consolidated<br />

financial statements. Other audit firms were engaged to provide<br />

expatriate and specialist tax advisory services as well as to advise<br />

on disposal transactions.<br />

PwC are prohibited from providing services to the Group that<br />

would be considered to jeopardise their independence, such as<br />

financial systems design and implementation, actuarial services,<br />

internal audit outsourcing services and investment services.<br />

The policy on non audit services has been reviewed during <strong>2011</strong><br />

to ensure it is in line with best practice.<br />

directors’ conflicts of interest<br />

The board has a formal system in place for directors to review<br />

regularly their interests and to deal with situations where a director<br />

reports any conflicts of interest. Any conflict situation reported to<br />

the chairman and the company secretary is considered by the<br />

board based on its particular facts. Any authorisations given to a<br />

director who has a conflict situation are recorded in the board<br />

minutes and in a register of directors’ conflicts which is reviewed<br />

annually by the board. No conflict situations were reported to the<br />

board during <strong>2011</strong> and up to the date of this annual report.<br />

code of conduct<br />

A worldwide Code of Conduct, which applies to all the Company’s<br />

employees, has been approved by the board and provides a clear<br />

statement for the benefit of stakeholders involved with or impacted<br />

by <strong>Rexam</strong>’s activities. It is communicated through an induction<br />

process for new employees, as part of the team briefings in the<br />

Group’s businesses, and on the Group’s intranet and website.<br />

The board is kept informed regarding the maintenance of the Code<br />

of Conduct and any breaches of it. An online training system has<br />

been introduced to ensure all management are aware of their<br />

responsibilities and are in compliance with the Code of Conduct.<br />

In addition, with the introduction of the UK Bribery Act, all policies<br />

and procedures relating to bribery and corruption were reviewed<br />

to ensure they are in line with best practice and that there<br />

are adequate procedures to prevent bribery or corruption<br />

taking place.


whistle blowing policy<br />

<strong>Rexam</strong> has an open door policy on communication whereby<br />

employees are encouraged to share concerns, raise issues,<br />

provide ideas for improvement, with all levels of management<br />

in the business. It is recognised, however, that there will be times<br />

when an employee might be uncomfortable raising concerns<br />

directly with local management and, in such cases, communication<br />

with business and Group management is encouraged.<br />

<strong>Rexam</strong> operates a whistle blowing policy which is supported<br />

by an external confidential telephone helpline, available to all<br />

employees for the raising of any concerns, including those of a<br />

financial nature. The Raise Your Concern policy is highlighted in<br />

team meetings to ensure the policy is understood and available<br />

to all employees.<br />

The Raise Your Concern telephone helpline has been beneficial as<br />

an independent point of contact for employees where, if requested,<br />

the anonymity of the employee is maintained. During <strong>2011</strong> there<br />

were 41 concerns logged (2010: 45 concerns) raising matters,<br />

in the majority of cases, related to human resource issues and<br />

practices. All concerns reported are investigated at the earliest<br />

opportunity by the director internal audit, in conjunction with the<br />

company secretary and, if appropriate, by management of the<br />

respective business. The director internal audit provides an update<br />

on all calls received, and the actions taken to respond to and<br />

resolve them, to Group management and the audit and risk<br />

committee on a regular basis. Any significant concerns are<br />

reported directly to the chairman of the audit and risk committee<br />

as well as to Group management.<br />

The committee reviews the whistle blowing policy and the Raise<br />

Your Concern process annually.<br />

In <strong>2011</strong> an external benchmark review was undertaken<br />

of the nature and volume of calls received under Raise<br />

Your Concern to ensure that the process was working<br />

effectively and was comparable with the experience of<br />

other organisations. The nature of the calls logged was<br />

found to be broadly in line with benchmark data and the<br />

committee was satisfied that concerns are investigated<br />

thoroughly and that the callers receive appropriate<br />

responses through the helpline.<br />

going concern<br />

The Group’s business activities, together with the factors likely<br />

to affect its future development, performance and position are<br />

set out in the business review on pages 10 to 41. The financial<br />

position of the Group, its cash flows, liquidity position and<br />

borrowing facilities are detailed in the financial review on pages<br />

31 to 33. In addition, notes 24, 25 and 26 to the consolidated<br />

financial statements include the Group’s objectives and policies<br />

for managing its capital, its financial risk management objectives,<br />

details of its financial instruments and hedging activities, and its<br />

exposures to credit risk and liquidity risk.<br />

The Group has considerable financial resources together with<br />

established agreements with a number of key customers and<br />

suppliers across different geographic areas and markets. The<br />

financial resources include £2.6bn of debt facilities with the next<br />

significant maturities due in March 2013 (£0.5bn) and June 2013<br />

(£0.5bn). The directors believe that the Group is well placed to<br />

manage its business despite the economic environment which<br />

increases risks and uncertainties.<br />

The directors, having made appropriate enquiries, are satisfied<br />

that the Company and the Group have adequate resources<br />

to continue in operational existence for the foreseeable future.<br />

For this reason, they continue to adopt the going concern basis in<br />

preparing the consolidated and Company financial statements.<br />

remuneration<br />

remuneration policy for directors<br />

The remuneration committee is responsible for making<br />

recommendations to the board on the Group’s remuneration<br />

policy and setting the remuneration levels and specific packages<br />

appropriate for the chairman and the executive directors<br />

taking into account the Group’s annual salary negotiations.<br />

The remuneration report is on pages 69 to 80 of this annual report.<br />

67<br />

overview<br />

financial statements governance<br />

sustainability<br />

business review


68 <strong>Rexam</strong> annual report <strong>2011</strong> directors’ report<br />

corporate governance<br />

shareholder relations<br />

dialogue with shareholders<br />

The board believes that it is a priority to communicate with<br />

shareholders and uses various methods to reach as many<br />

shareholders as possible. There are programmes for the chief<br />

executive, finance director and the head of investor relations<br />

to meet with the Company’s major institutional investors in the<br />

UK, the US and Europe. Presentations are made on the operating<br />

and financial performance of the Group, including corporate<br />

governance related matters, and the Group’s longer term strategy.<br />

The presentation slides shown to representatives of the investment<br />

community following the announcement of the half and full year<br />

results are available on the Company’s website, as is a live<br />

webcast of the related results presentation. Roadshows are held<br />

in the UK, the US and Europe following the announcement of the<br />

half and full year results. Where it is not possible to meet face<br />

to face, meetings are held by video or telephone conference.<br />

The Company also hosts plant visits and annual seminars for<br />

institutional shareholders and representatives of the investment<br />

community. The seminars are webcast live and replays, together<br />

with presentation slides, are available online.<br />

During <strong>2011</strong> investors were invited to attend a seminar in<br />

person or by telephone focusing on the global beverage<br />

can market. The seminar was well attended and investors<br />

commented that it had improved their understanding of<br />

the beverage can industry and its growth drivers, as well<br />

as <strong>Rexam</strong>’s position within the industry.<br />

Institutional shareholders can request an opportunity to meet<br />

with any of the executive and non executive directors. The non<br />

executive directors have an opportunity to meet with shareholders<br />

at the AGM and may attend analyst presentations made by the<br />

chief executive and finance director. The board fully supports the<br />

principle of the Code which seeks to encourage more active<br />

interest and contribution from institutional shareholders.<br />

The non executive directors are given regular updates as to the<br />

views of institutional shareholders. After the investor meetings<br />

held following the announcement of the half and full year results,<br />

a summary report on investor responses is prepared for the board,<br />

normally by the Company’s corporate brokers. The board also<br />

commissions an annual presentation of major investors’ views on<br />

Company management and performance, based on results of surveys<br />

and extensive interviews. This survey also helps to plan the investor<br />

relations programme for the following year.<br />

annual general meeting<br />

Communication with private shareholders is largely through the<br />

AGM, which is held at a central London location. The notice of the<br />

AGM is posted to shareholders with, if requested, the annual report<br />

and any related papers at least 20 working days before the date of<br />

the AGM to ensure that shareholders have sufficient time in which<br />

to consider the items of business to be voted upon. The majority of<br />

shareholders have elected to access the annual report and other<br />

shareholder documents online via the <strong>Rexam</strong> website rather than<br />

receiving a copy by post.<br />

A presentation is made at the AGM to update shareholders on the<br />

Group’s activities. Shareholders are given the opportunity to ask<br />

questions of the board and the chairman of each board committee<br />

during the AGM and to meet all the directors informally at the<br />

AGM. Separate resolutions are proposed at the AGM on a poll for<br />

each item of business and shareholders are asked to vote ‘for’,<br />

‘against’ or ‘vote withheld’ on each resolution. Votes are counted<br />

and an announcement confirming whether each resolution was<br />

passed at the AGM is made through the London Stock Exchange<br />

and can be viewed on the <strong>Rexam</strong> website, together with a<br />

summary of the number of votes cast in respect of each resolution.<br />

<strong>Rexam</strong>’s ADR investors receive details of the AGM and are entitled<br />

to instruct the depositary, The Bank of New York Mellon, to vote<br />

on the resolutions to be proposed at the AGM.<br />

Shareholders can ask questions of the Company at any<br />

time through the <strong>Rexam</strong> website or by contacting the<br />

company secretary’s department at the Company’s<br />

headquarters.


emuneration report<br />

strategy and focus<br />

Our focus has always been to define a<br />

remuneration strategy that clearly aligns with<br />

the Company’s business strategy and aims to<br />

incentivise people to deliver sustainable long term<br />

shareholder value.<br />

The Company’s remuneration policy allocates a<br />

significant proportion of executive compensation<br />

to performance related remuneration which is<br />

balanced between annual and long term incentives<br />

which are linked to these objectives. A proportion<br />

of the annual incentive for executive directors<br />

is awarded in shares and thus, ultimately, their<br />

future value is tied to the long term success of the<br />

Company. Executive directors are also expected<br />

to acquire and retain over time a significant<br />

shareholding.<br />

We have seen policies and practices evolve to<br />

align the interests of senior management with those<br />

of the shareholders. The remuneration committee<br />

ensures that the objectives and targets set for<br />

performance related compensation are stretching<br />

and have an acceptable degree of risk. Success<br />

over an annual period is judged against<br />

achievement of operating profit and cash flow<br />

generation targets and individual objectives. Over<br />

the longer term, the performance is based on three<br />

measures that reflect a balance between capital<br />

returns and earnings growth through a mixture of<br />

relative total shareholder return, return on capital<br />

employed and earnings per share growth.<br />

In reaching its decisions, the committee is very<br />

sensitive to the fact that delivering sustainable<br />

shareholder value requires all employees around<br />

the world to be appropriately paid and rewarded.<br />

Jean-Pierre Rodier<br />

remuneration committee chairman<br />

the remuneration committee<br />

The members of the committee are independent non executive<br />

directors.<br />

committee membership <strong>2011</strong> meetings <strong>2011</strong> 1<br />

Jean-Pierre Rodier 2<br />

(committee chairman from 6 December <strong>2011</strong>) 4/4<br />

Carl Symon 3<br />

(retired 23 November <strong>2011</strong>) 4/4<br />

John Langston 4<br />

(appointed 6 December <strong>2011</strong>) –<br />

Wolfgang Meusburger 4/4<br />

1 Number of scheduled meetings attended/maximum number of meetings that the<br />

director could have attended.<br />

2 Jean-Pierre Rodier has been a member of the committee since July 2006.<br />

3 Carl Symon retired from the committee and as committee chairman on<br />

23 November <strong>2011</strong>.<br />

4 No meetings were held in <strong>2011</strong> after 6 December <strong>2011</strong>.<br />

The committee invites the chairman of the Company to attend its<br />

meetings and normally also invites the chief executive and group<br />

director human resources. The company secretary attends in his<br />

capacity as secretary to the committee and as group general counsel.<br />

None of the above attend the part of the meeting where their own<br />

remuneration is being discussed. Other directors and senior<br />

managers are invited to attend meetings where their expertise is<br />

requested by the committee.<br />

Kepler Associates were appointed by the Company and acted<br />

as remuneration consultants to the committee and the Company.<br />

Representatives from Kepler Associates have attended committee<br />

meetings when requested to do so. The external advisors who<br />

provided services to the committee during the year are detailed<br />

below. In addition to their services to the committee, Aon Hewitt<br />

and Mercer provide pension consultancy and retirement benefits<br />

accounting advice to the Group, while Allen & Overy is the<br />

Group’s principal UK legal advisor.<br />

advisor services<br />

Kepler Associates Executive remuneration advice and<br />

provision of market data for salaries<br />

and incentive programmes<br />

Aon Hewitt Limited and Retirement benefits advice<br />

Mercer Limited<br />

Allen & Overy LLP Legal advice on cash and share<br />

incentive schemes, employment<br />

and retirement benefits matters<br />

1 Addleshaw Goddard LLP advised on share incentive arrangements until August <strong>2011</strong>.<br />

69<br />

overview<br />

financial statements governance<br />

sustainability<br />

business review


70 <strong>Rexam</strong> annual report <strong>2011</strong> directors’ report<br />

remuneration report<br />

role of the remuneration committee<br />

The board has approved the terms of reference delegating certain<br />

responsibilities to the committee. The terms of reference are<br />

reviewed annually and are available on the Company’s website.<br />

The main responsibilities of the committee are to:<br />

• determine the ongoing appropriateness of the<br />

remuneration principles and the remuneration and<br />

benefits policy, including retirement benefits, for the<br />

executive directors and band 1 executives who are<br />

the Group’s most senior management;<br />

• approve the terms and conditions for service contracts<br />

for the executive directors and band 1 executives<br />

including, when necessary, termination and<br />

compensation payments, and to approve the individual<br />

remuneration packages for the chairman of the<br />

Company, the executive directors and band 1<br />

executives;<br />

• supervise the Group’s remuneration practices and<br />

procedures;<br />

• approve and recommend to the board the design of<br />

any new executive or employee cash or share incentive<br />

arrangements and, for existing cash or shares incentive<br />

arrangements, annual awards and grants, the setting<br />

of performance conditions and parameters and any<br />

significant rule changes; and<br />

• approve the achievement of any performance targets<br />

for cash or share incentive arrangements.<br />

The committee holds a strategy meeting once a year to review<br />

market comparisons and discuss specifically the appropriateness<br />

of the Company’s remuneration principles and the policy for the<br />

following financial year.<br />

The performance and effectiveness of the committee are reviewed<br />

as part of the main performance evaluation of the board and all<br />

its committees. The committee chairman discusses the results of the<br />

evaluation with the committee and, where appropriate, areas for<br />

improvement are identified.<br />

remuneration principles, policy and package<br />

The Group’s aim is to increase shareholder value. It is key that<br />

the remuneration principles underpin this and that the committee<br />

is focused on facilitating the achievement of the corporate<br />

strategy through ensuring that achievement of the corporate<br />

strategy is reinforced through appropriate performance and<br />

management incentives.<br />

Rewards are aligned with the Company’s performance so that<br />

executive directors are incentivised to achieve demanding results<br />

but within an appropriate risk profile for the Group.<br />

The board believes that the remuneration principles and policy<br />

should ensure that the Company is focused on the social, ethical,<br />

environmental and governance issues that are relevant to the<br />

business. The board and the committee aim to have processes<br />

that reward all employees fairly according to their responsibilities,<br />

their performance and market practice in their country of<br />

employment. The committee is made aware of comparative<br />

data relating to the pay and employment conditions for other<br />

Group employees which is taken into consideration when the<br />

remuneration package for executive directors and band 1<br />

executives is being reviewed.<br />

remuneration principles for the Group<br />

To become an employer of choice by attracting, retaining and<br />

motivating highly qualified and talented people and to provide<br />

competitive remuneration to all employees appropriate to the<br />

countries in which we are based<br />

To create an integrated Group wide reward strategy, particularly<br />

in the area of long term incentives, providing a balance between<br />

annual and long term incentives and fixed and variable pay<br />

To ensure that a significant portion of the remuneration package is<br />

weighted towards variable, performance related pay to align the<br />

interests of the executive directors with those of the shareholders<br />

To promote a consistent, clear and transparent link between<br />

business performance and shareholder value<br />

To reward stretching and sustained financial and personal<br />

performance focused on profitable growth, sustainable margins<br />

and cash flow with an earnings opportunity in the upper quartile<br />

of market comparative data<br />

To ensure remuneration packages are market competitive<br />

To reinforce the <strong>Rexam</strong> values and leadership practices<br />

To provide transparency and simplicity in the reward strategy<br />

The committee considers the remuneration principles in<br />

determining the remuneration policy. To maintain a consistent<br />

global approach to reward, the remuneration policy is<br />

implemented not only for the executive directors, Graham<br />

Chipchase and David Robbie, but also for the band 1 executives<br />

who are charged with delivering long term shareholder value<br />

and sustained business performance improvement.


Following the annual remuneration review in November <strong>2011</strong>,<br />

the committee concluded that the basis on which the remuneration<br />

package is formulated remains relevant and that executive<br />

directors’ remuneration remains appropriate and closely aligned<br />

with the Company’s strategy. A summary of the main elements of<br />

the remuneration package as they apply to executive directors is<br />

shown below and further details are included in the respective<br />

sections of this report.<br />

remuneration policy <strong>2011</strong> and 2012<br />

The focus of the remuneration policy is to set base salaries, benefits<br />

and retirement benefits at or around the market median taking<br />

account of the job description, experience and personal<br />

performance, and reward exceptional achievement of stretching<br />

financial and personal performance.<br />

base Set at or around the market median<br />

salary<br />

annual<br />

incentives<br />

long term<br />

incentives<br />

clawback<br />

policy<br />

retirement<br />

benefits<br />

(UK)<br />

90% of base salary at target and maximum bonus<br />

opportunity of 180% of base salary with 25% of any<br />

earned bonus to be deferred into <strong>Rexam</strong> shares<br />

Performance conditions linked to compound annual<br />

underlying earnings per share growth (33.3%), relative<br />

total shareholder return (33.3%) and return on capital<br />

employed growth (33.3%)<br />

Provides for unvested shares or awards to be<br />

forfeited in whole or in part in the event of conduct<br />

detrimental to the Group or a material restatement<br />

of the Group’s results<br />

Career average revalued earnings defined benefit<br />

plan for current executive directors<br />

Executive directors appointed after 6 April <strong>2011</strong> will<br />

be entitled to membership of a defined contribution<br />

pension arrangement<br />

Based on achievement of targets for the annual cash incentives<br />

and the expected value of share awards vesting, the estimated<br />

percentage value of an annual remuneration package is<br />

illustrated below:<br />

2012 annual remuneration package<br />

Target/<br />

expected value<br />

Maximum<br />

Graham Chipchase and David Robbie<br />

32%<br />

14% 27% 27%<br />

18% 8% 33% 41%<br />

0%<br />

100%<br />

● Salary ● Retirement benet ● <strong>Annual</strong> incentive ● LTIP<br />

source: Kepler Associates<br />

The value placed on performance related incentives is an estimate<br />

of the expected value. It cannot be accurately quantified until<br />

the extent to which performance targets are met is known and<br />

the incentives crystallise. If the respective minimum performance<br />

targets are not achieved, then the incentive has no value. If share<br />

based incentives vest, the Company’s share price at the time<br />

of the vesting of the awards determines the value of the<br />

incentives received.<br />

base salary<br />

Salary reviews take effect in May each year and are based on<br />

the personal performance of the individual as well as reference to<br />

the market median for the position and experience of the executive<br />

director. The base salary for executive directors takes account of<br />

prevailing market and economic conditions and the levels of base<br />

salary provided for the broader employee base. All benchmarking<br />

data is reviewed carefully and in context and the committee does<br />

not accept unquestioningly benchmarking data but considers other<br />

relevant criteria when base salaries are reviewed.<br />

base salary <strong>2011</strong> base salary 2010<br />

Graham Chipchase £715,000 £675,000<br />

David Robbie £440,000 £418,200<br />

For 2012, salaries will be reviewed taking account of the<br />

remuneration policy, benchmark data as referred to above<br />

and the salary review parameters set for the Group as a whole.<br />

The committee is also sensitive to the levels of the remuneration<br />

packages of other employees within the Group. <strong>Rexam</strong> operates<br />

in many countries and has an employee base with a diverse range<br />

of skills. Employee remuneration packages are therefore determined<br />

locally to meet local needs, while respecting <strong>Rexam</strong>’s values.<br />

71<br />

overview<br />

financial statements governance<br />

sustainability<br />

business review


72 <strong>Rexam</strong> annual report <strong>2011</strong> directors’ report<br />

remuneration report<br />

annual incentives<br />

annual incentives for executive directors <strong>2011</strong><br />

To incentivise management to achieve profitable growth and to<br />

sustain the Group’s cash programme, the annual cash incentive<br />

financial targets in <strong>2011</strong> depended upon the realisation of targets<br />

for Group underlying profit before tax and free cash flow as well as<br />

personal performance. At target, the annual incentive achievement<br />

was 90% of base salary and the maximum incentive opportunity<br />

was 180% of base salary for achieving demanding financial<br />

targets and exceeding personal performance objectives. Personal<br />

performance was measured against personal objectives and<br />

<strong>Rexam</strong> specific leadership practices.<br />

The executive directors will receive 25% of any annual incentive<br />

awarded in 2012, in respect of <strong>2011</strong> annual incentives, as<br />

a deferred award over <strong>Rexam</strong> shares, with no additional<br />

performance conditions save that such shares must be held for<br />

a period of not less than three years and are subject to clawback.<br />

The policy relating to clawback is described in the long term<br />

incentives section of this report.<br />

annual incentive achievement for executive directors <strong>2011</strong><br />

The financial targets for <strong>2011</strong> were achieved and resulted in<br />

the executive directors being entitled to an annual incentive<br />

equivalent to 100.7% of base salary. In addition, the committee<br />

assessed the achievement by each executive director of their<br />

personal performance objectives set at the beginning of <strong>2011</strong>.<br />

The total annual incentive entitlement approved by the committee,<br />

including achievement of personal objectives, was 128.6% and<br />

125.9% of base salary for Graham Chipchase and David Robbie<br />

respectively. Executive directors will receive 75% of their annual<br />

incentive as cash and 25% as a deferred award over <strong>Rexam</strong><br />

shares which will vest in three years.<br />

performance conditions <strong>2011</strong> % of base salary <strong>2011</strong><br />

target maximum actual<br />

Underlying profit before tax 43.2 86.4 52.7<br />

Free cash flow 28.8 57.6 48.0<br />

Personal performance objectives 18.0 36.0 25.2–27.9<br />

annual incentives for executive directors 2012<br />

The performance conditions for 2012 continue to build on<br />

achieving improved profit before tax and generating free cash<br />

flow, together with achieving personal performance objectives.<br />

The basis of performance measures for 2012, therefore, remains<br />

unchanged to those in <strong>2011</strong>. In its assessment of personal<br />

performance, the committee will continue to ensure that there is an<br />

appropriate balance between payments for personal performance<br />

and the achievement of financial objectives. The target incentive<br />

opportunity is 90% of base salary with an opportunity to achieve<br />

180% of base salary for achieving demanding financial targets<br />

and exceeding personal performance objectives.<br />

The weighting of the performance targets for 2012 is shown below<br />

and remains unchanged to those in <strong>2011</strong>.<br />

performance conditions 2012 % of base salary 2012<br />

target maximum<br />

Underlying profit before tax 43.2 86.4<br />

Free cash flow 28.8 57.6<br />

Personal performance objectives 18.0 36.0<br />

Total 90.0 180.0<br />

As in <strong>2011</strong>, executive directors will receive in 2013, subject to<br />

achievement of 2012 performance targets, 75% of their annual<br />

incentive as cash and 25% as a deferred award over <strong>Rexam</strong> shares<br />

which will vest in three years.<br />

The band 1 executives participate in the annual incentive<br />

arrangements on the same basis as the executive directors<br />

but at a lower annual incentive opportunity and without any<br />

deferral into shares.<br />

long term incentives<br />

Long Term Incentive Plan 2009 (2009 LTIP)<br />

The 2009 LTIP is the primary long term incentive for executive<br />

directors, band 1 executives and other senior management.<br />

Awards to be granted in 2012<br />

In 2012 the committee intends that individual awards to the<br />

executive directors will be the same as in <strong>2011</strong> at 220% of base<br />

salary. As in <strong>2011</strong>, awards will be measured against improvement<br />

in compound annual growth in underlying earnings per share,<br />

relative total shareholder return, and return on capital employed.<br />

performance measure award % reason for performance condition<br />

Compound annual<br />

growth in underlying<br />

earnings per share<br />

(EPS)<br />

Return on capital<br />

employed (ROCE)<br />

Relative total<br />

shareholder return<br />

(TSR)<br />

33.3 Business performance<br />

A visible and recognised<br />

indicator of the Company’s<br />

financial returns<br />

33.3 Business performance<br />

Profitable use of assets<br />

33.3 Shareholder value<br />

An external, verifiable<br />

measurement that provides<br />

a robust and comparative<br />

indicator of the Company’s<br />

performance against other<br />

companies listed in the FTSE<br />

All three performance measures demonstrate the success of the<br />

Company’s strategy. A combined EPS, ROCE and TSR approach<br />

maximises alignment with shareholder interests and provides a<br />

clear link between management action and sustained business<br />

performance. The committee believes that the performance<br />

targets closely align executive director compensation with the<br />

Company’s strategy.


EPS performance will be measured by compound annual growth<br />

in earnings per share adjusted to exclude retirement benefit<br />

obligations net finance cost. For the awards to be granted in 2012,<br />

the committee has targeted EPS growth performance in a range<br />

between 3% pa and 12% pa (<strong>2011</strong>: 3% pa and 12% pa).<br />

EPS performance<br />

vesting of total award<br />

subject to EPS %<br />

Below minimum 3% pa None<br />

Between minimum and maximum 8.3–33.3<br />

Above maximum 12% pa 33.3<br />

ROCE performance will be measured by averaging the annual return<br />

on capital employed over the measurement period. The committee<br />

has targeted ROCE performance in a range between 12% pa<br />

and 16% pa for the 2012 awards (<strong>2011</strong>: 11% pa and 15% pa).<br />

These targets reflect the commitment of the management to further<br />

increase the ROCE of the Group.<br />

ROCE performance<br />

vesting of total award<br />

subject to ROCE %<br />

Below minimum 12% pa None<br />

Between minimum and maximum 8.3–33.3<br />

Above maximum 16% pa 33.3<br />

<strong>Rexam</strong>’s TSR will be compared with the TSRs of a comparator group<br />

comprising the largest 150 companies (excluding investment trusts)<br />

by market capitalisation within the FTSE All Share index on<br />

1 January 2012.<br />

TSR performance percentile within comparator group<br />

vesting of total award<br />

subject to TSR %<br />

Below median None<br />

Between median and 25th 8.3–33.3<br />

Above 25th 33.3<br />

The 2012 awards will include a dividend equivalent whereby<br />

executive directors will be entitled to receive in shares or cash the<br />

dividends notionally paid during the measurement period on any<br />

shares that vest.<br />

The awards will also be granted subject to a clawback provision<br />

whereby unvested shares or awards can be forfeited in whole or in<br />

part in the event of conduct detrimental to the Group; specifically<br />

conduct which results in material reputational damage, significant<br />

financial loss or a restatement of results other than pursuant to a<br />

change of the accounting rules.<br />

Under the rules of the 2009 LTIP, awards granted under this plan<br />

will vest to the extent that certain performance conditions have<br />

been achieved over a three year measurement period. In certain<br />

early leaver situations, the committee has discretion as to whether<br />

awards can be exercised and, if so, to determine the achievement<br />

of performance targets. Participants who leave the Group with a<br />

right to retain their awards under the rules of the 2009 LTIP must<br />

normally wait until the end of the measurement period. If the award<br />

vests, the participant will receive an entitlement which will be time<br />

apportioned for the period from the start of the performance<br />

period to the date on which employment ended.<br />

Similarly, on takeover or change of control of the Company, the<br />

committee will determine vesting according to the achievement<br />

of performance targets and time apportionment of the resulting<br />

entitlement.<br />

In 2012, band 1 executives will receive awards at a lower<br />

percentage level of base salary but with the same performance<br />

conditions and targets as the executive directors.<br />

other share incentive schemes<br />

The Company also operates the Savings Related Share Option<br />

Scheme 2007 in the United Kingdom in which eligible executive<br />

directors are permitted to participate.<br />

dilution limits<br />

During the year, the Company remained within the issued share<br />

capital headroom limits as set out in the rules of its share incentive<br />

arrangements for the issue of new shares.<br />

headroom limits<br />

5% in 10 years for discretionary<br />

share option schemes<br />

10% in 10 years for all share<br />

option schemes<br />

% of issued<br />

share capital<br />

as at 31.12.<strong>2011</strong><br />

% of issued<br />

share capital<br />

as at 31.12.2010<br />

0.9 1.3<br />

1.3 1.6<br />

Awards granted under the 2009 LTIP will be settled by the <strong>Rexam</strong><br />

Employee Share Trust from shares it purchases in the market.<br />

retirement benefits<br />

Current executive directors employed in the UK are members<br />

of the career average revalued earnings defined benefit <strong>Rexam</strong><br />

Pension Plan (the Plan). The maximum pensionable pay for<br />

executive directors who are members of the Plan is their base<br />

salary less an offset in accordance with the rules of the Plan.<br />

Each year they individually earn a pension entitlement equal to<br />

1/30th of their pensionable pay in that year which is then revalued<br />

to age 60, which is their expected retirement age under the Plan.<br />

Current executive directors are able to fully or partially opt out of<br />

the Plan for accrual of their individual retirement pension and<br />

receive a cash supplement instead. The value of this cash<br />

supplement is 44% of any eligible base salary not pensioned<br />

under the Plan. In the event of the death in service of a member<br />

of the Plan, and if the member has dependants, an age related<br />

amount of between 11 and 15 times salary is provided, with any<br />

amount not paid as a lump sum to beneficiaries being converted<br />

into dependants’ pensions.<br />

The benefits provided to executive directors are set out in the rules<br />

of the Plan and as such are valued and funded as part of the Plan’s<br />

normal actuarial valuation cycle. Any surplus and deficit in respect<br />

of executive directors are aggregated, and funded with that of all<br />

other Plan members. Discretionary benefits for executive directors<br />

are also dealt with in the same way as discretionary benefits for<br />

other Plan members. There are no allowances for discretionary<br />

increases in cash equivalent transfer value calculations. The<br />

funding position of the Plan on an accounting basis is reported<br />

in note 27 to the consolidated financial statements.<br />

73<br />

overview<br />

financial statements governance<br />

sustainability<br />

business review


74 <strong>Rexam</strong> annual report <strong>2011</strong> directors’ report<br />

remuneration report<br />

With the agreement of the employer and the Plan Trustee, early<br />

retirement benefits can be taken on cessation of employment after<br />

attainment of age 55 with accrued benefits for executive directors<br />

reduced by 3% pa before age 60. On retirement, a member<br />

can elect to convert some of the pension into a tax free lump<br />

sum payment and, accordingly, take a smaller monthly pension.<br />

Pensions in payment are increased annually in line with the retail<br />

prices index, subject to various minimum and maximum increases<br />

(according to periods of service) as set out in the rules of the Plan.<br />

Graham Chipchase and David Robbie are members of the Plan<br />

and their retirement benefit arrangements are on the basis<br />

summarised above. Each selected a pensionable salary for the<br />

year which was below the maximum and received a salary<br />

supplement on pension eligible basic salary. Details of their<br />

entitlements and transfer values under the Plan during <strong>2011</strong> are<br />

shown in the table on page 78 and their salary supplements are<br />

shown in the table on page 77.<br />

retirement benefits in 2012<br />

Any new executive director appointment, who is not currently a<br />

contributing member of the Plan, will be eligible to join a defined<br />

contribution pension arrangement with a Company contribution<br />

of 25% of base salary or alternatively elect for a cash supplement<br />

equivalent to 22% of base salary. Death in service life cover of<br />

4 times basic salary and a Group income replacement plan,<br />

providing continuing income for two years at 50% of base salary<br />

after short term sickness benefit expires, with a lump sum of 2 times<br />

base salary payable on cessation of service if there is no return to<br />

work, are also provided.<br />

shareholding requirement<br />

In order to forge a closer community of interest with shareholders,<br />

executive directors are required to accumulate a shareholding over<br />

time from shares acquired on the vesting of their share incentives.<br />

The minimum shareholding requirement was increased with effect<br />

from 1 January <strong>2011</strong>. The committee has reviewed the share<br />

ownership guidelines for the chief executive and the executive<br />

directors and consider that the current minimum shareholding<br />

requirement remains relevant.<br />

executive<br />

<strong>2011</strong><br />

shareholding requirement<br />

number of shares<br />

2010<br />

shareholding requirement<br />

number of shares<br />

Chief executive 320,000 125,000<br />

Executive directors 130,000 75,000<br />

No shares have been acquired through the exercise of share<br />

incentives as no share awards vested in the year. Each of the<br />

executive directors can purchase ordinary shares where there<br />

is an opportunity to do so. During <strong>2011</strong>, David Robbie acquired<br />

shares through the reinvestment of cash dividends.<br />

The band 1 executives have a shareholding requirement of<br />

50,000 shares.<br />

The shareholdings of directors are shown on page 80.<br />

share performance<br />

The graphs below illustrate the Company’s share performance<br />

in terms of total shareholder return compared with that of the<br />

FTSE 100 index of which the Company is a constituent member.<br />

This index has been selected as it is considered to be the most<br />

appropriate broad equity market index against which the Group’s<br />

performance should be measured as it provides a cross section of<br />

other leading UK listed companies. The first graph shows the value<br />

at each year end to 31 December <strong>2011</strong>, on a total shareholder<br />

return basis, of £100 invested in <strong>Rexam</strong> shares on 31 December<br />

2006 compared with the value of £100 invested over the same<br />

periods in the FTSE 100 share index.<br />

The <strong>Rexam</strong> share price for the period preceding the rights issue<br />

in 2009 has been adjusted for the bonus element inherent in that<br />

rights issue.<br />

comparison of ve year cumulative total<br />

shareholder return<br />

120<br />

100<br />

80<br />

60<br />

0<br />

2006 2007 2008 2009 2010 <strong>2011</strong><br />

<strong>Rexam</strong><br />

FTSE 100 index<br />

source: Alithos Limited<br />

Points on this graph show the value of an<br />

investment on the last trading day of each year.<br />

The graph below measures TSR since 2010 reflecting the period of<br />

time since the Company began its significant focus on the strategic<br />

priorities of controlling costs, optimising cash and improving the<br />

return on capital employed.<br />

comparison of two year cumulative total<br />

shareholder return<br />

140<br />

120<br />

100<br />

80<br />

0<br />

2009 2010 <strong>2011</strong><br />

<strong>Rexam</strong><br />

FTSE 100 index<br />

source: Alithos Limited<br />

Points on this graph show the value of an<br />

investment on the last trading day of each year.<br />

Total shareholder return reflected in the graphs above is not an<br />

indication of the likely vesting of awards granted under the LTIP<br />

2009, which is based on a different comparator group, as<br />

explained on page 79.


executive directors’ contracts of employment<br />

executive director notes<br />

date of<br />

appointment<br />

date of<br />

current contract<br />

notice period<br />

(company)<br />

notice period<br />

(director)<br />

compensation on<br />

early termination<br />

Graham Chipchase 1 10 February 2003 30 November 2009 12 months 12 months As policy<br />

David Robbie 2 3 October 2005 20 October 2010 12 months 12 months As policy<br />

1 Graham Chipchase had a contract of employment dated 1 October 2002 that was effective from his commencement of employment with <strong>Rexam</strong> in February 2003. On his appointment as<br />

chief executive, Graham Chipchase signed a new contract of employment on 30 November 2009 that was effective from 16 November 2009 and which acknowledged his continuous<br />

employment from February 2003.<br />

2 David Robbie had a contract of employment dated 24 August 2005 that was effective from his commencement of employment with <strong>Rexam</strong> in October 2005. Following the update of the<br />

Company’s policy for executive director contracts, David Robbie signed a new contract of employment on 20 October 2010 which acknowledged his continuous employment from October 2005.<br />

duration of contracts<br />

The Company’s current policy is that all executive directors serve under contracts terminable on one year’s notice. However, in exceptional<br />

circumstances, the policy allows for an externally recruited executive director to be offered a contract terminable by the Company on two<br />

years’ notice if terminated in the first year of appointment. Thereafter, the contract would become terminable on one year’s notice.<br />

Executive directors’ contracts continue until such date as agreed between the executive director and the Company. The contract can also<br />

be terminated by either party subject to required notice.<br />

termination of contracts<br />

The Company has the right to terminate a contract immediately, even where termination is without cause. In such circumstances, the<br />

contract provides for a payment in lieu of notice to be made and calculated by reference to base salary, retirement benefits and other<br />

benefits. There is no provision for payment of any annual incentive in respect of the termination notice period. The Company will make<br />

any termination payment in monthly instalments over what would have been the notice period until the earlier of the director commencing<br />

in a new position or the notice period expiring. The executive has a duty to mitigate his or her loss of office and actively seek alternative<br />

comparable employment at the earliest opportunity, thereby reducing the need for compensation.<br />

share based entitlements<br />

Any share based rights granted to an executive director will be determined at the discretion of the committee, as permitted by the rules<br />

of the relevant scheme. If an executive director resigns from employment or is dismissed for gross misconduct, he or she will not retain his<br />

or her right to acquire shares under awards or options granted to him or her.<br />

75<br />

overview<br />

financial statements governance<br />

sustainability<br />

business review


76 <strong>Rexam</strong> annual report <strong>2011</strong> directors’ report<br />

remuneration report<br />

external directorships<br />

The Company’s policy on executive directors having non executive directorships with other companies is that such appointments are<br />

permitted, subject to the approval of the chairman of the board. Any fees payable will be retained by the executive director unless<br />

otherwise agreed.<br />

non executive directors<br />

non executive director<br />

date of<br />

appointment<br />

date of original<br />

letter of appointment<br />

effective date of<br />

current letter of<br />

appointment expiry of term<br />

Stuart Chambers 1 February 2012 15 November <strong>2011</strong> 1 February 2012 31 January 2015<br />

Noreen Doyle 22 March 2006 20 March 2006 22 March 2012 21 March 2015<br />

Sir Peter Ellwood 1 February 2008 17 January 2008 1 February <strong>2011</strong> 31 January 2014<br />

John Langston 30 October 2008 30 October 2008 30 October <strong>2011</strong> 29 October 2014<br />

Wolfgang Meusburger 1 December 2006 26 October 2006 1 December 2009 30 November 2012<br />

Leo Oosterveer 1 September <strong>2011</strong> 10 August <strong>2011</strong> 1 September <strong>2011</strong> 31 August 2014<br />

Jean-Pierre Rodier 7 June 2006 6 June 2006 7 June 2009 6 June 2012<br />

Non executive directors serve under letters of appointment and are generally appointed for an initial three year term renewable thereafter,<br />

at the discretion of the board, for a maximum of two further three year terms, subject to election or re-election by shareholders at the AGM.<br />

Appointments of non executive directors are terminable without compensation by either the Company or the director giving written notice.<br />

The remuneration of the chairman is determined by the committee (the chairman absenting himself from the discussions if present at<br />

the meeting) and non executive directors’ fees are recommended by the chairman and chief executive and approved by the executive<br />

directors. The fees of the chairman, the senior independent director and the other non executive directors are reviewed annually in line<br />

with current market practice.<br />

non executive directors current fees per annum<br />

Basic fees £55,000<br />

Additional fees for:<br />

Chairs of board committees £10,000<br />

Senior independent director £10,000<br />

Sir Peter Ellwood, as chairman of the Company, received fees of £320,000 during <strong>2011</strong>. Stuart Chambers will receive the basic non<br />

executive director fees for the period from 1 February to 22 February 2012. From the date of his appointment as chairman of the Company<br />

on 23 February 2012, he will receive annual fees of £320,000. The fees of the non executive directors will remain at the current level<br />

for 2012.<br />

The executive directors’ contracts of employment and the non executive directors’ letters of appointment are available for inspection<br />

by any shareholder of the Company during normal business hours at the registered office of the Company on Monday to Friday<br />

(public holidays excepted), and will be available at the AGM 2012.


directors’ remuneration (audited information)<br />

<strong>2011</strong><br />

fees/<br />

base salary<br />

£000<br />

<strong>2011</strong><br />

pension<br />

supplement<br />

£000<br />

<strong>2011</strong><br />

annual<br />

incentive<br />

cash 1<br />

£000<br />

<strong>2011</strong><br />

annual<br />

incentive<br />

deferred<br />

shares 1<br />

£000<br />

<strong>2011</strong><br />

benefits<br />

£000<br />

chairman<br />

Sir Peter Ellwood 320 11 331 300<br />

non executive directors<br />

Noreen Doyle 65 5 70 60<br />

John Langston 65 5 70 60<br />

Wolfgang Meusburger 55 1 56 50<br />

Leo Oosterveer (appointed 1 September <strong>2011</strong>) 18 – 18 –<br />

Jean-Pierre Rodier 56 3 59 50<br />

Carl Symon (retired 23 November <strong>2011</strong>) 69 2 71 70<br />

648 – – – 27 675 590<br />

executive directors<br />

Graham Chipchase 702 254 690 229 36 1,911 1,703<br />

David Robbie 433 128 415 139 4 1,119 1,043<br />

1,135 382 1,105 368 40 3,030 2,746<br />

<strong>2011</strong> total 1,783 382 1,105 368 67 3,705<br />

2010 total 1,680 – 1,640 – 16 – 3,3362 1 The underlying profit before tax and free cash flow targets for <strong>2011</strong> were exceeded which, including the achievement of personal performance objectives, resulted in an annual incentive of 128.6%<br />

(2010: 150%) of base salary due to Graham Chipchase and 125.9% (2010: 150%) of base salary due to David Robbie. Details of the financial and personal performance targets are explained on<br />

page 72. Executive directors will receive 75% of their annual incentive as cash and 25% as a deferred share award which will vest in three years.<br />

2 The total remuneration reported in the annual report 2010 was £3,346,000. The amount of £3,336,000 shown above excludes amounts received in 2010 by Leslie Van de Walle, the former chief<br />

executive. Leslie Van de Walle did not receive any payments in <strong>2011</strong>.<br />

The benefits in kind provided to directors comprise one or more of healthcare, accommodation, subsistence and the payment of certain<br />

professional fees. Executive directors are offered membership of a Group pension scheme, which includes life assurance protection.<br />

No amounts were paid to third parties in respect of any executive director’s services to the Company and no termination payments were<br />

made to any past director during the year.<br />

Details of each director’s share incentives can be found on pages 79 and 80.<br />

<strong>2011</strong><br />

total<br />

£000<br />

2010<br />

total<br />

£000<br />

77<br />

overview<br />

financial statements governance<br />

sustainability<br />

business review


78 <strong>Rexam</strong> annual report <strong>2011</strong> directors’ report<br />

remuneration report<br />

retirement benefits (audited information)<br />

The following directors were members of defined benefit arrangements provided by the Company during the year. Entitlements and<br />

corresponding transfer values are shown in the table below. The values at 31.12.11 reflect the decision taken by both executive directors<br />

to pension a lower amount of their eligible basic salary in <strong>2011</strong>. Their eligible basic salary in 2010 was fully pensioned.<br />

<strong>2011</strong><br />

(a)<br />

gross increase<br />

in accrued<br />

pension<br />

per annum<br />

£000<br />

<strong>2011</strong><br />

(b)<br />

increase in<br />

accrued pension<br />

excluding<br />

inflation<br />

per annum<br />

£000<br />

<strong>2011</strong><br />

(c)<br />

total accrued<br />

pension<br />

31.12.11<br />

per annum<br />

£000<br />

<strong>2011</strong><br />

(d)<br />

transfer value<br />

of net increase<br />

in accrual over<br />

period<br />

£000<br />

<strong>2011</strong><br />

(e)<br />

change in<br />

transfer<br />

value during<br />

period<br />

£000<br />

<strong>2011</strong><br />

(f)<br />

transfer value<br />

of accrued<br />

pension at<br />

31.12.11<br />

£000<br />

2010<br />

(g)<br />

transfer value<br />

of accrued<br />

pension at<br />

31.12.10<br />

£000<br />

Graham Chipchase 13 8 101 126 583 1,886 1,294<br />

David Robbie 9 5 78 62 418 1,427 993<br />

1 Pension accruals shown are the amounts which would be paid annually on retirement based on service to 31 December <strong>2011</strong>.<br />

2 Transfer values (columns d, f and g) have been calculated in accordance with or consistent with the Occupational Pension Schemes (Transfer Values) Regulations 1996.<br />

3 The value of net increase in accrual (column d) represents the incremental value to the director of the benefit accrued. It is based on the increase in accrued pension (column b) after deducting<br />

contributions made by the director.<br />

4 The change in the transfer value (column e) includes the effect of fluctuations due to factors beyond the control of the Company or the director, such as market conditions which include long term<br />

interest rate movements. It is calculated after deducting contributions made by the director.<br />

There were no pension contributions paid by any Group employer for any executive director in respect of defined contribution schemes<br />

in <strong>2011</strong> or 2010.<br />

long term incentives (audited information)<br />

The interests of the directors in the shares of the Company through the Company’s share incentive arrangements are disclosed in the<br />

following tables. There is no requirement for an executive director to make a payment on the grant of an award or an option under any<br />

of the arrangements. No variations were made during the year to the terms and conditions of any awards or options.<br />

The vesting of awards granted under the 2009 LTIP will be satisfied from <strong>Rexam</strong> shares that the <strong>Rexam</strong> Employee Share Trust, a<br />

discretionary trust resident in Jersey, Channel Islands, has purchased or will purchase in the market and the cost will normally be met<br />

by the participant’s employing company. The exercise of options granted under the Company’s savings related share option scheme<br />

will be satisfied from the allotment of new ordinary shares.<br />

The market price of the Company’s shares at 31 December <strong>2011</strong> was £3.528 per share. The lowest and highest daily closing share<br />

prices during <strong>2011</strong> were £2.998 and £4.00 respectively. There were no gains from the exercise of directors’ share options during <strong>2011</strong><br />

through all share incentive arrangements (2010: £159,811).


Long Term Incentive Plan 2007 (2007 LTIP)<br />

The maximum number of shares to which the participant is entitled is reflected in the ‘outstanding’ columns of the table. Directors held the<br />

following options over shares.<br />

note grant date<br />

exercise<br />

price per<br />

holding<br />

£<br />

first<br />

exercise<br />

date<br />

note 1<br />

expiry<br />

date<br />

note 1<br />

outstanding<br />

01.01.11<br />

number<br />

lapsed<br />

during<br />

the year<br />

number<br />

outstanding<br />

31.12.11<br />

number<br />

Graham Chipchase 2 26.03.08 1 01.01.11 25.02.15 250,295 250,295 –<br />

David Robbie 2 26.03.08 1 01.01.11 25.02.15 244,346 244,346 –<br />

1 The first exercise date and the expiry date are dependent upon the options vesting but the final expiry date must be no later than six years and 11 months from the grant date for the 2007 LTIP .<br />

2 Options lapsed on 1 January <strong>2011</strong> as the TSR performance target had not been achieved. <strong>Rexam</strong> ranked 33rd which fell below the median percentile of its comparator group of 42 companies.<br />

3 No options were granted, vested, were exercised or lapsed during the year.<br />

Long Term Incentive Plan 2009 (2009 LTIP)<br />

The maximum number of shares to which the participant is entitled is reflected in the ‘outstanding’ columns of the table. Directors held the<br />

following awards over shares.<br />

note<br />

market value<br />

per share on<br />

date of grant<br />

£ grant date<br />

exercise<br />

price per<br />

holding<br />

£<br />

vesting<br />

date<br />

note 1<br />

expiry<br />

date<br />

note 1<br />

outstanding<br />

01.01.11<br />

number<br />

granted<br />

during<br />

the year<br />

number<br />

outstanding<br />

31.12.11<br />

number<br />

Graham Chipchase 2 2.911 11.03.10 – 11.03.13 11.03.13 519,230 – 519,230<br />

3 3.700 08.03.11 – 08.03.14 08.03.14 – 406,715 406,715<br />

Total 519,230 406,715 925,945<br />

David Robbie 2 2.911 11.03.10 – 11.03.13 11.03.13 315,384 – 315,384<br />

3 3.700 08.03.11 – 08.03.14 08.03.14 – 251,982 251,982<br />

Total 315,384 251,982 567,366<br />

1 The vesting date and the expiry date are dependent upon the awards vesting. The final expiry date is the close of business on the vesting date.<br />

2 The award is subject to the performance conditions shown below, measured over a three year period which commenced on 1 January 2010.<br />

3 The award is subject to the performance conditions shown below, measured over a three year period which commenced on 1 January <strong>2011</strong>.<br />

4 No awards vested, were exercised or lapsed during the year.<br />

performance measures<br />

compound earnings per share growth (EPS)<br />

This measure has been chosen as it is a visible and recognised indicator by both<br />

employees and shareholders of the Company’s financial returns. EPS performance<br />

will be measured by compound annual growth in underlying earnings per share.<br />

relative total shareholder return performance (TSR)<br />

This measure has been chosen as it is an external, verifiable measurement target<br />

that provides a robust and comparative indicator of the Company’s performance<br />

against other UK listed companies. <strong>Rexam</strong>’s TSR will be compared with the TSR of<br />

a comparator group comprising the largest 150 companies by market capitalisation<br />

within the FTSE All Share index on the 1 January of the year of grant. Investment trusts<br />

are excluded from this comparator group.<br />

return on capital employed (ROCE)<br />

This measure was introduced in <strong>2011</strong> to align more closely the performance<br />

measures with the Company’s strategy.<br />

1 Between the minimum and maximum targets, vesting will be calculated on a straight line basis.<br />

<strong>2011</strong><br />

grant<br />

target<br />

<strong>2011</strong> grant<br />

vesting of<br />

total award<br />

note 1<br />

2010<br />

grant<br />

target<br />

2010 grant<br />

vesting of<br />

total award<br />

note 1<br />

min 3% 8.3% 3% 15%<br />

max 12% 33.3% 12% 60%<br />

min median 8.3% median 10%<br />

max 25 th 33.3% 25 th 40%<br />

min 11% 8.3% – –<br />

max 15% 33.3% – –<br />

79<br />

overview<br />

financial statements governance<br />

sustainability<br />

business review


80 <strong>Rexam</strong> annual report <strong>2011</strong> directors’ report<br />

remuneration report<br />

Savings Related Share Option Scheme (2007 SAYE)<br />

Directors held the following options over shares through the 2007 SAYE.<br />

grant<br />

date<br />

exercise<br />

price<br />

per share<br />

£<br />

exercise<br />

period<br />

commences<br />

expiry<br />

date<br />

outstanding<br />

01.01.11<br />

number<br />

outstanding<br />

31.12.11<br />

number<br />

Graham Chipchase 15.10.09 2.12 01.12.14 31.05.15 7,334 7,334<br />

David Robbie 15.10.09 2.12 01.12.14 31.05.15 7,334 7,334<br />

1 No options were granted to executive directors, were exercised by or lapsed during the year.<br />

directors’ interests in shares (audited information)<br />

shares<br />

at 31.12.11<br />

shares<br />

at 01.01.11 1<br />

Graham Chipchase 168,441 168,441<br />

Noreen Doyle 8,636 8,466<br />

Sir Peter Ellwood 61,785 59,645<br />

John Langston 4,090 4,090<br />

Wolfgang Meusburger 13,198 12,742<br />

Leo Oosterveer (appointed 1 September <strong>2011</strong>) – –<br />

David Robbie 71,907 69,416<br />

Jean-Pierre Rodier 8,181 8,181<br />

1 Or date of appointment, if later.<br />

2 Stuart Chambers was appointed a non executive director on 1 February 2012. At the date of appointment and at the date of this report he held 30,000 shares.<br />

3 The above interests in shares, and awards and options over shares at 31 December <strong>2011</strong> remain unchanged at the date of this report.<br />

compliance<br />

The remuneration report for the year ended 31 December <strong>2011</strong> is presented by the remuneration committee on behalf of the board.<br />

The report covers the main responsibilities of the committee, the current remuneration policy for directors, together with details of directors’<br />

remuneration, annual and long term incentives and provision of retirement benefits for the year ended 31 December <strong>2011</strong>.<br />

The report has been prepared in accordance with the Companies Act and schedule 8 of the Large and Medium sized Companies and<br />

Groups (Accounts and <strong>Report</strong>s) Regulations 2008. In addition, the committee has followed the principles of good governance set out in<br />

the UK Corporate Governance Code and complied with the requirements of the Listing Rules.<br />

The sections of the report that have been referenced in PricewaterhouseCoopers LLP’s auditors’ report have been marked as audited<br />

information in this report.<br />

On behalf of the board<br />

Jean-Pierre Rodier<br />

remuneration committee chairman<br />

22 February 2012


other disclosures<br />

The annual report <strong>2011</strong> has been prepared for, and only for,<br />

the members of the Company, as a body, and no other persons.<br />

The Company, its directors, employees, agents and advisers do<br />

not accept or assume responsibility to any other person to whom<br />

this document is shown or into whose hands it may come and any<br />

such responsibility or liability is expressly disclaimed. This annual<br />

report may contain statements which are not based on current or<br />

historical fact and which are forward looking in nature. These<br />

forward looking statements reflect knowledge and information<br />

available at the date of preparation of this annual report and the<br />

Company undertakes no obligation to update these forward<br />

looking statements. Such forward looking statements are subject<br />

to known and unknown risks and uncertainties facing the Group<br />

including, without limitation, those risks described in this annual<br />

report, and other unknown future events and circumstances which<br />

can cause results and developments to differ materially from those<br />

anticipated. Nothing in this annual report should be construed<br />

as a profit forecast.<br />

statement of directors’ responsibilities<br />

The directors are responsible for preparing the annual report, the<br />

remuneration report and the financial statements in accordance<br />

with applicable law and regulations.<br />

Company law requires the directors to prepare financial statements<br />

for each financial year. Under that law the directors have prepared<br />

the consolidated financial statements in accordance with<br />

International Financial <strong>Report</strong>ing Standards (IFRSs) as adopted by<br />

the European Union and the parent company financial statements<br />

in accordance with UK Generally Accepted Accounting Practice<br />

(UK Accounting Standards and applicable law). Under company<br />

law the directors must not approve the financial statements unless<br />

they are satisfied that they give a true and fair view of the state of<br />

affairs of the Group and the Company and of the profit or loss of<br />

the Group for that year. In preparing these financial statements,<br />

the directors are required to:<br />

• select suitable accounting policies and then apply them<br />

consistently;<br />

• make judgements and accounting estimates that are reasonable<br />

and prudent;<br />

• state whether IFRSs as adopted by the European Union and<br />

applicable UK Accounting Standards have been followed,<br />

subject to any material departures disclosed and explained<br />

in the consolidated and parent company financial statements<br />

respectively; and<br />

• prepare the financial statements on the going concern basis<br />

unless it is inappropriate to presume that the Group and the<br />

Company will continue in business.<br />

The directors are responsible for keeping adequate accounting<br />

records that are sufficient to show and explain the Group’s and the<br />

Company’s transactions and disclose with reasonable accuracy<br />

at any time the financial position of the Company and the Group<br />

and enable them to ensure that the financial statements and the<br />

remuneration report comply with the Companies Act 2006 and,<br />

as regards the consolidated financial statements, Article 4 of the<br />

IAS Regulation. They are also responsible for safeguarding the<br />

assets of the Company and the Group and hence for taking<br />

reasonable steps for the prevention and detection of fraud<br />

and other irregularities.<br />

The directors are responsible for the maintenance and integrity<br />

of the Group’s website. Legislation in the UK governing the<br />

preparation and dissemination of financial statements may differ<br />

from legislation in other jurisdictions.<br />

Each of the current directors, whose names are listed on pages 54<br />

and 55 of the annual report, confirms that, to the best of his or<br />

her knowledge:<br />

• the consolidated financial statements, which have been prepared<br />

in accordance with IFRSs as adopted by the EU, give a true and<br />

fair view of the assets, liabilities, financial position and profit of<br />

the Group; and<br />

• the business review includes a fair review of the development<br />

and performance of the business and the position of the Group,<br />

together with a description of the principal risks and uncertainties<br />

that it faces.<br />

dividends<br />

Subject to shareholder approval, the directors have proposed<br />

a <strong>2011</strong> final dividend of 9.7p per share. The total dividend for the<br />

year ended 31 December <strong>2011</strong> is 14.4p per share (2010: 12.0p).<br />

dividend<br />

per share (p)<br />

ex dividend<br />

date<br />

record<br />

date<br />

payment<br />

date<br />

<strong>2011</strong> interim 4.7 07.09.11 09.09.11 04.10.11<br />

<strong>2011</strong> final 9.7 09.05.12 11.05.12 07.06.12<br />

principal acquisitions and disposals<br />

The disposal of the Group’s beverage and speciality closures<br />

business to Berry Plastics Inc for a cash consideration (net of costs)<br />

of £207m was announced on 20 June <strong>2011</strong> and was completed<br />

on 1 September <strong>2011</strong>.<br />

directors and directors’ interests<br />

The board of directors during the year ended 31 December <strong>2011</strong><br />

and at the date of this annual report is set out on pages 54 and 55.<br />

Leo Oosterveer was appointed a non executive director on<br />

1 September <strong>2011</strong> and Carl Symon retired as senior independent<br />

director on 23 November <strong>2011</strong>. The chairman of the Company,<br />

Sir Peter Ellwood, is to retire from office at the close of business<br />

on 22 February 2012. Sir Peter is succeeded as chairman by<br />

Stuart Chambers who was appointed a non executive director<br />

and chairman designate on 1 February 2012.<br />

81<br />

overview<br />

financial statements governance<br />

sustainability<br />

business review


82 <strong>Rexam</strong> annual report <strong>2011</strong> directors’ report<br />

other disclosures<br />

None of the directors had any interest during or at the end of<br />

the year in any contract of significance in relation to the business<br />

of the Company or its subsidiary undertakings.<br />

Full details of the interests in the share capital of the Company of<br />

those directors holding office on 31 December <strong>2011</strong>, including any<br />

interest of a connected person, are set out in the remuneration report.<br />

share capital<br />

At 31 December <strong>2011</strong>, the Company had 877,030,922 shares<br />

in issue as shown, together with details of the rights and restrictions<br />

attaching to the shares, in note 29 to the consolidated financial<br />

statements.<br />

powers given to directors<br />

The powers given to the directors are contained in the articles<br />

of association (the Articles) and are subject to relevant legislation<br />

and, in certain circumstances, (including in relation to the issuing<br />

or buying back by the Company of its shares), subject to authority<br />

being given to the directors by shareholders in general meeting.<br />

The Articles also govern the appointment and replacement<br />

of directors. The Articles, which may only be amended with<br />

shareholders’ approval in accordance with relevant legislation,<br />

can be found on the Company’s website.<br />

purchase of own shares<br />

At the AGM <strong>2011</strong>, shareholders passed a special resolution<br />

renewing the authority granted to the Company, in accordance<br />

with the Companies Act 2006 and relevant institutional guidelines,<br />

to purchase a limited number of its own shares in the market.<br />

No shares have been purchased in the market, nor has any<br />

contract been made to purchase shares under the previous or<br />

existing authorities from 1 January <strong>2011</strong> to the date of this report.<br />

The directors are seeking an annual renewal of the authority at<br />

the AGM 2012. Further details can be found in the notice of<br />

AGM 2012.<br />

AGM 2012 AGM <strong>2011</strong><br />

share purchase authority<br />

proposed approved<br />

10% of issued share capital 87.70m 87.68m<br />

substantial shareholdings<br />

At the date of this report, the Company had been advised of the<br />

following significant direct and indirect interests in the issued<br />

ordinary share capital of the Company, in accordance with<br />

the Disclosure and Transparency Rules (DTR) of the Financial<br />

Services Authority.<br />

name of shareholder<br />

number of shares<br />

disclosed<br />

% interest in issued<br />

share capital<br />

BlackRock Inc 44,138,256 5.03<br />

Legal & General Group Plc 34,660,260 3.95<br />

Information provided to <strong>Rexam</strong> pursuant to the DTR is publicly<br />

available via the regulatory information services and on the<br />

Company’s website.<br />

research and development<br />

The Group’s expenditure on research and development during<br />

the year amounted to £17m from continuing operations and £2m<br />

from discontinued operations (2010: £16m and £3m).<br />

significant agreements<br />

<strong>Rexam</strong> has a number of commercial agreements which are<br />

essential to the Group’s business, as discussed in the key risks<br />

section of the business review on pages 34 to 41. Mitigation<br />

arrangements are in place to safeguard, as far as possible,<br />

the Group’s business in the event of the unexpected termination<br />

or amendment of such agreements.<br />

The Company is also required to disclose any significant<br />

agreements that take effect, alter or terminate on a change<br />

of control of the Company following a takeover bid. Some<br />

commercial agreements allow the counterparties to alter or<br />

terminate the arrangements in these circumstances. The Company<br />

also has committed debt facilities all of which are directly or<br />

indirectly subject to change of control provisions, albeit the<br />

facilities do not necessarily require mandatory prepayment on<br />

a change of control.


At 31 December <strong>2011</strong> the debt facilities subject to these<br />

provisions were:<br />

debt facilities amount maturity<br />

Subordinated bond €750m June 2067<br />

US public bond US$550m June 2013<br />

US private placement US$225m June 2013<br />

Medium term note €638m March 2013<br />

Bilateral credit facility £50m December 2012<br />

Revolving credit facility £602m November 2016<br />

Bilateral credit facility £45m November 2016<br />

Bilateral credit facility £20m November 2016<br />

Bilateral credit facility £20m November 2016<br />

Bilateral credit facility £20m November 2016<br />

Bilateral credit facility £20m November 2016<br />

Bilateral credit facility £20m November 2016<br />

Bilateral credit facility £20m November 2016<br />

Bilateral credit facility £20m November 2016<br />

Bilateral credit facility £20m November 2016<br />

1 All of the above bilateral credit facilities and the revolving credit facility are multi currency.<br />

2 The revolving credit facility and certain of the bilateral credit facilities include options to<br />

extend the final maturity from November 2016 to November 2018, subject to the agreement<br />

of the banks.<br />

The service contracts of the executive directors do not contain<br />

a change of control provision.<br />

The trustee of the <strong>Rexam</strong> Employee Share Trust (the Trust) holds<br />

shares in order to satisfy awards under the <strong>Rexam</strong> employee share<br />

incentive plans. If an offer is made to acquire the Company’s<br />

shares, the trustee is not obliged to accept or reject any such offer<br />

in respect of any shares which are intended to satisfy awards<br />

which are outstanding. However, the trustee shall have regard to<br />

the interests of the beneficiaries and shall have the power to consult<br />

them to obtain their views on such offer and, subject to the<br />

foregoing, may consider any recommendations made to it by the<br />

Company but shall not be obliged to comply with such<br />

recommendations.<br />

The Company has granted a qualifying pension scheme indemnity<br />

in the form permitted by the Companies Act 2006 to the directors<br />

of <strong>Rexam</strong> Pension Trustees Limited, the Trustee to the <strong>Rexam</strong> Pension<br />

Plan. The indemnity remains in force at the date of this report.<br />

payments to suppliers<br />

The Group’s operating businesses are responsible for the terms<br />

and conditions under which they conduct business transactions<br />

with their suppliers. It is Group policy to agree the terms of payment<br />

and make payments to suppliers in accordance with those terms,<br />

provided that suppliers have complied with all relevant terms<br />

and conditions.<br />

The Company had 14 days (2010: 13 days) purchases outstanding<br />

at 31 December <strong>2011</strong> based on the average daily amount invoiced<br />

by suppliers.<br />

corporate governance statement<br />

The information that fulfils the requirements of the corporate<br />

governance statement in accordance with rule 7.2 of the DTR<br />

can be found in this directors’ report within pages 10 to 83.<br />

auditors<br />

disclosure of information to the auditors<br />

Each person who is a director of the Company at the date of<br />

approval of this annual report confirms that:<br />

• so far as the director is aware, there is no relevant audit<br />

information of which the Company’s auditors are unaware; and<br />

• each director individually has taken all the steps that he or she<br />

ought to have taken as a director to make him or herself aware<br />

of any relevant audit information and to establish that the<br />

Company’s auditors are aware of that information.<br />

reappointment of auditors<br />

PricewaterhouseCoopers LLP will be proposed for reappointment<br />

as the Company’s auditors at the AGM 2012 as recommended by<br />

the audit and risk committee.<br />

annual general meeting 2012<br />

The AGM of the Company, details of which can be found in the<br />

notice of AGM 2012, will be held at 11.00am on 3 May 2012 at<br />

One Great George Street, London SW1.<br />

On behalf of the board<br />

David Gibson<br />

company secretary<br />

22 February 2012<br />

83<br />

overview<br />

financial statements governance<br />

sustainability<br />

business review


84<br />

<strong>Rexam</strong> annual report <strong>2011</strong><br />

consolidated financial<br />

statements<br />

These caps are for <strong>Rexam</strong>’s innovative Advancia TM ,<br />

the world’s first all in one nasal spray pump.


86 independent auditors’ report to the members of <strong>Rexam</strong> <strong>PLC</strong><br />

87 consolidated income statement<br />

88 consolidated statement of comprehensive income<br />

89 consolidated balance sheet<br />

90 consolidated cash flow statement<br />

91 consolidated statement of changes in equity<br />

notes to the consolidated financial statements:<br />

92 note 1 – principal accounting policies<br />

98 note 2 – segment analysis<br />

100 note 3 – operating expenses<br />

101 note 4 – employee costs and numbers<br />

102 note 5 – auditors’ remuneration<br />

102 note 6 – exceptional items – continuing operations<br />

102 note 7 – interest<br />

103 note 8 – tax<br />

105 note 9 – earnings/(loss) per share<br />

106 note 10 – discontinued operations<br />

107 note 11 – equity dividends<br />

107 note 12 – goodwill<br />

109 note 13 – other intangible assets<br />

110 note 14 – property, plant and equipment<br />

111 note 15 – investments in subsidiaries<br />

111 note 16 – investments in associates and joint ventures<br />

112 note 17 – available for sale financial assets<br />

112 note 18 – insurance backed assets<br />

113 note 19 – inventories<br />

113 note 20 – trade and other receivables<br />

114 note 21 – cash and cash equivalents<br />

115 note 22 – assets and liabilities classified as held for sale<br />

115 note 23 – trade and other payables<br />

116 note 24 – borrowings<br />

117 note 25 – net borrowings<br />

118 note 26 – financial instruments<br />

125 note 27 – retirement benefit obligations<br />

129 note 28 – provisions<br />

130 note 29 – share capital<br />

130 note 30 – other reserves<br />

131 note 31 – share based payment<br />

133 note 32 – reconciliation of profit/(loss) before tax<br />

to cash generated/(used) from operations<br />

133 note 33 – contingent liabilities<br />

133 note 34 – commitments<br />

consolidated financial<br />

statements<br />

85<br />

financial statements<br />

governance<br />

sustainability<br />

business review<br />

overview


86 <strong>Rexam</strong> annual report <strong>2011</strong><br />

independent auditors’ report to the members of <strong>Rexam</strong> <strong>PLC</strong><br />

We have audited the consolidated financial statements of <strong>Rexam</strong> <strong>PLC</strong> for the year ended 31 December <strong>2011</strong> which comprise the<br />

consolidated income statement, the consolidated statement of comprehensive income, the consolidated balance sheet, the consolidated<br />

cash flow statement, the consolidated statement of changes in equity and the related notes. The financial reporting framework that<br />

has been applied in their preparation is applicable law and International Financial <strong>Report</strong>ing Standards (IFRSs) as adopted by the<br />

European Union.<br />

respective responsibilities of directors and auditors<br />

As explained more fully in the statement of directors’ responsibilities set out on page 81, the directors are responsible for the preparation<br />

of the consolidated financial statements and for being satisfied that they give a true and fair view. Our responsibility is to audit and express<br />

an opinion on the consolidated financial statements in accordance with applicable law and International Standards on Auditing (UK and<br />

Ireland). Those standards require us to comply with the Auditing Practices Board’s Ethical Standards for Auditors.<br />

This report, including the opinions, has been prepared for and only for the Company’s members as a body in accordance with Chapter 3<br />

of Part 16 of the Companies Act 2006 and for no other purpose. We do not, in giving these opinions, accept or assume responsibility for<br />

any other purpose or to any other person to whom this report is shown or into whose hands it may come save where expressly agreed by<br />

our prior consent in writing.<br />

scope of the audit of the financial statements<br />

An audit involves obtaining evidence about the amounts and disclosures in the financial statements sufficient to give reasonable assurance<br />

that the financial statements are free from material misstatement, whether caused by fraud or error. This includes an assessment of: whether<br />

the accounting policies are appropriate to the Group’s circumstances and have been consistently applied and adequately disclosed;<br />

the reasonableness of significant accounting estimates made by the directors; and the overall presentation of the financial statements.<br />

In addition, we read all the financial and non financial information in the <strong>Rexam</strong> annual report <strong>2011</strong> to identify material inconsistencies<br />

with the audited financial statements. If we become aware of any apparent material misstatements or inconsistencies we consider the<br />

implications for our report.<br />

opinion on financial statements<br />

In our opinion the consolidated financial statements:<br />

• give a true and fair view of the state of the Group’s affairs as at 31 December <strong>2011</strong> and of its profit and cash flows for the year<br />

then ended;<br />

• have been properly prepared in accordance with IFRSs as adopted by the European Union; and<br />

• have been prepared in accordance with the requirements of the Companies Act 2006 and Article 4 of the lAS Regulation.<br />

opinion on other matter prescribed by the Companies Act 2006<br />

In our opinion the information given in the directors’ report for the financial year for which the consolidated financial statements are<br />

prepared is consistent with the consolidated financial statements.<br />

matters on which we are required to report by exception<br />

We have nothing to report in respect of the following:<br />

Under the Companies Act 2006 we are required to report to you if, in our opinion:<br />

• certain disclosures of directors’ remuneration specified by law are not made; or<br />

• we have not received all the information and explanations we require for our audit.<br />

Under the Listing Rules we are required to review:<br />

• the directors’ statement, set out on page 67, in relation to going concern;<br />

• the part of the Corporate Governance Statement relating to the Company’s compliance with the nine provisions of the UK Corporate<br />

Governance Code specified for our review; and<br />

• certain elements of the report to shareholders by the board on directors’ remuneration.<br />

other matter<br />

We have reported separately on the parent Company financial statements of <strong>Rexam</strong> <strong>PLC</strong> for the year ended 31 December <strong>2011</strong> and on<br />

the information in the remuneration report that is described as having been audited.<br />

Robert Milburn (Senior Statutory Auditor)<br />

for and on behalf of PricewaterhouseCoopers LLP<br />

Chartered Accountants and Statutory Auditors<br />

London<br />

22 February 2012


consolidated income statement<br />

For the year ended 31 December notes<br />

Continuing operations<br />

Sales 2 4,734 4,619<br />

Operating expenses 3 (4,227) (4,146)<br />

Underlying operating profit 2 549 513<br />

Exceptional items 6 (16) (8)<br />

Amortisation of certain acquired intangible assets (26) (32)<br />

Operating profit 507 473<br />

Share of post tax profits of associates and joint ventures 16 9 5<br />

Retirement benefit obligations net finance cost 27 (16) (15)<br />

Underlying interest expense 7 (99) (117)<br />

Fair value changes on financing derivatives 7 23 (12)<br />

Interest expense 7 (76) (129)<br />

Interest income 7 7 4<br />

Underlying profit before tax 450 390<br />

Exceptional items 6 (16) (8)<br />

Amortisation of certain acquired intangible assets (26) (32)<br />

Fair value changes on financing derivatives 7 23 (12)<br />

Profit before tax 431 338<br />

Tax on underlying profit 8 (135) (116)<br />

Tax on exceptional items 6 4 1<br />

Tax on amortisation of certain acquired intangible assets 9 10<br />

Tax on fair value changes on financing derivatives (6) 3<br />

Tax 8 (128) (102)<br />

Profit for the financial year from continuing operations 303 236<br />

Discontinued operations<br />

Profit/(loss) for the financial year from discontinued operations 10 73 (112)<br />

Total profit for the financial year attributable to equity shareholders of <strong>Rexam</strong> <strong>PLC</strong> 376 124<br />

Underlying earnings per share (pence) 9<br />

Continuing operations 36.1 31.4<br />

Discontinued operations 0.9 1.4<br />

Total 37.0 32.8<br />

Basic earnings/(loss) per share (pence) 9<br />

Continuing operations 34.7 27.1<br />

Discontinued operations 8.4 (12.9)<br />

Total 43.1 14.2<br />

Diluted earnings/(loss) per share (pence) 9<br />

Continuing operations 34.5 27.0<br />

Discontinued operations 8.3 (12.9)<br />

Total 42.8 14.1<br />

For details of equity dividends paid and proposed see note 11 to the consolidated financial statements.<br />

The notes on pages 92 to 133 form part of these consolidated financial statements.<br />

<strong>2011</strong><br />

£m<br />

2010<br />

£m<br />

87<br />

overview<br />

financial statements governance<br />

sustainability<br />

business review


88 <strong>Rexam</strong> annual report <strong>2011</strong><br />

consolidated statement of comprehensive income<br />

For the year ended 31 December notes<br />

Profit for the financial year 376 124<br />

Actuarial losses 18, 27 (104) (64)<br />

Tax on actuarial losses 8 30 24<br />

Premium paid on annuitisation of certain pension obligations 17, 18 (2) –<br />

Cost recognised in the income statement on annuitisation of certain<br />

pension obligations (net of tax) 30 3 –<br />

Exchange differences before recognition of net investment hedges 30 (30) (12)<br />

Net investment hedges recognised 30 14 22<br />

Exchange differences recognised in the income statement on disposal of Closures 30 (89) –<br />

Cash flow hedges recognised 30 (92) 40<br />

Cash flow hedges transferred to inventory 30 (16) (25)<br />

Cash flow hedges recognised in the income statement 30 – 2<br />

Tax on cash flow hedges 8, 30 28 (4)<br />

Disposal of non controlling interests (2) –<br />

Change in market value of available for sale financial assets 30 – 1<br />

Other comprehensive loss for the year (260) (16)<br />

Total comprehensive income for the year attributable to equity shareholders of <strong>Rexam</strong> <strong>PLC</strong> 116 108<br />

<strong>2011</strong><br />

£m<br />

2010<br />

£m


consolidated balance sheet<br />

As at 31 December notes<br />

Assets<br />

Non current assets<br />

Goodwill 12 1,834 1,848<br />

Other intangible assets 13 343 383<br />

Property, plant and equipment 14 1,590 1,571<br />

Investments in associates and joint ventures 16 70 61<br />

Pension assets 27 – 19<br />

Insurance backed assets 18 23 –<br />

Deferred tax assets 8 294 252<br />

Trade and other receivables 20 106 120<br />

Available for sale financial assets 17 1 27<br />

Derivative financial instruments 26 265 256<br />

4,526 4,537<br />

Current assets<br />

Inventories 19 517 415<br />

Insurance backed assets 18 2 –<br />

Trade and other receivables 20 626 648<br />

Available for sale financial assets 17 1 1<br />

Derivative financial instruments 26 38 70<br />

Cash and cash equivalents 21 412 114<br />

1,596 1,248<br />

Assets classified as held for sale 22 2 282<br />

1,598 1,530<br />

Total assets 6,124 6,067<br />

Liabilities<br />

Current liabilities<br />

Borrowings 24 (53) (81)<br />

Derivative financial instruments 26 (63) (10)<br />

Current tax (13) (20)<br />

Trade and other payables 23 (861) (768)<br />

Provisions 28 (36) (39)<br />

(1,026) (918)<br />

Liabilities classified as held for sale 22 – (50)<br />

(1,026) (968)<br />

Non current liabilities<br />

Borrowings 24 (1,785) (1,800)<br />

Derivative financial instruments 26 (181) (186)<br />

Retirement benefit obligations 27 (540) (482)<br />

Deferred tax liabilities 8 (63) (77)<br />

Non current tax (87) (85)<br />

Other payables 23 (53) (81)<br />

Provisions 28 (70) (63)<br />

(2,779) (2,774)<br />

Total liabilities (3,805) (3,742)<br />

Net assets 2,319 2,325<br />

Equity<br />

Ordinary share capital 564 564<br />

Share premium account 989 989<br />

Capital redemption reserve 351 351<br />

Retained earnings 211 32<br />

Other reserves 30 204 386<br />

Shareholders’ equity 2,319 2,322<br />

Non controlling interests – 3<br />

Total equity 2,319 2,325<br />

Approved by the board on 22 February 2012<br />

Graham Chipchase, chief executive David Robbie, finance director<br />

<strong>2011</strong><br />

£m<br />

2010<br />

£m<br />

89<br />

overview<br />

financial statements governance<br />

sustainability<br />

business review


90 <strong>Rexam</strong> annual report <strong>2011</strong><br />

consolidated cash flow statement<br />

For the year ended 31 December notes<br />

Cash flows from operating activities<br />

Cash generated from operations 32 650 685<br />

Interest paid (91) (110)<br />

Tax paid (86) (75)<br />

Net cash flows from operating activities 473 500<br />

Cash flows from investing activities<br />

Capital expenditure (240) (206)<br />

Proceeds from sale of property, plant and equipment 1 8<br />

Disposal of Closures (net of cash and cash equivalents disposed) 10 205 –<br />

Loan from joint venture 4 5<br />

Interest received 7 4<br />

Other investing items (1) 6<br />

Net cash flows from investing activities (24) (183)<br />

Cash flows from financing activities<br />

Proceeds from borrowings 7 21<br />

Repayment of borrowings (36) (159)<br />

Purchase of <strong>Rexam</strong> <strong>PLC</strong> shares by Employee Share Trust 31 (18) (6)<br />

Dividends paid to equity shareholders 11 (111) (105)<br />

Dividends paid to non controlling interests (1) –<br />

Other financing items 10 (13)<br />

Net cash flows from financing activities (149) (262)<br />

Net increase in cash and cash equivalents 300 55<br />

Cash and cash equivalents at the beginning of the year 99 62<br />

Exchange differences and other non cash adjustments 3 (18)<br />

Net increase in cash and cash equivalents 300 55<br />

Cash and cash equivalents at the end of the year 402 99<br />

Cash and cash equivalents comprise:<br />

Cash at bank and in hand 21 83 46<br />

Short term bank deposits 21 329 68<br />

Bank overdrafts 25 (10) (15)<br />

<strong>2011</strong><br />

£m<br />

2010<br />

£m<br />

402 99


consolidated statement of changes in equity<br />

Ordinary<br />

share<br />

capital<br />

£m<br />

Share<br />

premium<br />

account<br />

£m<br />

Capital<br />

redemption<br />

reserve<br />

£m<br />

Retained<br />

earnings<br />

£m<br />

Other<br />

reserves<br />

£m<br />

Shareholders’<br />

equity<br />

£m<br />

Non<br />

controlling<br />

interests<br />

£m<br />

At 1 January <strong>2011</strong> 564 989 351 32 386 2,322 3 2,325<br />

Profit for the financial year – – – 376 – 376 – 376<br />

Actuarial losses – – – (104) – (104) – (104)<br />

Tax on actuarial losses – – – 30 – 30 – 30<br />

Premium paid on annuitisation of certain pension<br />

related liabilities – – – (2) – (2) – (2)<br />

Cost recognised in the income statement on<br />

annuitisation of certain pension related liabilities<br />

(net of tax) – – – – 3 3 – 3<br />

Exchange differences before recognition of net<br />

investment hedges – – – – (30) (30) – (30)<br />

Net investment hedges recognised – – – – 14 14 – 14<br />

Exchange differences recognised in the income<br />

statement on the disposal of Closures – – – – (89) (89) – (89)<br />

Cash flow hedges recognised – – – – (92) (92) – (92)<br />

Cash flow hedges transferred to inventory – – – – (16) (16) – (16)<br />

Tax on cash flow hedges – – – – 28 28 – 28<br />

Disposal of non controlling interests – – – – – – (2) (2)<br />

Other comprehensive loss for the year – – – (76) (182) (258) (2) (260)<br />

Total comprehensive income/(loss) for the year – – – 300 (182) 118 (2) 116<br />

Share options: value of services provided – – – 8 – 8 – 8<br />

Purchase of <strong>Rexam</strong> <strong>PLC</strong> shares by Employee Share Trust – – – (18) – (18) – (18)<br />

Dividends paid – – – (111) – (111) (1) (112)<br />

At 31 December <strong>2011</strong> 564 989 351 211 204 2,319 – 2,319<br />

At 1 January 2010 563 989 351 55 362 2,320 2 2,322<br />

Profit for the financial year – – – 124 – 124 – 124<br />

Actuarial losses – – – (64) – (64) – (64)<br />

Tax on actuarial losses – – – 24 – 24 – 24<br />

Exchange differences before recognition of net<br />

investment hedges – – – – (12) (12) – (12)<br />

Net investment hedges recognised – – – – 22 22 – 22<br />

Cash flow hedges transferred to inventory – – – – (25) (25) – (25)<br />

Cash flow hedges transferred to the income statement – – – – 2 2 – 2<br />

Cash flow hedges recognised – – – – 40 40 – 40<br />

Tax on cash flow hedges – – – – (4) (4) – (4)<br />

Changes in market value of available for sale<br />

financial assets – – – – 1 1 – 1<br />

Other comprehensive (loss)/income for the year – – – (40) 24 (16) – (16)<br />

Total comprehensive income for the year – – – 84 24 108 – 108<br />

Share options: value of services provided – – – 5 – 5 – 5<br />

Share option schemes: proceeds from shares issued 1 – – – – 1 – 1<br />

Purchase of <strong>Rexam</strong> <strong>PLC</strong> shares by Employee Share Trust – – – (6) – (6) – (6)<br />

Change in non controlling interests – – – (1) – (1) 1 –<br />

Dividends paid – – – (105) – (105) – (105)<br />

At 31 December 2010 564 989 351 32 386 2,322 3 2,325<br />

Total<br />

equity<br />

£m<br />

91<br />

overview<br />

financial statements governance<br />

sustainability<br />

business review


92 <strong>Rexam</strong> annual report <strong>2011</strong><br />

notes to the consolidated financial statements<br />

1 principal accounting policies<br />

The consolidated financial statements have been prepared in accordance with International Financial <strong>Report</strong>ing Standards (IFRS)<br />

and International Financial <strong>Report</strong>ing Interpretations Committee (IFRIC) interpretations as adopted by the European Union (EU) and with<br />

those parts of the Companies Act 2006 applicable to companies reporting under IFRS. The consolidated financial statements have been<br />

prepared under the historical cost convention as modified by the revaluation of certain financial instruments, share based payments and<br />

retirement benefit obligations.<br />

The Group adopted IAS24 (Revised) ‘Related Party Disclosures’ from 1 January <strong>2011</strong>. This revision to an existing accounting standard<br />

clarifies the definition of a related party and the disclosure of transactions between the Group and its subsidiaries, associates and<br />

joint ventures.<br />

The following accounting standards are not yet effective and have not been early adopted by the Group. The Group has yet to assess the<br />

full impact of these accounting standards. Intended adoption dates are subject to endorsement by the EU.<br />

(i) IAS19 (Revised) ‘Employee Benefits’, issued in June <strong>2011</strong>, requires the immediate recognition of all changes to the funded position of<br />

retirement benefit plans and changes the basis upon which income and expense is calculated for recognition in the income statement<br />

and the statement of comprehensive income. The Group intends to adopt IAS19 (Revised) for the accounting period beginning on<br />

1 January 2013.<br />

(ii) IFRS9 ‘Financial Instruments’, issued in November 2009, is the first step in the process to replace IAS39 ‘Financial Instruments:<br />

Recognition and Measurement’. The standard introduces new requirements for classifying and measuring financial assets.<br />

The Group intends to adopt IFRS9 no later than the accounting period beginning on 1 January 2015.<br />

There are no other IFRS or IFRIC interpretations that are not yet effective that are expected to have a material impact on the Group.<br />

key estimates and assumptions<br />

The preparation of consolidated financial statements in accordance with IFRS requires the use of estimates and assumptions that affect the<br />

reported amounts of assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and<br />

expenses during the reporting period. Although these estimates are based on management’s best knowledge of the amount, events or<br />

actions, actual results may ultimately differ from those estimates. The key estimates and assumptions used in these consolidated financial<br />

statements are set out below.<br />

goodwill impairment testing<br />

Goodwill is tested at least annually for impairment in accordance with the accounting policy for goodwill. The recoverable amounts of<br />

cash generating units relating to continuing operations are determined based on value in use calculations. These calculations require the<br />

use of estimates which include cash flow projections for each cash generating unit and discount rates based on the Group’s weighted<br />

average cost of capital, adjusted for specific risks associated with particular cash generating units. For details of impairment testing see<br />

note 12 to the consolidated financial statements. The accounting policies for goodwill and impairment testing are set out below.<br />

retirement benefits<br />

The consolidated financial statements include costs in relation to, and provision for, retirement benefit obligations. There are two principal<br />

funded defined benefit pension plans, in the UK and US, and an unfunded retiree medical plan in the US. The costs and the present value<br />

of any related pension assets and liabilities depend on factors such as life expectancy of the members, the salary progression of current<br />

employees, the returns that plan assets generate and the discount rate used to calculate the present value of the liabilities. The Group<br />

uses estimates based on previous experience and external actuarial advice in determining these future cash flows and in determining the<br />

discount rate. If the discount rates were to fall by 0.5%, the net liabilities of the plans at 31 December <strong>2011</strong> would rise by approximately<br />

£105m (2010: £110m). If equity values were to fall by 10%, then the plan assets at 31 December <strong>2011</strong> would fall by approximately £90m<br />

(2010: £100m). The accounting policy for retirement benefit obligations is set out below and details of the assumptions used for the two<br />

principal pension plans and the retiree medical plan are set out in note 27 to the consolidated financial statements.


1 principal accounting policies continued<br />

income taxes<br />

Judgement is required in determining the provision for income taxes. There are many transactions and calculations whose ultimate<br />

tax treatment is uncertain. The Group recognises liabilities for anticipated tax issues based on estimates of whether additional taxes are<br />

likely to be due. The Group recognises deferred tax assets and liabilities based on estimates of future taxable income and recoverability.<br />

Where a change in circumstance occurs, or the final tax outcome of these matters is different from the amounts that were initially recorded,<br />

such differences will impact the income tax and deferred tax balances in the year in which that change or outcome is known. The<br />

accounting policy for income taxes is set out below.<br />

basis of consolidation<br />

The consolidated financial statements comprise <strong>Rexam</strong> <strong>PLC</strong> and all its subsidiaries, together with the Group’s share of the results of its<br />

associates and joint ventures. The financial statements of subsidiaries, associates and joint ventures are prepared at the same reporting<br />

date using consistent accounting policies. Intercompany balances and transactions, including any unrealised profits arising from<br />

intercompany transactions, are eliminated in full.<br />

Subsidiaries are entities where the Group has the power to govern the financial and operating policies, generally accompanied by a share<br />

of more than 50% of the voting rights. Subsidiaries are consolidated from the date on which control is transferred to the Group and are<br />

included until the date on which the Group ceases to control them. Associates are entities over which the Group has significant influence<br />

but not control, generally accompanied by a share of between 20% and 50% of the voting rights. Joint ventures are entities over which the<br />

Group has joint control, whereby the strategic, financial and operating decisions relating to the venture require the unanimous consent of<br />

the parties sharing control and are generally accompanied by a 50% share of voting rights. Investments in associates and joint ventures<br />

are accounted for using the equity method. If the Group’s share of losses in an associate or joint venture equals or exceeds its investment<br />

in the associate or joint venture, the Group does not recognise further losses unless it has incurred obligations or made payments on behalf<br />

of the associate or joint venture.<br />

All acquisitions are accounted for by applying the purchase method. The cost of an acquisition is measured as the aggregate of the<br />

fair values, at the acquisition date, of the assets given, liabilities incurred or assumed, and equity instruments issued by the Group.<br />

The identifiable assets, liabilities and contingent liabilities of the acquiree are measured initially at fair value at the acquisition date,<br />

irrespective of the extent of any non controlling interests. The excess of the cost of the acquisition over the Group’s interest in the net fair<br />

value of the identifiable assets, liabilities and contingent liabilities is recognised as goodwill.<br />

foreign currencies<br />

The financial statements for each of the Group’s subsidiaries, associates and joint ventures are prepared using their functional currency.<br />

The functional currency is the currency of the primary economic environment in which an entity operates. Foreign currency transactions are<br />

translated into the functional currency using exchange rates prevailing at the dates of the transactions. Exchange differences resulting from<br />

the settlement of such transactions and from the translation at exchange rates ruling at the balance sheet date of monetary assets and<br />

liabilities denominated in currencies other than the functional currency are recognised directly in the consolidated income statement.<br />

Exceptions to this are where the monetary items form part of the net investment in a foreign operation or designated as hedges of a net<br />

investment, or designated as cash flow hedges. Such exchange differences are initially recognised in equity.<br />

The presentation currency of the Group is sterling. The balance sheets of foreign operations are translated into sterling using the exchange<br />

rate at the balance sheet date and the income statements are translated into sterling using the average exchange rate for the year. Where<br />

this average is not a reasonable approximation of the cumulative effect of the rate prevailing on the transaction date, the exchange rate on<br />

the transaction date is used. Exchange differences on translation into sterling arising since 1 January 2004 are recognised as a separate<br />

component of equity. On disposal of a subsidiary, any cumulative exchange differences held in equity are transferred to the consolidated<br />

income statement.<br />

On the repayment of a quasi equity loan, the proportionate share of the cumulative amount of the exchange differences on the loan<br />

recognised in other comprehensive income is not reclassified to the consolidated income statement unless the Group loses control over<br />

the entity to which the quasi equity loan related.<br />

The principal exchange rates against sterling used in these consolidated financial statements are as follows:<br />

Euro 1.15 1.19 1.17 1.17<br />

US dollar 1.60 1.54 1.55 1.54<br />

Average<br />

<strong>2011</strong><br />

Closing<br />

<strong>2011</strong><br />

Average<br />

2010<br />

Closing<br />

2010<br />

93<br />

overview<br />

financial statements governance<br />

sustainability<br />

business review


94<br />

<strong>Rexam</strong> annual report <strong>2011</strong><br />

notes to the consolidated financial statements<br />

1 principal accounting policies continued<br />

revenue recognition and other income<br />

Revenue from the sale of goods is measured at the fair value of the consideration, net of rebates and trade discounts. Revenue from the<br />

sale of goods is recognised when the Group has transferred the significant risks and rewards of ownership of the goods to the buyer,<br />

when the amount of revenue can be measured reliably and when it is probable that the economic benefits associated with the transaction<br />

will flow to the Group, typically on delivery of goods. The Group makes certain advance payments to customers in relation to contracts<br />

which are charged against sales in the consolidated income statement over their useful economic lives, typically being the contract term.<br />

Other income includes licence income and project management fees for the construction of manufacturing lines and equipment<br />

on behalf of customers.<br />

exceptional items<br />

Items which are exceptional, being material in terms of size and/or nature, are presented separately from underlying business<br />

performance in the consolidated income statement. The separate reporting of exceptional items helps provide an indication of the Group’s<br />

underlying business performance. The principal events which may give rise to exceptional items include the restructuring and integration<br />

of businesses, significant changes to retirement benefit obligations, gains or losses on the disposal of businesses, goodwill impairments,<br />

major asset impairments and disposals and significant litigation and tax claims.<br />

retirement benefit obligations<br />

The Group operates defined benefit pension plans and defined contribution pension plans.<br />

A defined benefit pension plan is one that specifies the amount of pension benefit that an employee will receive on retirement. The Group<br />

operates both funded defined benefit pension plans, where actuarially determined payments are made to trustee administered funds, and<br />

unfunded defined benefit pension plans, where no such payments are made. The asset or liability recognised in the consolidated balance<br />

sheet in respect of defined benefit pension plans is the present value of the defined benefit obligation less, for funded schemes, the fair<br />

value of plan assets at the balance sheet date. The defined benefit obligation is calculated, at least triennially, by independent actuaries<br />

using the projected unit credit method and is determined by discounting the estimated future cash outflows using interest rates of high<br />

quality corporate bonds that are denominated in the currency in which the benefits will be paid, and that have terms to maturity<br />

approximating to the terms of the related pension liability. The current service cost and gains and losses on settlements and curtailments<br />

are included in operating expenses in the consolidated income statement. Past service costs are similarly included where the benefits<br />

have vested, otherwise they are amortised on a straight line basis over the vesting period. The pension element of the net finance cost in<br />

the consolidated income statement comprises the expected return on assets of funded defined benefit pension plans, less administration<br />

expenses of pension plans, and the interest on pension plan liabilities. Differences between the actual and expected return on assets,<br />

experience gains and losses and changes in actuarial assumptions are included in the consolidated statement of comprehensive income.<br />

A defined contribution plan is one under which fixed contributions are paid to a third party. The Group has no further payment obligations<br />

once these contributions have been paid. The contributions are recognised in the consolidated income statement when they are due.<br />

Prepaid contributions are recognised in the consolidated balance sheet as an asset to the extent that a cash refund or a reduction in future<br />

payments is likely.<br />

The Group also provides post retirement healthcare benefits (retiree medical) to certain of its current and former employees. The entitlement<br />

to these benefits is usually conditional on an employee remaining in service up to retirement age and the completion of a minimum service<br />

period. The consolidated income statement and consolidated balance sheet accounting treatment with respect to retiree medical is similar<br />

to that for defined benefit pension plans. These obligations are valued by independent actuaries, usually on an annual basis.<br />

share based payment<br />

The Group operates equity and cash settled share option schemes. For equity settled share options, the services received from employees<br />

are measured by reference to the fair value of the share options. The fair value is calculated at grant date and recognised in the<br />

consolidated income statement, together with a corresponding increase in equity, on a straight line basis over the vesting period, based<br />

on an estimate of the number of options that will eventually vest. Vesting conditions, which comprise service conditions and performance<br />

conditions, are not taken into account when estimating the fair value. All non vesting conditions are included in the fair value. For cash<br />

settled share options, the services received from employees are measured at the fair value of the liability and recognised in the<br />

consolidated income statement on a straight line basis over the vesting period. The fair value of the liability is measured at each balance<br />

sheet date and at the date of settlement with changes in fair value recognised in the consolidated income statement. IFRS2 ‘Share based<br />

Payment’ has been applied to equity settled share options granted after 7 November 2002 and to all cash settled share options.<br />

The <strong>Rexam</strong> Employee Share Trust holds ordinary shares in <strong>Rexam</strong> <strong>PLC</strong> which are presented in the consolidated balance sheet<br />

as a deduction from equity.


1 principal accounting policies continued<br />

interest<br />

Interest on cash and cash equivalents and borrowings held at amortised cost is recognised in the consolidated income statement using<br />

the effective interest method. Interest includes exchange differences arising on cash and cash equivalents and borrowings, where such<br />

exchange differences are recognised in the consolidated income statement. Interest includes all fair value gains and losses on derivative<br />

financial instruments, and corresponding adjustments to hedged items under designated fair value hedging relationships, where<br />

they relate to financing activities and are recognised in the consolidated income statement. Interest relating to payments made over<br />

an extended period of development of large capital projects is added to the capital cost and amortised over the expected lives<br />

of those projects.<br />

Non hedge accounted financing derivative financial instruments fair value changes and hedge ineffectiveness on financing derivative<br />

financial instruments are separately disclosed, within interest, on the face of the consolidated income statement.<br />

segment reporting<br />

Operating segments are reported in a manner consistent with internal reporting provided to the chief operating decision maker. The chief<br />

operating decision maker has been identified as the executive leadership team, which comprises the executive directors and certain senior<br />

executives. The executive leadership team is responsible for assessing the performance of the operating segments for the purpose of<br />

making decisions about resources to be allocated. Operating segments are combined for external reporting purposes where they have<br />

similar economic characteristics, and the nature of products and production processes, the type and class of customers and the methods<br />

to distribute products are all similar.<br />

goodwill<br />

Goodwill represents the excess of the cost of an acquisition over the Group’s interest in the fair value of the identifiable assets and<br />

liabilities of the acquiree at the date of acquisition. Goodwill is tested for impairment at 31 December each year and at any time where<br />

there is any indication that goodwill may be impaired. Goodwill is carried at cost less accumulated impairment losses. At the date of<br />

acquisition, goodwill is allocated to cash generating units for the purpose of impairment testing. Goodwill arising on acquisitions on or<br />

before 31 December 1997 has been deducted from equity. Gains and losses on the disposal of a business include the carrying amount<br />

of goodwill relating to the business sold except for any goodwill deducted from equity. Goodwill arising on the acquisition of subsidiaries<br />

is presented in goodwill and goodwill arising on the acquisition of associates and joint ventures is presented in investments in associates<br />

and joint ventures. Internally generated goodwill is not recognised as an asset.<br />

other intangible assets<br />

Other intangible assets are carried at cost less accumulated amortisation and accumulated impairment losses. Amortisation begins when<br />

an asset is available for use and is calculated on a straight line basis to allocate the cost of the asset over its estimated useful life as follows:<br />

Computer software acquired 2 to 3 years<br />

Computer software developed Up to 7 years<br />

Customer contracts and relationships acquired 5 to 20 years<br />

Technology and patents acquired 5 to 20 years<br />

Other development projects Up to 5 years<br />

The cost of intangible assets acquired in an acquisition is the fair value at acquisition date. The cost of separately acquired intangible<br />

assets, including computer software, comprises the purchase price and any directly attributable costs of preparing the asset for use.<br />

Computer software development costs that are directly associated with the implementation of major business systems are capitalised as<br />

intangible assets. Expenditure on research is recognised as an expense in the consolidated income statement as incurred. Expenditure<br />

incurred on other development projects is capitalised as an intangible asset if it is probable that the expenditure will generate future<br />

economic benefits and can be measured reliably.<br />

The amortisation of certain acquired intangible assets, comprising acquired customer contracts and relationships and technology and<br />

patents, is separately disclosed within operating profit on the face of the consolidated income statement.<br />

95<br />

overview<br />

financial statements governance<br />

sustainability<br />

business review


96<br />

<strong>Rexam</strong> annual report <strong>2011</strong><br />

notes to the consolidated financial statements<br />

1 principal accounting policies continued<br />

property, plant and equipment<br />

Property, plant and equipment is carried at cost less accumulated depreciation and accumulated impairment losses. Cost comprises<br />

purchase price and directly attributable costs. Freehold land and assets under construction are not depreciated. For all other property,<br />

plant and equipment, depreciation is calculated on a straight line basis to allocate cost, less residual value of the assets, over their<br />

estimated useful lives as follows:<br />

Freehold buildings Up to 50 years<br />

Leasehold buildings Shorter of 50 years or lease term<br />

Manufacturing machinery 7 to 17 years<br />

Computer hardware Up to 8 years<br />

Fixtures, fittings and vehicles 4 to 10 years<br />

Residual values and useful lives are reviewed at least at each financial year end.<br />

impairment of assets<br />

This policy applies to all assets except inventories, deferred tax assets, financial assets and non current assets classified as held for sale.<br />

At each balance sheet date, the Group assesses whether there is any indication that an asset may be impaired. Where an indicator of<br />

impairment exists, the Group makes an estimate of recoverable amount. Where the carrying amount of an asset exceeds its recoverable<br />

amount the asset is written down to its recoverable amount. Recoverable amount is the higher of fair value less costs to sell and value<br />

in use and is determined for an individual asset (see also accounting policy for assets and liabilities classified as held for sale and<br />

discontinued operations below). If the asset does not generate cash inflows that are largely independent of those from other assets or<br />

groups of assets, the recoverable amount of the cash generating unit to which the asset belongs is determined. Discount rates reflecting the<br />

asset specific risks and the time value of money are used for the value in use calculation. When an asset is written down to its recoverable<br />

amount the impairment loss is recognised in the consolidated income statement in the year in which it is incurred. Impairment losses<br />

incurred in a cash generating unit or group of cash generating units are applied against the carrying amount of any goodwill allocated<br />

to the units. Where no goodwill exists, the impairment losses reduce the other non current assets of the cash generating units. Should<br />

circumstances change which result in a reversal of a previous impairment, the value of the asset is increased and the reversal is recognised<br />

in the consolidated income statement in the year in which it occurs. The increase in the carrying amount of the asset is limited to the<br />

amount which would have been recorded had no impairment been recognised in prior years. Impairment losses applied to goodwill<br />

are not reversed.<br />

inventories<br />

Inventories are measured at the lower of cost and net realisable value. Cost is determined on a first in first out or a weighted average cost<br />

basis. Cost comprises directly attributable purchase and conversion costs and an allocation of production overheads based on normal<br />

operating capacity. Net realisable value is the estimated selling price less estimated costs to completion and selling costs.<br />

cash and cash equivalents<br />

Cash and cash equivalents for the purposes of the consolidated cash flow statement comprise cash at bank and in hand, bank and money<br />

market deposits and other short term highly liquid investments generally with original maturities of three months or less and bank<br />

overdrafts. Bank overdrafts are presented in borrowings within current liabilities in the consolidated balance sheet.<br />

assets and liabilities classified as held for sale and discontinued operations<br />

Assets and liabilities are classified as held for sale when their carrying amount is to be recovered principally through a sale transaction<br />

and the sale is highly probable. Assets and liabilities classified as held for sale are stated at the lower of carrying amount and fair value<br />

less costs to sell. They are not depreciated or amortised. Operations are classified as discontinued when they are either disposed or<br />

are part of a single coordinated plan to dispose, and represent a major line of business or geographical area of operation.<br />

grants<br />

Grants received in respect of property, plant and equipment are capitalised and released to the consolidated income statement in equal<br />

instalments over the estimated useful lives of the related assets.<br />

leases<br />

Leases are classified as finance leases where substantially all the risks and rewards of ownership are transferred to the Group. Finance<br />

leases are capitalised at the inception of the lease at the lower of the fair value of the leased asset and the present value of the minimum<br />

lease payments. Lease payments are apportioned between the liability and finance charge to produce a constant rate of interest on the<br />

finance lease balance outstanding. Assets capitalised under finance leases are depreciated over the shorter of the useful life of the<br />

asset and the lease term. Leases other than finance leases are classified as operating leases. Payments made under operating leases<br />

are recognised as an expense in the consolidated income statement on a straight line basis over the lease term. Any incentives to enter<br />

into operating leases are recognised as a reduction of rental expense over the lease term on a straight line basis.


1 principal accounting policies continued<br />

income taxes<br />

The tax expense represents the sum of current tax, non current tax and deferred tax.<br />

Current tax and non current tax are based on taxable profit for the year. Taxable profit differs from net profit as reported in the<br />

consolidated income statement because it excludes items of income or expense that are taxable or deductible in other years and<br />

it further excludes items that are never taxable or deductible.<br />

Deferred tax is recognised in full, using the liability method, on temporary differences arising between the tax base of assets and liabilities<br />

and their carrying amounts in the consolidated financial statements. Deferred tax arising from initial recognition of an asset or liability<br />

in a transaction, other than an acquisition, that at the time of the transaction affects neither accounting nor taxable profit or loss, is not<br />

recognised. Deferred tax is measured using tax rates that have been enacted or substantively enacted at the balance sheet date and are<br />

expected to apply when the asset is realised or the liability is settled. Deferred tax assets are recognised to the extent that it is probable<br />

that future taxable profit will be available against which the temporary differences can be utilised. Deferred tax is provided on temporary<br />

differences arising on investments in subsidiaries, associates and joint ventures, except where the Group is able to control the timing<br />

of the reversal of the temporary difference and it is probable that the temporary difference will not reverse in the foreseeable future.<br />

Tax is recognised in the consolidated income statement, unless the tax relates to items recognised directly in equity, in which case the<br />

tax is recognised directly in equity through the consolidated statement of comprehensive income.<br />

provisions<br />

Provisions are recognised when a present obligation exists in respect of a past event and where the amount can be reliably estimated.<br />

Provisions for restructuring are recognised for direct expenditure on business reorganisations where plans are sufficiently detailed and<br />

well advanced, and where appropriate communication to those affected has been undertaken on or before the balance sheet date.<br />

Provisions are discounted where the time value of money is considered to be material.<br />

dividends<br />

Final equity dividends to the shareholders of <strong>Rexam</strong> <strong>PLC</strong> are recognised in the period that they are approved by the shareholders.<br />

Interim equity dividends are recognised in the period that they are paid.<br />

financial instruments<br />

Financial instruments that are measured at fair value are disclosed in the consolidated financial statements in accordance with the<br />

following fair value measurement hierarchy:<br />

(i) Quoted prices (unadjusted) in active markets for identical assets or liabilities (level 1).<br />

(ii) Inputs other than quoted prices included within level 1 that are observable for the asset or liability, either directly (that is, as prices)<br />

or indirectly (that is, derived from prices) (level 2).<br />

(iii) Inputs for the asset or liability that are not based on observable market data (that is, unobservable inputs) (level 3).<br />

The fair value of financial instruments that are not traded in an active market is determined by using valuation techniques. These valuation<br />

techniques maximise the use of observable market data where it is available and rely as little as possible on entity specific estimates.<br />

If all significant inputs required to fair value an instrument are observable, the instrument is included in level 2.<br />

Derivative financial instruments are measured at fair value. Derivative financial instruments utilised by the Group include interest rate<br />

swaps, cross currency swaps, forward foreign exchange contracts and forward aluminium, resin and energy commodity contracts.<br />

Certain derivative financial instruments are designated as hedges in line with the Group’s risk management policies. Hedges are classified<br />

as follows:<br />

(i) Fair value hedges where they hedge the exposure to changes in the fair value of a recognised asset or liability.<br />

(ii) Cash flow hedges where they hedge exposure to variability in cash flows that is attributable to a particular risk associated<br />

with a recognised asset or liability or a forecasted transaction.<br />

(iii) Net investment hedges where they hedge exposure to changes in the value of the Group’s interests in the net assets of<br />

foreign operations.<br />

For fair value hedges, any gain or loss from remeasuring the hedging instrument at fair value is recognised in the consolidated income<br />

statement. Any gain or loss on the hedged item attributable to the hedged risk is adjusted against the carrying amount of the hedged item<br />

and similarly recognised in the consolidated income statement.<br />

For cash flow hedges and net investment hedges, the portion of the gain or loss on the hedging instrument that is determined to be an<br />

effective hedge is recognised in equity, with any ineffective portion recognised in the consolidated income statement. When hedged<br />

cash flows result in the recognition of a non financial asset or liability, the associated gains or losses previously recognised in equity<br />

are included in the initial measurement of the asset or liability. For all other cash flow hedges, the gains or losses that are recognised in<br />

equity are transferred to the consolidated income statement in the same period in which the hedged cash flows affect the consolidated<br />

income statement.<br />

Any gains or losses arising from changes in fair value of derivative financial instruments not designated as hedges are recognised<br />

immediately in the consolidated income statement.<br />

97<br />

overview<br />

financial statements governance<br />

sustainability<br />

business review


98<br />

<strong>Rexam</strong> annual report <strong>2011</strong><br />

notes to the consolidated financial statements<br />

1 principal accounting policies continued<br />

Gains and losses on derivative financial instruments related to operating activities are included in operating profit when recognised in the<br />

consolidated income statement. Gains and losses on derivative financial instruments related to financing activities are included in interest<br />

when recognised in the consolidated income statement.<br />

Borrowings are measured at amortised cost except where they are hedged by an effective fair value hedge, in which case the carrying<br />

value is adjusted to reflect the fair value movements associated with the hedged risk. Where borrowings are used to hedge the Group’s<br />

interests in the net assets of foreign operations, the portion of the exchange gain or loss on the borrowings that is determined to be an<br />

effective hedge is recognised in equity.<br />

Upfront fees paid on the establishment of loan facilities are initially capitalised as transaction costs of the loan and amortised in interest<br />

over the expected term of the loan. Ongoing commitment fees are expensed in interest as incurred.<br />

Available for sale financial assets are measured at fair value. Unrealised gains and losses are recognised in equity except for impairment<br />

losses, interest and dividends arising from those assets which are recognised in the consolidated income statement.<br />

Trade and other receivables are initially measured at fair value and subsequently measured at amortised cost less any provision for<br />

impairment. They are discounted when the time value of money is considered material. Trade and other payables are measured at cost.<br />

2 segment analysis<br />

For internal reporting, <strong>Rexam</strong> is organised into three operating segments for Beverage Cans based on the geographical locations of<br />

Europe and Asia, North America and South America, and into one operating segment for Plastic Packaging. For external reporting,<br />

the three operating segments for Beverage Cans are combined into one reportable segment.<br />

Beverage Cans comprise aluminium and steel cans for a wide variety of beverages including carbonated soft drinks, energy drinks and<br />

beer. Plastic Packaging comprises rigid plastic products for customers in the healthcare and personal care markets.<br />

The Closures division has been reported as discontinued operations in the segment information set out below.<br />

(i) segment information <strong>2011</strong><br />

Sales<br />

£m<br />

Underlying<br />

operating<br />

profit<br />

£m<br />

Underlying<br />

return on<br />

sales<br />

%<br />

Underlying<br />

return on<br />

net assets<br />

%<br />

Exceptional<br />

and other<br />

items 1<br />

£m<br />

Continuing operations<br />

Beverage Cans 3,786 447 11.8 31.6 (7) 440<br />

Plastic Packaging 948 102 10.8 23.3 (35) 67<br />

Total reportable segments 4,734 549 11.6 29.7 (42) 507<br />

Share of post tax profits of associates and joint ventures 9<br />

Retirement benefit obligations net finance cost (16)<br />

Net interest expense (69)<br />

Profit before tax 431<br />

Tax (128)<br />

Profit for the financial year from continuing operations 303<br />

Discontinued operations<br />

Profit for the financial year from discontinued operations (note 10) 73<br />

Total profit for the financial year 376<br />

Assets<br />

£m<br />

Liabilities<br />

£m<br />

Capital<br />

expenditure<br />

£m<br />

Depreciation and<br />

amortisation<br />

£m<br />

Impairment:<br />

intangible<br />

assets<br />

£m<br />

Profit<br />

£m<br />

Impairment:<br />

property, plant<br />

and equipment 2<br />

£m<br />

Continuing operations<br />

Beverage Cans 3,488 (771) 174 134 – 4<br />

Plastic Packaging 1,532 (249) 65 83 – 2<br />

Total reportable segments 5,020 (1,020) 239 217 – 6<br />

Associates and joint ventures 70 – – – – –<br />

Unallocated assets and liabilities 1,034 (2,785) – – – –<br />

Total continuing operations 6,124 (3,805) 239 217 – 6<br />

Discontinued operations (note 10) – – 10 – 20 14<br />

6,124 (3,805) 249 217 20 20<br />

1 Other items comprise the amortisation of certain acquired intangible assets.<br />

2 Net of impairment reversals.


2 segment analysis continued<br />

Share of post tax profits of associates and joint ventures are wholly attributable to Beverage Cans. Segment assets are disclosed after<br />

deducting inter segment assets of £3m for Beverage Cans and £1m for Plastic Packaging. Segment liabilities are disclosed after deducting<br />

inter segment liabilities of £3m for Beverage Cans and £1m for Plastic Packaging. The assets of associates and joint ventures are wholly<br />

attributable to Beverage Cans.<br />

Underlying operating profit comprises operating profit from continuing operations before exceptional items and the amortisation of certain<br />

acquired intangible assets. Underlying operating profit from continuing operations is included as it is felt that adjusting operating profit<br />

for exceptional items and the amortisation of certain acquired intangible assets provides a better indication of the Group’s performance.<br />

Underlying return on sales comprises underlying operating profit from continuing operations divided by sales from continuing operations.<br />

Underlying return on net assets is based on underlying operating profit plus share of associates and joint ventures after tax divided by the<br />

average of opening and closing net assets after adding back retirement benefit obligations (net of tax) and net borrowings and excluding<br />

goodwill and certain acquired intangible assets.<br />

Non specific central costs are allocated on the basis of underlying operating profit.<br />

Unallocated assets comprise derivative financial instrument assets, deferred tax assets, pension assets, insurance backed assets and cash<br />

and cash equivalents which are used as part of the Group’s financing offset arrangements. Unallocated liabilities comprise borrowings,<br />

derivative financial instrument liabilities, current and non current tax, deferred tax liabilities and retirement benefit obligations.<br />

(ii) segment information 2010<br />

Sales<br />

£m<br />

Underlying<br />

operating<br />

profit<br />

£m<br />

Underlying<br />

return on<br />

sales<br />

%<br />

Underlying<br />

return on<br />

net assets<br />

%<br />

Exceptional<br />

and other<br />

items 1<br />

£m<br />

Continuing operations<br />

Beverage Cans 3,677 394 10.7 27.6 (11) 383<br />

Plastic Packaging 942 119 12.6 29.1 (29) 90<br />

Total reportable segments 4,619 513 11.1 27.9 (40) 473<br />

Share of post tax profits of associates and joint ventures 5<br />

Retirement benefit obligations net finance cost (15)<br />

Net interest expense (125)<br />

Profit before tax 338<br />

Tax (102)<br />

Profit for the financial year from continuing operations 236<br />

Discontinued operations<br />

Loss for the financial year from discontinued operations (note 10) (112)<br />

Total profit for the financial year 124<br />

Assets<br />

£m<br />

Liabilities<br />

£m<br />

Capital<br />

expenditure<br />

£m<br />

Depreciation and<br />

amortisation<br />

£m<br />

Impairment:<br />

goodwill<br />

£m<br />

Impairment:<br />

intangible<br />

assets<br />

£m<br />

Profit/<br />

(loss)<br />

£m<br />

Impairment:<br />

property, plant<br />

and equipment 2<br />

£m<br />

Continuing operations<br />

Beverage Cans 3,449 (683) 141 142 – – 6<br />

Plastic Packaging 1,566 (268) 51 87 – – (3)<br />

Total reportable segments 5,015 (951) 192 229 – – 3<br />

Associates and joint ventures 61 – – – – – –<br />

Unallocated assets and liabilities 711 (2,741) – – – – –<br />

Total continuing operations 5,787 (3,692) 192 229 – – 3<br />

Discontinued operations (notes 10, 22) 280 (50) 19 36 59 65 55<br />

6,067 (3,742) 211 265 59 65 58<br />

1 Other items comprise the amortisation of certain acquired intangible assets.<br />

2 Net of impairment reversals.<br />

Share of post tax profits of associates and joint ventures from continuing operations are wholly attributable to Beverage Cans. Segment<br />

assets are disclosed after deducting inter segment assets of £2m for Beverage Cans and £1m for Plastic Packaging. Segment liabilities are<br />

disclosed after deducting inter segment liabilities of £1m for Beverage Cans and £2m for Plastic Packaging. The assets of associates and<br />

joint ventures are wholly attributable to Beverage Cans.<br />

99<br />

overview<br />

financial statements governance<br />

sustainability<br />

business review


100<br />

<strong>Rexam</strong> annual report <strong>2011</strong><br />

notes to the consolidated financial statements<br />

2 segment analysis continued<br />

(iii) geographic and other information<br />

<strong>2011</strong><br />

Sales<br />

£m<br />

<strong>2011</strong><br />

Non current<br />

assets<br />

£m<br />

2010<br />

Sales<br />

£m<br />

2010<br />

Non current<br />

assets<br />

£m<br />

Continuing operations<br />

US 1,576 1,398 1,586 1,470<br />

Brazil 747 482 700 432<br />

Austria 327 86 288 91<br />

Russia 281 191 267 208<br />

Spain 226 93 218 102<br />

UK 203 210 200 200<br />

France 188 349 178 339<br />

Germany 136 288 131 327<br />

Other countries 1,050 847 1,051 841<br />

4,734 3,944 4,619 4,010<br />

Unallocated non current assets – 582 – 527<br />

Total continuing operations 4,734 4,526 4,619 4,537<br />

Discontinued operations 205 – 343 –<br />

4,939 4,526 4,962 4,537<br />

Sales are stated by external customer location. One customer, principally in Beverage Cans, contributed sales of £1,171m<br />

(2010: £1,394m), and another Beverage Cans customer contributed sales of £507m (2010: £610m).<br />

Unallocated non current assets comprise derivative financial instrument assets, pension assets, insurance backed assets and deferred<br />

tax assets.<br />

3 operating expenses<br />

<strong>2011</strong><br />

Continuing<br />

operations<br />

underlying<br />

£m<br />

<strong>2011</strong><br />

Continuing<br />

operations<br />

exceptional<br />

and other<br />

items 1<br />

£m<br />

<strong>2011</strong><br />

Continuing<br />

operations<br />

total<br />

£m<br />

<strong>2011</strong><br />

Discontinued<br />

operations<br />

total<br />

£m<br />

2010<br />

Continuing<br />

operations<br />

underlying<br />

£m<br />

2010<br />

Continuing<br />

operations<br />

exceptional<br />

and other<br />

items 1<br />

£m<br />

2010<br />

Continuing<br />

operations<br />

total<br />

£m<br />

2010<br />

Discontinued<br />

operations<br />

total<br />

£m<br />

Raw materials used (2,520) – (2,520) (107) (2,371) – (2,371) (169)<br />

Changes in inventories of WIP and finished goods (7) – (7) 1 (10) – (10) (5)<br />

Employee benefit expense (731) (8) (739) (43) (730) – (730) (80)<br />

Depreciation of property, plant and equipment (179) – (179) – (183) – (183) (21)<br />

Amortisation of intangible assets (12) (26) (38) – (14) (32) (46) (15)<br />

Impairment of goodwill – – – – – – – (59)<br />

Impairment of intangible assets – – – (20) – – – (65)<br />

Impairment of property, plant and equipment<br />

Reversal of impairment of property,<br />

(5) (2) (7) (14) (6) – (6) (55)<br />

plant and equipment 1 – 1 – – 3 3 –<br />

Freight costs (222) – (222) (6) (224) – (224) (10)<br />

Operating lease rental expense (33) – (33) (3) (33) – (33) (6)<br />

Operating lease rental income 2 – 2 – 2 – 2 –<br />

Other operating expenses (500) (6) (506) (39) (552) (11) (563) (37)<br />

Other operating income 21 – 21 – 15 – 15 2<br />

(4,185) (42) (4,227) (231) (4,106) (40) (4,146) (520)<br />

1 Other items comprise the amortisation of certain acquired intangible assets.<br />

Operating expenses include research and development expenditure of £17m from continuing operations and £2m from discontinued<br />

operations (2010: £16m and £3m); and fair value gains on forward foreign exchange contracts not hedge accounted of £2m from<br />

continuing operations (2010: £3m).


4 employee costs and numbers<br />

(i) employee benefit expense<br />

Continuing operations<br />

Wages and salaries (611) (615)<br />

Social security (85) (80)<br />

Share based payment (19) (11)<br />

Retirement benefit obligations (24) (24)<br />

Total continuing operations (739) (730)<br />

Discontinued operations (43) (80)<br />

(782) (810)<br />

(ii) key management compensation (including directors of <strong>Rexam</strong> <strong>PLC</strong>)<br />

Salaries and short term employee benefits (10) (10)<br />

Post employment benefits (1) (1)<br />

Share based payment (4) (2)<br />

(15) (13)<br />

Key management comprises all directors of <strong>Rexam</strong> <strong>PLC</strong> and band 1 executives. For details of directors’ remuneration see the<br />

remuneration report.<br />

A member of key management has an outstanding loan of £0.5m at 31 December <strong>2011</strong> (2010: £0.5m). The remaining term of the loan<br />

is 13 years (2010: 14 years) and is on a secured arms length basis. Interest charged on the loan during the year was £26,000<br />

(2010: £26,000).<br />

(iii) average number of employees<br />

<strong>2011</strong><br />

£m<br />

<strong>2011</strong><br />

£m<br />

<strong>2011</strong><br />

Number<br />

2010<br />

£m<br />

2010<br />

£m<br />

2010<br />

Number<br />

Continuing operations<br />

Beverage Cans 7,600 7,500<br />

Plastic Packaging 11,400 12,100<br />

Total continuing operations 19,000 19,600<br />

Discontinued operations 1,200 2,100<br />

20,200 21,700<br />

<strong>2011</strong><br />

Number<br />

2010<br />

Number<br />

Continuing operations<br />

US 4,500 4,600<br />

China 4,300 4,900<br />

France 2,300 2,300<br />

Brazil 2,000 1,800<br />

Germany 1,100 1,100<br />

Russia 700 700<br />

UK 600 600<br />

Other countries 3,500 3,600<br />

Total continuing operations 19,000 19,600<br />

Discontinued operations 1,200 2,100<br />

20,200 21,700<br />

101<br />

overview<br />

financial statements governance<br />

sustainability<br />

business review


102<br />

<strong>Rexam</strong> annual report <strong>2011</strong><br />

notes to the consolidated financial statements<br />

5 auditors’ remuneration<br />

Fees payable to PricewaterhouseCoopers LLP for the audit of the consolidated financial statements 0.9 0.8<br />

Statutory audit fees payable to associate members of PricewaterhouseCoopers LLP 2.5 2.5<br />

Total audit fees 3.4 3.3<br />

Audit related assurance services 0.2 0.2<br />

Other assurance services 2.2 –<br />

Tax advisory services 0.3 0.4<br />

Tax compliance services – 0.1<br />

All other non audit services 0.5 0.6<br />

<strong>2011</strong><br />

£m<br />

2010<br />

£m<br />

6.6 4.6<br />

Included in total audit fees are amounts payable to associate members of PricewaterhouseCoopers LLP of £0.1m in relation to discontinued<br />

operations (2010: £0.2m). Other assurance services comprise assurance reporting on historic financial information required for business<br />

disposals.<br />

6 exceptional items – continuing operations<br />

Restructuring (14) (11)<br />

Impairment of property, plant and equipment (net of reversals) (2) 3<br />

Exceptional items before tax (16) (8)<br />

Tax on exceptional items 4 1<br />

Total exceptional items after tax (12) (7)<br />

Exceptional items before tax include £9m (2010: £6m) for restructuring costs and £2m for impairment of property, plant and equipment<br />

(2010: £3m reversal of impairment) in Plastic Packaging in respect of previously announced plant closures and restructuring of some of the<br />

remaining continuing businesses following the disposal of the Closures division. They also include £5m (2010: £5m) of restructuring costs<br />

in Beverage Cans in respect of previously announced plant closures.<br />

7 interest<br />

Interest expense<br />

Bank overdrafts (9) (8)<br />

Bank loans (8) (26)<br />

US public bond (24) (25)<br />

US private placement (9) (9)<br />

Subordinated bond (45) (41)<br />

Medium term notes (25) (31)<br />

Interest on financing derivatives 24 21<br />

Foreign exchange (losses)/gains (3) 2<br />

Underlying interest expense (99) (117)<br />

Fair value gains/(losses) on financing derivatives 23 (12)<br />

Interest income<br />

(76) (129)<br />

Cash and cash equivalents 7 4<br />

Bank loans in 2010 included £10m of capitalised facility fees written off on the cancellation of related bank facilities.<br />

<strong>2011</strong><br />

£m<br />

<strong>2011</strong><br />

£m<br />

2010<br />

£m<br />

2010<br />

£m


7 interest continued<br />

An analysis of fair value gains/(losses) on financing derivatives is set out below.<br />

Fair value hedges<br />

Interest rate swaps (3) (1)<br />

Cross currency swaps 30 11<br />

Fair value adjustment to borrowings (18) (5)<br />

Not hedge accounted<br />

9 5<br />

Interest rate swaps 5 (7)<br />

Cross currency swaps 9 (10)<br />

14 (17)<br />

Fair value gains/(losses) on financing derivatives 23 (12)<br />

The net gain on fair value hedges of £9m (2010: £5m) represents the total hedge ineffectiveness for the year.<br />

8 tax<br />

(i) tax included in the consolidated income statement<br />

<strong>2011</strong><br />

Underlying<br />

profit<br />

£m<br />

<strong>2011</strong><br />

Exceptional<br />

and other<br />

items 1<br />

£m<br />

<strong>2011</strong><br />

Total<br />

£m<br />

2010<br />

Underlying<br />

profit<br />

£m<br />

<strong>2011</strong><br />

£m<br />

2010<br />

Exceptional<br />

and other<br />

items 1<br />

£m<br />

Continuing operations<br />

Current and non current tax (82) (5) (87) (82) 6 (76)<br />

Adjustment in respect of prior years 2 – 2 7 – 7<br />

Current and non current tax (80) (5) (85) (75) 6 (69)<br />

Origination and reversal of temporary differences (55) 12 (43) (38) 8 (30)<br />

Adjustment in respect of prior years – – – (3) – (3)<br />

Deferred tax (55) 12 (43) (41) 8 (33)<br />

Total continuing operations (135) 7 (128) (116) 14 (102)<br />

Discontinued operations (5) 39 34 (9) 74 65<br />

(140) 46 (94) (125) 88 (37)<br />

1 Other items comprise the amortisation of certain acquired intangible assets and fair value changes on financing derivatives.<br />

(ii) tax credited/(charged) in equity<br />

Actuarial losses 30 24<br />

Cash flow hedges 28 (4)<br />

Annuitisation of certain pension obligations (1) –<br />

Tax included in equity 57 20<br />

<strong>2011</strong><br />

£m<br />

2010<br />

£m<br />

2010<br />

Total<br />

£m<br />

2010<br />

£m<br />

103<br />

overview<br />

financial statements governance<br />

sustainability<br />

business review


104<br />

<strong>Rexam</strong> annual report <strong>2011</strong><br />

notes to the consolidated financial statements<br />

8 tax continued<br />

(iii) tax reconciliation<br />

A reconciliation of the tax charge applicable to the Group’s profit/(loss) before tax on continuing operations at the UK statutory rate of<br />

26.5% (2010: 28%) with the tax charge on continuing operations based on the Group’s effective rate is set out below.<br />

<strong>2011</strong><br />

Underlying<br />

profit/tax<br />

£m<br />

<strong>2011</strong><br />

Exceptional<br />

and other<br />

items 1<br />

£m<br />

<strong>2011</strong><br />

Total<br />

£m<br />

2010<br />

Underlying<br />

profit/tax<br />

£m<br />

2010<br />

Exceptional<br />

and other<br />

items 1<br />

£m<br />

Profit/(loss) before tax on continuing operations 450 (19) 431 390 (52) 338<br />

Tax on continuing operations at the UK statutory rate (119) 5 (114) (109) 14 (95)<br />

Non deductible and non taxable items (2) (1) (3) 6 (2) 4<br />

(Higher)/lower domestic tax rates on overseas earnings (16) 3 (13) (17) 2 (15)<br />

Tax overprovided in prior years 2 – 2 4 – 4<br />

Tax in the consolidated income statement (135) 7 (128) (116) 14 (102)<br />

Effective rate of tax on continuing operations 30% 30% 30% 30%<br />

1 Other items comprise the amortisation of certain acquired intangible assets and fair value changes on financing derivatives.<br />

(iv) analysis of deferred tax<br />

Deferred tax assets 294 252<br />

Deferred tax liabilities (63) (77)<br />

Net deferred tax assets 231 175<br />

Retirement<br />

benefit<br />

obligations<br />

£m<br />

Tax<br />

losses<br />

£m<br />

Accelerated<br />

tax<br />

depreciation<br />

£m<br />

Goodwill<br />

and other<br />

intangible assets<br />

£m<br />

<strong>2011</strong><br />

£m<br />

Other<br />

temporary<br />

differences<br />

£m<br />

At 1 January <strong>2011</strong> 146 59 (90) 50 10 175<br />

Exchange differences – – (1) 2 1 2<br />

(Charge)/credit for the year (7) (22) (15) 25 15 (4)<br />

Credit to equity 30 – – – 28 58<br />

At 31 December <strong>2011</strong> 169 37 (106) 77 54 231<br />

At 1 January 2010 117 61 (106) 12 18 102<br />

Exchange differences 4 2 (1) 1 1 7<br />

Credit/(charge) for the year 1 (4) 13 37 (6) 41<br />

Credit/(charge) to equity 24 – – – (4) 20<br />

Transfer to liabilities classified as held for sale – – 4 – 1 5<br />

At 31 December 2010 146 59 (90) 50 10 175<br />

Deferred tax assets and liabilities are presented as non current in the consolidated balance sheet. Of the total deferred tax assets,<br />

£36m (2010: £29m) are recoverable within one year. Deferred tax assets and liabilities are only offset where there is a legally enforceable<br />

right of offset and there is an intention to settle the balance net.<br />

Deferred tax assets have been recognised where it is probable that they will be recovered. In recognising deferred tax assets, the<br />

Group has considered if it is more likely than not that sufficient future profits will be available to absorb tax losses and other temporary<br />

differences. Deferred tax assets of £80m (2010: £61m) have not been recognised in respect of losses and other temporary differences due<br />

to the uncertainty of the availability of suitable profits in the foreseeable future. The principal items on which no deferred tax assets have<br />

been recognised are tax losses, including capital losses, of £288m (2010: £227m) of which £57m (2010: £nil) expire within five years.<br />

No deferred tax has been recognised on the unremitted earnings of overseas subsidiaries except where it is probable that the temporary<br />

difference will reverse in the forseeable future. If the earnings were remitted in full, tax of £20m (2010: £25m) would be payable.<br />

2010<br />

Total<br />

£m<br />

2010<br />

£m<br />

Total<br />

£m


9 earnings/(loss) per share<br />

(i) basic and diluted earnings/(loss) per share<br />

Continuing operations 34.7 34.5 27.1 27.0<br />

Discontinued operations 8.4 8.3 (12.9) (12.9)<br />

Total 43.1 42.8 14.2 14.1<br />

Profit/(loss) for the financial year attributable to equity shareholders of <strong>Rexam</strong> <strong>PLC</strong><br />

Continuing operations 303 237<br />

Discontinued operations 73 (113)<br />

Total 376 124<br />

Weighted average number of shares in issue 872.6 875.6<br />

Dilution on conversion of outstanding share options 6.2 2.6<br />

Weighted average number of shares in issue on a diluted basis 878.8 878.2<br />

(ii) underlying earnings per share<br />

Continuing operations 36.1 31.4<br />

Discontinued operations 0.9 1.4<br />

Total 37.0 32.8<br />

Basic<br />

<strong>2011</strong><br />

Pence<br />

<strong>2011</strong><br />

Continuing<br />

operations<br />

£m<br />

Diluted<br />

<strong>2011</strong><br />

Pence<br />

<strong>2011</strong><br />

Discontinued<br />

operations<br />

£m<br />

Basic<br />

2010<br />

Pence<br />

<strong>2011</strong><br />

£m<br />

<strong>2011</strong><br />

Millions<br />

<strong>2011</strong><br />

Pence<br />

2010<br />

Continuing<br />

operations<br />

£m<br />

Diluted<br />

2010<br />

Pence<br />

2010<br />

£m<br />

2010<br />

Millions<br />

2010<br />

Pence<br />

2010<br />

Discontinued<br />

operations<br />

£m<br />

Underlying profit before tax 450 13 390 22<br />

Tax on underlying profit (135) (5) (116) (9)<br />

Underlying profit for the financial year 315 8 274 13<br />

Attributable to:<br />

Shareholders of <strong>Rexam</strong> <strong>PLC</strong> 315 8 275 12<br />

Non controlling interests – – (1) 1<br />

315 8 274 13<br />

Underlying earnings per share is based on underlying profit for the financial year attributable to shareholders of <strong>Rexam</strong> <strong>PLC</strong> divided by the<br />

weighted average number of shares in issue. Underlying profit for the financial year is profit before exceptional items, the amortisation of<br />

certain acquired intangible assets and fair value changes on financing derivatives. Underlying earnings per share is included as it is felt<br />

that adjusting basic earnings per share for exceptional items, the amortisation of certain acquired intangible assets and fair value changes<br />

on financing derivatives provides a better indication of the Group’s performance.<br />

105<br />

overview<br />

financial statements governance<br />

sustainability<br />

business review


106<br />

<strong>Rexam</strong> annual report <strong>2011</strong><br />

notes to the consolidated financial statements<br />

10 discontinued operations<br />

The sale of the discontinued Closures division completed on 1 September <strong>2011</strong>. In 2010 the division was reported in the consolidated<br />

balance sheet within assets and liabilities classified as held for sale.<br />

A summary of results, exceptional items, profit on disposal, cash flows and other comprehensive loss are set out below.<br />

(i) summary of results<br />

Sales 205 343<br />

Operating expenses (231) (520)<br />

Underlying operating profit 13 22<br />

Exceptional items (note ii) (39) (185)<br />

Amortisation of certain acquired intangible assets – (14)<br />

Loss before tax (26) (177)<br />

Tax on underlying profit (5) (9)<br />

Tax on exceptional items (note ii) 13 68<br />

Tax on amortisation of certain acquired intangible assets – 6<br />

Tax 8 65<br />

Loss after tax (18) (112)<br />

Profit on disposal (note iii) 91 –<br />

Net profit/(loss) 73 (112)<br />

(ii) exceptional items<br />

Impairment of Closures (28) (171)<br />

Other impairment (6) (8)<br />

Restructuring (5) (6)<br />

Exceptional items before tax (39) (185)<br />

Tax on impairment of Closures 10 63<br />

Tax on other impairment and restructuring 3 5<br />

Exceptional items after tax (26) (117)<br />

Impairment of Closures comprises goodwill of £nil (2010: £59m), intangible assets of £16m (2010: £65m) and property, plant and<br />

equipment of £12m (2010: £47m). Other impairment in <strong>2011</strong> comprises £4m related to the write off of certain software licenses and £2m<br />

related to the write down of a plastic packaging plant in Poland. Other impairment in 2010 of £8m comprised the closure of a facility in<br />

Constantine, US.<br />

(iii) profit on disposal<br />

<strong>2011</strong><br />

£m<br />

Gross proceeds (net of costs of £10m) 207<br />

Cash and cash equivalents disposed (2)<br />

Net cash inflow in the cash flow statement 205<br />

Net assets disposed (net of tax) (197)<br />

Accrued costs (6)<br />

Exchange differences recognised in the income statement on disposal 89<br />

Profit on disposal 91<br />

(iv) cash flows<br />

Net cash flows from operating activities (19) 30<br />

Net cash flows from investing activities (14) (12)<br />

Net cash flows from financing activities (1) –<br />

Net cash (outflow)/inflow (34) 18<br />

<strong>2011</strong><br />

£m<br />

<strong>2011</strong><br />

£m<br />

<strong>2011</strong><br />

£m<br />

2010<br />

£m<br />

2010<br />

£m<br />

2010<br />

£m


10 discontinued operations continued<br />

(v) other comprehensive loss<br />

Exchange differences recognised in the income statement on disposal (89) –<br />

Disposal of non controlling interests (2) –<br />

Total other comprehensive loss (91) –<br />

11 equity dividends<br />

Interim dividend for <strong>2011</strong> of 4.7p paid on 4 October <strong>2011</strong> 41 –<br />

Final dividend for 2010 of 8.0p paid on 7 June <strong>2011</strong> 70 –<br />

Interim dividend for 2010 of 4.0p paid on 5 October 2010 – 35<br />

Final dividend for 2009 of 8.0p paid on 3 June 2010 – 70<br />

<strong>2011</strong><br />

£m<br />

<strong>2011</strong><br />

£m<br />

2010<br />

£m<br />

2010<br />

£m<br />

111 105<br />

A final dividend per equity share of 9.7p has been proposed for <strong>2011</strong> and, subject to shareholder approval, is payable on 7 June 2012.<br />

The proposed final dividend has not been accrued in these consolidated financial statements.<br />

12 goodwill<br />

(i) summary<br />

Cost<br />

At 1 January 1,852 2,085<br />

Exchange differences (15) 30<br />

Transfer to assets classified as held for sale – (263)<br />

At 31 December 1,837 1,852<br />

Impairment<br />

At 1 January (4) (199)<br />

Exchange differences 1 (9)<br />

Impairment of Closures – (59)<br />

Transfer to assets classified as held for sale – 263<br />

At 31 December (3) (4)<br />

Carrying value at 31 December 1,834 1,848<br />

The carrying value of goodwill at 31 December is allocated to cash generating units or groups of cash generating units (CGUs) as set out<br />

below.<br />

Europe 639 647<br />

US 367 367<br />

Brazil 197 197<br />

Russia 42 44<br />

Egypt 33 35<br />

Mexico 7 7<br />

Beverage Cans 1,285 1,297<br />

Healthcare 327 330<br />

Personal Care 222 221<br />

Plastic Packaging 549 551<br />

Carrying value at 31 December 1,834 1,848<br />

<strong>2011</strong><br />

£m<br />

<strong>2011</strong><br />

£m<br />

2010<br />

£m<br />

2010<br />

£m<br />

107<br />

overview<br />

financial statements governance<br />

sustainability<br />

business review


108<br />

<strong>Rexam</strong> annual report <strong>2011</strong><br />

notes to the consolidated financial statements<br />

12 goodwill continued<br />

(ii) impairment testing<br />

The recoverable amounts of CGUs or groups of CGUs were determined based on value in use calculations at 31 December <strong>2011</strong>.<br />

The cash flow projections used in these calculations are based on the Group’s financial budget for 2012, as approved by the board in<br />

December <strong>2011</strong>, and the Group’s financial plans in respect of 2013 and 2014. As highlighted in the principal accounting policies, the<br />

calculation of value in use requires the use of estimates which, although based on management’s best knowledge, may ultimately differ<br />

from actual results.<br />

Key assumptions<br />

The key assumptions for the value in use calculations are:<br />

(a) Discount rates. The pre tax discount rates used in the value in use calculations are set out in the table below. These discount rates are<br />

derived from the Group’s pre tax weighted average cost of capital (WACC), as adjusted for the specific risks relating to each region in<br />

which the CGUs operate. The Group’s pre tax WACC fell by 1% due primarily to a fall in the underlying risk free rate.<br />

Europe 10 11<br />

US 10 11<br />

Brazil 13 15<br />

Russia 15 18<br />

China 13 14<br />

Egypt 20 21<br />

Mexico 14 16<br />

(b) Growth rates. Cash flows beyond the three year planning horizon have been extrapolated using growth rates ranging between<br />

1.6% and 7.5%. The growth rates used do not exceed the medium to long term GDP growth rates relating to each region in which<br />

the CGUs operate.<br />

(c) Operating profit. Forecasts for sales and margins are based on analyses of sales, markets, costs and competitors. Consideration is<br />

given to past experience and knowledge of future contracts. Forecasts for aluminium and resin are based on forward prices and time<br />

projections after taking into account pass through of costs and hedging. Forecasts for other raw materials and energy are based on<br />

inflation forecasts and supply and demand factors.<br />

Sensitivities<br />

The recoverable amount of the goodwill allocated to the Personal Care CGUs was calculated using discount rates between 10% and 13%<br />

and growth rates between 1.6% and 7.5% to reflect the different regions in which the CGUs operate. A comparison of the recoverable<br />

amount with carrying value gave rise to minimal goodwill headroom. A 1% increase in discount rates would reduce the recoverable<br />

amount by approximately £60m. Similarly, a 1% decrease in either growth rates or operating profit would reduce the recoverable amount<br />

by approximately £70m and £10m, respectively.<br />

With respect to all other CGUs or groups of CGUs, management considers that no reasonably possible change in any of the key<br />

assumptions would cause the recoverable amount of goodwill to fall below carrying value.<br />

<strong>2011</strong><br />

%<br />

2010<br />

%


13 other intangible assets<br />

Computer<br />

software<br />

acquired<br />

£m<br />

Computer<br />

software<br />

developed<br />

£m<br />

Customer<br />

contracts and<br />

relationships<br />

acquired<br />

£m<br />

Technology<br />

and patents<br />

acquired<br />

£m<br />

Other<br />

development<br />

projects<br />

£m<br />

Cost<br />

At 1 January <strong>2011</strong> 98 24 346 127 16 611<br />

Exchange differences (1) – (3) (1) – (5)<br />

Additions 4 – – – 1 5<br />

Disposals (5) (4) – – (1) (10)<br />

At 31 December <strong>2011</strong> 96 20 343 126 16 601<br />

Accumulated amortisation<br />

At 1 January <strong>2011</strong> (71) (18) (86) (46) (7) (228)<br />

Exchange differences 1 1 1 – – 3<br />

Amortisation for the year (9) (2) (18) (8) (1) (38)<br />

Disposals 5 4 – – – 9<br />

Impairment (2) (2) – – – (4)<br />

At 31 December <strong>2011</strong> (76) (17) (103) (54) (8) (258)<br />

Carrying value at 31 December <strong>2011</strong> 20 3 240 72 8 343<br />

Cost<br />

At 1 January 2010 95 26 498 188 13 820<br />

Exchange differences (1) 1 19 6 – 25<br />

Additions 9 – – – 2 11<br />

Disposals (2) (1) – – – (3)<br />

Transfers 1 – – – 2 3<br />

Transfer to assets classified as held for sale (4) (2) (171) (67) (1) (245)<br />

At 31 December 2010 98 24 346 127 16 611<br />

Accumulated amortisation<br />

At 1 January 2010 (65) (17) (91) (46) (6) (225)<br />

Exchange differences 1 (1) (2) (1) – (3)<br />

Amortisation for the year (11) (3) (32) (14) (1) (61)<br />

Disposals 1 1 – – – 2<br />

Impairment – – (65) – – (65)<br />

Transfer to assets classified as held for sale 3 2 104 15 – 124<br />

At 31 December 2010 (71) (18) (86) (46) (7) (228)<br />

Carrying value at 31 December 2010 27 6 260 81 9 383<br />

The impairment of £4m in <strong>2011</strong> comprises the write off of certain software licenses. The impairment of £65m in 2010 related to the<br />

discontinued Closures division.<br />

Total<br />

£m<br />

109<br />

overview<br />

financial statements governance<br />

sustainability<br />

business review


110<br />

<strong>Rexam</strong> annual report <strong>2011</strong><br />

notes to the consolidated financial statements<br />

14 property, plant and equipment<br />

Property<br />

£m<br />

Plant and<br />

equipment<br />

£m<br />

Assets under<br />

construction<br />

£m<br />

Cost<br />

At 1 January <strong>2011</strong> 579 2,289 127 2,995<br />

Exchange differences (7) (23) (4) (34)<br />

Additions 5 61 168 234<br />

Disposals (2) (37) (2) (41)<br />

Reclassifications 19 117 (136) –<br />

At 31 December <strong>2011</strong> 594 2,407 153 3,154<br />

Accumulated depreciation<br />

At 1 January <strong>2011</strong> (160) (1,264) – (1,424)<br />

Exchange differences 1 12 – 13<br />

Disposals – 34 – 34<br />

Depreciation for the year (21) (158) – (179)<br />

Impairment – (9) – (9)<br />

Reversal of impairment – 1 – 1<br />

At 31 December <strong>2011</strong> (180) (1,384) – (1,564)<br />

Carrying value at 31 December <strong>2011</strong> 414 1,023 153 1,590<br />

Cost<br />

At 1 January 2010 602 2,389 113 3,104<br />

Exchange differences 4 13 2 19<br />

Additions 3 43 154 200<br />

Disposals (9) (48) (1) (58)<br />

Transfers – 2 (3) (1)<br />

Reclassifications 23 95 (118) –<br />

Transfer to assets classified as held for sale (44) (205) (20) (269)<br />

At 31 December 2010 579 2,289 127 2,995<br />

Accumulated depreciation<br />

At 1 January 2010 (150) (1,231) – (1,381)<br />

Exchange differences (2) (5) – (7)<br />

Disposals 3 43 – 46<br />

Depreciation for the year (22) (182) – (204)<br />

Impairment – (61) – (61)<br />

Reversal of impairment – 3 – 3<br />

Transfer to assets classified as held for sale 11 169 – 180<br />

At 31 December 2010 (160) (1,264) – (1,424)<br />

Carrying value at 31 December 2010 419 1,025 127 1,571<br />

The carrying value of property, plant and equipment includes finance leased assets of £33m (2010: £34m) in respect of property<br />

and £nil (2010: £1m) in respect of plant and equipment.<br />

Of the impairment of £9m in <strong>2011</strong>, £5m relates to the write down of assets on conversion from steel to aluminium in the Indian beverage<br />

cans business and £4m relates to write downs of assets in Plastic Packaging in respect of previously announced plant closures and<br />

restructuring in some of the remaining continuing businesses following disposal of the Closures division. In 2010 the impairment of £61m<br />

comprised £6m on continuing operations and £55m in respect of the discontinued Closures division. Of the £6m from continuing<br />

operations, £5m related to the write down of assets on conversion of plants from steel to aluminium in the European beverage cans<br />

business and £1m related to over capacity in the Mexican beverage cans business.<br />

The reversal of impairment of £1m in <strong>2011</strong> is an over provision relating to the write down of assets on conversion from steel to aluminium in<br />

a Spanish beverage cans plant. The reversal of impairment in 2010 of £3m related to the North American plastic packaging business<br />

whereby the proceeds from the sale of assets were higher than previously expected.<br />

Total<br />

£m


15 investments in subsidiaries<br />

The principal subsidiaries, all of which are wholly owned, are shown below. An asterisk indicates that the capital is directly owned by<br />

<strong>Rexam</strong> <strong>PLC</strong>. Subsidiaries incorporated in the UK are registered in England and Wales. All subsidiaries are included in the consolidated<br />

financial statements.<br />

Country of<br />

incorporation<br />

Principal area<br />

of operation<br />

Identity of<br />

capital held<br />

Nature of<br />

business activities<br />

<strong>Rexam</strong> Beverage Can Company US US Common stock Consumer packaging<br />

<strong>Rexam</strong> Beverage Can Naro Fominsk LLC Russia Russia Capital stock Consumer packaging<br />

<strong>Rexam</strong> Beverage Can South America SA Brazil South America Common stock Consumer packaging<br />

<strong>Rexam</strong> do Brazil Ltda Brazil South America Quotas Consumer packaging<br />

<strong>Rexam</strong> European Holdings Limited UK UK Ordinary shares Holding company<br />

<strong>Rexam</strong> France SA France France Ordinary shares Consumer packaging<br />

<strong>Rexam</strong> Group Holdings Limited UK UK Ordinary shares Holding company<br />

<strong>Rexam</strong> Holdings AB Sweden Continental Europe Ordinary shares Holding company<br />

<strong>Rexam</strong> Inc US US Common stock Holding company<br />

<strong>Rexam</strong> Overseas Holdings Limited UK UK Ordinary shares Holding company<br />

<strong>Rexam</strong> Plastic Packaging Inc US US Common stock Holding company<br />

16 investments in associates and joint ventures<br />

The principal associate and joint venture are set out below.<br />

Country of<br />

incorporation and<br />

area of operation Issued capital Group share<br />

Hanil Can Company Limited – associate South Korea 1.7m shares of 5,000 won each 40%<br />

Controladora Envases Universales <strong>Rexam</strong> SA – joint venture Guatemala 334.5m shares of 1 quetzal each 50%<br />

Associates<br />

£m<br />

Joint ventures<br />

£m<br />

At 1 January <strong>2011</strong> 35 26 61<br />

Share of post tax profits 4 5 9<br />

At 31 December <strong>2011</strong> 39 31 70<br />

At 1 January 2010 31 23 54<br />

Exchange differences 2 1 3<br />

Share of post tax profits 2 3 5<br />

Transfer to assets classified as held for sale – (1) (1)<br />

At 31 December 2010 35 26 61<br />

There is £3m of goodwill allocated to the joint venture in Guatemala (2010: £3m).<br />

The following table sets out summary information on all associates and joint ventures on a 100% basis.<br />

<strong>2011</strong><br />

Associates<br />

£m<br />

<strong>2011</strong><br />

Joint ventures<br />

£m<br />

2010<br />

Associates<br />

£m<br />

Total<br />

£m<br />

2010<br />

Joint ventures<br />

£m<br />

Sales 187 70 153 56<br />

Profit after tax 11 9 5 5<br />

Assets 161 73 150 62<br />

Liabilities (64) (11) (63) (10)<br />

111<br />

overview<br />

financial statements governance<br />

sustainability<br />

business review


112<br />

<strong>Rexam</strong> annual report <strong>2011</strong><br />

notes to the consolidated financial statements<br />

17 available for sale financial assets<br />

At 1 January 28 23<br />

Exchange differences (1) 1<br />

Income for the year 2 2<br />

Changes in market value – 1<br />

Cash injection – 3<br />

Payments in respect of pension obligations (2) (2)<br />

Disposals (25) –<br />

At 31 December 2 28<br />

Non current assets 1 27<br />

Current assets 1 1<br />

At 31 December 2 28<br />

Available for sale financial assets at 31 December <strong>2011</strong> include £1m (2010: £27m) of investments used to satisfy certain US retirement<br />

obligations, of which £nil (2010: £27m) comprises fixed rate listed investments, the fair values of which were determined directly by<br />

reference to published price quotations in an active market, and £1m (2010: £nil) comprises cash and cash equivalents. Also included in<br />

available for sale financial assets at 31 December <strong>2011</strong> are unlisted investments of £1m (2010: £1m).<br />

Disposals comprise £23m of assets transferred to insurance backed assets and a £2m loss on the ‘buy in’ of insurance policies on the<br />

transfer, as set out in note 18. The £2m is recognised in the consolidated statement of comprehensive income.<br />

The carrying amounts of available for sale financial assets are denominated in the following currencies, which are the functional currencies<br />

of the relevant subsidiaries.<br />

US dollar 1 27<br />

Euro 1 1<br />

18 insurance backed assets<br />

<strong>2011</strong><br />

£m<br />

<strong>2011</strong><br />

£m<br />

<strong>2011</strong><br />

£m<br />

2010<br />

£m<br />

2010<br />

£m<br />

2 28<br />

At 1 January – –<br />

Exchange differences 1 –<br />

Additions 23 –<br />

Payments in respect of pension obligations (1) –<br />

Actuarial gains 2 –<br />

2010<br />

£m<br />

25 –<br />

Non current assets 23 –<br />

Current assets 2 –<br />

At 31 December 25 –<br />

The Group, through its subsidiary <strong>Rexam</strong> Inc, has a number of non qualified defined benefit pension plans in the US, some of which are<br />

structured as Rabbi Trusts, whereby investments held by the Group are linked to the obligations in the plans.<br />

Historically the Group was required to maintain its defined benefit Rabbi Trust assets at 100% of the value of the related US defined benefit<br />

pension obligations and this gave rise to volatile cash funding requirements. To eliminate this investment and demographic related<br />

volatility, the Group purchased a number of non qualifying insurance policies in July <strong>2011</strong> at a cost of £25m, including a £2m ‘buy in’<br />

insurance premium, recognised in the consolidated statement of comprehensive income. The insurance policies pay the benefits to the<br />

Group as they fall due, and the Group in turn makes the payments to the eligible beneficiaries.<br />

Although eligible beneficiaries have no vested rights in the insurance policies, the policies remain under the Rabbi Trust structure and as<br />

such they cannot be used by the Group, but they would revert to the benefit of general creditors in the event of <strong>Rexam</strong> Inc’s bankruptcy.<br />

The insurance backed assets are recognised in the consolidated balance sheet at the present value of the matching defined benefit pension<br />

obligations and are accounted for in accordance with the Group’s accounting policy for retirement benefit obligations.


19 inventories<br />

Raw materials, stores and consumables 211 176<br />

Work in progress 17 15<br />

Finished goods 289 224<br />

An analysis of provisions against inventories is set out below.<br />

<strong>2011</strong><br />

£m<br />

2010<br />

£m<br />

517 415<br />

At 1 January (29) (32)<br />

Charge for the year (22) (13)<br />

Released in the year 6 3<br />

Utilised 5 4<br />

Transfer to assets classified as held for sale – 9<br />

At 31 December (40) (29)<br />

20 trade and other receivables<br />

Non current assets<br />

Trade receivables 4 4<br />

Provision for impairment (4) (4)<br />

Net trade receivables – –<br />

Prepayments 62 68<br />

Taxes 11 9<br />

Other receivables 33 43<br />

106 120<br />

Current assets<br />

Trade receivables 527 509<br />

Provision for impairment (9) (17)<br />

Net trade receivables 518 492<br />

Prepayments 36 55<br />

Taxes 33 37<br />

Other receivables 39 64<br />

626 648<br />

Total trade and other receivables 732 768<br />

An analysis of provisions for impairment of trade and other receivables is set out below.<br />

At 1 January (21) (16)<br />

Impairment in the year (7) (7)<br />

Released in the year 14 1<br />

Utilised 1 1<br />

At 31 December (13) (21)<br />

<strong>2011</strong><br />

£m<br />

<strong>2011</strong><br />

£m<br />

<strong>2011</strong><br />

£m<br />

2010<br />

£m<br />

2010<br />

£m<br />

2010<br />

£m<br />

113<br />

overview<br />

financial statements governance<br />

sustainability<br />

business review


114<br />

<strong>Rexam</strong> annual report <strong>2011</strong><br />

notes to the consolidated financial statements<br />

20 trade and other receivables continued<br />

An analysis of total trade and other receivables including those which are past due but not impaired is set out below.<br />

Not yet due 691 715<br />

Past due less than 1 month 31 21<br />

Between 1 and 2 months 7 4<br />

Between 2 and 3 months 2 1<br />

Between 3 and 6 months – 2<br />

Between 6 and 12 months 1 5<br />

In more than 12 months – 20<br />

<strong>2011</strong><br />

£m<br />

2010<br />

£m<br />

732 768<br />

The maximum amount of credit risk with respect to customers is represented by the carrying amount on the balance sheet. Customer credit<br />

facilities for new customers must be approved by designated managers at business level or by senior sector management. Credit limits are<br />

set with reference to trading history and reports from credit rating agencies. Customer credit facilities are reviewed at the sales order entry<br />

stage and at the time of shipment so as not to exceed customer limits. Overdue accounts are regularly reviewed and impairment provisions<br />

are created where necessary. As a matter of policy, all outstanding trade balances greater than three months are fully provided except as<br />

approved by senior sector management and with due regard to the historical risk profile of the customer. The Group has extremely low<br />

historical levels of customer credit defaults, due in part to the large multinational nature of many of its customers and the long term<br />

relationships it has with them. There were no major new customers in <strong>2011</strong> where the Group considered there was a risk of significant<br />

credit default. There are no trade and other receivables that would otherwise be past due or impaired whose terms have been<br />

renegotiated.<br />

The carrying amounts of total trade and other receivables are denominated in the following currencies which, in most instances, are the<br />

functional currencies of the relevant subsidiaries.<br />

Euro 259 259<br />

US dollar 204 242<br />

Brazilian real 154 154<br />

Other 115 113<br />

21 cash and cash equivalents<br />

<strong>2011</strong><br />

£m<br />

2010<br />

£m<br />

732 768<br />

Cash at bank and in hand 83 46<br />

Short term bank deposits 329 68<br />

The Group has provided letters of credit, secured by short term bank deposits, totalling £1m (2010: £1m) as part of its insurance<br />

arrangements.<br />

The carrying amounts of cash and cash equivalents are denominated in the following currencies.<br />

<strong>2011</strong><br />

£m<br />

2010<br />

£m<br />

412 114<br />

US dollar 184 72<br />

Sterling 166 2<br />

Euro 22 20<br />

Other 40 20<br />

<strong>2011</strong><br />

£m<br />

2010<br />

£m<br />

412 114


22 assets and liabilities classified as held for sale<br />

Assets 2 282<br />

Liabilities – (50)<br />

<strong>2011</strong><br />

£m<br />

2010<br />

£m<br />

2 232<br />

Assets classified as held for sale in <strong>2011</strong> comprise properties in the US deemed surplus to requirements (2010: £2m). In 2010 assets and<br />

liabilities classified as held for sale included £230m relating to the discontinued Closures division.<br />

23 trade and other payables<br />

Current liabilities<br />

Trade payables (510) (438)<br />

Social security and other taxes (66) (60)<br />

Accrued expenses (198) (202)<br />

Loan from joint venture (9) (5)<br />

Other payables (78) (63)<br />

Non current liabilities<br />

(861) (768)<br />

Accrued expenses (21) (30)<br />

Other payables (32) (51)<br />

(53) (81)<br />

Total trade and other payables (914) (849)<br />

The carrying amounts of total trade and other payables are denominated in the following currencies, which in most instances are the<br />

functional currencies of the relevant subsidiaries.<br />

US dollar (464) (398)<br />

Euro (255) (259)<br />

Brazilian real (80) (92)<br />

Sterling (43) (41)<br />

Other (72) (59)<br />

(914) (849)<br />

<strong>2011</strong><br />

£m<br />

<strong>2011</strong><br />

£m<br />

2010<br />

£m<br />

2010<br />

£m<br />

115<br />

overview<br />

financial statements governance<br />

sustainability<br />

business review


116<br />

<strong>Rexam</strong> annual report <strong>2011</strong><br />

notes to the consolidated financial statements<br />

24 borrowings<br />

Current liabilities<br />

Bank overdrafts (10) (15)<br />

Bank loans (4) (25)<br />

US public bond (1) (1)<br />

US private placement (1) (1)<br />

Subordinated bond (21) (21)<br />

Medium term notes (16) (17)<br />

Finance leases – (1)<br />

Non current liabilities<br />

(53) (81)<br />

Bank loans (28) (43)<br />

US public bond (356) (356)<br />

US private placement (146) (146)<br />

Subordinated bond (715) (706)<br />

Medium term notes (540) (549)<br />

(1,785) (1,800)<br />

Total borrowings (1,838) (1,881)<br />

The Group has a range of bank facilities maturing between 2012 and 2016. These facilities may generally be drawn in a range of freely<br />

available currencies and are at floating rates of interest. In addition, the Group has a US public bond, a US private placement,<br />

a subordinated bond and medium term notes in issue. The US public bond and US private placement totalling US$775m were issued at<br />

a fixed price and mature in 2013. The subordinated bond is denominated in euros with a maturity in 2067. It was issued at a fixed rate<br />

of interest but has been swapped into US dollar floating rates of interest through the use of cross currency and interest rate derivatives.<br />

The medium term notes are denominated in euros and mature in 2013. They were issued at fixed rates of interest although some have<br />

been swapped to floating rates of interest in euro through the use of interest rate derivatives. The bulk of the Group’s drawn debt is currently<br />

represented by various bond issues with significant headroom available under its committed bank facilities.<br />

Total minimum lease payments at 31 December <strong>2011</strong> are £nil (2010: £1m).<br />

Included within borrowings are secured loans of £1m (2010: £15m), the security for which is principally property.<br />

The carrying amounts of total borrowings are denominated in the following currencies.<br />

Euro (1,291) (1,296)<br />

US dollar (509) (529)<br />

Other (38) (56)<br />

(1,838) (1,881)<br />

<strong>2011</strong><br />

£m<br />

<strong>2011</strong><br />

£m<br />

2010<br />

£m<br />

2010<br />

£m


25 net borrowings<br />

Net borrowings at 31 December by instrument.<br />

Cash and cash equivalents 412 114<br />

Bank overdrafts (10) (15)<br />

Bank loans (32) (68)<br />

US public bond (357) (357)<br />

US private placement (147) (147)<br />

Subordinated bond (736) (727)<br />

Medium term notes (556) (566)<br />

Finance leases – (1)<br />

Financing derivatives 114 83<br />

Movement in net borrowings.<br />

<strong>2011</strong><br />

£m<br />

2010<br />

£m<br />

(1,312) (1,684)<br />

At 1 January (1,684) (1,828)<br />

Exchange differences 29 (38)<br />

Increase in cash and cash equivalents 300 55<br />

Proceeds from borrowings (7) (21)<br />

Repayment of borrowings 36 159<br />

Fair value and other changes 14 (11)<br />

At 31 December (1,312) (1,684)<br />

Reconciliation of net borrowings to the consolidated balance sheet.<br />

Total derivative financial instruments (net) 59 130<br />

Derivatives not included in net borrowings 55 (47)<br />

Financing derivatives included in net borrowings 114 83<br />

Cash and cash equivalents 412 114<br />

Borrowings included in current liabilities (53) (81)<br />

Borrowings included in non current liabilities (1,785) (1,800)<br />

<strong>2011</strong><br />

£m<br />

<strong>2011</strong><br />

£m<br />

2010<br />

£m<br />

2010<br />

£m<br />

(1,312) (1,684)<br />

117<br />

overview<br />

financial statements governance<br />

sustainability<br />

business review


118<br />

<strong>Rexam</strong> annual report <strong>2011</strong><br />

notes to the consolidated financial statements<br />

26 financial instruments<br />

(i) carrying amount and fair value of financial assets and liabilities<br />

Analysis of the carrying values and fair values at 31 December, by category and by class, of financial assets and liabilities.<br />

Derivatives<br />

used for<br />

hedging<br />

£m<br />

Derivatives<br />

used for<br />

trading<br />

£m<br />

Loans<br />

and<br />

receivables<br />

£m<br />

Available<br />

for sale<br />

assets<br />

£m<br />

Other<br />

financial<br />

liabilities<br />

£m<br />

Total<br />

carrying<br />

amount<br />

£m<br />

Total<br />

fair value<br />

£m<br />

At 31 December <strong>2011</strong><br />

Financial assets<br />

Cash and cash equivalents – – 412 – – 412 412<br />

Trade and other receivables1 – – 590 – – 590 590<br />

Available for sale financial assets – – – 2 – 2 2<br />

Derivative financial instruments<br />

Financial liabilities<br />

300 3 – – – 303 303<br />

Trade and other payables2 – – – – (848) (848) (848)<br />

Bank overdrafts – – – – (10) (10) (10)<br />

Bank loans – – – – (32) (32) (32)<br />

US public bond – – – – (357) (357) (381)<br />

US private placement – – – – (147) (147) (156)<br />

Subordinated bond – – – – (736) (736) (595)<br />

Medium term notes – – – – (556) (556) (569)<br />

Derivative financial instruments (72) (172) – – – (244) (244)<br />

At 31 December 2010<br />

Financial assets<br />

228 (169) 1,002 2 (2,686) (1,623) (1,528)<br />

Cash and cash equivalents – – 114 – – 114 114<br />

Trade and other receivables1 – – 599 – – 599 599<br />

Available for sale financial assets – – – 28 – 28 28<br />

Derivative financial instruments<br />

Financial liabilities<br />

324 2 – – – 326 326<br />

Trade and other payables2 – – – – (789) (789) (789)<br />

Bank overdrafts – – – – (15) (15) (15)<br />

Bank loans – – – – (68) (68) (68)<br />

US public bond – – – – (357) (357) (392)<br />

US private placement – – – – (147) (147) (160)<br />

Subordinated bond – – – – (727) (727) (642)<br />

Medium term notes – – – – (566) (566) (585)<br />

Finance leases – – – – (1) (1) (1)<br />

Derivative financial instruments (6) (190) – – – (196) (196)<br />

318 (188) 713 28 (2,670) (1,799) (1,781)<br />

1 Excludes prepayments and taxes.<br />

2 Excludes social security and other taxes.<br />

Market values have been used to determine the fair values of available for sale financial assets, bank overdrafts and floating rate bank<br />

loans. The carrying values of trade and other receivables and trade and other payables are assumed to approximate their fair values<br />

due to their short term nature. The fair values of the US public bond, subordinated bond and medium term notes have been determined by<br />

reference to quoted market prices at the close of business on 31 December. The US private placement is not a publicly traded instrument<br />

and its fair value has been approximated using the market value of the US public bond, which has a similar maturity date. The fair values<br />

of interest rate swaps, cross currency swaps, fixed rate loans and finance leases have been determined by discounting cash flows at<br />

prevailing interest rates. The fair value of forward foreign exchange contracts has been determined by marking those contracts to market<br />

against prevailing forward foreign exchange rates. The fair value of forward commodity contracts has been determined by marking those<br />

contracts to market at prevailing forward prices.<br />

In both <strong>2011</strong> and 2010, all financial instruments measured at fair value are categorised as level 2 in the fair value measurement hierarchy,<br />

whereby the fair value is determined by using valuation techniques. In 2010 there were £27m of fixed rate listed investments included in<br />

available for sale financial assets that were classified as level 1. The valuation techniques for level 2 instruments use observable market<br />

data where it is available, for example quoted market prices, and rely less on estimates.


26 financial instruments continued<br />

(ii) financial risk management<br />

The Group bases its financial risk management on sound economic objectives and good corporate practice. Group treasury<br />

operations are carried out under policies and parameters defined by the <strong>Rexam</strong> board and supervised by its finance committee.<br />

Group treasury is not operated as a separate profit centre nor does it enter into any transactions for speculative purposes.<br />

The Group’s major operational hedges comply with IAS39 and hedge accounting treatment is applied. Some smaller operational<br />

exposures are hedged on an economic basis and hedge accounting treatment is not applied where the compliance burden is deemed<br />

to be onerous and the income statement volatility arising is not expected to be significant.<br />

(a) market risk: currencies<br />

Currency risks arise from the multi currency cash flows within the Group. These risks arise from exchange rate fluctuations relating<br />

to the translation of balance sheet items of foreign subsidiaries (translation risk) and from currency flows from sales and purchases<br />

(transaction risk).<br />

The policy regarding translation risk is to mitigate the impact of foreign exchange movements between overseas currencies and sterling<br />

arising on the translation of the value of non UK operations into sterling for reporting purposes. This is achieved by borrowing a proportion<br />

of debt, either directly or through the use of cross currency swaps and forward foreign exchange contracts, in currencies which match or<br />

are closely linked to the currencies of the overseas businesses. This approach also provides some protection against the foreign exchange<br />

translation of overseas earnings as it matches the currency of earnings to the currency of the interest expense. These amounts are included<br />

in the consolidated financial statements by translation into sterling at the balance sheet date and, where hedge accounted, offset in equity<br />

against the translation movement in net assets. Some cross currency swaps used to manage the Group’s currency exposures, whilst<br />

economically effective, are ineligible for hedge accounting treatment.<br />

The policy regarding transaction risk is to hedge the reported net transaction exposure in full less an allowance for variability in<br />

forecasting. This is generally achieved through the use of forward foreign exchange contracts with amounts hedged being based on<br />

the reporting from individual Group businesses. None of the foreign exchange derivative instruments at 31 December <strong>2011</strong> related to<br />

derivative trading activity, although some fair value gains and losses were taken to the consolidated income statement because IAS39<br />

hedge accounting treatment was not applied. Foreign exchange derivative instruments are used for hedging general business exposures<br />

in foreign currencies such as the purchase and sale of goods, capital expenditure and dividend flows.<br />

Transactional foreign exchange risks are hedged by Group treasury unless it is a legal requirement in the country where the foreign<br />

exchange risk arises that hedging is carried out locally. In the latter case, hedging is carried out by the individual responsible for treasury<br />

within the local business, but still operating within the overall Group policy on foreign exchange management.<br />

The currency denomination of borrowings at 31 December <strong>2011</strong> was 68% in US dollars and 32% in euros (2010: 75% US dollars,<br />

22% euros, 3% all other currencies).<br />

(b) market risk: interest rates<br />

Changes in interest rates on interest bearing receivables and floating rate debt in different currencies create interest rate risk. The objective<br />

of the Group’s interest rate risk management is to manage its exposure to the impact of changes in interest rates in the currencies in which<br />

debt is borrowed. Group policy is to keep between 35% and 85% of interest on borrowings at fixed rates. Interest rate risk is managed<br />

through the issue of fixed rate debt and through the use of interest rate derivatives that are used to manage the overall fixed to floating mix<br />

of debt, which was 75% fixed and 25% floating at 31 December <strong>2011</strong> (2010: 76% and 24%). Group treasury operates within a broad<br />

framework in respect of the mix of fixed and floating rate debt, as the optimum blend will vary depending on the mix of currencies and the<br />

Group’s view of the debt markets at any point in time.<br />

Cash at bank earns interest at floating rates based on bank deposit rates in the relevant currency. Short term deposits are usually made<br />

for periods varying between one day and three months depending on the immediate cash requirements of the Group and earn interest at<br />

the respective short term deposit rates. Other floating rate financial instruments are at the appropriate LIBOR interest rates as adjusted by<br />

variable margins. Interest on floating rate financial instruments is repriced at intervals of less than one year. Interest on fixed rate financial<br />

instruments is fixed until maturity of the instrument.<br />

Some interest rate swaps used to manage the Group’s fixed to floating debt mix, whilst economically effective, are ineligible for hedge<br />

accounting treatment. Fair value gains and losses on these hedges are recognised in the consolidated income statement. In <strong>2011</strong>, there<br />

was a gain of £23m (2010: loss £12m) on fair value changes on financing derivatives, disclosed separately within interest expense in the<br />

consolidated income statement.<br />

119<br />

overview<br />

financial statements governance<br />

sustainability<br />

business review


120<br />

<strong>Rexam</strong> annual report <strong>2011</strong><br />

notes to the consolidated financial statements<br />

26 financial instruments continued<br />

(c) market risk: commodity prices<br />

Changes in the market price of commodities used by the Group create commodity risk. Group policy is to manage these risks through both<br />

its supply chain management and through use of financial derivatives. Where financial derivatives are used, the Group uses mainly over<br />

the counter instruments transacted with banks, which are themselves priced through a recognised commodity exchange, such as the<br />

London Metal Exchange. The Group manages the purchase of certain raw materials, including aluminium, resin and energy costs through<br />

physical supply contracts which, in the main, relate directly to commodity price indices. With regard to aluminium, which represents the<br />

Group’s largest commodity exposure, the policy is to eliminate as far as possible any market price variability through hedging in tandem<br />

with contractual commitments to customers. Where <strong>Rexam</strong> assumes the aluminium price risk on customer contracts, it has defined a risk<br />

appetite with a predetermined aggregate consolidated income statement limit arising from any related aluminium hedging activities.<br />

Its position against this limit is monitored and reported on a monthly basis. For other commodities, the policy is to follow an incremental<br />

hedge approach over a period of up to three years in order to manage the price year over year and limit uncertainty. None of the<br />

commodity derivative financial instruments at 31 December <strong>2011</strong> related to derivative trading activity, although some fair value gains<br />

and losses were taken to the consolidated income statement because hedge accounting was not applied. The commodity hedges mainly<br />

relate to contracted and expected future purchases of aluminium, but also include resin and energy.<br />

(d) market risk: euro<br />

In response to the current instability in Europe, a ‘euro crisis committee’ has been established by the Group to monitor risks, create<br />

contingency plans and take action as appropriate.<br />

(e) market risk: sensitivities<br />

A sensitivity analysis for financial assets and liabilities affected by market risk is set out below. Each risk is analysed separately and shows<br />

the sensitivity of financial assets and liabilities when a certain risk is changed. The sensitivity analysis has been performed on balances<br />

at 31 December each year. The rates used are based on historical trends and, where relevant, projected forecasts.<br />

Key methods and assumptions made when performing the sensitivity analysis (net of hedging):<br />

(a) For the floating rate element of interest rate swaps, the sensitivity calculation is performed based on the floating rates at 31 December<br />

each year.<br />

(b) The translation impact of overseas subsidiaries into sterling is not included in the sensitivity analysis.<br />

(c) The sensitivity analysis ignores any tax implications.<br />

currencies<br />

The foreign exchange rate sensitivity analysis set out in the table below is based on foreign currency positions, other than each Group<br />

entity’s own functional currency, on the balance sheet at 31 December. The analysis includes only risks arising from financial instruments<br />

and gives the estimated impact on profit before tax and equity of a 10% increase and decrease in exchange rates between currency pairs<br />

with significant currency positions.<br />

Increase<br />

%<br />

Impact on<br />

profit<br />

before tax<br />

£m<br />

Impact<br />

on equity<br />

£m<br />

Decrease<br />

%<br />

Impact on<br />

profit<br />

before tax<br />

£m<br />

Impact<br />

on equity<br />

£m<br />

At 31 December <strong>2011</strong><br />

Sterling/US dollar 10 (4) – (10) 5 –<br />

Sterling/euro 10 11 29 (10) (13) (36)<br />

Euro/US dollar 10 (1) (23) (10) 1 23<br />

At 31 December 2010<br />

Sterling/US dollar 10 (19) 4 (10) 23 (5)<br />

Sterling/euro 10 23 32 (10) (28) (39)<br />

Euro/US dollar 10 15 (16) (10) (16) 16<br />

The impact of currency risk on net investment hedges is offset by the translation of overseas subsidiaries on consolidation.<br />

The net impact of currency translation resulted in sales and underlying profit from continuing operations (reducing)/increasing<br />

as set out below.<br />

<strong>2011</strong><br />

Sales<br />

£m<br />

<strong>2011</strong><br />

Underlying<br />

operating<br />

profit<br />

£m<br />

2010<br />

Sales<br />

£m<br />

2010<br />

Underlying<br />

operating<br />

profit<br />

£m<br />

US dollar (81) (9) 31 3<br />

Euro 20 3 (51) (3)<br />

Other currencies 8 – 42 7<br />

(53) (6) 22 7


26 financial instruments continued<br />

interest rates<br />

At 31 December <strong>2011</strong>, if the US dollar interest rate were increased by 1% with all other variables held constant, profit before tax would<br />

increase by £12m (2010: £7m) as a result of US dollar denominated floating rate debt and interest rate and cross currency derivatives that<br />

are not hedge accounted. If euro and sterling interest rates were increased by 1% with all other variables held constant, profit before tax<br />

would reduce by £9m (2010: £8m) as a result of fixed rate debt being swapped into floating rate debt. A reduction in interest rates would<br />

not have a significant effect on profit before tax. There was no significant interest rate risk relating to equity in either year.<br />

commodity prices<br />

At 31 December <strong>2011</strong>, there was no price risk relating to the income statement since all significant commodity derivatives were treated<br />

as cash flow hedges with movements being reflected in equity. If the aluminium price was increased or reduced by 10% with all other<br />

variables held constant, equity would increase or decrease by £48m (2010: £45m).<br />

equity prices<br />

The Group is not subject to any significant equity price risk.<br />

(f) liquidity risk<br />

An analysis of undiscounted contractual maturities for non derivative financial liabilities, derivative financial instruments and undrawn<br />

committed debt facilities is set out below.<br />

Within<br />

1 year<br />

£m<br />

1 to 2<br />

years<br />

£m<br />

2 to 5<br />

years<br />

£m<br />

More than<br />

5 years<br />

£m<br />

Total<br />

contractual<br />

amount<br />

£m<br />

At 31 December <strong>2011</strong><br />

Non derivative financial liabilities:<br />

Trade and other payables (795) (13) (15) (25) (848)<br />

Bank overdrafts (10) – – – (10)<br />

Bank loans (4) (2) – (26) (32)<br />

US public bond (24) (381) – – (405)<br />

US private placement (9) (155) – – (164)<br />

Subordinated bond (43) (43) (128) (673) (887)<br />

Medium term notes (23) (559) – – (582)<br />

Derivative financial instruments:<br />

Derivative contracts – settled gross payments (403) (124) (148) (1,186) (1,861)<br />

Derivative contracts – settled gross receipts 433 151 204 1,189 1,977<br />

Derivative contracts – net settlements 1 4 (1) – 4<br />

Commodity contracts (49) (10) (3) – (62)<br />

Undrawn committed debt facilities 50 – 809 – 859<br />

At 31 December 2010<br />

Non derivative financial liabilities:<br />

Trade and other payables (708) (18) (38) (25) (789)<br />

Bank overdrafts (15) – – – (15)<br />

Bank loans (24) (7) (7) (29) (67)<br />

US public bond (24) (24) (381) – (429)<br />

US private placement (9) (9) (155) – (173)<br />

Subordinated bond (43) (43) (130) (728) (944)<br />

Medium term notes (24) (24) (569) – (617)<br />

Finance leases (1) – – – (1)<br />

Derivative financial instruments:<br />

Derivative contracts – settled gross payments (607) (103) (205) (1,276) (2,191)<br />

Derivative contracts – settled gross receipts 631 123 228 1,282 2,264<br />

Derivative contracts – net settlements (3) 2 5 – 4<br />

Commodity contracts 36 12 1 – 49<br />

Undrawn committed debt facilities – 50 1,028 – 1,078<br />

121<br />

overview<br />

financial statements governance<br />

sustainability<br />

business review


122<br />

<strong>Rexam</strong> annual report <strong>2011</strong><br />

notes to the consolidated financial statements<br />

26 financial instruments continued<br />

The Group monitors its liquidity to maintain a sufficient level of undrawn committed debt facilities, thereby ensuring financial flexibility.<br />

As at 31 December <strong>2011</strong>, <strong>Rexam</strong> had £859m of undrawn committed debt facilities available (2010: £1,078m).<br />

The Group mitigates refinancing risk by raising its debt requirements from a range of different sources. The range of maturity dates arising<br />

on committed debt facilities is set out below.<br />

Maturity date<br />

2012 50 50<br />

2013 1,039 1,048<br />

2015 – 1,028<br />

2016 809 –<br />

2067 654 654<br />

<strong>2011</strong><br />

£m<br />

2010<br />

£m<br />

2,552 2,780<br />

(g) credit risk<br />

The maximum credit risk exposure of the Group’s financial assets at 31 December is represented by the amounts reported under the<br />

corresponding balance sheet headings. There are no significant concentrations of credit risk associated with financial instruments of<br />

the Group. Credit risk arises from exposures to external counterparties. In order to manage this risk, the Group has strict credit control<br />

quality measures that are applied to counterparty institutions and also limits on maximum exposure levels to any one counterparty.<br />

To manage credit risk, the maximum limits for bank exposures held under Group policy are set out in the table below by individual<br />

counterparty credit rating category. These limits are used when making investments and for the use of derivative instruments. The table also<br />

sets out the Group’s financial asset exposure at 31 December for each counterparty credit rating category.<br />

Credit rating<br />

<strong>2011</strong><br />

Individual<br />

counterparty<br />

limit<br />

£m<br />

<strong>2011</strong><br />

Cash<br />

and cash<br />

equivalents<br />

£m<br />

<strong>2011</strong><br />

Derivatives<br />

£m<br />

<strong>2011</strong><br />

Total<br />

£m<br />

2010<br />

Individual<br />

counterparty<br />

limit<br />

£m<br />

2010<br />

Cash<br />

and cash<br />

equivalents<br />

£m<br />

2010<br />

Derivatives<br />

£m<br />

AA 70 to 90 – – – 70 to 90 12 46 58<br />

AA– 60 to 80 13 48 61 60 to 80 75 65 140<br />

A+ 50 to 70 132 77 209 50 to 70 1 68 69<br />

A 40 to 60 136 87 223 40 to 60 25 147 172<br />

A– 20 to 40 130 91 221 20 to 40 – – –<br />

BBB+ and below 10 to 30 1 – 1 10 to 30 1 – 1<br />

412 303 715 114 326 440<br />

Since 31 December <strong>2011</strong>, the credit ratings of certain banks included in the above table have been downgraded. However, none of the<br />

Group’s individual counterparty limits have been breached as a result of these downgrades.<br />

See note 20 for information on credit risk with respect to customers.<br />

(h) capital risk management<br />

The Group’s objective is to minimise its cost of capital by optimising the efficiency of its capital structure, being the balance between equity<br />

and debt. The Group views its ordinary share capital as equity. This objective is always subject to an overriding principle that capital must<br />

be managed to ensure the Group’s ability to continue as a going concern in order to provide returns for shareholders and benefits for other<br />

stakeholders. The Group is able to adjust its capital structure through the issue or redemption of either debt or equity and by adjustment to<br />

the dividend paid to equity holders. The Group uses a range of financial metrics to monitor the efficiency of its capital structure, including<br />

its weighted average cost of capital and net debt to EBITDA and ensures that its capital structure provides sufficient financial strength to<br />

allow it to secure access to debt finance at reasonable cost.<br />

At 31 December <strong>2011</strong>, the Group’s net debt to EBITDA for financial covenant purposes was 1.3 times (2010: 1.8 times). The Group aims<br />

to keep this ratio below 2.5 times. For this purpose, net debt is broadly net borrowings adjusted to exclude interest accruals, certain<br />

derivative financial instruments and an equity portion of the subordinated bond and reflects non sterling amounts at average exchange<br />

rates. EBITDA is underlying operating profit after adding back depreciation and amortisation of computer software and adjusted where<br />

appropriate to include acquisitions on a pro forma basis and excludes disposed businesses.<br />

2010<br />

Total<br />

£m


26 financial instruments continued<br />

(iii) derivative financial instruments<br />

The net fair values of the Group’s derivative financial instruments designated as fair value or cash flow hedges and those not designated<br />

as hedging instruments are set out below.<br />

Fair value hedges<br />

Cross currency swaps 276 257<br />

Interest rate swaps 9 13<br />

Cash flow hedges<br />

285 270<br />

Forward aluminium commodity contracts (64) 50<br />

Forward gas commodity contracts (2) (2)<br />

Forward foreign exchange contracts 9 –<br />

(57) 48<br />

Total hedge accounted 228 318<br />

Not hedge accounted<br />

Cross currency swaps (166) (175)<br />

Interest rate swaps (5) (10)<br />

Forward foreign exchange contracts 2 (3)<br />

Total not hedge accounted (169) (188)<br />

Total net fair value of derivative financial instruments 59 130<br />

fair value hedges<br />

The Group has designated interest rate swaps and the interest element of cross currency swaps as fair value hedges whereby interest is<br />

receivable at fixed interest rates varying from 4.375% to 6.75% (2010: 4.375% to 6.75%) and payable at floating rates. These swaps<br />

hedge the exposure to changes in the fair value of medium term notes which mature in 2013 (2010: 2013). The cross currency swaps<br />

hedge changes in the fair value of the euro subordinated bond which matures in 2067. Net ineffectiveness gains of £9m were included<br />

in interest in <strong>2011</strong> (2010: £5m).<br />

cash flow hedges<br />

The Group has designated forward foreign exchange contracts and aluminium, gas and resin commodity contracts as cash flow hedges.<br />

Forward foreign exchange contracts hedge foreign currency transaction risk and mature between 2012 and 2014 (2010: between<br />

<strong>2011</strong> and 2013). The aluminium commodity, gas and resin commodity contracts hedge anticipated future purchases of aluminium and gas<br />

respectively, and mature between 2012 and 2014 (2010: between <strong>2011</strong> and 2013).<br />

not hedge accounted<br />

Derivatives are not used for trading purposes. However, some derivatives may not qualify for hedge accounting, or are specifically not<br />

designated as a hedge where natural offset is more appropriate.<br />

<strong>2011</strong><br />

£m<br />

2010<br />

£m<br />

123<br />

overview<br />

financial statements governance<br />

sustainability<br />

business review


124<br />

<strong>Rexam</strong> annual report <strong>2011</strong><br />

notes to the consolidated financial statements<br />

26 financial instruments continued<br />

net investment hedges<br />

An analysis of the Group’s non derivative financial instruments designated as net investment hedges with respect to its subsidiaries,<br />

principally in the eurozone and the US, are set out below.<br />

Medium<br />

term notes<br />

£m<br />

US public<br />

bond<br />

£m<br />

At 1 January <strong>2011</strong> (373) (43) (416)<br />

Net decrease in designations 13 41 54<br />

Exchange differences recognised in equity 12 2 14<br />

At 31 December <strong>2011</strong> (348) – (348)<br />

At 1 January 2010 (483) (194) (677)<br />

Net decrease in designations 86 153 239<br />

Exchange differences recognised in equity 24 (2) 22<br />

At 31 December 2010 (373) (43) (416)<br />

An analysis of the notional amounts and maturity dates for derivative financial instruments is set out below.<br />

Currency<br />

Maturity<br />

date<br />

<strong>2011</strong><br />

Notional<br />

amounts<br />

£m<br />

Total<br />

£m<br />

2010<br />

Notional<br />

amounts<br />

£m<br />

Fair value hedges<br />

Cross currency swaps Euro 2017 630 641<br />

Cross currency swaps Sterling 2017 (505) (505)<br />

Interest rate swaps Euro 2013 168 171<br />

Forward aluminium commodity contracts US dollar 2012 (4) (5)<br />

Cash flow hedges<br />

Forward foreign exchange contracts US dollar 2012 to 2014 177 141<br />

Forward foreign exchange contracts Sterling 2012 (30) (24)<br />

Forward foreign exchange contracts Swedish krone 2012 (17) (21)<br />

Forward aluminium commodity contracts US dollar 2012 to 2014 493 408<br />

Forward gas commodity contracts US dollar 2012 to 2014 8 8<br />

Forward resin commodity contracts US dollar 2012 5 –<br />

Not hedge accounted<br />

Cross currency swaps Sterling 2017 505 505<br />

Cross currency swaps US dollar 2017 (654) (654)<br />

Interest rate swaps US dollar 2012 to 2014 803 364<br />

Interest rate swaps Euro 2014 168 –<br />

Forward foreign exchange contracts US dollar 2012 to 2014 52 (210)<br />

Forward aluminium commodity contracts US dollar 2012 (17) –<br />

Forward resin commodity contracts US dollar <strong>2011</strong> – 2<br />

For forward foreign exchange contracts, there are other currencies traded which have been excluded as the fair values for these contracts<br />

were immaterial.


27 retirement benefit obligations<br />

(i) summary<br />

UK<br />

defined<br />

benefit<br />

pensions<br />

£m<br />

US<br />

defined<br />

benefit<br />

pensions<br />

£m<br />

Other<br />

defined<br />

benefit<br />

pensions<br />

£m<br />

Total<br />

defined<br />

benefit<br />

pensions<br />

£m<br />

Other<br />

pensions<br />

£m<br />

Total<br />

pensions<br />

£m<br />

Retiree<br />

medical<br />

£m<br />

Gross<br />

retirement<br />

benefit<br />

obligations<br />

£m<br />

At 1 January <strong>2011</strong> 19 (315) (38) (334) (18) (352) (111) (463)<br />

Exchange differences – (1) 1 – – – (1) (1)<br />

Service cost – continuing operations (7) (5) (1) (13) (10) (23) (1) (24)<br />

Service cost – discontinued operations – – – – (1) (1) – (1)<br />

Net finance (cost)/credit (see note below) 11 (15) (2) (6) – (6) (6) (12)<br />

Actuarial losses (68) (27) (7) (102) – (102) (4) (106)<br />

Cash contributions and benefits paid 32 11 3 46 10 56 9 65<br />

Transfers – 2 – 2 – 2 – 2<br />

At 31 December <strong>2011</strong> (13) (350) (44) (407) (19) (426) (114) (540)<br />

At 1 January 2010 (11) (218) (37) (266) (19) (285) (111) (396)<br />

Exchange differences – (11) – (11) 1 (10) (5) (15)<br />

Service cost – continuing operations (9) (4) (1) (14) (9) (23) (1) (24)<br />

Service cost – discontinued operations – (1) – (1) (3) (4) – (4)<br />

Exceptional items – discontinued operations – 2 – 2 – 2 – 2<br />

Net finance (cost)/credit 8 (14) (2) (8) – (8) (7) (15)<br />

Actuarial (losses)/gains 9 (73) (1) (65) – (65) 1 (64)<br />

Cash contributions and benefits paid 22 2 3 27 12 39 12 51<br />

Transfers – 2 – 2 – 2 – 2<br />

At 31 December 2010 19 (315) (38) (334) (18) (352) (111) (463)<br />

Pension assets – 19<br />

Retirement benefit obligations (540) (482)<br />

Gross retirement benefit obligations (540) (463)<br />

Tax 169 146<br />

Net retirement benefit obligations (371) (317)<br />

In addition to the £12m net finance cost for <strong>2011</strong> set out above, there is also a £4m transfer from the available for sale financial assets<br />

reserve relating to market value losses transferred to the consolidated income statement following the annuitisation of certain pension<br />

obligations. This gives a total net finance cost for <strong>2011</strong> of £16m as disclosed in the consolidated income statement.<br />

The Group operates various defined benefit pension plans throughout the world, the largest being the funded plans in the UK and the US.<br />

With respect to the UK, a full actuarial valuation by a qualified actuary was carried out as at 31 March <strong>2011</strong>. This valuation is in its final<br />

stages and it is expected that the plan will be fully funded at that date. The next full actuarial valuation is due no later than 31 March 2014.<br />

With respect to the US, a full actuarial valuation by a qualified actuary is carried out annually, the latest being as at 1 January <strong>2011</strong>.<br />

As part of the 31 March <strong>2011</strong> UK valuation, <strong>Rexam</strong> <strong>PLC</strong> and the trustees to the plan expect to agree a six year escrow investment with<br />

contributions of £10m in 2012 and £15m for each of the following five years. At each subsequent valuation date, the assets in escrow will<br />

either be allocated to the plan, to <strong>Rexam</strong> <strong>PLC</strong>, or remain in escrow subject to the funding position of the plan. If there is a change of control<br />

with a subsequent material decline in <strong>Rexam</strong>’s credit rating or <strong>Rexam</strong>’s financial covenant, the escrow would be paid into the plan.<br />

In 2009, <strong>Rexam</strong> <strong>PLC</strong> entered into a security agreement with the trustees of the UK pension plan, granting them a charge over the Beverage<br />

Cans UK facilities and machinery at Milton Keynes and Wakefield, enforceable up to 1 January 2013 in the event of a contribution default<br />

or a material decline in <strong>Rexam</strong>’s financial covenant.<br />

IFRIC 14 ‘IAS19 – The limit on a defined benefit asset, minimum funding requirements and their interaction’ had no impact on the Group in<br />

<strong>2011</strong> or 2010.<br />

<strong>2011</strong><br />

£m<br />

2010<br />

£m<br />

125<br />

overview<br />

financial statements governance<br />

sustainability<br />

business review


126<br />

<strong>Rexam</strong> annual report <strong>2011</strong><br />

notes to the consolidated financial statements<br />

27 retirement benefit obligations continued<br />

(ii) defined benefit pension plans<br />

UK<br />

<strong>2011</strong><br />

£m<br />

(a) Amounts recognised in the consolidated<br />

balance sheet<br />

Fair value of plan assets 1,719 1,079 13 2,811 1,598 1,026 13 2,637<br />

Present value of funded obligations (1,732) (1,380) (20) (3,132) (1,579) (1,295) (16) (2,890)<br />

Funded defined benefit pension plans (13) (301) (7) (321) 19 (269) (3) (253)<br />

Present value of unfunded obligations – (49) (37) (86) – (46) (35) (81)<br />

Net (liability)/asset (13) (350) (44) (407) 19 (315) (38) (334)<br />

(b) Amounts recognised in the consolidated<br />

income statement<br />

Continuing operations<br />

Current service cost (7) (5) (1) (13) (8) (4) (1) (13)<br />

Past service cost – – – – (1) – – (1)<br />

Exceptional items – past service credit – – – – – (1) – (1)<br />

Exceptional items – curtailments – – – – – 1 – 1<br />

Employee benefit expense (7) (5) (1) (13) (9) (4) (1) (14)<br />

Expected return on plan assets 95 46 1 142 92 52 – 144<br />

Interest cost (84) (61) (3) (148) (84) (66) (2) (152)<br />

Net finance (cost)/credit 11 (15) (2) (6) 8 (14) (2) (8)<br />

Total 4 (20) (3) (19) (1) (18) (3) (22)<br />

Discontinued operations<br />

Current service cost – – – – – (1) – (1)<br />

Exceptional items – curtailment – – – – – 2 – 2<br />

Employee benefit expense – – – – – 1 – 1<br />

(c) Amounts recognised in the consolidated<br />

statement of comprehensive income<br />

Actuarial gains/(losses) on plan assets 52 88 (1) 139 57 46 1 104<br />

Actuarial losses on retirement benefit obligations (120) (115) (6) (241) (48) (119) (2) (169)<br />

Total (68) (27) (7) (102) 9 (73) (1) (65)<br />

(d) Changes in the fair value of plan assets<br />

At 1 January 1,598 1,026 13 2,637 1,489 980 11 2,480<br />

Exchange differences – 2 (2) – – 44 – 44<br />

Expected return on plan assets 95 46 1 142 92 52 – 144<br />

Actuarial gains/(losses) 52 88 (1) 139 57 46 1 104<br />

Employer contributions 32 9 1 42 22 – 1 23<br />

Plan participant contributions 2 – 1 3 2 – 1 3<br />

Benefits paid (60) (92) – (152) (64) (96) (1) (161)<br />

At 31 December 1,719 1,079 13 2,811 1,598 1,026 13 2,637<br />

US<br />

<strong>2011</strong><br />

£m<br />

Other<br />

<strong>2011</strong><br />

£m<br />

Total<br />

<strong>2011</strong><br />

£m<br />

UK<br />

2010<br />

£m<br />

US<br />

2010<br />

£m<br />

Other<br />

2010<br />

£m<br />

Total<br />

2010<br />

£m


27 retirement benefit obligations continued<br />

UK<br />

<strong>2011</strong><br />

%<br />

(e) Major categories of plan assets<br />

Equities 45 12 74 32 50 18 74 38<br />

Bonds 54 88 23 67 49 82 22 61<br />

Cash and other 1 – 3 1 1 – 4 1<br />

(f) changes in the present value of defined benefit pension obligations<br />

UK<br />

<strong>2011</strong><br />

£m<br />

US<br />

<strong>2011</strong><br />

£m<br />

At 1 January (1,579) (1,341) (51) (2,971) (1,500) (1,198) (48) (2,746)<br />

Exchange differences – (3) 3 – – (55) – (55)<br />

Current service cost – continuing operations (7) (5) (1) (13) (8) (4) (1) (13)<br />

Current service cost – discontinued operations – – – – – (1) – (1)<br />

Past service cost – continuing operations – – – – (1) – – (1)<br />

Exceptional items – discontinued operations – – – – – 2 – 2<br />

Interest cost (84) (61) (3) (148) (84) (66) (2) (152)<br />

Actuarial losses (120) (115) (6) (241) (48) (119) (2) (169)<br />

Plan participant contributions (2) – (1) (3) (2) – (1) (3)<br />

Benefits paid 60 94 2 156 64 98 3 165<br />

Transfer from available for sale financial assets – 2 – 2 – 2 – 2<br />

At 31 December (1,732) (1,429) (57) (3,218) (1,579) (1,341) (51) (2,971)<br />

(g) principal actuarial assumptions<br />

Future salary increases 4.60 4.00 3.10 5.00 4.00 3.08<br />

Future pension increases 3.10 – 1.32 3.50 – 1.35<br />

Discount rate 4.70 4.00 4.54 5.40 4.90 5.20<br />

Inflation rate 3.10 2.50 2.00 3.50 2.50 2.00<br />

Expected return on plan assets<br />

(net of administration expenses):<br />

Equities 6.11 7.46 7.00 7.51 7.67 8.25<br />

Bonds 3.51 4.46 3.60 4.61 4.37 3.90<br />

Cash and other 0.31 2.56 0.20 0.31 2.77 1.00<br />

To develop the expected return on plan assets assumptions, the Group considered the current level of expected returns on risk free<br />

investments, primarily government bonds, the historical level of the risk premium associated with the asset class concerned and the<br />

expectations for future returns of the asset class. The resulting returns for equities, bonds and cash were then reduced to allow for<br />

administration expenses.<br />

The mortality assumptions used in valuing the liabilities of the UK pension plan are based on the standard tables S1NA as published by<br />

the Institute and Faculty of Actuaries. These tables are adjusted to reflect the circumstances of the plan membership. The life expectancy<br />

assumed for a 65 year old pensioner is 86.9 years (2010: 86.2 years) for a male and 89.1 years (2010: 89.3 years) for a female.<br />

The life expectancy for a non pensioner currently aged 45 is 88.7 years (2010: 88.4 years) for a male and 90.9 years (2010: 91.7 years)<br />

for a female.<br />

The mortality assumptions used in valuing the liabilities of the US pension plans are based on the RP2000 combined active and retiree<br />

mortality table projected to 2017 (2010: 2017), weighted 70% blue collar and 30% white collar. The life expectancy assumed for a<br />

65 year old pensioner is 83.6 years (2010: 83.6 years) for a male and 85.7 years (2010: 85.7 years) for a female.<br />

US<br />

<strong>2011</strong><br />

%<br />

UK<br />

<strong>2011</strong><br />

%<br />

Other<br />

<strong>2011</strong><br />

£m<br />

Other<br />

<strong>2011</strong><br />

%<br />

US<br />

<strong>2011</strong><br />

%<br />

Total<br />

<strong>2011</strong><br />

£m<br />

Total<br />

<strong>2011</strong><br />

%<br />

UK<br />

2010<br />

£m<br />

Other<br />

<strong>2011</strong><br />

%<br />

UK<br />

2010<br />

%<br />

US<br />

2010<br />

£m<br />

UK<br />

2010<br />

%<br />

US<br />

2010<br />

%<br />

Other<br />

2010<br />

%<br />

Other<br />

2010<br />

£m<br />

US<br />

2010<br />

%<br />

Total<br />

2010<br />

%<br />

Total<br />

2010<br />

£m<br />

Other<br />

2010<br />

%<br />

127<br />

overview<br />

financial statements governance<br />

sustainability<br />

business review


128<br />

<strong>Rexam</strong> annual report <strong>2011</strong><br />

notes to the consolidated financial statements<br />

27 retirement benefit obligations continued<br />

(h) historic information on defined benefit plans<br />

Fair value of plan assets 2,811 2,637 2,480 2,505 2,361<br />

Present value of defined benefit obligations (3,218) (2,971) (2,746) (2,586) (2,424)<br />

Net liability (407) (334) (266) (81) (63)<br />

Cumulative actuarial (losses)/gains (130) (28) 37 223 253<br />

<strong>2011</strong> 2010 2009 2008 2007<br />

Experience gains/(losses) arising on plan assets:<br />

Amount (£m) 139 104 73 (221) 81<br />

Percentage of plan assets (%)<br />

Experience (losses)/gains arising on defined benefit obligations:<br />

5 4 3 (9) 3<br />

Amount (£m) (241) (169) (259) 191 136<br />

Percentage of present value of defined benefit obligations (%) (7) (6) (9) 7 6<br />

The Group expects to contribute £53m in cash to its defined benefit pension plans in 2012, excluding any amounts deposited in escrow.<br />

(iii) other pension plans<br />

The Group operates a number of US based defined contribution plans, included as part of other pensions in (i) above, for which the charge<br />

in the consolidated income statement for the year was £7m for continuing operations and £1m for discontinued operations (2010: £7m<br />

and £3m) and total cash contributions were £8m (2010: £10m).<br />

(iv) retiree medical<br />

Certain current and former employees in the US are provided with cover for medical costs and life assurance, referred to in these<br />

consolidated financial statements as retiree medical. These unfunded benefits are assessed with the advice of a qualified actuary.<br />

(a) Amounts recognised in the consolidated balance sheet<br />

Present value of the retiree medical obligation (114) (111)<br />

(b) Amounts recognised in the consolidated income statement<br />

Continuing operations<br />

Current service cost (1) (1)<br />

Interest cost (including administration costs of £1m (2010: £1m)) (6) (7)<br />

(7) (8)<br />

(c) Amounts recognised in the consolidated statement of comprehensive income<br />

Actuarial (losses)/gains (4) 1<br />

(d) Changes in the present value of the retiree medical obligation<br />

At 1 January (111) (111)<br />

Exchange differences (1) (5)<br />

Current service cost (1) (1)<br />

Interest cost (6) (7)<br />

Actuarial (losses)/gains (4) 1<br />

Benefits paid 9 12<br />

At 31 December (114) (111)<br />

<strong>2011</strong><br />

£m<br />

2010<br />

£m<br />

2009<br />

£m<br />

2008<br />

£m<br />

<strong>2011</strong><br />

£m<br />

2007<br />

£m<br />

2010<br />

£m


27 retirement benefit obligations continued<br />

(e) principal actuarial assumptions<br />

Discount rate 4.00 4.90<br />

Healthcare cost trend rate 8.00 reducing to<br />

4.50 over 16 years<br />

<strong>2011</strong><br />

%<br />

2010<br />

%<br />

8.30 reducing to<br />

4.50 over 17 years<br />

The mortality assumptions used in valuing the liabilities for retiree medical are based on the RP2000 combined active and retiree table<br />

projected to 2017 (2010: 2017), weighted 85% blue collar and 15% white collar. The life expectancy assumed for a 65 year old<br />

pensioner is 83.4 years (2010: 83.4 years) for a male and 85.5 years (2010: 85.5 years) for a female.<br />

Healthcare cost trend rates do not have a significant impact on the Group with respect to retiree medical. A one percentage point change<br />

in assumed rates would have the impact as set out below.<br />

1% increase – service cost and interest cost combined increase – –<br />

1% increase – retiree medical obligation increase (3) (3)<br />

1% decrease – service cost and interest cost combined reduction – –<br />

1% decrease – retiree medical obligation reduction 3 3<br />

(f) historic information on retiree medical<br />

<strong>2011</strong> 2010 2009 2008 2007<br />

Present value of retiree medical obligation (£m) (114) (111) (111) (127) (98)<br />

Cumulative actuarial gains (£m) 16 20 19 14 15<br />

Experience (losses)/gains arising on retiree medical obligation:<br />

Amount (£m) (4) 1 5 (1) –<br />

Percentage of present value of retiree medical obligation (%) (4) 1 5 (1) –<br />

28 provisions<br />

Environmental<br />

compliance<br />

£m<br />

Restructuring<br />

of businesses<br />

£m<br />

Indirect tax<br />

exposures<br />

£m<br />

Regulatory<br />

and other<br />

claims<br />

£m<br />

<strong>2011</strong><br />

£m<br />

Share<br />

based<br />

payment<br />

£m<br />

At 1 January <strong>2011</strong> (21) (21) (32) (22) (6) (102)<br />

Exchange differences – – 2 – – 2<br />

Charge for the year – (19) (3) – (11) (33)<br />

Release for the year – – – 5 – 5<br />

Utilised 2 20 – 2 – 24<br />

Transfers – (2) – – – (2)<br />

At 31 December <strong>2011</strong> (19) (22) (33) (15) (17) (106)<br />

Current liabilities (5) (20) – (11) – (36)<br />

Non current liabilities (14) (2) (33) (4) (17) (70)<br />

At 31 December <strong>2011</strong> (19) (22) (33) (15) (17) (106)<br />

Current liabilities (3) (18) – (18) – (39)<br />

Non current liabilities (18) (3) (32) (4) (6) (63)<br />

At 31 December 2010 (21) (21) (32) (22) (6) (102)<br />

Environmental compliance mainly relates to the US and France and is long term in nature with the timing of utilisation unknown due to the<br />

need to complete remedial investigations, to negotiate remedial plans with local authorities and to implement agreed plans. The provision<br />

for restructuring of businesses comprises £15m relating to Plastic Packaging in respect of restructuring following the disposal of Closures<br />

and £7m relating to Beverage Cans for previously announced plant closures. Indirect tax exposures relate to Brazil and are long term in<br />

nature, with the timing of payment, if any, dependent upon the outcome of tax cases and exposures. Regulatory and other claims relate to<br />

various proceedings where the timing of payment, if any, is dependent upon the outcome of the proceedings. Share based payment<br />

relates to cash settled share option schemes, the timing of payment being dependent on various performance criteria being met.<br />

2010<br />

£m<br />

Total<br />

£m<br />

129<br />

overview<br />

financial statements governance<br />

sustainability<br />

business review


130<br />

<strong>Rexam</strong> annual report <strong>2011</strong><br />

notes to the consolidated financial statements<br />

29 share capital<br />

Number of issued and fully paid ordinary shares of 64 2 /7p<br />

<strong>2011</strong><br />

Thousands<br />

2010<br />

Thousands<br />

At 1 January 876,864 876,829<br />

Issued under employee share option schemes 167 35<br />

At 31 December 877,031 876,864<br />

The rights and restrictions attaching to the shares and the provisions relating to the transfer of shares are as governed by law and in<br />

accordance with the Company’s articles of association. Holders of shares are entitled to receive all shareholder documents, to attend,<br />

speak and exercise voting rights, either in person or by proxy, on resolutions proposed at general meetings and participate in any<br />

distribution of income or capital. The directors may refuse to register a transfer of shares where such transfer documents are not lodged by<br />

acceptable means or proof of title is required. Shares are held by the <strong>Rexam</strong> Employee Share Trust (Trust) for the satisfaction of certain<br />

share options (note 31). The independent trustee of the Trust has the same rights as any other shareholder. Participants in option schemes<br />

do not hold any voting rights on the shares until the date of exercise. There are no restrictions on the voting rights of holders of shares nor<br />

any known agreements between holders of shares under which financial rights are held by any person other than the registered holder, or<br />

voting rights or the transfer of shares are restricted.<br />

30 other reserves<br />

Translation<br />

reserve<br />

£m<br />

Net<br />

investment<br />

hedge<br />

reserve<br />

£m<br />

Cash flow<br />

hedge<br />

reserve<br />

£m<br />

Available<br />

for sale<br />

financial<br />

assets<br />

reserve<br />

£m<br />

At 1 January <strong>2011</strong> 429 (104) 64 (3) 386<br />

Cost recognised in the income statement on annuitisation of<br />

certain pension obligations (net of tax) – – – 3 3<br />

Exchange differences before recognition of net investment hedges (30) – – – (30)<br />

Net investment hedges recognised – 14 – – 14<br />

Exchange differences recognised in the income statement on<br />

disposal of Closures (89) – – – (89)<br />

Cash flow hedges recognised – – (92) – (92)<br />

Cash flow hedges transferred to inventory – – (16) – (16)<br />

Tax on cash flow hedges – – 28 – 28<br />

At 31 December <strong>2011</strong> 310 (90) (16) – 204<br />

At 1 January 2010 441 (126) 51 (4) 362<br />

Exchange differences before recognition of net investment hedges (12) – – – (12)<br />

Net investment hedges recognised – 22 – – 22<br />

Cash flow hedges recognised – – 40 – 40<br />

Tax on cash flow hedges – – (4) – (4)<br />

Cash flow hedges transferred to inventory – – (25) – (25)<br />

Cash flow hedges transferred to the income statement – – 2 – 2<br />

Changes in market value of available for sale financial assets – – – 1 1<br />

At 31 December 2010 429 (104) 64 (3) 386<br />

Total<br />

£m


31 share based payment<br />

(i) summary of <strong>Rexam</strong>’s share based payment schemes<br />

Scheme name Abbreviation Scheme status Settlement basis<br />

Long Term Incentive Plan 2009 LTIP Open Equity and cash<br />

Long Term Incentive Plan 2007 LTIP 2007 Closed Equity<br />

Executive Share Option Scheme ESOS Closed Equity<br />

Phantom Stock Plan Phantoms Closed Cash<br />

Savings Related Share Option Schemes SAYE Open Equity<br />

LTIP<br />

The LTIP is the primary long term incentive plan for <strong>Rexam</strong>’s executive directors, band 1 executives and other senior management. The LTIP<br />

measures performance targets over a three year period. Options will normally vest, subject to performance targets being achieved, on the<br />

third anniversary of the date of grant at a nominal cost to the employee. Employees who leave with a right to exercise options must<br />

normally wait until the end of the measurement period. If the option vests, the employee will receive an entitlement which normally will be<br />

time apportioned for the period from the start of the measurement period to the date on which employment ended.<br />

Options granted in <strong>2011</strong> to executive directors and band 1 executives are subject to three performance conditions, compound annual<br />

growth in underlying earnings per share (EPS), return on capital employed (ROCE) and relative Total Shareholder Return (TSR), in the<br />

proportion 33%, 33% and 33%, respectively. These options are equity settled. Options granted in <strong>2011</strong> to other senior management are<br />

subject to two performance conditions, EPS and ROCE, in the proportion 67% and 33% respectively. These options are either equity<br />

settled or cash settled depending on the seniority of the employee.<br />

Options granted in <strong>2011</strong> include a dividend equivalent element whereby employees will be entitled to receive, in shares or cash, the<br />

notional dividends paid during the measurement period on any options that vest.<br />

For further details of the LTIP refer to the remuneration report.<br />

LTIP 2007<br />

Prior to 2009, annual grants of options were made to executive directors and senior executives under the LTIP 2007. All outstanding<br />

options lapsed in <strong>2011</strong>.<br />

ESOS<br />

Prior to 2009, annual grants of options over ordinary shares were made to certain senior management. For grants up to and<br />

including 2006, shares vested if a performance target (growth in economic profit) was met over the three year measurement period.<br />

No performance targets were set for the 2007 and 2008 grants. Options are exercisable three years after grant date and expire ten years<br />

after grant date. The exercise price was set at market value using the market price of a <strong>Rexam</strong> share at the grant date.<br />

Phantoms<br />

This cash settled scheme operates in the same way as the ESOS scheme and relates to certain senior management located outside the UK<br />

and Europe.<br />

SAYE<br />

All employee SAYE schemes are open to eligible employees resident in the UK and Ireland. <strong>Annual</strong> grants of options over shares are<br />

currently made at an exercise price of 80% of the market value of <strong>Rexam</strong> shares at the grant date. Options vest three, five or seven<br />

years after the commencement of the savings contract, depending on the term selected by the employee at grant and expire six<br />

months after vesting.<br />

(ii) employee benefit expense<br />

Equity settled 9 6<br />

Cash settled 10 5<br />

Total 19 11<br />

<strong>2011</strong><br />

£m<br />

2010<br />

£m<br />

131<br />

overview<br />

financial statements governance<br />

sustainability<br />

business review


132<br />

<strong>Rexam</strong> annual report <strong>2011</strong><br />

notes to the consolidated financial statements<br />

31 share based payment continued<br />

(iii) key assumptions used in valuing options granted during the year<br />

LTIP SAYE<br />

Valuation models TSR – Monte Carlo Binomial<br />

EPS/ROCE – Black – Scholes<br />

Expected dividend growth (%) – 3.8<br />

Expected historical volatility (%) TSR – 25.4 to 36.4 29 to 35<br />

Risk free interest rate (%) TSR – 0.85 to 1.85 0.9 to 1.9<br />

Expected life (years) 2.2 to 2.7 3.25, 5.25, 7.25<br />

Weighted average share price (£) 3.40 to 3.70 3.40<br />

Weighted average fair value (£) 2.38 to 3.70 0.84 to 0.89<br />

The assumptions made to incorporate the effects of expected early exercise have been included by assuming an expected option life<br />

based on historical exercise patterns for each option scheme. Historical volatilities are arrived at using a period comparable with the<br />

expected life of the option. The correlation coefficient for LTIP is calculated using the correlation matrix for the TSR simulation using three<br />

year daily historical stock price series for each company in the comparator group, including <strong>Rexam</strong>, from the beginning of the<br />

measurement period.<br />

(iv) number of options and weighted average exercise prices of all option schemes<br />

<strong>2011</strong><br />

Number of<br />

options<br />

Thousands<br />

<strong>2011</strong><br />

Weighted average<br />

exercise price<br />

£<br />

2010<br />

Number of<br />

options<br />

Thousands<br />

2010<br />

Weighted average<br />

exercise price<br />

£<br />

Outstanding at 1 January 21,502 1.18 13,043 2.34<br />

Granted 10,857 0.05 13,195 0.04<br />

Exercised (252) 2.71 (93) 0.89<br />

Lapsed (3,771) 0.52 (4,643) 1.22<br />

Outstanding at 31 December 28,336 0.82 21,502 1.18<br />

Exercisable at 31 December 4,823 3.98 2,665 4.06<br />

(v) exercise prices and average remaining contractual lives of options by scheme<br />

<strong>2011</strong><br />

Number of<br />

options<br />

Thousands<br />

<strong>2011</strong><br />

Range of<br />

exercise prices<br />

£<br />

<strong>2011</strong><br />

Weighted average<br />

remaining<br />

contractual life<br />

Years<br />

2010<br />

Number of<br />

options<br />

Thousands<br />

2010<br />

Range of<br />

exercise prices<br />

£<br />

2010<br />

Weighted average<br />

remaining<br />

contractual life<br />

Years<br />

LTIP 21,674 – 1.7 12,224 – 2.2<br />

LTIP 2007 – – – 2,058 – 4.2<br />

ESOS 2,808 2.71 to 4.58 5.5 3,090 2.14 to 4.61 6.3<br />

SAYE 1,878 2.12 to 3.88 2.8 1,866 2.12 to 3.88 3.4<br />

Phantoms 1,976 2.71 to 4.57 5.4 2,264 2.71 to 4.57 6.3<br />

(vi) <strong>Rexam</strong> Employee Share Trust<br />

The Group operates an employee share trust, the <strong>Rexam</strong> Employee Share Trust, that owns 7,468,028 ordinary shares of 64 2 / 7 p in <strong>Rexam</strong><br />

<strong>PLC</strong> at 31 December <strong>2011</strong> (2010: 2,468,028) acquired at an average cost per share of £3.50 (2010: £3.38) and included in the<br />

consolidated balance sheet within retained earnings at a cost of £26m (2010: £8m). These shares will be used to satisfy LTIP exercises.<br />

The purchases are funded by cash contributions from participating companies. Dividends receivable during the year have been waived.<br />

The administration expenses of the Trust are borne by the Trust. Shares are allocated by the Trust when related LTIP options are exercised.<br />

The market value of the shares at 31 December <strong>2011</strong> was £26m (2010: £8m).


32 reconciliation of profit/(loss) before tax to cash generated/(used) from operations<br />

<strong>2011</strong><br />

Continuing<br />

operations<br />

£m<br />

<strong>2011</strong><br />

Discontinued<br />

operations<br />

£m<br />

<strong>2011</strong><br />

Total<br />

operations<br />

£m<br />

2010<br />

Continuing<br />

operations<br />

£m<br />

2010<br />

Discontinued<br />

operations<br />

£m<br />

2010<br />

Total<br />

operations<br />

£m<br />

Profit/(loss) before tax 431 (26) 405 338 (177) 161<br />

Adjustments for:<br />

Share of post tax profits of associates and joint ventures (9) – (9) (5) – (5)<br />

Net interest expense 69 – 69 125 – 125<br />

Impairment of goodwill – – – – 59 59<br />

Impairment of intangible assets – 20 20 – 65 65<br />

Impairment of property, plant and equipment 7 14 21 6 55 61<br />

Reversal of impairment of property, plant and equipment (1) – (1) (3) – (3)<br />

Depreciation of property, plant and equipment 179 – 179 183 21 204<br />

Amortisation of intangible assets 38 – 38 46 15 61<br />

Movement in working capital (19) (24) (43) (20) – (20)<br />

Movement in provisions 5 (1) 4 (8) (2) (10)<br />

Movement in retirement benefit obligations (29) 1 (28) (12) 2 (10)<br />

Other adjustments (7) 2 (5) (3) – (3)<br />

Cash generated/(used) from operations 664 (14) 650 647 38 685<br />

33 contingent liabilities<br />

In an international group a variety of claims arise from time to time; some have little or no foundation in law or in fact and others cannot<br />

be quantified. The claims include litigation against Group companies, investigations by regulatory and fiscal authorities and obligations<br />

arising under environmental legislation. Provision has been made in these consolidated financial statements against those claims which<br />

the directors consider are likely to result in significant liabilities. There are no contingent liabilities at 31 December <strong>2011</strong> or 31 December<br />

2010 that require disclosure.<br />

34 commitments<br />

(i) operating lease commitments<br />

The Group leases offices and warehouses under non cancellable operating leases. The leases have varying terms, purchase options,<br />

escalation clauses and renewal rights. The Group also leases plant and equipment under cancellable operating leases.<br />

An analysis of the total future minimum lease payments under non cancellable operating leases is set out below.<br />

<strong>2011</strong><br />

Property<br />

£m<br />

<strong>2011</strong><br />

Plant and<br />

equipment<br />

£m<br />

2010<br />

Property<br />

£m<br />

2010<br />

Plant and<br />

equipment<br />

£m<br />

Less than 1 year 23 5 22 2<br />

Between 1 and 5 years 43 5 47 2<br />

Over 5 years 43 – 42 –<br />

Total 109 10 111 4<br />

Total future minimum sublease receipts under non cancellable operating leases are £8m (2010: £10m).<br />

(ii) capital commitments<br />

Contracts placed for future capital expenditure not provided in the consolidated financial statements:<br />

Property, plant and equipment 52 51<br />

<strong>2011</strong><br />

£m<br />

2010<br />

£m<br />

133<br />

overview<br />

financial statements governance<br />

sustainability<br />

business review


134<br />

<strong>Rexam</strong> annual report <strong>2011</strong><br />

five year financial summary<br />

For the year ended 31 December<br />

Consolidated income statement<br />

Continuing operations<br />

Sales 4,734 4,619 4,533 4,254 3,423<br />

Underlying operating expenses (4,185) (4,106) (4,115) (3,831) (3,097)<br />

Underlying operating profit 549 513 418 423 326<br />

Underlying share of post tax profits of associates and joint ventures 9 5 2 2 –<br />

Retirement benefit obligations net finance cost (16) (15) (31) (7) (14)<br />

Underlying net interest expense (92) (113) (131) (132) (94)<br />

Underlying profit before tax 450 390 258 286 218<br />

Exceptional and other items 1 (19) (52) (124) (65) 22<br />

Profit before tax 431 338 134 221 240<br />

Tax (128) (102) (44) (62) (78)<br />

Profit for the financial year 303 236 90 159 162<br />

Discontinued operations<br />

Profit/(loss) for the financial year 73 (112) (119) 12 78<br />

Total profit/(loss) for the financial year 376 124 (29) 171 240<br />

As at 31 December<br />

Consolidated balance sheet<br />

Goodwill and other intangible assets 2,177 2,231 2,481 2,949 2,216<br />

Property, plant and equipment 1,590 1,571 1,723 1,982 1,310<br />

Retirement benefit obligations (net of tax) (371) (317) (279) (170) (128)<br />

Other net assets/(liabilities) 235 524 225 16 (3)<br />

Underlying net assets 3,631 4,009 4,150 4,777 3,395<br />

Shareholders’ equity 2,319 2,322 2,320 2,174 1,831<br />

Non controlling interests – 3 2 2 2<br />

Total equity 2,319 2,325 2,322 2,176 1,833<br />

Net borrowings 1,312 1,684 1,828 2,601 1,562<br />

Capital employed 3,631 4,009 4,150 4,777 3,395<br />

Statistics<br />

Underlying return on sales 2 % 11.6 11.1 9.2 9.9 9.5<br />

Underlying earnings per share 2 Pence 36.1 31.4 23.0 27.7 22.4<br />

Basic earnings per share 3 Pence 34.7 27.1 11.4 22.2 23.5<br />

Dividends per ordinary share 4 Pence 14.4 12.0 8.0 18.7 17.8<br />

Interest cover 5 Times 6.0 4.5 3.2 3.2 3.5<br />

Free cash flow £m 245 316 290 (128) 24<br />

Capital expenditure (gross) £m 240 206 184 389 311<br />

Return on net assets 6 % 29.5 27.0 22.1 27.5 30.3<br />

Return on capital employed 7 % 13.7 12.3 9.5 11.0 11.9<br />

Gearing % 57 72 79 120 85<br />

Average number of employees 3 Number 19,000 19,600 20,700 22,500 21,100<br />

1 Other items comprise the amortisation of certain acquired intangible assets and fair value changes on financing derivatives.<br />

2 Based on continuing operations before exceptional and other items.<br />

3 Based on continuing operations.<br />

4 Includes proposed final dividends.<br />

5 Based on underlying operating profit from continuing operations and underlying net interest expense from continuing operations.<br />

6 Underlying operating profit from total operations (excluding Glass, sold in 2007) plus share of associates and joint ventures profit after tax divided by the average of opening and closing<br />

shareholders’ equity after adding back retirement benefit obligations (net of tax) and net borrowings and excluding goodwill and certain acquired intangible assets.<br />

7 Underlying operating profit from total operations (excluding Glass, sold in 2007) plus share of associates and joint ventures profit after tax divided by the average of opening and closing<br />

shareholders’ equity after adding back retirement benefit obligations (net of tax) and net borrowings.<br />

<strong>2011</strong><br />

£m<br />

<strong>2011</strong><br />

£m<br />

2010<br />

£m<br />

2010<br />

£m<br />

2009<br />

£m<br />

2009<br />

£m<br />

2008<br />

£m<br />

2008<br />

£m<br />

2007<br />

£m<br />

2007<br />

£m


company<br />

financial<br />

statements<br />

136 independent auditors’ report to the members of <strong>Rexam</strong> <strong>PLC</strong><br />

137 <strong>Rexam</strong> <strong>PLC</strong> balance sheet<br />

notes to the Company financial statements:<br />

138 note 1 – principal accounting policies<br />

139 note 2 – employee costs and numbers<br />

139 note 3 – equity dividends<br />

140 note 4 – tangible assets<br />

140 note 5 – investments in subsidiaries<br />

141 note 6 – debtors receivable within one year<br />

141 note 7 – other creditors<br />

141 note 8 – borrowings<br />

142 note 9 – derivative financial instruments<br />

142 note 10 – operating lease commitments<br />

142 note 11 – contingent liabilities<br />

143 note 12 – capital and reserves<br />

143 note 13 – share based payment<br />

<strong>Rexam</strong> produces a variety of can ends, some of<br />

which have coloured and customised tabs – giving<br />

our customers an enhanced on-shelf presence.<br />

135<br />

financial statements governance sustainability<br />

business review<br />

overview


136 <strong>Rexam</strong> annual report <strong>2011</strong><br />

independent auditors’ report to the members of <strong>Rexam</strong> <strong>PLC</strong><br />

We have audited the Company financial statements of <strong>Rexam</strong> <strong>PLC</strong> for the year ended 31 December <strong>2011</strong> which comprise the <strong>Rexam</strong> <strong>PLC</strong><br />

balance sheet and the related notes. The financial reporting framework that has been applied in their preparation is applicable law and<br />

United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice).<br />

respective responsibilities of directors and auditors<br />

As explained more fully in the statement of directors’ responsibilities set out on page 81, the directors are responsible for the preparation of<br />

the Company financial statements and for being satisfied that they give a true and fair view. Our responsibility is to audit and express an<br />

opinion on the Company financial statements in accordance with applicable law and International Standards on Auditing (UK and<br />

Ireland). Those standards require us to comply with the Auditing Practices Board’s Ethical Standards for Auditors.<br />

This report, including the opinions, has been prepared for and only for the company’s members as a body in accordance with Chapter 3<br />

of Part 16 of the Companies Act 2006 and for no other purpose. We do not, in giving these opinions, accept or assume responsibility for<br />

any other purpose or to any other person to whom this report is shown or into whose hands it may come save where expressly agreed by<br />

our prior consent in writing.<br />

scope of the audit of the financial statements<br />

An audit involves obtaining evidence about the amounts and disclosures in the financial statements sufficient to give reasonable assurance<br />

that the financial statements are free from material misstatement, whether caused by fraud or error. This includes an assessment of: whether<br />

the accounting policies are appropriate to the Company’s circumstances and have been consistently applied and adequately disclosed;<br />

the reasonableness of significant accounting estimates made by the directors; and the overall presentation of the financial statements. In<br />

addition, we read all the financial and non financial information in the <strong>Rexam</strong> annual report <strong>2011</strong> to identify material inconsistencies with<br />

the audited financial statements. If we become aware of any apparent material misstatements or inconsistencies we consider the<br />

implications for our report.<br />

opinion on financial statements<br />

In our opinion the Company financial statements:<br />

• give a true and fair view of the state of the company’s affairs as at 31 December <strong>2011</strong>;<br />

• have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and<br />

• have been prepared in accordance with the requirements of the Companies Act 2006.<br />

opinion on other matters prescribed by the Companies Act 2006<br />

In our opinion:<br />

• the part of the remuneration report to be audited has been properly prepared in accordance with the Companies Act 2006; and<br />

• the information given in the directors’ report for the financial year for which the Company financial statements are prepared is<br />

consistent with the Company financial statements.<br />

matters on which we are required to report by exception<br />

We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you if, in our opinion:<br />

• adequate accounting records have not been kept by the Company, or returns adequate for our audit have not been received from<br />

branches not visited by us; or<br />

• the Company financial statements and the part of the remuneration report to be audited are not in agreement with the accounting<br />

records and returns; or<br />

• certain disclosures of directors’ remuneration specified by law are not made; or<br />

• we have not received all the information and explanations we require for our audit.<br />

other matter<br />

We have reported separately on the consolidated financial statements of <strong>Rexam</strong> <strong>PLC</strong> for the year ended 31 December <strong>2011</strong>.<br />

Robert Milburn (Senior Statutory Auditor)<br />

for and on behalf of PricewaterhouseCoopers LLP<br />

Chartered Accountants and Statutory Auditors<br />

London<br />

22 February 2012


<strong>Rexam</strong> <strong>PLC</strong> balance sheet<br />

As at 31 December notes<br />

Fixed assets<br />

Tangible assets 4 14 15<br />

Investments in subsidiaries 5 5,202 5,204<br />

Derivative financial instruments 9 276 243<br />

Current assets<br />

5,492 5,462<br />

Debtors receivable within one year 6 20 14<br />

Derivative financial instruments 9 10 27<br />

Cash at bank and in hand 343 69<br />

Creditors: amounts falling due within one year<br />

373 110<br />

Borrowings 8 (39) (41)<br />

Derivative financial instruments 9 (2) (3)<br />

Other creditors 7 (333) (420)<br />

(374) (464)<br />

Net current liabilities (1) (354)<br />

Total assets less current liabilities<br />

Creditors: amounts falling due after more than one year<br />

5,491 5,108<br />

Borrowings 8 (1,753) (1,753)<br />

Derivative financial instruments 9 (170) (184)<br />

Other creditors 7 (693) (674)<br />

(2,616) (2,611)<br />

Provisions for liabilities and charges (2) (1)<br />

Net assets 2,873 2,496<br />

Capital and reserves<br />

Ordinary share capital 564 564<br />

Share premium account 989 989<br />

Capital redemption reserve 351 351<br />

Profit and loss reserve 814 437<br />

Other reserves 155 155<br />

Total capital and reserves 12 2,873 2,496<br />

Approved by the board on 22 February 2012<br />

Graham Chipchase, chief executive David Robbie, finance director<br />

<strong>2011</strong><br />

£m<br />

2010<br />

£m<br />

137<br />

overview<br />

financial statements governance<br />

sustainability<br />

business review


138 <strong>Rexam</strong> annual report <strong>2011</strong><br />

notes to the Company financial statements<br />

1 principal accounting policies<br />

The financial statements of <strong>Rexam</strong> <strong>PLC</strong> are prepared under UK GAAP using the historical cost convention as modified by the revaluation<br />

of certain financial instruments and share based payments and in accordance with applicable accounting standards. As permitted by<br />

section 408 of the Companies Act 2006, the profit and loss account is not presented.<br />

foreign currencies<br />

All exchange differences arising on foreign currencies are taken to the profit and loss account.<br />

interest<br />

Interest on cash and cash equivalents and borrowings held at amortised cost is recognised in the profit and loss account using the effective<br />

interest method. Interest includes exchange differences arising on cash and cash equivalents and borrowings. Interest includes all fair<br />

value gains and losses on derivative financial instruments, and corresponding adjustments to hedged items under designated fair value<br />

hedging relationships, where they relate to financing activities and are recognised in the profit and loss account.<br />

retirement benefits<br />

The pension rights of <strong>Rexam</strong> <strong>PLC</strong> employees are dealt with through a self administered scheme, the assets of which are held independently<br />

of the Group. The scheme is a defined benefit scheme that is funded partly by contributions from members and partly by contributions from<br />

<strong>Rexam</strong> <strong>PLC</strong> and its subsidiaries at rates advised by independent professionally qualified actuaries. In accordance with FRS17, <strong>Rexam</strong> <strong>PLC</strong><br />

accounts for its contributions as though it were a defined contribution scheme. This is because the underlying assets and liabilities of the<br />

scheme cover <strong>Rexam</strong> <strong>PLC</strong> and a number of its subsidiaries and it cannot be split between each subsidiary on a consistent and reasonable<br />

basis, as the scheme has a large number of members who were employed by companies which are no longer in existence or are no longer<br />

part of the Group. An actuarial valuation at a Group level on an FRS17 basis has not been performed, but a deficit at 31 December <strong>2011</strong><br />

of £13m (2010: surplus £19m) has been calculated in accordance with IAS19. Further details of the scheme and its accounting deficit can<br />

be found in note 27 to the consolidated financial statements.<br />

share based payment<br />

<strong>Rexam</strong> <strong>PLC</strong> operates various equity settled share option schemes. The services received from employees are measured by reference to<br />

the fair value of the share options. The fair value is calculated at grant date and recognised in the profit and loss account, together with a<br />

corresponding increase in shareholders’ funds. Equity settled share options granted directly to subsidiary company employees are treated<br />

as a capital contribution to the subsidiary. The capital contribution is measured by reference to the fair value of the share options and<br />

recognised as an increase in the cost of investment with a corresponding increase in shareholders’ funds. The recognition of the fair value<br />

is based on a straight line basis over the vesting period, based on an estimate of the number of options that will eventually vest. Vesting<br />

conditions, which comprise service conditions and performance conditions, are not taken into account when estimating the fair value.<br />

All non vesting conditions are included in fair value. FRS20 has been applied to equity settled share options granted after 7 November<br />

2002. The <strong>Rexam</strong> Employee Share Trust holds shares in <strong>Rexam</strong> <strong>PLC</strong> which are presented in the balance sheet as a deduction from<br />

shareholders’ funds.<br />

tangible fixed assets<br />

Tangible fixed assets are stated in the balance sheet at cost less provision for depreciation. Depreciation is calculated to write off the cost,<br />

less estimated residual value, of tangible fixed assets over their expected lives by equal annual instalments. Depreciation is provided on all<br />

tangible fixed assets. Assumed lives vary according to the class of asset as follows:<br />

Computer hardware and software 2 to 7 years<br />

Fixtures and fittings 4 to 10 years<br />

investments in subsidiaries<br />

Investments in subsidiaries are stated at cost less provisions for impairment where appropriate.<br />

dividends<br />

Under FRS21, final ordinary dividends payable to the shareholders of <strong>Rexam</strong> <strong>PLC</strong> are recognised in the period that they are approved by<br />

the shareholders. Interim ordinary dividends payable are recognised in the period that they are paid. Dividends receivable are recognised<br />

when the Company’s right to receive payment is established.


1 principal accounting policies continued<br />

financial instruments<br />

Derivative financial instruments are measured at fair value. Derivative financial instruments used by the Company include interest rate<br />

swaps, cross currency swaps, forward foreign exchange contracts and forward aluminium commodity contracts.<br />

Certain derivative financial instruments are designated as hedges in line with the Company’s risk management policies. Hedges are<br />

classified as follows:<br />

(i) fair value hedges where they hedge the exposure to changes in the fair value of a recognised asset or liability.<br />

(ii) cash flow hedges where they hedge exposure to variability in cash flows that is attributable to a particular risk associated with<br />

a recognised asset or liability or a forecast transaction.<br />

For fair value hedges, any gain or loss from remeasuring the hedging instrument at fair value is recognised in the profit and loss account.<br />

Any gain or loss on the hedged item attributable to the hedged risk is adjusted against the carrying amount of the hedged item and<br />

similarly recognised in the profit and loss account.<br />

For cash flow hedges, the portion of the gain or loss on the hedging instrument that is determined to be an effective hedge is recognised<br />

in reserves, with any ineffective portion recognised in the profit and loss account. When hedged cash flows result in the recognition of a<br />

non financial asset or liability, the associated gains or losses previously recognised in reserves are included in the initial measurement of<br />

the asset or liability. For all other cash flow hedges, the gains or losses that are recognised in reserves are transferred to the profit and loss<br />

account in the same period in which the hedged cash flows affect the profit and loss account.<br />

Any gains or losses arising from changes in fair value of derivative financial instruments not designated as hedges are recognised<br />

immediately in the profit and loss account.<br />

Borrowings are measured at amortised cost except where they are hedged by an effective fair value hedge, in which case the carrying<br />

value is adjusted to reflect the fair value movements associated with the hedged risk.<br />

Up front fees paid on the establishment of loan facilities are initially capitalised as transaction costs of the loan and amortised in interest<br />

over the expected term of the loan. Ongoing commitment fees are expensed in interest as incurred.<br />

Debtors are measured at amortised cost less any provision for impairment. Debtors are discounted when the time value of money<br />

is considered material.<br />

2 employee costs and numbers<br />

Employee costs including directors:<br />

Wages and salaries 18 17<br />

Social security 2 2<br />

Retirement benefits 10 8<br />

Share based payment 4 2<br />

For details of directors’ remuneration see the remuneration report.<br />

<strong>2011</strong><br />

£m<br />

<strong>2011</strong><br />

Number<br />

2010<br />

£m<br />

34 29<br />

Average employee numbers 126 109<br />

3 equity dividends<br />

For details of equity dividends see note 11 to the consolidated financial statements.<br />

2010<br />

Number<br />

139<br />

overview<br />

financial statements governance<br />

sustainability<br />

business review


140<br />

<strong>Rexam</strong> annual report <strong>2011</strong><br />

notes to the Company financial statements<br />

4 tangible assets<br />

Computer<br />

hardware<br />

and software<br />

£m<br />

Fixtures and<br />

fittings<br />

£m<br />

Cost<br />

At 1 January <strong>2011</strong> 25 2 27<br />

Additions 2 1 3<br />

At 31 December <strong>2011</strong> 27 3 30<br />

Accumulated depreciation<br />

At 1 January <strong>2011</strong> (11) (1) (12)<br />

Depreciation for the year (4) – (4)<br />

At 31 December <strong>2011</strong> (15) (1) (16)<br />

Carrying value at 31 December <strong>2011</strong> 12 2 14<br />

Cost<br />

At 1 January 2010 18 2 20<br />

Additions 7 – 7<br />

At 31 December 2010 25 2 27<br />

Accumulated depreciation<br />

At 1 January 2010 (8) (1) (9)<br />

Depreciation for the year (3) – (3)<br />

At 31 December 2010 (11) (1) (12)<br />

Carrying value at 31 December 2010 14 1 15<br />

5 investments in subsidiaries<br />

At 1 January <strong>2011</strong> 2,000 3,204 5,204<br />

Exchange differences – (37) (37)<br />

Additions/advances 15 341 356<br />

Disposals/repayments – (321) (321)<br />

At 31 December <strong>2011</strong> 2,015 3,187 5,202<br />

At 1 January 2010 1,778 3,555 5,333<br />

Exchange differences – 42 42<br />

Additions/advances 611 1,007 1,618<br />

Disposals/repayments (389) (1,400) (1,789)<br />

At 31 December 2010 2,000 3,204 5,204<br />

For details of the principal subsidiaries of <strong>Rexam</strong> <strong>PLC</strong> see note 15 to the consolidated financial statements.<br />

Shares<br />

£m<br />

Loans<br />

£m<br />

Total<br />

£m<br />

Total<br />

£m


6 debtors receivable within one year<br />

Trade debtors 2 1<br />

Trade balances due from subsidiaries 2 2<br />

Prepayments 3 3<br />

Other debtors 13 8<br />

7 other creditors<br />

<strong>2011</strong><br />

£m<br />

2010<br />

£m<br />

20 14<br />

Amounts falling due within one year<br />

Trade creditors (3) (1)<br />

Interest bearing loans due to subsidiaries (306) (402)<br />

Other tax and social security (2) (2)<br />

Accruals (10) (12)<br />

Other creditors (12) (3)<br />

(333) (420)<br />

Amounts falling due after more than one year<br />

Due to subsidiaries (693) (672)<br />

Other creditors – (2)<br />

8 borrowings<br />

<strong>2011</strong><br />

£m<br />

2010<br />

£m<br />

(693) (674)<br />

Unsecured<br />

Bank overdrafts (1) –<br />

Bank loans net of capitalised financing fees 5 3<br />

US public bond (357) (357)<br />

US private placement (147) (147)<br />

Subordinated bond (736) (727)<br />

Medium term notes (556) (566)<br />

Repayment analysis<br />

Amounts falling due after more than one year:<br />

(1,792) (1,794)<br />

In more than one year but not more than two years (1,040) –<br />

In more than two years but not more than five years 5 (1,044)<br />

In more than five years (718) (709)<br />

(1,753) (1,753)<br />

Amounts falling due within one year (39) (41)<br />

(1,792) (1,794)<br />

In <strong>2011</strong> a fair value loss of £1m (2010: £nil) on medium term notes and a fair value gain of £10m (2010: loss of £5m) on the subordinated<br />

bond under designated fair value hedge relationships were included in retained profit for the year.<br />

<strong>2011</strong><br />

£m<br />

2010<br />

£m<br />

141<br />

overview<br />

financial statements governance<br />

sustainability<br />

business review


142<br />

<strong>Rexam</strong> annual report <strong>2011</strong><br />

notes to the Company financial statements<br />

9 derivative financial instruments<br />

For details of the financial risk management objectives and policies and principal financial risks see note 26 to the consolidated<br />

financial statements.<br />

Fair value of derivative financial instruments at 31 December<br />

Cross currency swaps 110 82<br />

Interest rate swaps 4 3<br />

Forward foreign exchange contracts – (2)<br />

<strong>2011</strong><br />

£m<br />

2010<br />

£m<br />

114 83<br />

Market values have been used to calculate the fair value of cross currency swaps. The fair value of interest rate swaps has been determined<br />

by discounting cash flows at prevailing interest rates. The fair value of forward foreign exchange contracts has been determined by<br />

marking those contracts to market against prevailing forward foreign exchange rates.<br />

Fair value changes included in retained profit at 31 December<br />

Cross currency swaps (57) 40<br />

Interest rate swaps 3 9<br />

Forward foreign exchange contracts (3) (1)<br />

<strong>2011</strong><br />

£m<br />

2010<br />

£m<br />

(57) 48<br />

cross currency swaps<br />

At 31 December <strong>2011</strong> and 2010 two cross currency swaps were outstanding. The first swapped €750m to £505m receiving fixed interest<br />

rates of 6.75% and paying floating interest rates. The second swapped £505m to US$1,007m receiving and paying floating interest rates.<br />

Both of these swaps mature in 2017.<br />

interest rate swaps<br />

Principal<br />

Start<br />

date<br />

Maturity<br />

date Receive Pay<br />

€200m 2006 2013 4.375% Floating + margin<br />

US$400m 2009 2012 Floating 2.06%<br />

US$161m 2010 2012 Floating 1.0% to 3.7%<br />

€200m 2013 2014 Floating 1.56%<br />

US$350m 2013 2014 Floating 1.27%<br />

US$325m 2013 2014 Floating 1.10%<br />

forward foreign exchange contracts<br />

At 31 December <strong>2011</strong>, forward foreign exchange contracts had principal amounts equivalent to £41m (2010: £269m). The main<br />

currencies traded were the US dollar, euro and rouble. These contracts mature in 2012 (2010: <strong>2011</strong>).<br />

10 operating lease commitments<br />

Operating lease rentals payable in 2012 relating to contracts expiring after five years are £1m (<strong>2011</strong>: £1m).<br />

11 contingent liabilities<br />

Guarantees 2 44<br />

<strong>2011</strong><br />

£m<br />

2010<br />

£m


12 capital and reserves<br />

Ordinary<br />

share<br />

capital<br />

£m<br />

Share<br />

premium<br />

account<br />

£m<br />

Capital<br />

redemption<br />

reserve<br />

£m<br />

Profit<br />

and loss<br />

reserve<br />

£m<br />

Merger<br />

and other<br />

reserves<br />

£m<br />

At 1 January <strong>2011</strong> 564 989 351 437 155 2,496<br />

Retained profit for the year – – – 377 – 377<br />

Share options: value of services provided – – – 3 – 3<br />

Share options: cost of investment – – – 15 – 15<br />

Purchase of <strong>Rexam</strong> <strong>PLC</strong> shares by Employee Share Trust – – – (18) – (18)<br />

At 31 December <strong>2011</strong> 564 989 351 814 155 2,873<br />

At 1 January 2010 563 989 351 342 155 2,400<br />

Retained profit for the year – – – 90 – 90<br />

Share options: value of services provided – – – 2 – 2<br />

Share options: proceeds from shares issued 1 – – – – 1<br />

Share options: cost of investment – – – 9 – 9<br />

Purchase of <strong>Rexam</strong> <strong>PLC</strong> shares by Employee Share Trust – – – (6) – (6)<br />

At 31 December 2010 564 989 351 437 155 2,496<br />

The profit after tax for the financial year dealt within the financial statements of <strong>Rexam</strong> <strong>PLC</strong> is £488m (2010: £195m). Other reserves reflect<br />

unrealised gains related to the transfer of investments between subsidiaries. The profit and loss reserve of £814m (2010: £437m) arose<br />

partly as a result of a provision of £214m against certain investments in subsidiaries in 2001 of which £156m was reversed in 2005. The<br />

directors consider the value of the remaining investments in subsidiaries is considerably more than their book value. Accordingly, the<br />

remaining provision of £58m does not impact the distributable reserves of <strong>Rexam</strong> <strong>PLC</strong> which were £842m at 31 December <strong>2011</strong><br />

(2010: £480m) after deducting £30m (2010: £15m) in respect of share options capitalised in cost of investment.<br />

For details of ordinary shares see note 29 to the consolidated financial statements.<br />

13 share based payment<br />

<strong>Rexam</strong> <strong>PLC</strong>’s share based payment schemes comprise LTIP, LTIP 2007, ESOS and SAYE. For further information on these schemes, including<br />

the valuation models, assumptions used and settlement basis, see note 31 to the consolidated financial statements.<br />

The number of options and weighted average exercise prices of share option schemes relating to <strong>Rexam</strong> <strong>PLC</strong> are set out below.<br />

<strong>2011</strong><br />

Number of<br />

options<br />

Thousands<br />

<strong>2011</strong><br />

Weighted average<br />

exercise price<br />

£<br />

2010<br />

Number of<br />

options<br />

Thousands<br />

Total<br />

equity<br />

£m<br />

2010<br />

Weighted average<br />

exercise price<br />

£<br />

Outstanding at 1 January 5,450 0.88 4,598 1.22<br />

Granted 2,567 0.06 2,814 0.03<br />

Transferred in 57 – 8 2.12<br />

Exercised (52) 2.24 (62) 0.16<br />

Lapsed (1,464) 0.09 (1,908) 0.47<br />

Outstanding at 31 December 6,558 0.72 5,450 0.88<br />

Exercisable at 31 December 967 3.99 505 4.03<br />

The exercise prices and average remaining contractual lives of share options relating to <strong>Rexam</strong> <strong>PLC</strong> by scheme are set out below.<br />

<strong>2011</strong><br />

Number of<br />

options<br />

Thousands<br />

<strong>2011</strong><br />

Range of<br />

exercise prices<br />

£<br />

<strong>2011</strong><br />

Weighted average<br />

remaining<br />

contractual life<br />

Years<br />

2010<br />

Number of<br />

options<br />

Thousands<br />

2010<br />

Range of<br />

exercise prices<br />

£<br />

2010<br />

Weighted average<br />

remaining<br />

contractual life<br />

Years<br />

LTIP 5,211 – 1.7 2,726 – 2.2<br />

LTIP 2007 – – – 1,343 – 4.2<br />

ESOS 958 2.71 to 4.57 5.5 1,024 2.14 to 4.57 6.3<br />

SAYE 389 2.12 to 2.91 2.8 357 2.12 to 3.65 3.5<br />

143<br />

overview<br />

financial statements governance<br />

sustainability<br />

business review


144 <strong>Rexam</strong> annual report <strong>2011</strong><br />

shareholder information<br />

<strong>Rexam</strong> website<br />

www.rexam.com<br />

The <strong>Rexam</strong> website has a range of information on the Group.<br />

You can view online or download publications such as the<br />

Consumer Packaging <strong>Report</strong> (packaging unwrapped), <strong>Rexam</strong>’s<br />

annual reports, half year results announcements, press releases<br />

and AGM related information and documents. There is practical<br />

information such as real time and historic <strong>Rexam</strong> shares prices and,<br />

in the Investors’ section, information on dividend payments and<br />

record dates, and choices as to how your dividend can be paid<br />

directly to your bank account or reinvested in shares through the<br />

dividend reinvestment plan.<br />

stock exchange listing<br />

The Company’s ordinary shares of 642 /7p each are listed with<br />

the UK Listing Authority and trade on the London Stock Exchange<br />

under the code REX. In the US, shares are traded in the form<br />

of ADRs under the symbol REXMY on the Pink Sheets electronic<br />

trading market.<br />

holders of ordinary shares<br />

registrar<br />

www.shareview.co.uk<br />

Equiniti<br />

Aspect House<br />

Spencer Road<br />

Lancing<br />

West Sussex BN99 6DA<br />

United Kingdom<br />

Tel: 0800 169 6946 for UK shareholders1 Tel: +44 121 415 7008 for overseas shareholders2 Please write to Equiniti or contact their helpline to:<br />

• check your shareholding<br />

• register change of address or name<br />

• obtain a replacement dividend cheque or tax voucher<br />

• record the death of a shareholder<br />

• amalgamate multiple accounts<br />

• ask any other question about your shareholding.<br />

1 Calls to this number are free of charge when dialled from a BT landline. Other telephone<br />

provider costs may vary. Lines open 8.30am to 5.30pm, Monday to Friday.<br />

2 Lines open 8.30am to 5.30pm, Monday to Friday.<br />

holders of american depositary receipts (ADRs)<br />

depositary<br />

www.bnymellon.com/shareowner<br />

The Bank of New York Mellon<br />

PO Box 358516<br />

Pittsburgh, PA 15252-8516<br />

United States<br />

Tel: +1 201 680 6825<br />

Tel: 1 888 BNY ADRS (toll free within the US)<br />

email: shrrelations@bnymellon.com<br />

Please write to The Bank of New York Mellon or contact their<br />

helpline to ask any question about <strong>Rexam</strong>’s ADR programme.<br />

capital gains tax<br />

The market value of <strong>Rexam</strong> shares at 31 March 1982 was 75.3p per<br />

share, as adjusted for the subdivision of shares in November 1992<br />

and the capital reorganisation in October 1998.<br />

Shareholders requiring clarification of their capital gains tax<br />

position should consult their professional advisor.<br />

ShareGift<br />

www.sharegift.org<br />

Tel: +44 (0)20 7930 3737<br />

ShareGift is an independent charity share donation scheme that<br />

provides a charitable solution to the problem of unwanted small<br />

holdings of shares. If you have shares that you wish to dispose of<br />

and whose value makes it uneconomic to sell, you may wish to<br />

consider donating them to charity through ShareGift.<br />

fraudulent transactions<br />

http://www.fsa.gov.uk/consumerinformation<br />

The Financial Services Authority (FSA)<br />

25 The North Colonnade<br />

Canary Wharf<br />

London E14 5HS<br />

United Kingdom<br />

Tel: 0845 606 1234 if calling from within the UK<br />

Tel: +44 20 7066 1000 if calling from outside the UK<br />

The FSA has issued a warning to all UK shareholders about<br />

unsolicited phone calls or correspondence concerning investment<br />

matters. If you receive such calls and are concerned, report the<br />

matter to the FSA either by calling them or visiting their website.<br />

financial calendar 2012<br />

Please check the <strong>Rexam</strong> website nearer to the expected dates<br />

to ensure there have been no changes to them.<br />

Events 2012<br />

Announcement of <strong>2011</strong> final results 22 February<br />

Announcement of 1 st interim management statement 3 May<br />

<strong>Annual</strong> General Meeting 2012 3 May<br />

Ex dividend date for <strong>2011</strong> final dividend 9 May<br />

Record date for <strong>2011</strong> final dividend 11 May<br />

Proposed payment date for <strong>2011</strong> final dividend 7 June<br />

Announcement of 2012 half year results 1 August<br />

Proposed payment date for 2012 interim dividend 4 September<br />

Announcement of 2 nd interim management statement 15 November<br />

Financial year end 31 December<br />

shareholder profile<br />

An analysis of <strong>Rexam</strong> <strong>PLC</strong> ordinary shares by category and size of<br />

holding, as at 21 February 2012, is as follows:<br />

holdings<br />

number %<br />

shares<br />

number %<br />

Category<br />

Individuals 13,824 74 20,874,240 2<br />

Institutions 4,917 26 856,164,013 98<br />

18,741 100 877,038,253 100<br />

Size of holding<br />

Up to 2,000 shares 13,583 73 9,998,966 1<br />

2,001 – 20,000 shares 4,389 23 20,281,777 2<br />

20,001 – 100,000 shares 356 2 17,117,760 2<br />

Over 100,000 shares 413 2 829,639,750 95<br />

18,741 100 877,038,253 100


addresses<br />

registered office and headquarters<br />

<strong>Rexam</strong> <strong>PLC</strong><br />

4 Millbank<br />

London SW1P 3XR<br />

United Kingdom<br />

Tel: +44 (0)20 7227 4100<br />

Fax: +44 (0)20 7227 4109<br />

main overseas service centre<br />

USA<br />

<strong>Rexam</strong> Inc<br />

4201 Congress Street<br />

Suite 340<br />

Charlotte<br />

NC 28209<br />

United States<br />

Tel: +1 704 551 1500<br />

Fax: +1 704 551 1572<br />

For details of our individual operations<br />

please go to our website www.rexam.com<br />

Board photography: Marcus Lyon<br />

Feature photography:<br />

L2PM Films and Lasse Davidsson<br />

design and production by Radley Yeldar<br />

www.ry.com<br />

This report has been printed on Hello Silk,<br />

a paper which is certified by the Forest<br />

Stewardship Council ® . The paper is made<br />

in a mill registered to EMAS, the Eco<br />

Management Audit Scheme, and with<br />

ISO14001 environmental management<br />

system accreditation. This report was<br />

printed using vegetable oil based inks by<br />

a CarbonNeutral ® printer registered to<br />

EMAS and with ISO14001 environmental<br />

management system accreditation.<br />

operational headquarters<br />

<strong>Rexam</strong> Beverage Can Europe & Asia<br />

100 Capability Green<br />

Luton<br />

Bedfordshire LU1 3LG<br />

United Kingdom<br />

Tel: +44 (0)1582 408999<br />

Fax: +44 (0)1582 726065<br />

<strong>Rexam</strong> Beverage Can North America<br />

8770 W Bryn Mawr Avenue<br />

Chicago<br />

IL 60631<br />

United States<br />

Tel: +1 773 399 3000<br />

Fax: +1 773 399 8088<br />

<strong>Rexam</strong> Beverage Can South America<br />

Av. Luis Carlos Prestes<br />

290 – sala 101<br />

Barra da Tijuca<br />

Rio de Janeiro – RJ<br />

CEP 22.775-055<br />

Brazil<br />

Tel: +55 21 2104 3300<br />

Fax: +55 21 2104 3425<br />

<strong>Rexam</strong> Plastic Packaging<br />

4 Millbank<br />

London SW1P 3XR<br />

United Kingdom<br />

Tel: +44 (0)20 7227 4100<br />

Fax: +44 (0)20 7227 4109<br />

find out more online<br />

Our website www.rexam.com<br />

contains a full interactive version<br />

of the <strong>2011</strong> annual report. It also<br />

contains annual reports from<br />

previous years (back to 1999)<br />

as well as investor presentations,<br />

publications and other material<br />

on <strong>Rexam</strong>, its markets and business.<br />

145


<strong>Rexam</strong> <strong>PLC</strong><br />

4 Millbank<br />

London SW1P 3XR<br />

United Kingdom<br />

www.rexam.com

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!